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CHAPTER 1 
Introduction 
Chapter 1 Introduction 
Stress is defined as a state of threatened homeostasis, which can be of physical and/or 
psychological nature (Selye, 1950). Different regulatory systems of the body are activated 
and orchestrated various brain responses to improve the ability of the organism to adapt to 
internal or external challenges (Armario, 2006). Stress is involved in psychopathology at all 
levels ranging from development, maintenance to relapse of disorders such as schizophrenia, 
depression, and addiction (Kalia, 2005; Jankord and Herman, 2008). Body responds to stress 
by the way of allostasis in which there is a continuous effort to maintain physiological 
functions within a certain range which is variable to demand (McEwen, 2000). However, too 
much stress or inefficient management of allostasis leads to allostatic load leading to 
development of various clinical disorders. Thus, the role of stressful life events in the 
etiology of various diseases has been a fertile field of research during the last decade. Stress 
modulates the autonomic nervous system and Hypothalamus-Pituitary-Adrenal (HPA)-axis 
that subsequently leads to behavioral, physiological and neurobiological changes (Herman et 
al., 2005; Joels et al., 2007). The hypothalamus responds to stress by releasing corticotrophin 
releasing factor (CRF), which stimulates the corticotrophs of the pituitary to secrete 
adrenocorticotrophic hormone (ACTH). ACTH targets the adrenal cortex to bring about the 
release of glucocorticoids (Armario, 2006). Glucocorticoids are the final effectors of the 
HPA-axis and participate in the control of whole body homeostasis and the organism's 
response to stress. They play a key regulatory role on the basal activity of the HPA-axis and 
on the termination of the stress response by acting at extrahypothalamic centers (frontal 
cortex and hippocampus), the hypothalamus and the pituitary gland (De Kloet, 1991). Thus, 
the key players of HPA-axis are CRF, ACTH and glucocorticoids (Lamberts et al., 1984), 
which integrate the neural and endocrine systems to give a coordinated stress response 
(Herman and Cullinan, 1997). The monoamines such as noradrenaline (NA), dopamine (DA) 
and 5-hydroxy tryptamine (5-HT) are widely distributed in the brain and played important 
modulatory role during different stressful conditions (Tsigos and Chrousos, 2002; Carrasco 
and Van de Kar, 2003). The frontal cortex and striatum have a high DA content (Miyazaki 
and Asanuma 2008), while the hippocampus has a high concentration of glucocorticoid 
receptors (Jankord and Herman 2008). These brain regions are connected with each other 
through different neurotransmitter systems (Bekris et al. 2005; Herman et al. 2005). 
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Temporal prolongation of adaptation response during stressful conditions results in 
various pathophysiological states that cut across the traditional concept of disease and 
include a range of disorders like hypertension, coronary heart disease (Roy et al., 2001), 
gastric ulcers (Mayer, 2000) and host of other diseases (Andersen, 2004; Lucca et al., 2009). 
Due to the limitations of sedation and physical dependence on prolonged use of 
Benzodiazepines drugs which are generally used to reduce stressful symptoms, the 
identification of new effective and safe anti-stress agents is therefore desperately needed. 
Due to the non-specific nature of the stress pathogenesis, a separate class of therapeutic 
agents was evolved known as "adaptogens". The term adaptogen was described by Lazarev 
(1947) as "the substance which can develop a state of raised resistance", enabling an 
organism to cope with stressful situations. Medicinal plants and plant-derived products play 
an essential holistic role in the primary health care. Scientific approaches are directed 
towards the isolation, purification and characterizafion of various constituents of traditionally 
used herbal medicines (Newman et al., 2003; Cooper, 2008). Pharmacological invesfigations 
have shown that the basic effect of Panax ginseng, Elutherococcus senticosus and Rhodiola 
rosea, is their ability to increase non- specific resistance of the organism to various untoward 
influences (Brekhman and Dardymove, 1969). The concept of treating stress-related 
conditions with medicinal plants is familiar to most traditional healing models throughout the 
world (Pannosian, 1999). Further enrichment of the study on plant derived adaptogens was 
enabled by the substantial work carried out on plants such as Ocimnm sanctum (Bhargava 
and Singh, 1981), Emblica officinalis (Rege et al., 1999), Bacopa monniera (Rai et al., 
2003a), Ginkgo biloba (Rai et al., 2003c) and Withania somnifera (Bhattacharya and 
Muruganandam, 2003) and several other plants whose anti-stress activity was partially 
evaluated. 
Thus, the primary objective of the present study was to identify various components 
involved in stress response and evaluating lead molecules (plant/synthetic origin) for their 
therapeutic efficacy. In order to study the stress-induced changes and the modulatory role of 
various medicinal plants, their fracfions and active lead molecules, under different stressful 
condition, we aimed to develop different stress models in rats. These stress models differ in 
intensity, duration and predictability of stressors, which may help to understand the 
differential stress responses, and in evaluating the anti-stress efficacy in terms of 
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preventing/restoring the stress-induced peripheral and/or central perturbations. It includes the 
identification and standardization of physiological stress biomarkers such as adrenal 
hypertrophy, gastric ulcer severity, plasma glucose, creatine kinase activity and 
corticosterone levels. 
The brain monoamine and antioxidant systems interact closely with the HPA-axis and 
are implicated in the acquisition and maintenance of psychological and physical stress 
responses (Perez-Nievas et al., 2007, Lucca et al., 2009). Thus, it was very essential to assess 
the anti-stress activity of any medicinal plant or its constituents in relation to the changes in 
central monoamines and cellular redox state. Thus, the simultaneous changes in the central 
monoaminergic (monoamines and metabolites levels) and antioxidant (enzymatic and non-
enzymatic) systems were also evaluated. We evaluated monoamine metabolite concentrations 
to provide information about the monoamine metabolism resulting from stress. In order to 
evaluate oxidative alterations during stress, we measured the activities of Cu-Zn superoxide 
dismutase (SOD), catalase (CAT), selenium dependent glutathione peroxidase (GSH-Px), 
extent of lipid peroxidation (Malondialdehyde concentrations) and reduced glutathione 
(GSH) concentrations in the frontal cortex, striatum and hippocampus. 
Further, to elucidate the molecular mechanism through which lead molecules 
modulates the stress responses during acute and chronic exposure of stress and their crosstalk 
with other signaling pathways influencing their anti-stress actions, the alterations in the 
expression levels of CRF, Pro-opimelanocortin (POMC), Glucocorticoid receptor (GR), Heat 
shock protein (HSP)-70 and Tyrosine hydroxylase (TH) enzyme were examined in various 
important brain regions. 
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2. Stress 
As long as humans have been around, there has been stress. It is well known fact 
that stress is a common condition of life and is significantly involved in the maintenance 
of health or the development of disease. A large proportion of diseases (perhaps 70-
80%) are believed to occur because of stress. There are critical differences in how 
different individuals respond to stress. These differences have far-reaching 
consequences for survival. Imposition of environmental or physical change, either 
negative (that is, threatening) or positive (that is, rewarding), elicits a spectrum of 
physiologic changes that can be construed as adaptive to the organism. Adaptive 
responses can be specific to the stressor or can be generalized and nonspecific 
(Chrousos and Gold, 1992). Stress related diseases require scientific assessment and 
medical evaluation. Focus should be on stress-disease phenomena, its prevention and 
treatment by various anti-stress agents of plant or synthetic origin. 
2.1. History of Stress 
The concept of stress in the modem sense is not easily found but defined in the 
traditional texts of Indian culture and tradition such as Charak Sanhita, Patanjali's 
Yogasutras and Bhagawat Gita. However, a number of concepts developed by ancient 
Indian scholars relate to appear similar to the phenomenon of stress. Some of these, for 
example, are dukha (pain, misery or suffering), klesa (afflictions), kama or trisna 
(desires), atman and ahamkara (self and ego), adhi (mental aberrations) and 
prajnaparadha (failure or lapse of consciousness). It is interesting to note that the body-
mind relationship, characteristic of modem stress studies, is emphasized in the 
Ayurvedic (Indian) system of medicine. In the beginning of the classic era, Heracleitus 
was the first to suggest that a static, unchanged state is not the natural condition, but 
rather that the capacity to undergo constant change was intrinsic to all things. Shortly 
afterward Empedocies proposed the corollary idea that all matter consisted of elements 
and qualities in a dynamic composition or alliance to one another, and that balance or 
hannony was a necessary condition for the survival of the living organisms. One 
hundred years later, Hippocrates equated health to a harmonious balance of elements 
and qualities of life and disease to a systematic disharmony of these elements. 
Hippocrates also suggested that the disturbing forces that reduced the disharmony of 
disease derived from natural rather than supernatural sources and that counterbalancing 
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or adaptive forces were of a natural origin as well. On years of the Renaissance, Thomas 
Sydenham extended the Hippocratic concept of disease as a systematic disharmony 
brought about by disturbing forces, when he suggested that an individual's adaptive 
response to such forces could itself be capable of producing pathological changes. 
A key to the understanding of the aspects of stress is the concept of milieu 
interieur (the internal environment of the body), which was first advanced by the great 
French physiologist, Claude Bernard in 1878. In this concept, he described the 
principles of dynamic equilibrium. In dynamic equilibrium, constancy, a steady state 
(situation) in the internal bodily environment, is essential to survival. Therefore, 
external changes in the environment or external forces that change the internal balance 
must be reacted to and compensated for if the organism is to survive. The great 
neurologist Walter Cannon (1929) coined the term 'homeostasis' to further define the 
dynamic equilibrium that Bernard had described. He also was the first to recognize that 
stressors could be emotional as well as physical. Through his experiments, he 
demonstrated the "fight or flight" response that man and other animals share when 
threatened. Further, Cannon traced these reactions to the release of powerful 
neurotransmitters from a part of the adrenal gland, the medulla. The adrenal medulla 
secretes two neurotransmitters, epinephrine and norepinephrine, in the response to 
stress and leads to the physiologic effects seen in the fight or flight response, e.g., a 
rapid heart rate, increased alertness, etc. 
Hans Selye, another early scientist who studied stress, extended Cannon's 
observations. He included, as part of the body's stress response system, the pituitary 
gland. He described the control by this gland of the secretion of hormones (e.g., Cortisol) 
that are important in the physiological response to stress by the other part of the adrenal 
gland known as the cortex. Additionally, Selye actually introduced the term stress fi-om 
physics and engineering and defined it as "mutual actions of forces that take place 
across any secfion of the body, physical or psychological." The physiological responses 
to massive or ongoing stress were summarized in the stress triad, including the 
enlargement and hyperactivity of the adrenal cortex; the shrinking or atrophy of the 
thymus, spleen, lymph nodes, and the lymphatic system; and the appearance of 
gastrointestinal and bowel ulcerafion as shown in figure 1 (Selye, 1950). 
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Figure 1: The three major events during stress; Stress Traid. 
Hans Selye also suggested that the processes, which were adaptive (heahhy, 
appropriate adjustment) and normal for the organism in warding off stress, could become 
much like illnesses. That is, the adaptive processes, if they were excessive, could damage 
the body. Here then is the beginning of an understanding of why stress, really overstress, 
can be harmful, and why the word stress has earned such a bad name. He concluded that 
individuals can develop different types of diseases under the influence of the same kind of 
stressor. In his concept of four basic variations of stress, Selye pointed out that stress can 
be based on overstress ("hyperstress"), understress ("hypostress")/ damaging stress 
("distress"), or good stress ("eustress"). Many views concerning what stress means and 
how to define and approach it exists. Some of these theories are discussed in table 1. 
Table: 1 
Author 
Bernard 
Cannon 
Selye 
Mason 
Definition of stress 
Introduced the term milieu interieur 
Introduced the term homeostasis. 
Introduced the terms stress, eustress, distress, and stressor. 
Introduced the general adaptation syndrome. Defined 
stress as the nonspecific response of the body to any 
demand upon it. 
Criticized Selye's doctrine of nonspecificity. Anxiety and 
fear understood as the main factors contributing to 
nonspecific responses upon exposure to various stressors. 
References 
Bernard, 1878 
Cannon, 1929 
Selye, 1936; 
1950; 1974. 
Mason, 1968 
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Chrousos 
and Gold 
Goldstein 
McEwen 
Defined stress as a state of disharmony or of threatened 
homeostasis evoking both specific and non-specific 
responses. 
Defined stress as a condition where expectations, whether 
genetically programmed, established by prior learning, or 
deduced from circumstances, do not match the current or 
anticipated perceptions of the internal or external 
environment. 
Incorporated the term allostasis as the process of 
adaptation of the body upon the exposure to various 
stressors 
Chrousos and 
Gold, 1992 
Goldstein, 
1995 
McEwen, 
2000 
2.2. General Adaptation Syndrome 
Dr. Hans Selye's General Adaptation Syndrome (GAS) is one of the most widely 
accepted and has been widely held as a comprehensive theory regarding stress and its 
effect on the human system. The concept of GAS encompasses an alarm reaction, a stage 
of resistance, and finally a stage of exhaustion. Stages of GAS are shown in Figure 2. 
2.2.1. Alarm Stage 
In the alarm stage, the body becomes aware of a stressor. This stage includes an 
inifial 'shock phase' in which the resistance is lowered, and a counter-shock phase in 
which defensive mechanisms becomes active. During this stage, the body prepares to take 
emergency action to defend itself against or escape fi-om the danger. It is in this stage that 
the physiological "fight or flight" response happens. This stage is characterized by 
autonomous excitability, adrenaline discharge, increased heart rate and blood pressure, 
muscles tense, gastro-intestinal ulceration and other physiological reactions (Pestonjee, 
1997). 
2.2.2. Resistance Stage 
After the initial reaction to the stressor, the body attempts to restore its 
equilibrium (homeostatic state) and the bodily signs characteristic of the alarm reaction 
disappear. The adaptation occurs primarily because the nervous and endocrine systems 
help the body deal with the stressor. Maximum adaptation occurs during this stage. 
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Resistance increases to levels above normal as indicated in figure 2. In the case of short-
term stressors, the resistance state continues until the stressor ceases (Pestonjee, 1997). 
2.2.3. Exhaustion Stage 
The stage of exhaustion occurs if the stressors continue as mentioned above or if 
the stressors return repeatedly. If the stress continues in these two cases, the body's ability 
to resist appropriately diminishes resuhing in the depletion of adaptation energy, failure 
of the immune system to function properly, and stress related disease would occur. Signs 
of the alarm reaction reappear, and the resistance level begins to decline irreversibly and 
the organism collapses (Pestonjee, 1997). 
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Figure 2: Stages of General Adaptation Syndrome 
2.3. Types of stressors 
In contrast to Selye, Mason in 1968 described stress as a multi hormonal response 
pattern organized in a rather specific or selective manner depending on the particular 
stimulus. Stressors can be defined as conditions that endanger, or are perceived to 
endanger, the survival of individual (Van de Kar and Blair, 1999). In general, these 
stressors can be grouped into three broad categories. 
I. Psychological stressors based on a learned response to the threat of an impending 
adverse condition (Fear, anxiety, exposure to a novel or uncontrollable environment). 
II. Stressors that consist of a physical stimulus have a strong psychological component 
(Pain, foot shock, Immobilization). 
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III. Stressors which challenge cardiovascular homeostasis (hemorrhage, orthostatic stress/ 
upright tilt exercise and heat exposure) (Van de Kar and Blair, 1999) and many other 
manifested in humans daily as shown in Table-2. 
Table 2: 
Psychological/Psychosocial 
Stress 
Unemployment 
Financial problems 
Competitive life 
Disagreement 
Loss of love ones 
Physical 
Stress 
Early menopause 
Starvation 
Insomnia 
Excretion 
Alteration in circadian rhythm 
Aging 
Internal 
Stress 
Chronic 
illness 
External 
Stress 
Pollution 
Weather 
Noise 
Traffic 
2.4. Healthy response of stress 
Exposure to stressors results in a series of coordinated responses organized to 
enhance the probability of survival. These coordinated responses, often referred to as 
"Stress responses". A key aspect of a healthy response to stress is the time course. 
Responses must be initiated rapidly, maintained for a proper amount of time, and then 
turned off to ensure an optimal result (Armario, 2006). An over-response to stress or the 
failure to shut off a stress response can have negative biological consequences for an 
individual (Andersen, 2004). Healthy human responses to stress involve three 
components. The brain handles the immediate response. This response signals the 
adrenal medulla to release epinephrine and nor-epinephrine. The hypothalamus and the 
pituitary gland initiate the slower maintenance response by signalling the adrenal cortex 
to release cortisol/corticosterone and other hormones (Jankord and Herman, 2008). 
Many neural circuits are involved in the behavioural response. This response increases 
arousal (alertness, heightened awareness), focuses attention, inhibits feeding and 
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reproductive behaviour, reduces pain perception, and redirects behaviour (Leussis and 
BoHvar, 2006). The combined resuhs of these components of the stress response 
maintain the internal balance (homeostasis), increase energy production and utilization, 
and alter electrolyte (chemical elements) and fluid balance in the body (Pacak and 
Palkovits, 2001). 
2.5. Theory of allostasis 
The central nervous system (CNS), endocrine system and immune system 
interact in a way to maintain homeostasis while under severe or chronic stress. 
Researchers are in general agreement that humans and other mammals exploit a separate 
cascade of physiological processes in order to adapt to stress beyond everyday life 
homeostasis (McEwen, 2003). This second system is explained by the theory of 
allostasis, which suggests a process to protect organisms from unexpected or severe 
stressors. Such chronic or continued types of stressors can result in wear and tear on 
tissues and organs, termed allostatic overload. This overloading causes a predictable 
dysfunction of regulation of stress neurotransmitters and hormones, leading to a wide 
range of pathological conditions (McEwen and Wingfield, 2003). 
Allostasis was first introduced by Sterling and Eye in 1988 to describe an 
additional process of re-establishing homeostasis, but one that responds to a challenge 
instead of to daily ebb and flow. This theory suggests that both homeostasis and 
allostasis are endogenous systems responsible for maintaining the internal stability of an 
organism. Homeostasis, fi^om the Greek homeo, means "same," while stasis means 
"stable;" thus, "remaining stable by staying the same." Allostasis was coined similarly, 
from the Greek alio, which means "variable;" thus, "remaining stable by being 
variable." 
Homeostasis functions to set daily body points such as temperature or raising 
Cortisol levels in preparation for waking. The allostatic mechanism responds to 
unexpected challenges such as severe temperature drop or running to protect your child 
from an accident. Allostasis works well when needed and then shut off when not 
needed. However, chronic stimulation of the allostatic regulatory system causes wear 
and tear on tissues and it is this damage that accelerates dysfunctional responses and 
leads to pathologic conditions such as panic disorder, heart disease and memory deficit 
(Andersen, 2004). This wear and tear is referred to as allostatic overload. It occurs 
when allostatic systems remain active even though they are no longer needed. The 
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origin of allostatic overload is thought to be due to the dysfunction of the 
neurotransmitters and hormones of the organs responsible for regulation of allostasis 
(Hirooka, 2008). 
2.6. Central and peripheral components of stress system 
The central control stations of the stress system are located in the hypothalamus 
and the brain stem and include the parvocellular corticotrophin releasing hormone 
(CRH) and arginine-vasopressin (AVP) neurons of the paraventricular nuclei (PVN) of 
the hypothalamus, and the locus ceroleus-norepinephrine system (central sympathetic 
system) (Chrousos and Gold, 1992; Tsigos and Chrousos, 2002). The hypothalamic-
pituitary-adrenal (HPA) axis, together with the efferent sympathetic/adrenomedullary 
system, represents the effector limbs, via which the brain influences all body organs 
during exposure to threatening stimuli (Armario, 2006). The brain also differentially 
activates a subset of vagal and sacral parasympathetic efferents that mediate the gut 
responses to stress (Habib et al., 2001). There are mutual interactions of the central 
stress stations with three higher brain control areas that influence affect and anticipatory 
phenomena (mesocortical/mesolimbic systems); the initiation, propagation and 
termination of stress system activity (amygdala/hippocampus complex); and the setting 
of the pain sensation (arcuate nucleus) (Roth et al., 1988; Nikolarakis et al., 1986). The 
CRH/AVP neurons and central catecholaminergic neurons of the LC/NE system 
reciprocally innervate and activate each other. The HPA-axis is controlled by several 
feedback loops that tend to normalize the time-integrated secretion of Cortisol, yet 
glucocorticoids stimulate the fear centres in the amygdala. Activation of the HPA-axis 
leads to suppression of the GH/IGF-1, LH/testosterone/E2 and TSH/T3 axes; activation 
of the sympathetic system increases IL-6 secretion. The brain circuits that initiate and 
maintain the stress response are illustrated in figure 3. 
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Figure 3. A simplified schematic representation of the central and peripheral components 
of the stress system, their functional interrelations and relations to other central systems 
involved in the stress response. Solid lines indicate stimulation; dashed lines indicate 
inhibition (Adapted from Chrousos and Gold, 1998). 
2.7. The Hypothalamic-Pituitary-Adrenal (HPA) axis 
The HPA-axis is a grouping of responses to stress by the brain and the pituitary 
and adrenal glands. First, the hypothalamus releases a compound called corticotrophin 
releasing factor (CRF), which was discovered in 1981. The CRF then travels to the 
pituitary gland, where it triggers the release of a hormone, adrenocorticotrophic 
hormone (ACTH) (Lamberts et al., 1984). ACTH is released into the bloodstream and 
causes the cortex of the adrenal gland to release the stress hormones (glucocorticoids), 
particularly Cortisol, which is a corticosteroid hormone (Jankord and Herman, 2008). 
Glucocorticoids are the final effectors of the HPA-axis and participate in the control of 
whole body homeostasis and the organism's response to stress. They play a key 
regulatory role on the basal activity of the HPA-axis and on the termination of the stress 
response by acting at extrahypothalamic centers, the hypothalamus and the pituitary 
gland (De Kloet, 1991), shown in Figure 4. The inhibitory glucocorticoid feedback on 
the ACTH secretory response acts to limit the duration of the total fissue exposure to 
12 
Chapter 2 Review of Literature 
glucocorticoids, thus, minimizing the catabolic, anti-reproductive and 
immunosuppressive effects of these hormones. Glucocorticoids exert their effects 
through their ubiquitous cytoplasmic receptors (Smith and Toft, 1993; Pratt, 1990). On 
ligand binding, the glucocorticoid receptors translocate into the nucleus, where they 
interact as homodimers with specific glucocorticoid responsive elements (GREs) within 
the DNA to activate appropriate hormone-responsive genes (Pratt, 1990). The activated 
receptors also inhibit, through protein-protein interactions, other transcription factors, 
such as c-jun/c-fos and NF-kB, which are positive regulators of the transcription of 
several genes involved in the activation and growth of immune and other cells 
(Scheinman et al., 1995; McKay et al., 1998). Furthermore, glucocorticoids change the 
stability of messenger RNAs and hence the translation of several glucocorticoid-
responsive proteins, as well as the electrical potential of neuronal cells. 
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Figure 4: Schematic representation of the HPA-axis. The main sites for feedback control 
by circulating blood Cortisol are the pituitary gland (1) and the hypothalamic-
corticotropin releasing centre (2) which secretes CRH. Feedback control also involves 
higher nerve centres (3), i.e. the hypothalamus and hippocampus of the brain, and is 
triggered by stress. There is also a short feedback loop dealing with inhibition of CRH by 
ACTH (4). The hypothalamic neurotransmitters influence the secretion of CRH and 
ACTH as well as the inhibition of CRH. 
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2.8. The Sympatho-Adrenergic-Noradrenergic System 
This system is also termed as Locus Coeruleus-Noradrenaline (LC-NA) or 
Autonomic System. The central regulatory components of the LC-NA system are the 
hypothalamus and the LC. These structures build the conjunction to the classical 
endocrine system. Activation of the LC-NA / autonomic (sympathetic) nervous system, 
located in the brain stem, leads to the discharge of the neurotransmitter NA from a dense 
network of neurons throughout the brain (Valentino et al., 1993), resulting in enhanced 
arousal, vigilance, and increased anxiety (Chrousos and Gold, 1992). In contrast to 
other classical endocrine axes, the sympathetic-adrenal medulla (SAM) axis is not 
characterized by a hierarchical organization with integrated feedback loops. 
Sympathetic nerve fibers project to single chromaffin mark cells in the adrenal medulla 
with cholinergic synapses. The LC has many connections to other parts of the brain, 
particularly areas that bring in and process sensory information (information from sight, 
hearing, smell, taste, and touch). The LC secretes NA and stimulates other brain centers 
to do the same. It is like the pacemaker (meaning it controls the tempo) of the brain. 
Thus, it increases arousal (heightened awareness, alertness) and vigilance (watchfulness, 
carefulness), and adjusts (modulates) the action of the autonomic nervous system, which 
includes the sympathetic nervous system (Anisman and Zacharko, 1990). The 
autonomic nervous system regulates blood flow, heart rate, blood pressure, and 
breathing (respiration). It can also temporarily shut down the gastrointestinal and sexual 
systems until the crisis is over. These initial reactions, to get our blood flowing, heart 
pumping, and muscles energized, occur very quickly and automatically (Tsigos and 
Chrousos, 2002). 
2.9. Corticosterone Biosynthesis 
The end hormones of the HPA-axis are glucocorticoids. They are synthesized by 
the cells of the zona reficulosa in the adrenal cortex. Cholesterol is cleaved to 
pregnenolone, which undergoes dehydrogenation and subsequent hydroxylations to 
form corticosterone. 
2.10. Glucocorticoid receptors 
Corticosteroids interact with specific receptor proteins in target tissues to 
regulate the expression of corticosteroid-responsive genes, thereby changing the levels 
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and array of proteins synthesized by various target tissues. Most of the effects of 
corticosteroids are not immediate but become apparent after several hours due to the 
time required for changes in gene expression and protein synthesis. AUhough 
glucocorticoids predominantly act to increase the expression of target genes, there are 
several well-documented examples to show that they also decrease the transcription of 
some target genes (Schimmer and Parker, 2001). Immediate actions of glucocorticoids 
are mediated by membrane bound receptors. Glucocorticoids being lipophilic molecules 
hormones readily pass through the plasma membrane of all cells in the body. Using 
receptor binding and audiography, it was found that there are two types of binding sites 
that recognize corticosteroids (Reul and De kleot, 1985). Type I receptor has a higher 
affinity to cortisol/corticosterone than Type II, whereas Type II has more affinity to 
aldosterone than Type I. These receptors have been cloned and identified as the 
glucocorticoid receptor (GR) which corresponds to Type II binding and the 
mineralocorticoid receptor, which in the kidney recognizes aldosterone and in the brain, 
corresponds to Type I binding (Reul and De Kloet, 1985). GR is highly expressed in 
numerous brain regions (Ahima et al, 1991; Aronsson et al., 1988; Arriza et al., 1988); 
this receptor has 5-10 nM affinity and is extensively bound only during periods of 
intermediate to high glucocorticoid secretion (as occurs during the circadian 
corticosterone peak and following stress) (Reul and De Kloet, 1985). The 
mineralocorticoid receptor (MR) has an approximately 5-10 fold greater affinity and as 
a consequence is extensively bound even during periods of basal secretion (Reul and De 
Kloet, 1985). Expression of the MR is considerably more restricted than that of GR 
(Ahima et al., 1991; Aronsson et al., 1988; Arriza et al., 1988). The binding 
characterisfics of the two receptors have led some to postulate that the GR is important 
in mediating glucocorticoid feedback following stress, whereas the MR regulates basal 
HPA tone (De Kloet et al., 1998). There is pharmacological evidence in support of both 
of these suppositions (Dallman et al., 1989; Ratka et al., 1989). Numerous studies 
provide evidence for fast membrane actions of glucocorticoids, mediating the 
phenomenon known as fast feed-back. Membrane glucocorticoid binding has been 
observed in non-mammalian species (Orchinik et al., 1991), and it is clear that 
glucocorticoids have rapid effects on glutamate signalling in the PVN (Di et al., 2003). 
In both cases, binding profiles suggest that the membrane receptor is structurally distinct 
fi-om GR or MR (Di et al., 2003; Orchinik et al, 1991). The receptor responsible for 
rapid glucocorticoid action remains to be isolated and characterized. The sensitivity of 
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animals and humans to glucocorticoid feedback is not a constant. In rats, chronic stress 
can decrease the sensitivity of the HPA-axis to dexamethasone (Mizoguchi et al., 2003). 
These data are similar to effects seen in subpopulations of human depressives (Carroll et 
al., 1976; Kathol et al., 1989). The mechanism underlying this adjustment of feedback 
sensitivity is a subject of considerable attention, and may involve altered glucocorticoid 
receptivity in central pathways controlling responses of the HPA-axis. 
3: 
CRH 
irX-»|ACTH 
'Pituitary 
Adrenal, 
: Circulating Blood 
. 
• 
y 
'r~-^ 
• 
Unbound 
Cortisol 
Cortisone 
Target Cell 
.^i^onisoi 
t 
11 beta HSD1 
1 
^ ^ifOnisuiie 
c 
d 
GR 
Figure 5: Schematic displaying the HPA-axis regulating the secretion of both inactive 
cortisone and "unbound" Cortisol in the circulating blood. These steroids are shown 
crossing a target cell membrane in an area such as the hippocampus activating the 
glucocorticoid conversion and stimulating the receptors that then supplies the HPA-axis 
maintaining the metabolic process. 
2.11. GR localization and activation 
The GR resides primarily in the cytoplasm in an inactive form until it binds to 
the glucocorticoid steroid ligand. Steroid binding results in receptor activation and 
translocation to the nucleus. The inactive GR is found as a complex with other proteins 
including heat shock protein (HSP)-90 (Dalman et al., 1989), a member of the heat-
shock family of stress induced proteins, HSP-70 and a 56 KD immunophilin, one of the 
group of intracellular proteins that bind immunosuppressive agents. HSP-90 facilitates 
the folding of the GR into an appropriate conformation that is essential for ligand 
binding, through interactions with the steroid-binding domain, illustrated in figure 6. 
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Figure 6: Schematic representation of glucocorticoid receptor localization and activation; 
Glucocorticoid receptor (GR), Glucocorticoid response element (GRE) and (Heat Shock 
Protein) HSPs. 
Once the GR binds to its ligand it dissociates from its associated proteins and 
translocates into the nucleus, where it interacts with specific DNA sequences within the 
regulatory regions of the affected genes. These sequences are termed as Glucocorticoid 
Responsive Elements (GREs) and they provide specificity to the induction of gene 
transcription. The mechanisms by which GR activates transcription are complex and are 
not completely understood. They appear to involve the interaction of the GR with 
transcriptional cofactors and with proteins that make up the basal transcription apparatus. 
2.12. Receptor independent mechanism for corticosterone specificity: 
Aldosterone and corticosterone bind to the MR with equal affinity (Reul and De 
Kloet, 1985). The specificity of the MR for aldosterone is maintained in spite of higher 
circulating levels of corticosterone, with the help of a type-2 isozyme 11 B-
hydroxysteroid dehydrogenase. This enzyme metabolizes glucocorticoids such as 
corticosterone to receptor-inactive 11-keto derivatives. Aldosterone escapes metabolism 
by this enzyme, as its predominant form in a physiological setting is the hemiacetal 
derivative, which is resistant to 11 B-hydroxysteroid dehydrogenase actions (Jankord and 
Herman, 2008). In the absence of this enzyme, the MR is swamped by corticosterone. 
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leading to severe hypokalemia and mineralocorticoid-related hypertension (De Kloet et 
al., 1998). 
2.13. Physiological effects of glucocorticoids: 
2.13.1. Metabolism 
Glucocorticoids are among the hormones which maintain the plasma glucose 
facilitating stress responses requiring rapid and intense physical exertion such as fight and 
flight response. 
2.13.2. Carbohydrate and protein metabolism 
Glucocorticoids protect glucose dependant tissues such as the heart and brain firom 
starvation by stimulating the liver to form glucose from amino acids and glycerol and by 
stimulation the deposition of glucose as liver glycogen. They diminish the utilization of 
glucose, increase protein breakdown and activate lipolysis thereby providing amino acids 
for gluconeogenesis in the periphery. The direct consequence of this effect is the increase 
in blood glucose levels (Bhattacharya et al., 2000). 
2.13.3. Lipid metabolism 
Two effects of corticosteroids on lipid metabolism are established. The first is the 
redistribution of body fat that is seen in disorders of hypercorticism, such as Cushing's 
syndrome. The second is the permissive facilitation of the effect of other agents, such as 
growth hormone and B-adrenergic receptor agonists, in inducing lipolysis in adipocytes, 
with a resultant increase in free fatty acids following glucocorticoid administration. There 
is an increased fat distribution in the back of the neck, face and supraclavicular area, 
coupled with a loss of fat in the extremities (Rai et al., 1997). 
2.13.4. Electrolyte and water balance 
Glucocorticoids exert effects on electrolyte and water balance largely due to the 
pennissive effects on tubular function and actions that maintain the glomerular filtration 
rate. They also play a permissive role in the renal excrefion of free water. Glucocorticoids 
94-
exert multiple effects on Ca metabolism (Schimmer and Parker, 2001). They interfere 
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with Ca^ "^  uptake by unknown mechanisms and there is an increased Ca^ "^  excretion at the 
level of the kidney. These effects collectively lead to decreased total body Ca^ "^  stores. 
2.13.5. Cardiovascular system 
The most prominent effects on the cardiovascular system are due to mineralocorticoid-
induced changes in renal Na^ excretion. Glucocorticoids increase expression of 
adrenergic receptors in the vascular wall. So they enhance vascular reactivity to 
vasoactive substances. Hypoadrenalism leads to hypotension and decreased response to 
vasoconstrictors such as nor epinephrine and angiotensin II. Conversely, excess 
glucocorticoid secretion leads to hypertension (Williams et al., 1998). 
2.13.6. Catabolic effects 
Chronic high levels of glucocorticoids lead to massive catabolic effects on protein and 
other components of peripheral tissue and redistribution of fat. Bone and cartilage are also 
targets for complex glucocorticoids actions. Under physiological conditions 
glucocorticoids may exert permissive effects by increasing levels of receptor and 
sensitivity of parathyroid hormone, Vitamin D and insulin like growth factor (De Kloet et 
al., 1991). 
2.13.7. Immune and anti-inflammatory reactions 
Major application of glucocorticoids hormones are in the therapy for suppression of 
inflammatory and immune reactions. Glucocorticoids may modulate the immune 
responses in numerous ways, including gene expression, transcription, translation, post-
translational processing, protein secretion and cell progenitor proliferation and 
differentiation (Gustafsson et al., 1985). They block the IL-ip, IL-6 at the level of 
transcription, translation, and secretion. TNF-a and granulocyte-macrophage-colony 
stimulating factor (GM-CSF) are blocked by degradation of their mRNA's. IL-2, 3 and 
interferon-y (IFN-y) are blocked at transcription level (Bergmann et al., 2004). Immune 
response is indirectly suppressed by glucocorticoids through inhibition of pro-
inflammatory transcription factors such as nuclear factor (NF-kP) and activating protein 
(AP-I) (Bergmann et al., 2004). Glucocorticoids suppress the production of eicosanoids 
by inhibiting the expression of cyclooxygenase. 
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2.14. The "Switch on" and "Switch off stress systems 
Stress systems can be broadly classified into two categories. They can be both 
activating - "switch on" system - which activates energetic and other resources of the 
organisms, and deactivating - "switch off system - which protect cells and whole 
organism from overreacting to the activating messengers. The balance between the 
activities of the "switch on" and "switch off systems reflects the well being of the 
organism (Pannosian et al., 1999). Stress-induced modulation of immune function by 
the components of CNS and sympathetic nervous system (Herman et al., 2005) and 
mechanisms by which peripheral inflammatory mediators signals the CNS (Sternberg 
and Licinio, 1995). Activation of HPA-axis induces various effects on target tissues 
including fatty tissue, liver, smooth muscle tissue, platelets, etc. Activated immuno-
competent cells also interact with endocrine system activating CRF release and 
consequently corticosteroids. It is recognized that IL-1 and IL-6 have a direct activating 
effects on hypothalamic-hypophyseal-adrenal axis. Both cytokines induce the release of 
CRF (Van Den Eede et al, 2005). Activation of the immune system induces 
inflammation and "disease". Intracellular mediators of the activation of defence system 
are c-AMP, c-GMP, Ca+2, PKC, DAG, IP3, TxA2, LTs, HETEs, NO. They "switch 
on" defence mechanisms. Corticosteroids and PGE2 are mediators of extra- and 
intracellular communications. Their proposed function is to prevent defence 
mechanisms from overreacting (Piazza and Le Moal, 1997). Corticosteroids are 
recognized as important regulators in the activation and suppression of immune and 
neuroendocrine systems (Pariante and Miller, 2001). An increased secretion of 
glucocorticoids in response to injury or infection is to prevent defence mechanisms from 
overreacting and themselves threatening homeostasis (Gustafsson et al., 1987). To do 
this, they "switch off defence mechanisms (including stimulation of cytokines, nitric 
oxide, leukotriene B4 and PAF formation which "switch on" the defence system).These 
systems are illustrated in figure 7. 
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Figure 7: Components of the stress system and their functional interrelations to the other 
systems involved in stress responses. c-AMP; Cyclic adenosine monophosphate, c-GMP; 
Cyclic guanosine monophosphate; PKC; Protein Kinase C, DAG; Diacylglycerol, IP3; 
Inositol-triphosphate, LT; Leukotri-enes, NO; Nitric oxide, PAF; Proliferation avtivating 
factor, IL; Interleukins. 
2.15. Limbic structures in HPA-axis integration 
The primary area of the brain that deals with stress is limbic system. Because of 
its enormous influence on emotions and memory, the limbic system is often referred to 
as the emotional brain (Herman et al., 2005). The limbic system is a set of brain 
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structures including the hippocampus, amygdala, anterior thalamic nuclei, and limbic 
cortex. Environmental stimuli are perceived as sensory input by the sensory receptors, 
which convey information to their respective sensory thalamus, primary sensory 
cortices, and higher order sensory cortices. Basic sensory information is simultaneously 
transmitted to the amygdala from these structures, and from association cortices, 
particularly the prefrontal cortex, through transitional cortices and the hippocampus 
(Jankord and Herman, 2008). Therefore, these limbic structures regulate the activation 
of both neural and neuroendocrine responses: the neural component involves the 
noradrenergic system, represented by the nucleus locus coeruleus (NLC), and the 
adrenergic system, through the lateral nucleus of the hypothalamus, which activates the 
sympatho-noradrenergic-system (SNS) and the adrenal medulla. The neuroendocrine 
component involves the activation of the PVN of the hypothalamus, the anterior 
pituitary, and the adrenal cortex, with the consequent release of CRH, ACTH, and 
Cortisol (Armario, 2006). Thus, the major limbic structures involved in stress response 
are as follows: 
2.15.1. Frontal cortex 
The medial prefrontal cortex is clearly involved in processing stressful 
information. Like the hippocampus, the medial prefrontal cortex appears to have a 
prominent negative effect upon HPA activity. Ablation of this region produces 
hypersecretion of both ACTH and corticosterone in response to stress (Diorio et al., 
1993). Restraint stress induced increases were blocked by corticosterone implants 
placed in the medial prefrontal area, suggesting that corticosterone has the capacity to 
modulate HPA activity by receptors localized to this region (Diorio et al., 1993). 
However the pathway by which prefrontal neurons might impact the HPA-axis remain 
unclear, for the region lacks direct input to the PVN. 
2.15.2. Hippocampus 
Numerous studies have connected the hippocampus with inhibition of the 
HPA-axis (Herman and CuUinan, 1997; Jacobson and Sapolsky, 1991; Sapolsky et al., 
1986). Hippocampal stimulation decreases glucocorticoid secretion in rat and human 
(Dunn and Orr, 1984), suggesting that this region is sufficient to inhibit HPA 
activation. In support of this hypothesis, numerous studies indicate that total 
hippocampectomy, fimbria-fornix lesion or excitotoxic lesions of the hippocampus 
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increase corticosterone and/or ACTH release (Fendler et al., 1961; Knigge and Hays, 
1963). Damage to the hippocampal system also elevates parvocellular PVN CRH 
and/or AVP mRNA levels (Herman et al., 2005), indicating that lesions affect ACTH 
secretagogue biosynthesis in hypophysiotrophic neurons. Hippocampal regulation of 
the HPA-axis appears to be both region and stressor-specific. 
2.15.3. Striatum and Amygdala 
Numerous studies have shown the importance of the amygdala and bed nucleus 
of the striatal terminalis in the mediation of neuroendocrine and autonomic response to 
stress. The Electrical stimulation of the amygdala increases corticosteroid secretion in 
rats (Redgate and Fahringer, 1973). Lesions of large portions of amygdaloid complex 
have been shown to decrease the release of ACTH and corticosterone (Allen and 
Allen, 1974). Bed nucleus of the striatal terminalis plays an integrative role in HPA-
stress regulation. 
2.16. Neuropeptides in stress 
CRF, a primary regulator of ACTH secretion is a 41-amino acid peptide is 
generated by cleavage of the 196-amino-acid C-terminus of pro-CRF (Vale et al., 1981). 
The actions of CRF are mediated through receptor subtypes designated CRFl, CRF2 
and CRF3 (Dautzenberg, and Hauger, 2002). CRFl receptors are relatively selective 
over CRF2 receptors. Those are widely distributed in the CNS and are involved sensory 
information processing and motor controls (Sanchez et al., 1999). The CRH system is 
widespread throughout the brain but is best characterized in the PVN of the 
hypothalamus and one of the principal components of general adaptation syndrome 
(Van Pett et al., 2000). CRF mRNA express in the cerebral cortex, amygdala and 
hippocampus (Bittencourt and Sawchenko, 2000) as well as in periphery like adrenal 
gland, testis, spleen and thymus (Dautzenberg and Hauger, 2002). CRF and 
noradrenergic neurons are stimulated by serotonin and acetylcholine and inhibited by 
glucocoticoids, gamma-amino butyric acid (GABA), ACTH and opioid peptides 
(Calogero et al., 1988; Tsigos and Chrousos, 2002). CRF has been hypothesized to be an 
integrator of multiple components of the stress response (Vale et al., 1981) and elicits 
activation of autonomic nervous system, arousal, anxiety like behaviors, suppression of 
the immune sytem and eating behaviour (Lowry and Moore, 2006). These central 
actions of CRF are appropriate to facilitate "fight or flight" responses (Kalin et al., 
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1994). Expression of both CRF and CRFl receptor mRNA in the parvicellular neurons 
of the hypothalamic PVN is increased substantially and rapidly (with in the first 5min) 
by stress (Imaki et al., 2001). Studies examined the correlation between cellular 
activation and increased levels of c-fos m RNA, and CRFl receptor levels in different 
brain areas highly involved in the neuroendocrine response to stress such as 
parvicellular hypothalamic PVN (Imaki et al., 2001), which is blocked by antagonist 
treatment. Peptide and non-peptide CRF receptor antagonists reduce the behavioral and 
neuroendocrine effects of different acute and chronic stressors in rodents (Lowry and 
Moore, 2006). It is also proposed that CRF may act as a neurotransmitter or 
neuromodulator in extra-hypothalamic circuits to integrate brain multi system responses 
to stress (Jankord and Herman, 2008). 
Effects of CRH are mediated by two types of receptors namely CRH-1 and 
CRH-2. CRH-1 is found in hypothalamus, limbic system, central sympathetic systems 
(LC-NA) in the brain stem and spinal cord (Dautzenberg, and Hauger, 2002). CRH-2 is 
expressed in peripheral vasculature, heart and subcortical structures in brain. LC-NA 
cell groups are present in medulla and pons. Role of LC-NA is very well established for 
activafion of autonomic, endocrine and responses to stress (Chrousos, 1998). NA 
activates the amygdale, which is the principal locus for fear related behaviour. 
Reciprocal connections exist between NA and CRH system each stimulating each other. 
NA activates through al receptors (Tsigos and Chrousos, 2002). Negative controls 
include glucocorticoids, GABA, opioid peptide which inhibits both CRH and LC-NA 
neurons (Calogero, 1988). Both the synthesis and secretion of ACTH are controlled by 
CRH in addition to AVP, angiotensin II and various cytokines and lipid mediator of 
inflammation which act on hypothalamic, pituitary and adrenal components of HPA-
axis potentiating their activity (Holmes, 1986). ACTH is produced as part of larger 
precursor protein POMC which is also progenitor of P-endorphin and lipoprotein. 
Circulating ACTH is the key regulator of glucocorticod secretion by adrenal cortex in 
addition to other hormones or cytokines originating from the adrenal medulla or 
systemic circulation as well as neuronal excitation (Armario, 2006). ACTH stimulates 
steroidogenesis by binding to membrane receptors on adrenal cells which activates 
adenylate cyclase and also causes hypertrophy of adrenal cortex. Glucocorticoids inhibit 
pituitary ACTH secretion by directly suppressing the expression of POMC in pituitary 
corticotrophs. 
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2.17. Central Monoaminergic system 
Noradrenaline (NA), dopamine (DA) and 5-hydroxy tryptamine (5-HT) are the 
important monoamines which are widely distributed in brain and their functional role is 
well established during stressful conditions (Tsigos and Chrousos, 2002; Carrasco and 
Van de Kar, 2003). Changes in monoaminergic activity results in behavioral changes as 
well as a cascade of hormonal release from the HPA-axis. Dysfunction of these 
monoamines due to prolonged stressful conditions has been associated with a wide 
range of central and peripheral disorders like depression, anxiety, drug abuse, obsessive 
compulsive disorder, eating and sleeping disorders, hyperglycemia, and decreased 
immune response (Kalia, 2005; Pijl and Edo, 2002; Neveu et al., 1994). 
2.17.1. The Noradrenergic system 
The noradrenergic system is regulated primarily by neurons of the NLC, 
located in the dorsal tegmentum of the brain stem. This nucleus projects diffusely, 
through the dorsal bundle to the cerebral cortex, and through both the dorsal and the 
ventral bundle to various structures, including the amygdala, the hippocampus, and the 
PVN of the hypothalamus (Valentino et al., 1993). Acute activation of this system 
leads to release of NA from an extensive network of neurons throughout the brain, 
producing an enhanced state of arousal, which is critical for adaptive responses to 
stress (Anisman and Zacharko, 1990). Prolonged activation leads to compensatory 
increases in the biosynthesis of NA and consequently, to a sustained increase in NA 
release (Adell et al., 1988; Roth et al., 1982) such that brain NA contents does not 
decline and may even increase (Roth et al., 1982). In response to chronic stress, central 
NA activity is affected by environmental cues, such as the availability of effective 
coping responses. The integration of the central and peripheral components of the SAN 
system is the reason for the broad spectrum of central and autonomic symptoms 
observed in different stress situations. 
2.17.2. The Serotonergic system 
Serotonin has been implicated in the stress-related regulation of the HPA-axis. 
The serotonergic system has its cell groups mainly in the raphe nuclei, and also 
projects diffusely to limbic structures and neocortex. The ascending serotonergic 
projections to the forebrain originate mainly in the superior group of the raphe nuclei. 
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particularly in the dorsal raphe nucleus (DRN) and the median raphe nucleus (MRN) 
(Robertson et al., 2005). The DRN-forebrain tract innervates the amygdala, the 
nucleus accumbens (NAC), and other forebrain structures (Lopez-Figueroa et al., 
2004). This system would mediate the state of anticipatory anxiety, which has an 
adaptive function in situations of alarm. It is supposed to inform the limbic system that 
a stimulus or situation is associated with unpleasant experiences, and is involved in 
controlling emotional reactions to them (Smelik, 1987). Dysfunctional activation of 
the DRN-forebrain tract was associated with phobic and generalized anxiety disorders 
(Lopez-Figueroa et al., 2004). The MRN-forebrain tract innervates complementary 
structures to those innervated by the DRN, most prominently the hippocampus 
(Robertson et al., 2005). This system would mediate tolerance to unavoidable, 
persistent aversive stimuli so that acute defensive responses become attenuated with 
repetition (Kennett et al., 1985). It is associated with conferment of neutralizing 
control on negative emotional experiences by generating relaxation, satisfaction and 
inertia (Smelik, 1987). Dysfunction of the MRN-forebrain tract was associated with 
learned helplessness and subsequent depression (Anisman and Zacharko, 1990). In 
addition, serotonergic fibers from the DRN and the MRN have been shown to 
innervate CRH neurons in the PVN, together with serotonergic neurons located 
entirely in the hypothalamus There is evidence that central serotonergic systems exert 
a positive control on the HPA-axis and the ANS, and that reciprocally, glucocorticoids 
and catecholamines mediate stress-induced alterations in the central serotonergic 
systems (Chauloff, 1993; Fuller, 1981). 
2.17.3. The Dopaminergic system 
DA has been implicated in the stress-related regulation of the HPA-axis, as 
well as in depression (Anisman and Zacharco, 1991; Cabib and Puglisi-Allegra, 1996). 
There is evidence that central dopaminergic systems exert a positive control on the 
HPA-axis and the SNS, and reciprocally, glucocorticoids and catecholamines mediate 
stress-induced alterations. The dopaminergic system is subdivided in various 
subsystems, such as the mesolimbic (ML) and mesocortical (M-C), which are involved 
in adaptation processes (Smelik, 1987). Both, subsystems are activated by the NLC 
and the ANS during stress. The ML pathway projects from the VTA to the NAC and 
the septum, and is involved in the processing and reinforcement of rewarding stimuli 
and in motivation of behavioral responses (Willner, 1983). This system is believed to 
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be involved in the activation of goal-directed behavior, and its inhibition may lead to 
emotional indifference and lack of initiative (Smelik, 1987). This system has been 
shown to be highly sensitive to stress (Abercrombie et al., 1989; Cabib et al, 1988). 
The M-C pathway projects mainly to the frontal cortex, which is critical for cognitive 
functions such as judgment and planning of behavioral responses (Cabib and Puglisi-
Allegra, 1996), and more specially to the prefrontal cortex, a region thought to be 
involved in anticipatory phenomena and focused attention (Smelik, 1987). It was 
suggested that stressftil experiences alter DA metabolism and release in the M-L 
system (Imperato et al., 1992). Moreover, repeated exposure to stress may lead to 
different responsiveness to subsequent stressful experiences depending on the stressor, 
leading to different changes on M-L function. Exposure to a single 
unavoidable/uncontrollable aversive experience may lead to inhibition of DA release 
in the NAC as well as to impaired response to both rewarding and aversive stimuli 
(Cabib and Puglisi-Allegra, 1996). The effects of stressfiil experiences on DA 
functioning in the ML system, can be very different or even opposite depending on the 
controllability of the situation, the genetic background of the organism and its life 
history (Cabib and Puglisi-Allegra, 1996).The intricate relationship of various 
neurotransmitter systems are illustrated in figure 8. 
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Figure 8: Schematic representation of three neurotransmitter systems involved in the 
adaptive response to stress. The dopaminergic system is represented by the ventral 
tegmental area (VTA) and its projections to the nucleus accumbens (NAC) and the 
frontal cortex. The noradrenergic system is represented by projections from the 
noradrenergic locus ceruleus (NLC) to the amygdala, the hippocampus, and the 
frontal cortex. The serotonergic system is represented by the raphe nuclei and 
projections from the dorsal raphe nucleus (DRN) to the amygdala and from the 
median raphe nucleus (MRN) to the hippocampus. 
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2.18. Heat Shock Proteins 
Heat shock proteins (HSPs) are a group of proteins whose expression is increased 
when the cells are exposed to elevated temperatures or other stressors (Gupta and Briyal, 
2006, Belay and Brown, 2006). This increase in expression is transcriptionally regulated. 
This dramatic up-regulation of the HSPs induced mostly by Heat Shock Factor (HSF) is a 
key part of the heat shock response (Tu et al., 2004). The HSPs are named according to 
their molecular weights. For example, HSP-60, HSP-70 and HSP-90 (the most widely-
studied HSPs) refer to families of heat shock proteins on the order of 60, 70 and 90 kilo-
daltons in size, respectively. 
2.18.1. Up-regulation of HSPs by stress 
Production of high levels of heat shock proteins can be triggered by exposure to 
different kinds of environmental stress conditions. Heat shock/stress response is a 
conserved and physiological adaptive response to various stress conditions, including 
exposure to heat shock, inflammatory stimuli, infection, and oxidative stress (Gupta and 
Briyal, 2006; Samson et al., 2007). Changes in the redox status following exposure to 
oxidizing agents like ROS have also been suggested to mediate such types of stress 
response (Kukreja et al., 1994). All organisms share a common molecular response that 
includes a dramatic change in the pattern of gene expression and the elevated synthesis of 
a family of stress induced proteins (Janssen et al, 1993). Induction of the so-called heat 
shock proteins (HSPs) by oxidants has long been used as a marker for cell and tissue 
injury. In addition to the chaperoning activities, HSP exerts its protection primarily at 
mitochondrial level and by inhibiting the apoptotic program (Jacquier-Sarlin et al., 1994). 
However, the protective effect of HSP cannot be extrapolated to all apoptotic models 
(Vayssier et al., 2002). HSPs also occur under non-stressful conditions, simply 
"monitoring" the cell's proteins. Some examples of their role as "monitors" are that they 
carry old proteins to the cell's "recycling bin" and they help newly synthesized proteins 
fold properly. These activities are part of a cell's own repair system, called the "cellular 
stress response" or the "heat-shock response". HSPs are molecular chaperones for 
protein molecules. They are usually cytoplasmic proteins and they perform functions in 
various intra-cellular processes. They play an important role in protein-protein 
interactions such as folding and assisting in the establishment of proper protein 
conformation (shape) and prevention of unwanted protein aggregation. 
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2.18.2. Heat Shock Protein (HSP)-70: Marker of stress 
Protein damage and misfolded protein structure are common denominators of 
various stress types. These states lead to the activation of HSP chaperons, e.g., HSP-70, 
which represents the major stress-induced chaperon in mammals (Hightower and 
Hendershot, 1997). Stress responses in brain cells by de-naturation of proteins, changes 
of protein synthesis, and changes of protein glycosylation, which leads to the induction 
of HSPs. Interestingly, HSP-70 not present normally is highly inducible during stress 
and can be considered as a marker of neurotoxicity (Rajdev and Sharp, 2000). The 
expression of HSP has been seen in endothelial cells in the neurons, and glia cells in the 
brain. This expression of HSP-70 in the brain can be attributed to oxidative stress, as 
there are studies to suggest that free radicals do increase the expression of HSP-70 
(Kukreja et al, 1994; Ambrosio et al., 1995). Since normal brain cells have little 
detectable HSP protein and are induced in response to stress, their increased expression 
serves as a marker of cellular injury. Stress inducible, HSP-70 has been studied 
extensively for its potential to protect the brain from several injuries. HSP-70 is up-
regulated in response to different stress conditions in the brain, such as hypoxia, 
ischemia, hyperthermia and exposure to toxic compounds (Nowak et al., 1990; Nowak, 
1991; Tu et al., 2004). The sustained expression of HSP-70 in vulnerable regions of the 
brain appears to be a constitutive marker for the cellular pathophysiology. 
2.19. Pathophysiology of deregulated stress response 
Catecholamines, glucocorticoids and cytokines all respond at first to help the 
body adapt when stressors activate the HPA-axis. Short term effects of these mediators 
are protective and their release induces a negative feedback process on these systems. In 
fact, acute stress can enhance immunity while chronic stress suppresses the immune 
response (Carrasco and Van de Kar, 2003). However, continued release of these 
mediators results in prolonged effects on target cells and this can lead to receptor 
desensitization, tissue damage (McEwen, 2003) and hypo-flinctioning or suppression of 
immune responses (McEwen and Wingfield, 2002). Chronic release of stress honnones 
under excessive or long-term stress leads to a cumulative allostatic load on the body or 
"cost" of adaptation (McEwen, 2003). Normally, a built-in feedback system is in place 
that protects the organism from over secretion by turning off these mediators. The 
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abnormal continued release of stress mediators has been shown to lead to three kinds of 
overload: 
1) Over stimulation by frequent stress, resulting in excessive stress hormone 
exposure; 
2) Failure to inhibit allostatic responses when they are not needed or an inability 
to habituate to the same stressor, both of which result in overexposure to stress 
hormones; and 
3) Inability to stimulate allostatic responses when needed, in which case other 
systems (e.g., inflammatory cytokines) become hyperactive and produce other 
types of wear and tear. 
CRF has been shown to induce negative effects such as motor activation, 
anxiety-like behaviour, anorexia, decreased sexual behaviour and altered cognitive 
performance (Lowry and Moore, 2006). Chronic release of Cortisol has been linked to a 
pathological suppression of the immune system. Similarly, hyposecretion of stress 
mediators has also been linked to pathological conditions such as autoimmune diseases 
(Chrousos and Gold, 1992). Dysfunctional release of stress mediators, characterized by 
both excess and deficiency have been linked to pathological conditions such as loss of 
libido, bone demineralization, atrophy of the amygdala and hippocampus, abdominal 
obesity, long-term depression, memory deficits and free radical damage, high 
cholesterol and cardiovascular diseases (Kathol et al., 1989; McEwen, 1999; Kalia, 
2005). In general, excessive and continued stress has been shown to be a crucial factor 
in chronic anxiety disorder, depression, fatigue states, sleep disorders, addictive 
behavior, neurodegeneration, allergic and autoimmune disorders, metabolic syndrome, 
gastrointestinal diseases and pre-term labor (Torres et al ., 2004; Smith et al., 2008; 
Lucca et al., 2009). Thus, the hallmark of pathologies that seem to be caused by a wide 
variety of stressors is the deregulation of stress mediators, specific neurotransmitters and 
hormones. When regulated appropriately, these endogenous chemicals are responsible 
for protecting the organism from continued and severe stressors. It is these substances, 
then, that are involved in the mechanism of action of adaptogenic plant remedies. 
Various events during deregulated HPA-axis are illustrated in figure 9. 
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Figure 9: Schematic representation of deregulated HPA-axis; The HPA-axis is 
upregulated with a down-regulation of its negative feedback controls. CRF is 
hypersecreted from the hypothalamus and induces the release of ACTH from the 
pituitary. ACTH interacts with receptors on adrenocortical cells and Cortisol is released 
from the adrenal glands; adrenal hypertrophy can also occur. Release of Cortisol into the 
circulation has a number of effects, including elevation of blood glucose. The negative 
feedback of Cortisol to the hypothalamus, pituitary and immune system is impaired. This 
leads to continual activation of the HPA-axis and excess Cortisol release. Cortisol 
receptors become desensitized leading to increased activity of the pro-inflammatory 
immune mediators and disturbances in neurotransmitter transmission. 
2.20. Behavioral disorders 
Stress is linked with number of behavioural disorders like anxiety, mood and 
depression. However, the best-studied case of a stress axis interface with a psychiatric 
illness is that of major depressive disorders (Harro and Oreland, 2001). Depressive 
disorders are common in humans and are believed to be influenced and /or induced by a 
wide variety of factors including biological, environmental and genetic ones. The 
correlation between stress and depression has face validity, not only because being 
profoundly depressed is unquestionably stressful, but also because an external stressful 
even often precipitates depressive episodes (Kalia, 2005). Recent findings indicate that 
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the "catecholaminergic hypothesis" (Schildkraut, 1995) and the serotonergic hypothesis 
(Maes and Meltzer, 1995) of major depression. Neuromodulators like P endorphin or 
other putative neurotransmitters/neuromodulators, such as GABA, neuropeptides (such as 
neuropeptides Y, substance P and corticotrophin releasing factor and growth factors may 
also be involved, albeit not centrally in manifestation of depressive behaviour (Nestler, 
1998; Ressler and Nemero, 1999). 
2.21. Hypertension and heart diseases 
Stress has been postulated to be involved in etiopathogenisis of hypertension and 
coronary heart disease. A growing body of evidence also indicates that elevation in 
hematocrit and hemoglobin are present in situations involving both physical and mental 
stressors and have been identified as an independent risk factor for the development of a 
number of diseases, including hypertension, coronary heart disease and stroke (Roy et al., 
2001). Persistent high catecholamine levels are also associated with increased vascular 
endothelial turnover and permeability to calcium and lipoproteins, increased blood 
velocity, abnormal blood flow patterns and atheroma formation which also accounts for a 
number of cardiovascular disorders (Cruickshank and Smith, 1989). Furthermore 
increased works load in response to stress and leads to an increase in oxidative challenge 
in heart muscles thereby increasing the probability of coronary heart disease and stroke 
(Hu et al., 2000). 
2.22. Metabolic disorders 
Stress has been associated with alteration of number of cellular, molecular and 
morphological changes resulting in metabolic disorders such as diabetes and lipid 
metabolism (Reagan et al., 2000). Stress has been reported to cause glucose intolerance 
and subsequently to diabetes of particular importance, high levels of glucose can produce 
permanent chemical alterations in proteins and increase lipid peroxidation in a variety of 
experimental models of hyperglycemia (Folmer et al., 2002). Various forms of acute 
stressful stimuli have been generally accepted to cause a hyperglycemic response The 
CNS and HPA-axis plays an important role in regulation of hepatic glucose and lipid 
metabolism via the sympathetic nervous system and cytokines (Gotoh et al., 2001). 
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2.23. Gastric ulcer and stress 
Among various ulcerogenic factors, the stress-induced gastric ulceration is 
proposed to be mediated by CRF (Bhatia and Tandon, 2005), corticosteroids (Mayer, 
2000), prostaglandins (Dharmani et al., 2005) acid secretion (Hoogerwerf and Pasricha, 
2006) and neurotransmitters (Saad et al., 2001). Understanding the intricate 
relationships between gastric ulcers and stress mediators under different stressfiil 
conditions is crucial, as the patients suffering from shock, sepsis, severe trauma, or 
head injury can develop acute erosive gastric mucosal changes or frank ulceration with 
bleeding, which are life threatening (Hoogerwerf and Pasricha, 2006; Valle, 2008). The 
interactions between mucosal, vascular, neurohumoral factors and the autonomic 
nervous system play a crucial role in the genesis of ulcers. The CNS and more 
importantly, the brain-gut axis are important mediators of stress ulcerogenesis and 
complex neural mechanism are proposed. Among the various neurotransmitters, the 
dopaminergic system, in particular is proposed to play regulatory role in stress induced 
gastric ulcers (Glavin, 1991). Interestingly, a higher rate of ulcer disease in patients with 
a DA deficiency (Parkinson's) and a relatively lower incidence of gastric lesions in 
patients with DA excess and/or over activity (Schizophrenia) emphasized a link between 
the DA levels and gastric pathology. Gastric cytomodulatory effects are also proposed 
through the modulation of DA-ergic transmission by specific DA drugs (Hernandez et 
al, 1986). Other contributing factors to stress ulcers are increased gastric motility 
(Garric et al, 1986), Vagal over activity (Cho et al., 1976; Hierlihry, 1993), decreased 
gastric mucosal blood flow (Hase et al., 1975; Kitagawa et al., 1979) and various 
neuroendocrinological factors (Gaton et al., 1993). Elevated corticosteroid level also 
known to modulate gastric glands to secrete acid and pepsin (Gray et al., 1951), which 
can ftirther deteriorate gastric mucosal integrity. Stress is also implicated in peptic ulcer 
disease. And the uropepsin excretion in the urine reflects the peptic activity of the 
stomach. It is derived from the secretion of pepsinogen directly in to the blood stream 
by the peptic cells of the stomach. Pepsinogen is then transported to the kidney and is 
excreted in the urine as uropepsin (Gray et al., 1951). Pathway of stress ulcer is shown 
in figure 10. 
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affect Figure 10: Hormonal pathways by which psychological and physical stress may ii  
the stomach, resulting in an increased production of gastric hydrochloric acid and pepsin. 
2.24. Oxidative load and stress 
Many studies showed that exposure to different stressful conditions increases the 
production of reactive oxygen species (ROS), and consequent oxidative damage, with a 
concomitant decline in in-vivo antioxidant defences (Zaidi and Banu, 2004; Zaidi et al, 
2005). Stress exerts detrimental effects on several cell functions, through impairment of 
antioxidant defences, leading to oxidative damage, which plays critical role in the 
pathophysiology of neurodegenerative diseases, neuropsychiatric disorders and stress 
induced depression (Jenner, 1991; Sapolsky, 2000; Bilici et al., 2001; Torres et al., 
2004). Oxidative stress induces many damaging processes in stress disorders such as 
mitochondrial dysfunction, deregulation of calcium homeostasis (Amoroso et al., 2000), 
disruption of energy pathways (Papadopoulos et al., 1997), damage to neuronal 
precursors, impairment of neurogenesis (Kroemer, 1997), induction of signalling events 
in apoptotic cell death (Cregan et al., 2002), ultimately leading to atrophy and 
morphological changes in the brain characteristic in stress-induced depression 
(Bremner, 1999; Sapolsky, 2000). Furthermore, brain is more vulnerable to oxidative 
damage compared to other organs for several reasons (Metodiewa and Costa, 2000). 
Brain consumes higher rate of oxygen per unit mass of tissue, contains high levels of 
peroxidizable lipids, excitotoxic amino acids and low levels of antioxidants (Anderson, 
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2004; Metodiewa and Costa, 2000). Furthermore, stress leads to increased serum 
glucocorticoid levels which may alter antioxidant enzyme activities in brain (Mcintosh 
et al, 1998; Zafir and Banu, 2009). Importantly, some studies indicate a link between 
the alterations in central monoaminergic system and increased oxidative load during 
physiological adverse conditions (Wrona and Dryhurst, 1998; Siraki and O'Brien, 2002). 
But the extent to which oxidation products contribute to the perturbed redox state during 
stressful condition in the monoaminergic innervated regions warrants further study. 
Monoamines oxidation products are postulated to contribute neurodegenerative disease 
process (Anderson, 2004). During stress elevated catecholamine levels may undergo 
autoxidation, in which electrons are generated, which in turn can produce ROS 
(Carpagnano et al., 2003). In order to neutralize ROS, the body uses enzymatic (SOD, 
CAT and GSH-Px) and non-enzymatic (GSH) antioxidant system. 
2.25. Antioxidant Enzymes 
The antioxidant enzymes SOD, catalase and GSH-Px exist to catalyze the 
reduction of oxidants primarily in the intracellular environment. These enzymes are 
present in mitochondria and cytosol (Cheesman and Scater, 1993). The enzyme SOD 
catalyzes the conversion of 'O2 into H2O2. Catalases remove hydrogen peroxide, are 
found in peroxisomes in most of the tissues, and probably serve to remove peroxide 
generated by peroxisomal oxidase enzymes. Glutathione peroxidases are major enzymes 
that remove hydrogen peroxide generated by SOD in cytosol and mitochondria, by 
oxidizing the tripeptide bearing a thiol group, glutathione (GSH) into its oxidized form 
(GSSG). 
2.25.1. Superoxide dismutase (SOD) 
Many one-electron processes have been described that convert O2 to its radical 
anion reduction product, 'O2 , superoxide. SOD catalyse the conversion of 'O2 to 
H2O2 and oxygen (Halliwell and Gutteridge, 2007). 
2 O2 + 2H^ —^^ • H2O2 + O2 
This reaction is quite rapid even without enzymatic catalysis at ordinary 
physiological pHs (at a rate approximately four orders of magnitude less at pH 7.4. SOD 
is a powerful enough catalyst to increase the rate of the reaction by several orders of 
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magnitude at physiological pHs. Superoxide, like H2O2, is not directly reactive toward 
most organic compounds (at least not as an oxidant), but it probably gives rise to more 
reactive oxygen species of higher potential toxicity (Miyazaki and Asanuma, 2008). 
2.25.2. Catalase 
A long-known metalloenzyme, catalase is one of the most efficient protein 
catalysts known; it promotes the redox reaction 
Catalase 
2H2O2 • 2H2O + O2 
Hydrogen peroxide itself is not particularly reactive with most biologically important 
molecules, but it is probably an intracellular precursor for more reactive oxidants such as 
"OH (Halliwell, 1991). It is relatively stable (Half Ufe 10"^  sec), poorly reactive, non-
radical oxygen species, which easily crosses cell membrane and attacks different sites by 
converting into OH (Halliwell and Gutteridge, 2007). 
2.25.3. Glutathione Peroxidase 
Glutathione Peroxidase (GSH-Px) also reduces peroxides like catalase. The 
selenium-dependent GSH-Px reduces H2O2 as well as organic hydroperoxides (Cheesman 
and Scater, 1993). The selenium independent GSH-Px accepts hydroperoxides as 
substrate: 
ROOH + 2GSH • ROH + GSSG + H2O 
GSH is found in very high concentrations in many cells. It reacts with many 
oxidants such as H2O2 to form the oxidized form, a disulphide known as GSSG. GSH also 
reacts without enzyme catalysis (GSH-Px) with many other potentially damaging 
intracellular oxidants such as 'O2, 02 , and OH (Halliwell and Gutteridge, 2007). 
2.25.4. Preventive Antioxidants: Sequestration of Metal Ions 
Many transition metals have variable oxidation numbers, e.g., iron has Fe^^ and 
Fe'^ ^ ions and copper has Cu"^  and Cu^ ^ ions. Changing between oxidation states involves 
accepting and donating single electrons, e.g. 
Fe^^ + e" ^ » Fe^^ 
Cu^^  + e 4 ^ Cu^ 
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Transition metal ions are remarkably good promoters of free radical reactions 
(Cheesman and Scater, 1993; Halliwell, 1991). They act as a template for the formation 
of the highly destructive hydroxyl radical by. 
Fe^^ + H2O2 • OH' + OH + Fe^... Fentonreaction 
•O2 + H2O2 — ^ ^ ° ^ ^ " • OH + O H " + 02...Haber-Weiss reaction 
ions 
These are important reactions that should not disseminate in the transformation of 
H2O2 into hydroxyl radical (OH). OH is extremely reactive. Although it is uncertain 
whether "OH or iron-oxygen complex is the ultimate reactive initiating species, it is 
evident that safe storage of iron ions is crucial (Halliwell, 1991). Two thirds of the 4 g 
iron present in an adult is stored in hemoglobin. Ten percent of the iron is found in 
myoglobin and a small portion in iron-containing enzymes and in the transport protein 
transferrin. The remainder is present in intracellular storage proteins such as ferritin and 
hemosiderin (Halliwell and Gutteridge 1987). 
2.25.5. Non-enzymatic antioxidant defense system; Glutatliione 
The tripeptide glutathione (GSH; gama-glutamyl-cysteinyl-glycine) is the most 
abundant thiol present in mammalian cells. GSH plays an important role in the 
detoxification of ROS in brain. It is reported that stress reduces GSH levels and leads to 
increased levels of ROS (Sahin and Gumuslu, 2007). Evidence has been presented that 
the neuronal defense against H202, which is the most toxic molecule to the brain, is 
mediated primarily by the glutathione system (Zafir and Banu, 2007). The GSH system 
has multifunctional roles in combating oxidative stress via direct scavenging of free 
radicals, detoxification of electrophilic compounds, modulation of cellular redox status 
and thiol-disulphide status of proteins, and regulation of cell signalling and repair 
pathways (Dringen et al, 2000). 
2.25.6. Lipid Peroxidation 
Lipid peroxidation is considered a critical mechanism of injury occurring in cells 
during oxidative stress (Halliwell and Gutteridge, 2007). An initial formation of large 
amounts of ROS during stress may also initiate lipid peroxidation as demonstrated to 
occur in brain (Liu et al, 1996) and other tissues (Sahin and Gumuslu, 2007). 
Psychological stress, which accompanies severe depression, may enhance lipid 
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peroxidation (Lucca et al, 2009) and recent clinical studies have directly demonstrated 
higher levels of MDA in patients with affective disorders (Anderson, 2004). Thus, based 
on the known pathophysiological effects of stress, it is plausible that associated increases 
in metabolism may lead to increased oxidant production and oxidative damage to cellular 
macromolecules. Lipid peroxidation is a secondary effect of oxidative stress. It has great 
potential to affect several aspects of brain function, due to the high content of oxidizable 
polyunsaturated fatty acids in the brain (Metodiewa and Koska, 2000). Peroxidation of 
lipids has disruptive potential by altering membrane viscosity, fluidity, permeability, and 
impairing the functions of membrane transport proteins and ion channels, thereby 
adversely affecting electrical potential and controlled transport of metabolites across 
membrane (Keller and Mattson, 1998). 
2.26. Remedies of allostatic overload: the Adaptogens 
The concept of treating stress-related conditions with medicinal plants is familiar 
to most traditional healing models throughout the world (Pannosian et al., 1999). Two of 
the oldest models, traditional Chinese medicine and the Ayurveda model from India, both 
employ remedies to counteract stress, fatigue, loss of memory and to rejuvenate both 
those who are recovering fi-om illness and those who are aging (Rege et al, 1999). In 
India, rasayana remedies such as Withania somnifera are believed to nourish and 
strengthen the primordial tissue or rasa in order to delay old age, promote vital energy 
and improve the mental intellect (Fugh-Berman and Cott, 1999). Though conventional 
medicine does not use these remedies, citing lack of research, the popular health market 
has been touting their benefits and providing these herbal products for many decades in 
the United States and elsewhere. Thus began the effort to find remedial substances that 
would increase the protective state of resistance during conditions of stress. Lazarev 
(1962) showed that ingestion of certain plant extracts could improve stress markers in 
laboratory animals. By 1958 he had coined these plant remedies adaptogens and 
suggested three criteria that described their remedial action (Brekhman and Dardymov, 
1969). 
An adaptogen: 
1) Should be innocuous and cause minimal disturbance to the normal 
physiological fianction of an organism. 
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2) Its action should be non-specific (i.e., should increase resistance to a wide range 
of stressors), and 
3) It should have a normalizing action irrespective of the direction of the preceding 
pathological changes (i.e., be able to normalize either high or low physiological 
responses to stressors). 
Continued research on adaptogenic plants in Russia, India, China and other 
countries resulted in the production of hundreds of over the counter remedies (Caius, 
1990; Pannosian et al., 1999). Surprisingly few well-designed, randomized, placebo-
controlled, double-blinded clinical studies have been conducted in the United States on 
adaptogenic products. However, open clinical uses of these herbs have been taking place 
for millennia in the indigenous practice of China and India (Rege et al., 1999; Pannosian 
etal., 1999). 
2.27. The appeal of Herbal medicines: 
The desire to control the coping mechanisms during stress has led to the origin of 
the science of adaptation and hence recently the researchers all over the world show 
enormous amount of interest on understanding the mechanisms underlying the process of 
adaptation, identifying what controls this phenomenon and more importantly discovering 
methods to modify them so that we can deal with stress very specifically and can avoid 
unnecessary or faulty responses. It is in this regard the concept of Adaptogens (Lazarev, 
1946) becomes more relevant and significant as these adaptogens are natural plant 
products that increase the body's ability to cope (adaptation) with internal and external 
stress factors and thus help in normalizing body functions. However like stress the term 
"adaptogen" is carelessly used, without sufficient experimental evidence to support the 
criteria for the proper definition of such a substance. Treatment of stress pathologies is of 
great concern today because of their increasing incidence (McEwen, 2003). The role of 
stress in disease has only recently been appreciated by medicine. Stress has been 
associated with the progression of chronic gastritis, HIV, trauma, allergies, tumor growth, 
many chronic diseases such as syndrome X, diabetes, and the common cold (Elenkov and 
Chrousos, 1999). Medicine is in need of novel remedies that can treat condifions resulting 
from dysfunctional stress response despite recent developments of new drugs to treat 
stress (Dubowchik et al., 2003). The contribution of plant compounds to pharmacology 
has been estimated in the billions of dollars, though the interest in plants as sources of 
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novel medicines has diminished mainly because of political and technological reasons 
(Newman et al, 2003). Yet many scientists feel that billions of dollars worth of natural 
products still remains undiscovered and unexplored (Carlini, 2003; Wu et al., 2003). 
2.27.1. Herbal versus Synthetic Drugs 
Herbal medications are drugs in every sense of the word. They chemically modify 
bodily processes and can have therapeutic or harmful effects, depending on how they are 
used. However, there are a few general differences between herbal and pharmaceutical 
drugs (Pannosian and Wagner, 2005). Herbal drugs tend to be more dilute than 
pharmaceutical drugs. Another significant difference between herbal and pharmaceutical 
drugs is that pharmaceutical drugs consist of a purified single active drug. Herbal 
medications, on the other hand, may have multiple active constituents. The active 
chemical of a plant may each have different individual effects, so that the effect of the 
total herb is a combination of the effects of several different constituents (Newman et al., 
2003). 
Conversely, active constituents may have cooperative effects and together act in 
an addictive manner. In such cases it would be better to consume the whole plant/extract, 
because the combination of constituents would give a greater effect than one alone. Thus, 
to blindly either the use of whole herb or refined single constituents is naive. To fully 
know what is best for the desired effect, herbs must be considered on a case a case by 
basis and the nature of the interactions between the chemical constituents must be 
carefully considered. Not only must be understand what the plant's chemical constituents 
do, we must also investigate how they interact (Table 5). 
Herbal Refined/Pharmaceutical 
Pro 
Multiple and cooperating constituents 
Lower toxicity of dilute drug 
Pro 
Avoids extraneous constituents 
Avoids antagonistic constituents 
Higher potency of concentrated drug 
Standard administration methods 
Con 
Lower potency of dilute drug 
Variable administration methods 
Con 
Higher toxicity of concentrated drug 
Table 5: It illustrated the potential pros and cons of herbal vs. refined/pharmaceutical. 
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2.28. Plant drugs known for anti-stress effects: 
Since the introduction of the concept of 'adaptogen' several plants have been 
investigated starting with Eleutherococccus senticosus (Siberian ginseng), Panax 
ginseng, Raponticum carthamoides and Rhodiola rosea. These were used as tonics in 
folk medicine, and were found to fulfill the criteria laid down by Brekhman and 
Dardymov (1969) and therefore qualified as adaptogens. These initial studies opened a 
vast arena for research and in India work has been carried out on plants such as 
Acanthopanax sessiliflorum and Rhodiola rosea fi"om Russia, Albizzia julibrissin and 
Cicer arietinum from Japan, Codonopsis pilosula and Panax ginseng fi"om China as 
well as Withania somnifera, Ocimum sanctum, Hoppea dichotoma, Alium sativum and 
Emblica officinalis from India (Rege et al., 1999). 
Anfi-stress drugs depending on their offering non-specific resistance were 
classified to be adaptogens. Adaptogens confers their acfion by mediafing through 
diverse modules and were proved to be effective against chronic stress induced adverse 
effects on immunity, behaviour cognition etc which were there by separated from 
benzodiazepine anxiolytics despite having significant anti-stress activity (Costa and 
Guidotti, 1996). Starting fi-om Eleuthrococcus senticosus and Panax ginseng (Pannosian 
et al., 1999), these initial studies opened a vast area for research both abroad and in 
India and substantial work has been carried out on plants such as Withania somnifera 
(Rege et al., 1999) Ocimum sanctum (Bhargava and Singh, 1981), and Emblica 
officinalis (Rege et al., 1999) etc. 
2.28.1. Ginseng 
Ginseng is the root of perennial herbs of Panax quinquifolium L., which grow 
in Unites States and Canada and Panax ginseng (Araliaceae). The former is known as 
American ginseng and the latter, designated Korean or Chinese ginseng. Panax 
species have been traditionally used as medicinal herbs particularly in Southern Asia 
for more than 5000 years as a tonic and restorative, promoting health and longevity. 
The root of Panax species is known to contain various saponins, including 
ginsenosides Rbl, Rb2, Re, Rd, Re and Rgl. Panax quinquefolium (PQ) or American 
ginseng belongs to the family Araliaceae and is believed to possess effects similar to 
those of Panax ginseng (Persons, 1986). Ginseng or individual ginsenosides have a 
potent tumor therapeutic activity and improve immune functions (Xiaoguang et al.. 
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1998) and also exert anti-anxiety effect (Carr et al., 2006). Various reports have 
claimed the efficacy of ginsenosides to combat stress with increased resistance to 
physical exercise (Brekhman and Dardymov, 1969). Many of these activities were 
postulated to have corticosteroid-like actions. On the contrary, ginseng total saponins 
(GTS) injected intracerebroventricularly inhibits stress-induced plasma corticosterone 
levels (Kim et al., 1998). CRH and ACTH hormone studies have suggested that 
ginsenosides may augment adrenal steroidogenesis via an indirect action on the 
pituitary gland (Hiai et al., 1979). Thus, overall effects of ginsenoids may vary 
depending on the route of administration. However, the mechanism of action of GTS 
on HPA-axis is not yet fully understood. 
2.28.2. Ginkgo biloba 
Ginkgo biloba (G. biloba) is one of the widely used Chinese plants for its 
medicinal properties for several thousand years. At present, it is among the most 
commonly used phytopharmaceutical. It has been used in the treatment of various 
common geriatric complaints including vertigo, short-term memory loss and lack of 
attention or vigilance. The standardized extract of G. biloba has been shown to have 
beneficial effects on cerebral vascular disorders (Clostre, 1999), MAO inhibitory 
(Pardon et al., 2000) and immune stimulating properties (Puebla-Perez et al., 2003). G. 
biloba has received attention as potential cognitive enhancers (Ward et al., 2002) for 
the treatment of Alzheimer's disease and other cognitive disorders (Oken et al., 1998). 
Findings suggest that G. biloba extract may also facilitate the successfiil behavioral 
adaptation to stressors or noxious stimulants (Ward et al., 2002; Walesiuk et al., 2006). 
The extract of G. biloba has been shown to inhibit the corticosterone secretion in rats 
via acting directly at the level of adrenal gland through diminution of the number of 
peripheral benzodiazepine receptors as well as may have a direct hypothalamic or 
supra-hypothalamic action which has drawn attention for anti-stress properties and has 
been proposed to revert back some of stress induced perturbations (Marcilhac et al, 
1998). 
2.28.3. Withania somnifera L., Solanaceae [Aswagandha, Indian ginseng] 
Ashwagandha is a small shrub is widely cultivated throughout India and is still 
immensely popular in traditional Ayurvedic and folk medicine. However it is the roots 
of Ashwagandha that are considered to be medicinally tonic, adaptogenic and 
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strengthening. It is said to "protect the organism from illness through maintaining the 
healthy balance of the physical energy. Traditionally, they are recommended for 
indigestion, heart disease, arthritis, lumbarpain, to lower fevers, and as a general 
strengthening medicine for children and for people recovering from illness (Rege et 
al., 1999). The root contains the steroid lactone Withaferin A and related withanolides 
beside various alkaloids. They showed anti-depressive effect, apparently through 
diminishing the stress effect, or through intervention in the monoamine metabolism of 
the brain (Bhattacharya and Muruganandam, 2003). Examinations showed that stress 
effects in rats led to a significant increase of the dopamine receptors in the corpus 
striatum and this effect can be suppressed through pre-treatment with Withania 
somnifera or with Panax ginseng extracts (Bhattacharya and Muruganandam, 2003). 
The oral application of sitoindosides IX and X has been reported for the improvement 
in learning and memory patterns in mice. Sitoindosides VII, VIII, IX and X have been 
reported as adaptogenic active substances of Withania somnifera, in spite of diverse 
steroidal structures. 
2.28.4. Eleutherococcus senticosus 
Taiga root, originating from Siberia was screened to replace the expensive 
ginseng root. The chief constituents are phenyl propane compounds (syringin= 
eleutheroside B). Lignanes (Eleutheroside E (D)), Cumarins (Isofraxidin-7-o-
glucoside) and polysaccharides along with sterins, oleanolic acid essential oil and 
sugar. The importance oiEleutherococcus senticoccus in various pathologies is clearly 
evident from its array of therapeutic activities (Rege et al., 1999; Pannosian and 
Wagner, 2005). The adaptogenic effect of Eleutherococcus during and /or after 
extensive exercise and at high altitude could be explained as the protective antioxidant 
effect of vitamin E and other anti-oxidants contained in plant extracts. In addition to 
this the anti-stress effect of eleutherococcus extracts have been demonstrated in animal 
experiments, through a raised protection from the typical organic changes during the 
alarm phase, as described by Selye, 1950. Improved resistance occurred in diverse 
models, with regard to a series of stressors. 
2.28.5. Bacopa monniera (Brahmi) 
Bacopa monniera (BM) (Linn) (family: Scrophulariaceae) is a perennial 
creeping annual plant found throughout the Indian subcontinent in wet, damp and 
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marshy areas (Chunekar, 1960; Satyavati et al., 1976). Commonly known as Brahmi, 
the plant has been used by Ayurvedic medical practitioners in India for almost 3000 
years and is classified as a medhyarasayana, a drug used to improve memory and 
intellect (medhya). After clinical trials in human volunteers, a chemically standardized 
extract of BM has now been made available for clinical use by the Central Drug 
Research Institute in India (Singh and Dhawan, 1982). BM has been reported to 
possess anxiolytic and memory enhancing activity (Das et al., 2002). In previous 
studies, the potential of BM as an effective adaptogen was identified that normalizes 
the stress-induced elevation in plasma glucose, creatine kinase and adrenal gland (Rai 
et al., 2003b). All these effects indicate the attenuating effect of BM on dysregulated 
HPA-axis in stressful conditions. Triterpinoid saponins and bacosides present in BM 
are considered to be responsible for enhancing cognitive function (Russo and Borrelli, 
2005). 
2.28.6. Ocimum sanctum (Tulsi) 
Ocimum sanctum (OS), popularly known as 'Tulsi' in Hindi and 'Holy Basil' in 
English and is considered sacred for its medicinal properties in Indian sub-continent. 
OS contains a number of chemical, constituents that interact in a complex way to elicit 
their pharmacological responses. 
(a) Plant description 
The plant is distributed and cultivated throughout India. It is an erect, much 
branched softly pubescent. Thus is a shrub of 30-60cm height with red or purple sub -
quadrangular branches. Leaves are simple, opposite, elliptic, oblong, obtuse or acute, 
with entire, sub-serrate, or dentate margins, pubescent on both sides, minutely gland 
dotted, with slender, hairy petioles. Flowers are purplish in elongate racemes in close 
whorls, stamens exerted, upper pair with a small bearded appendage at the base fiiiits 
nut lets, smooth, not mucilaginous when wetted. The plant is bitter and acrid. The 
whole plant of as has medicinal value, few of them are aromatic, stomachic, 
demulcent, diaphoretic, digestive, diuretic, expectorant, febrifuge, vermifuge and 
alexiteric properties. Mostly leaves and sometimes the seeds are also used (Rege et 
al., 1999). 
In several ancient systems of medicine including Aired, Greek, Roman, 
Sridhar and Inane, OS has vast number of therapeutic applications such as in 
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cardiopathy, haemopathy, leucoderma, asthma, bronchitis, catarrhal fever, 
hepatopathy, vomiting, lumbago, hiccups, ophthalmia, gastropathy, genitourinary 
disorders, ringworm, and skin diseases etc (Singh and Majumdar, 1999; Uma Devi, 
2001; Kelm, 2000; Pannosian and Wagner, 2005). 
(b) Chemical constituents 
OS leaves contain 0.7% volatile oil comprising about 71 % eugenol and 20% 
methyl eugenol. The oil also contains carvacrol and sesquiterpine hydrocarbon 
caryophyllene. Ursolic acid has been isolated from the OS leaves (Nair et al., 1982; 
Balanehru and Nagarajan, 1991). Nair et al. (1982) also isolated apigenin, luteolin, 
apigenin7-a-glucuronide, luteolin-7-a-glucuronide, orientin, and molludistin. Isolation 
of two flavonoids, orientin and vicenin from the aqueous leaf extract of OS is also 
reported by Umadevi et al. (2001). Kelm (2000) have extracted, and purified phenolic 
compounds from the fresh leaves and stems of OS such as cirsilineol, cirsimaritin, 
isothymusin, isothymonin, apigenin, rosmarinic acid and appreciable quantities of 
eugenol. The structures of these compounds have also been elucidated. Seeds of OS 
possess the fatty oil (17.82%) consisting 6.9%) palmitic acid, 2.1 %> stark acid, 15.7% 
linolenic acid, 66.1 % linoleic acid and 9% oleic acid. The unsaponifiable matter 
yielded a small quantity of sitosterol. 
(c) Pharmacological profile studied for OS to till date. 
(1) Hypoglycemic and hypolipidemic activity 
Holy basil leaves obtained from two closely related species, as and Eclipta 
alba possessed similar therapeutic values and was used for treating diabetes, arthritis 
and bronchial asthma (Dhar et al., 1968; Giri et al., 1987). Experimental studies in 
albino rats showed the efficacy of basil leaves in decreasing blood glucose in 
hyperglycemic rats and rabbits (Sarkar and Pant, 1989). In the latter study, seeds were 
found to be less effective than leaves. Further, oral administration of ethanolic as leaf 
extract potentates the action of exogenous insulin in normal rats. The activity of the 
extract was 91.55 and 70.43% of that of tolbutamide in normal and streptozotocin 
induced diabetic rats respectively (Chattopadhyay, 1993). To explore further 
evidence, effect of treatment with holy basil leaves on fasting and post-prandial blood 
glucose and serum cholesterol levels in humans were assessed through a randomixed 
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placebo controlled crossover single blind trial in patients of non insulin dependent 
diabetes mellitus (NIDDM) (Agarwal and Singh, 1996). The results of the trial 
indicated a significant decrease in fasting and post-prandial blood glucose levels 
during treatment as compared to placebo and the findings suggested that basil leaves 
might be prescribed as an adjunct to dietary therapy and as a drug treatment in mild to 
moderate NIDDM. Tulsi leaf powder supplementation at 1% dose level showed 
significant hypoglycemic and hypolipidaemic effects in diabetic rats with could be 
associated with the essential oil, eugenol present in OS leaf powder (Rai et al., 1997). 
(2) Anti-ulcerogenic activity 
The fixed oil of OS was found to possess significant antiulcer activity against 
aspirin, indomethacin, alcohol, histamine, reserpine, serotonin and stress induced 
ulcerafion in experimental animal models (Mandal et al., 1993; Singh and Majumdar, 
1999). Significant inhibifion was also observed in gastric secretion and aspirin 
induced gastric ulceration in pylorus ligated rats. Recently a study has demonstrated 
the anfi- ulcerogenic and ulcer healing properties of ethanolic of OS (Dharmani et al, 
2005). The studies were carried out in cold restraint, asprin, pyloric ligafion and 
histamine induced ulcer models. The ulcer healing activity was demonstrated in 
chronic acefic acid induced ulcerafion. The anti-ulcer effect of OS was said to be due 
to its anti secretory and cytoprotective effect. 
(3) Antifertility activity 
Anfifertility activity of as leaves has been reported in rats, mice and 
rabbits. In one of the above studies benzene extract was more effective than petroleum 
ether extract or other extracts. Benzene extract of fresh OS leaves in male rats 
indicated significant reducfion in sperm count, sperm mofility and weight of tesfis 
(Batta and Santhakumari, 1971). Long term feeding (up to 3 months) of Tulsi leaves 
(200 and 400 mg/kg) to adult male and female albino rats along with normal diet 
decreased sperm count, sperm mofility and the weight of male reproductive organs. 
The mating behavior of both male and female rats was inhibited severely (Batta and 
Santhakumari, 1971). 
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(4) Hepato-protective activity 
The cold-water extract at 3g/100g body weight dose when fed orally for 6 days 
was found to be effective against carbon tetrachloride (0.2 ml/100 g subcutaneously) 
induced liver injury (necrosis, fatty degeneration and hydroid degeneration) in albino 
rats (Seethalaksmi et al., 1982). Similar effect was observed with 70% ethanolic 
extract. 
(5) Immunomodulatory activity 
Steam distilled extract from the fresh leaves showed modification in the 
humoral immune response in albino rats, which could be attributed to such 
mechanisms as antibody production, release of mediators of hypersensitivity reactions 
and tissue responses to these mediators in the target organs (Mediratta, 1988). 
(6) Anti-oxidant activity 
Uma Devi has reviewed the antioxidant activity of OS (Umadevi, 2001). 
Antioxidant properties of flavonoids from different sources have been reported (Hu et 
al., 1995, Saija et al., 1995). Ursolic acid isolated from as offered remarkable 
protection against lipid peroxidation in isolated liver and heart microsomes in vitro. 
The compound did not induce lipid peroxidation by itself and thus improved 
therapeutic application. It also provided mild protection as compared to strong 
protection by oleanolic acid against adriamycin induced lipid per oxidation 
(Balanehru and Nagarajan, 1991). Protective role of aqueous leaf extract against ra-
diation-induced lipid per oxidation, glutathione and allied antioxidant enzymes in 
liver of mice was observed (Umadevi, 2001) as leaf extract exhibited significant 
antioxidant activity against several paradigms of oxidative stress induced by a variety 
of techniques in different rat tissues, which was comparable to that of vitamin E 
(Shetty et al., 2008). 
(7) Chemo-preventive and anti-carcinogenic activity 
The anti-proliferative and chemo-preventive activity of OS aqueous leaf 
extract and seed oil was studied using 3-(4,5- dimethylthiazole-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT) assay on HeLa cells. Significant antiproliferative activity 
was observed only with high concentrations (83.33 and 250g/ml) of seed oil. Leaf 
extract and low doses of seed oil did not affect the proliferation of the cells 
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(Samudralwar and Garg, 1996). Anticarcinogenic potential of OS has significantly de-
creased the incidence of benzopyrene induced neoplasia of stomach and 3'-methyl-4-
dimethylaminoazobenzene induced hepatomas in rats Topical treatment of as leaf 
extract in DMBA induced papillomagenesis significantly reduced the tumour 
incidence, average number of papillomas/mouse and cumulative number of 
papillomas in mice. Topical application of the extract significantly elevated reduced 
glutathione content and glutathione-S-transferase (GST) activity (Uma Devi, 2001). 
The chemopreventive action of as leaf extract is probably through the induction of 
hepatid extrahepatic GST in mice. Ethanolic leaf extract also had significant modula-
tory influence on carcinogen metabolizing enzymes (cytochrome P450, cytochrome bs 
and aryl hydrocarbon hydroxylase, GST and GSH levels in mice (Banerjee et al, 
1996). 
(8) Psychopharmacological activity 
The ethanolic leaf extract of as was screened for psychopharmacological 
activities. The extract prolonged the time of lost reflex (the time interval between the 
loss and regaining to righting reflex after administration of pentobarbital sodium at a 
dose of 40 mg/kg Lp. in mice), decreased the recovery time and severity of electro-
shock and pentylenetetrazole induced convulsions. It also decreased apomorphine 
induced fighting time and ambulation in open field studies. Using a behavioral despair 
model involving forced swimming in rats and mice, the extract lowered immobility in 
a manner comparable to imipramine. This action is blocked by haloperidol and 
sulpiride, indicating a possible action involving dopaminergic neurones. In a similar 
study, there was a synergistic action has been reported when extract was combined 
with bromocriptine, a potent D2-receptor agonist (Sakina et al., 1990). 
(9) Adaptogenic activity 
The ethanolic leaf extract of OS was screened for antistress activity against 
acute and chronic noise induced changes in plasma corticosterone level in albino rats 
(Sembulingam et al., 1997). Changes in leukocyte count during noise induced stress 
and the normalization by OS were reported (Archana and Sembulingum, 2000). 
Methanolic and ethanolic extracts tested for anti stress activity in swimming 
endurance model increased physical endurance during swimming, prevented stress 
induced ulcers and milk induced leucocytosis in rats and mice, respectively, 
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indicating induction of non-specifically increased resistance against a variety of stress 
induced biological changes by OS in animals (Bhargava and Singh, 1981). Some 
workers observed lowering effect on stress-induced increase in cholesterol, lactate 
dehydrogenase and alkaline phosphatase levels (Sen et al., 1992). From these 
experimental findings, authors suggested the involvement of neurotransmitters for the 
anfi-stress activity of OS. Studies conducted to till date proves the multiflincfional 
nature of OS was conformed that the anti-stress effect is due to the cumulative effort 
of all the constituents extracted with specific solvents used in the study but a complete 
study of fractions and the major active constituents is lacking. 
2.28.7, Evolvulus alsinoides (Shankhpuspi) 
Evolvulus alsinoides (EA) is an important plant that has been well documented 
in Ayurveda for its therapeutic values. EA (Linn) (Family: Convolvulaceae) 
commonly known as Shankhpuspi is found throughout India ascending to 6000 ft in 
the Himalayas. It is well known for its therapeutic effect on brain disorders like 
insanity, epilepsy, memory enhancement and nervous debility in Indian Ayurvedic 
system of medicine (Chatterjee, 1990). Recent pharmacological studies on leaves and 
whole plant of EA have indicated its anti-ulcer (Asolkar et al., 1992) and 
immunomodulatory properties (Lilly et al., 2003). Some in vitro experiments have 
revealed the anti-oxidant properties of EA (Auddy et al., 2003). In Africa EA is used 
to treat low spirits and depression (Bussman et al 2006). 
(a) Anti-oxidant properties 
Ethanolic extract and aqueous infiision of leaves was tested for Lipid 
peroxidation and ABTS radical scavenging properties in plasma and brain 
homogenate of rat. Ethanolic extract at a dose of 10-lOOfjgm/ml and aqueous infiision 
at a dose of 50-400pgm/ml were effective in scavenging ABTS radical and preventing 
lipid peroxidation. Cytotoxicity studies were conducted in PC 12 cell lines for both 
Ethanolic extract, aqueous infiision and were found to be non-cytotoxic at a 
concentration ranging from 25^gmyml- Img/ml. Both the extracts were again 
considered for Ex-vivo studies for the effect on rat plasma TBARS and ABTS radicals 
and found to be significantly effective. The authors also concluded from their study 
that aqueous extract is having potential anti-Oxidant capacity compared to the 
ethanolic extract of EA (Auddy et al., 2003). 
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(b) Immunomodulatory properties 
Immunomodulatory properties of EA were evaluated by Lilly et al. (2003) in 
adjuvant induced arthritic (AIA) rat model. AIA is an erosive autoimmune 
polyarthritis involving both humoral and cell mediated immune responses that 
resemble human rheumatoid arthritis. In this study the dose was optimized and was 
found to be effective at 25mg/kg body weight of rat. The Aqueous extract was 
effective in reducing AIA by lymphocyte suppression and Macrophage inactivation as 
reflected in lymphocyte proliferation assay and Nitric-oxide release estimation by 
activated macrophages and was concluded to be having potential immunosuppressive 
properties. In our literature survey not much scientific validation of EA was reported 
for its various therapeutic activities as recorded in Ayurvedic texts. So, this plant is 
considered to screen the crude extracts and isolated compounds for anti-stress which 
may provide scientific basis for activities reported in Ayurvedic texts. 
2.29. Other important medicinal plants: 
2.29.1. Nardostachys jatamansi 
Nardostachys jatamansi Jones DC (commonly named as jatamansi), belonging 
to family Valerianaceae, is described in Indian traditional system of medicine 
(Ayurveda), for its use in mental disorders, insomnia, hyperlipidemia, hypertension 
and heart diseases (Subashini et al., 2007). It has protective effect in Parkinsonism, 
epilepsy, cerebral ischemia, liver damage (Ali et al., 2000). Jatamansi showed marked 
tranquilizing activity in mice. Jatamansi is capable of lowering norepinephrine as well 
as serotonin in brain (Ahmad et al, 2006). Various sesquiterpenes (such as Jatamansic 
acid and Jatamansone) have been reported to be present in the rhizomes of the plant 
(Chatterjee et al, 2000). 
2.29.2. Commiphora whighitii (Guggulipid) 
Commiphora whighitii (Family: Burseraceae) commonly called, as gum 
guggulu is highly valued in Ayurveda an Indian system of medicine. The gum resin 
exudate of C. whighitii tree has been used in Ayurvedic medicine for more than 2000 
years to treat a variety of ailments like obesity, lipid disorders, rheumatoid arthritis 
(Dev, 1987). Experimental studies with extracts and fractions of guggulu demonstrated 
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anti-inflammatory activity (Gujral et al., 1960). Gugulipid, an ethyl acetate extract of 
the resin of plant C. whighitii is an established hypolipidemic agent. The major 
constituent of gugulipid is guggulsterone [4, 17 (20)-pregnadiene-3, 16-dione]. 
2.29.3. Tinospora sinensis 
Tinospora sinensis (Lour.) Merrill (syn Tinospora malabarica) belonging to the 
family Menispermaceae, is commonly known as Gurch in Hindi and Sudarsana in 
Sanskrit (Jain and De Filipps, 1991). It is a large deciduous climber with rambling 
stems, bearing aerial roots from branches and is found almost throughout India, 
ascending to an altitude of 1,000 m. It has been used in traditional Ayurvedic medicine 
for treating debility, dyspepsia, fever, syphilis, bronchitis, jaundice, urinary, skin, and 
liver diseases. It is also reported to possess anti-inflammatory (Li et al., 2003) and 
antidiabetic (Yonemitsu et al, 1993) activities. It also inhibits cyclophosphamide 
induced anemia, increase WBC count in mice, and possess immunomodulatory 
activity. Stem of this plant is used as a brain tonic, in chronic rheumatism and for 
fumigation in piles and ulcerated wounds (Li et al., 2003). A white starchy substance 
extracted from stems and roots, known as galo is used for treating fever. 
2.29.4. Pterospermum acerifolium 
Pterospermum acerifolium (PA) wild (Sterculiaceae) commonly known as 
'Kanak champa' is a shrub distributed in tropical Asia. It has been traditionally used 
for blood troubles, inflammation, ulcer, tumors and leprosy for small pox eruptions 
(Kiritikar and Basu, 1935). The ethanolic extract of PA was found to possess anti-
inflammatory and analgesic activity (Balachandran and Govindrajan, 2005). PA has a 
wide application in traditional system of Indian medicine for example; in ayurvedic 
anticancer treatment flowers are mixed with sugars and applied locally (Balachandran 
and Govindrajan, 2005). Flowers and bark, charred and mixed with kamala applied for 
treatment of smallpox. Flowers made into paste with rice water used as application for 
hemicranias (Caius, 2005). Stem bark of the plant was found to have antimicrobial 
activity (Khond et al., 2009). Isolation of boscialin glucosides from leaves of PA have 
been reported (Mamun et al., 2000). Hepatoprotective effect of ethanol extract of 
leaves of PA was also reported (Kharpate et al., 2007). Chronic effects of PA on 
glycemic and lipidemic status of type 2 model diabetic rats was found beneficial 
(Mursheed et al., 2000). 
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2.30, Synthetic Isoxazoline Moieties 
Previous studies showed that several isoxazoline moieties, possessed a wide 
spectrum of activities like protein tyrosine phosphatases IB inhibitory activity (Ahmad 
et al., 2006) (Maurya et al., 2008), antimicrobial (Gaonkar et al., 2007), anti-influenza 
virus (Kai et al, 2001), antifungal (Basappa et al., 2003), glycoprotein Ilb/IIIa receptor 
antagonists (Sielecki et al., 2001), anti-HIV (Ichiba et al., 1993), analgesic and anti-
inflammatory, (Habeeb et al., 2001) and a-adrenergic receptor antagonist properties 
(Conti et al., 1998). However, their role during stressful condition is not known. 
Synthesis of series of new 3, 5-disubsituted isoxazolines and their evaluation for anti-
stress activity could be an interesting area to identify new anti-stress agents from 
synthetic origin. 
2.31. Chemistry of plant adaptogens 
Plants synthesize thousands of primary and secondary plant compounds that 
have a dizzying array of chemical structures (Pannosian et al., 1999). For adaptogens, 
finding which compounds produce adaptogenic effects has been a challenging task 
because of the multitude of targets and activities of these plants. Adding to this 
challenge is that, compared to drug remedies that are usually concentrated, single 
substances, plant extracts have a complex synergistic action that has made the scientific 
investigation of adaptogen remedies a precipitous and tortuous affair. Panossian et al. 
(1999) and researchers before them have paved the way for identifying the primary 
chemical compounds thought to be responsible for adaptogenic activity. They suggest 
that three main classes of plant compounds are responsible for increasing resistance to 
stress: triterpenes, phenylpropanoids and oxylipins. Some examples of these compounds 
in adaptogenic plant species are given in Table 6. 
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Table 6: 
Chemical compound Common name Latin name Citation 
Triterpenoids 
Phyenylpropanoids 
Oxylipins 
bacoside 
eleutheroside 
ginsenoside 
withanolide 
flavonoids 
rosarin 
brahmi 
Siberian ginseng 
ginseng 
ashwagandha 
holy basil 
rose root 
Bacopa 
monniera 
Eleutherococcus 
senticosus 
Panax ginseng 
Withania somnifera 
Ocimum 
sanctum 
Rhodiola rosea 
Vohora at al., 
2000 
Baranov, 1982 
Rudakewich and 
Benishin, 2001 
Evans, 2002 
Wagner et al., 
1994 
Brown et al., 
2000 
hydroxylated 
FAs licorice 
Glycyrrhiza 
glabra Panossian, 2003 
It has been suggested by Panossian (2003) that these three main classes of plant 
compounds may be mimicking the neurotransmitter and hormones involved in allostasis 
and in allostatic load by providing a sparing action or competitive binding. If so, it would 
explain how adaptogenic plant remedies are able to attenuate stress mediator dysfunction. 
Some of these plant compounds have been shown to bind to 5-HT, DA, and muscarine 
receptors and the Ca^ ^ channel (Panossian, 1999, Rege et al., 1991, Pannosian and 
Wagner, 2005). It is possible that they may reduce allostatic load by mimicry and thus, 
provide a sparing action or weak response. The support for such mimicry is found in both 
the biosynthetic pathways common to both plants and humans, resulting in similar 
chemical structures. 
2.32. Need of Scientific approach for the development anti-stress agents 
Nature has been a source of medicinal treatments for thousands of years and 
plant-derived products continue to play an essential role in the primary health care of 
about 80-85 % of the world's population. Hence, these herbal extracts traditionally used 
should have been evaluated scientifically in the present day studies to define the role of 
these agents in limiting the deleterious affects of stress-related disorders by providing 
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scientific data to validate their use as prophylactic approaches or as an adjunct to 
standard treatment (Satyawati et al., 1976). The benzodiazepine anxiolytic, despite 
having significant anti-stress/adaptogenic activity have not been proven effective 
against chronic stress induced adverse effects on immunity, behavior, cognition etc 
(Costa and Guidotti, 1996). Additionally the problem of tolerance, sedation and physical 
dependence on prolonged use causes limitation of these drugs clinically. Owing to these 
limitations of modem anti-stress drugs there is an urgent need to carefully evaluate the 
importance of using traditionally available anti-stress/adaptogenic plants and address the 
whole issue in a very sensitive and specific manner so that the therapeutic use of 
adaptogens becomes more reliable and target oriented. Development of indigenous 
herbal products may be a boon in developing countries like India and South East Asian 
Nations as the exogenous antioxidant/anti-stress agents are costly and therefore patients 
belonging to weaker sections of the society may be non-complaint in therapy on long 
term basis. 
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Objectives of the Research Work: -:^ ' 
The primary objective of the study was to understand the biological basis of stress by 
identifying the peripheral and central alterations correlating with intensity and duration of 
stressors. It also included evaluation of anti-stress activity of plant extracts/fractions/pure 
compounds in relation to the changes at neuroendocrine, biochemical and expression levels 
in rats. Following are the aims and objectives in accordance with the plan of work: 
(i) Standardization of different stress models (Flowchart, Part 1) 
This includes: 
> Standardization of acute, chronic predictable (homotypic stressors) and chronic 
unpredictable (heterotypic stressors) stress models in rats. 
> Evaluation of physiological (adrenal gland weight and ulcer severity) and 
biochemical peripheral changes (glucose, creatine kinase and corticosterone) in all 
the three stress models. 
> Evaluation of central neurotransmitter levels in discrete brain regions in all the 
three stress models. 
> Evaluation of in-vivo anti-oxidative status under acute and chronic unpredictable 
stress condition in selected brain regions. 
(ii) Standardization of anti-stress potential of various plants extracts/fractions/pure 
compounds and synthetic (isoxazolines) molecules at various doses 
[Flowchart, Part 2(i) and (ii)] 
This includes: 
> Identification of anti-stress potential of various plants extracts/fractions/pure 
compounds and synthetic molecules (isoxazolines) at various doses on stress-
induced physiological (adrenal gland weight and ulcer severity) and 
biochemical (glucose, creatine kinase and corticosterone) parameters in acute 
stress (AS) model. 
> Extracts/fractions/pure compounds with anti-stress potential under AS 
condition were further examined under chronic unpredictable stress (CUS) 
condition at respective effective doses. 
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(iii) Evaluation of anti-stress activity of lead molecules of Ocimum sanctum (OS) 
and examining their mechanism of action (Flowchart, Part 3) 
This includes: 
> Evaluation of the effect of OS compounds on stress-induced physiological 
(adrenal gland weight and ulcer severity) and biochemical (glucose, creatine 
kinase and corticosterone) alterations, both in AS and CUS condition. 
> Evaluation of the effect of OS compounds on AS and CUS-induced changes in 
the levels of monoamines and their metabolites in selected brain regions. 
> Evaluation of the effect of stress (AS and CUS) and OS compounds 
pretreatment on in vivo antioxidant status and lipid peroxidation in selected 
brain regions. 
> Elucidation of the effect of stress (AS and CUS) and OS compounds 
pretreatment on the expression of glucocorticoid receptor (GR) and heat shock 
protein (HSP)-70 in selected brain regions by Western Blotting. 
> Elucidation of the effect of stress (AS and CUS) and OS compounds 
pretreatment on the expression of Tyrosine Hydroxylase (TH) enzyme, GR and 
corticotropin releasing factor (CRF) in selected brain regions by Immuno-
histochemistry. 
> Examining the effect of stress (AS and CUS) and OS compounds pretreatment 
on the expression of various stress responsive genes like CRF, GR and pro-
opiomelanocortin (POMC) mRNA in selected brain regions by RT-PCR. 
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Plan of study 
P a r t i 
Standardization of stress models 
Acute stress (AS) 
T 
Clironic stress (CS) Chronic unpredictable stress (CUS) 
Parameters to examine stress-induced effects of different stress models 
Gastric 
pathology 
Gastric Ulcer 
(Mean ulcer score) 
Adrenal 
Hypertrophy 
Weight of 
adrenal gland 
Biochemical Hormonal 
Plasma 
Glucose 
Creatine Kinase 
Plasma 
Corticosterone 
ZL 
Neurotransmitters 
Noradrenaline 
Dopamine 
Serotonin & their 
Metabolites 
Part 2(i). 
Evaluation of effective doses for anti-stress activity of various plants 
(Extracts/fractions/pure compounds) and synthetic molecules (Isoxazoiines) 
I Acute stress I 
Gastric 
pathology 
Gastric Ulcer 
(Severity Index) 
Parameters studied 
Adrenal 
Hypertrophy 
Weight of 
Adrenal gland 
T 
Biochemical Hormonal 
Plasma Glucose 
and 
Creatine Kinase 
Plasma 
Corticosterone 
Part 2(ii), 
Extracts/fractions having anti-stress potential under AS model, were further 
examined for anti-CUS efficacy at respective effective doses in similar stress markers 
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Chapter 3 Materials and Methods 
3. Animals 
Experimental protocols were approved by our Institutional Ethical and Usage Committee 
following the guidelines of Committee for the Purpose of Control and Supervision of 
Experiments on Animals (CPCSEA). Adult male Sprague-Dawley rats, weighing 180-220 g 
were used in the study and were procured from National Laboratory Animal Centre (NLAC), 
Central Drug Research Institute (CDRI), Lucknow. Rats from control, stressed and treated 
groups were housed three per cage. Rats were kept in raised mesh bottom cages to prevent 
caprophagy at constant temperature (22 ± 2°C) and 12/12-h light/dark cycle. Standard chow 
pellet and water was given ad libitum, except during the period when food or water 
deprivation was applied. 
3.1 Materials used 
3.1.1 Chemicals used are listed below along with the manufacturer's names. 
Chemicals/Biochemicals 
Agarose 
Boric acid 
Bovine serum albumin (BSA) 
Chloroform 
Copper sulphate 
Diethyl pyrocarbonate (DEPC) 
5, 5'-dithiobis (2-nitrobenzoic acid) (DTNB) 
Di sodium hydrogen phosphate (Na2HP04), 
Dithiotreitol (DTT) 
Dihydroxybenzylamine (DHBA) 
Dopamine (DA) 
Dihydroxyphenylacetic acid (DOPAC) 
Eosin 
Ethanol 
Manufacturer 
Genei, India 
SD Fine Chemicals Ltd.,India 
Sigma Chemicals, USA 
Merck, Germany 
Sisco Research Laboratories 
(SRL), India 
Sigma Chemicals, USA 
Sigma Chemicals, USA 
SRL, India 
Sigma Chemicals, USA 
Sigma Chemicals, USA 
Sigma Chemicals, USA 
Sigma Chemicals, USA 
SRL, India 
Merck, Germany 
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Ethidium bromide 
Ethylene tetra-acetic acid (EDTA) 
Folin's Reagent 
Formaldehyde 
Formalin 
Formamide 
Glacial Acetic acid 
Glycine 
Hematoxylin 
5-Hydroxy Indole Acetic Acid (5-HIAA) 
Homovanilic Acid (HVA) 
Isoporopanol 
Leupeptin 
Magnesium chloride (MgCli) 
Methanol 
Melatonin 
Nor-epinephrine (NA) 
Paraffin 
Pepstatin 
Phenyl methyl sulphonyl fluoride (PMSF) 
Polymerase Chain 
Reaction (PCR) 
Chemicals 
Panax 
quinquefolium{PQ) 
PCR buffer 
Magnesium chloride (MgCli) 
Deoxynucleotides (dNTPs) 
Taq polymerase 
Crude root powder 
Anti-stress Standard drug 
Potassium dihydrogen phosphate (KH2PO4) 
Reduced glutathione (GSH) 
Serotonin; 5-Hydroxy Tryptaraine (5-HT) 
Sodium acetate 
Sigma Chemicals, USA 
Sigma Chemicals, USA 
SRL, India 
SRL, India 
SRL, India 
SRL, India 
SD Fine Chemicals Ltd.,India 
SRL, India 
SRL, India 
Sigma Chemicals, USA 
Sigma Chemicals, USA 
Merck, Germany 
Sigma Chemicals, USA 
SRL, India 
Merck, Germany 
Sigma Chemicals, USA 
Sigma Chemicals, USA 
Merck, Germany 
Sigma Chemicals, USA 
Sigma Chemicals, USA 
Fermentas, USA 
Sigma Chemicals, USA 
SRL, India 
Sigma Chemicals, USA 
Sigma Chemicals, USA 
SRL, India 
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Sodium azide (NaN3) 
Sodium bicarbonate (NaHCOs) 
Sodium Chloride (NaCl) 
Sodium dodecyl sulphate (SDS) 
Sodium fluoride 
Sodium hydroxide (NaOH) 
Sodium - metavanadate 
Sodium potassium tartarate 
Sucrose 
Thiobarbituric acid 
Tert-butyl hydroperoxide 
1,3,3 -tetraethoxypropane 
Tris hydroxymethyl aminomethane (Tris buffer) 
Triton-X 
TRIZOL 
Tween-20 
Sigma Chemicals, USA 
SRL, India 
SRL, India 
Sigma Chemicals, USA 
Sigma Chemicals, USA 
SRL, India 
Sigma Chemicals, USA 
SRL, India 
Spectrochem, India 
Sigma Chemicals, USA 
Sigma Chemicals, USA 
Sigma Chemicals, USA 
SRL, India 
SRL, India 
Invitrogen, USA 
SRL, India 
3.1.2 Kits 
Retro script cDNA preparation Kit 
Glucose and Creatine kinase estimation 
Kits 
Fermentas, USA 
Beckman Coulter International, Nyon, 
Switzerland 
3.L3 Instruments 
Weighing Balance 
Auto analyzer 
Gel documentation system -Alpha Image 
Analyzer'^'2200 
Hoefer" '^' mini horizontal electrophoresis system 
(Chyo,modelJS110),USA 
(Synchron Cx-9, Beckman 
Coulter International, 
Nyon, Switzerland) 
Alpha Innotech, CA, USA 
Amersham Biosciences, 
San Francisco, CA, USA 
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Polytron homogenizer 
Sigma Laboratory Centrifuge, 3K30 
Thermocycler 
Table Top Refrigerated centrifuge 
High Performance Liquid Chromatography (HPLC) 
system consisting of 1525 Binary HPLC Pump, 2487 
Dual Wave length Absorbance Detector, 2465 
Electrochemical detector with Spherisorb RP-C18 
column, 5^m particle size, 4.6mm x 250 mm. 
Littau-Luceme, 
Switzerland 
Germany 
Bioer XP Cycler, China 
Rami, Mumbai, India 
Waters, Wein, Austria 
Image analysis system 
Freezing Micrtotome 
Whatmann GF/C filters 
Leica Qwin 500 image 
analysis software, 
Germany 
Slee Manz Co., Germany 
Millipore, U.S.A 
AH the other chemicals used in the study were of analytical or HPLC grade, which were 
purchased locally. 
3.1.4 
Genes 
GR 
CRH/ 
CRF 
POMC 
P-Actin 
Primers 
Sequence 
FP: 5'-GATTCCAAGCAGCAGA-3' 
RP: 5'-CGAGAAGGAATGGATCATC-3' 
FP: 5'-AAAATGTGGATCCAAGGAGGA-3' 
RP: 5'- TGCCACCCCTCAAGAATGAA -3' 
FP: 5'- TGGCCCTCCTGCTTCAGAC-3' 
RP: 5'- CTCACTGGCCCTTCTTGTGC-3' 
FP: 5'- GCTGTGTTGTCCCTGTAT-3' 
RP: 5'- CCGCTCATTGCCGATAGTG-3' 
Product 
Size 
(bp) 
607 
104 
679 
352 
Annealing 
Temp. & No. 
of cycles 
55°C 
& 
30 
64°C 
& 
35 
59.5°C 
& 
30 
55°C 
& 
30 
Reference 
Yan-yan et 
al., 2007 
Sitte et al., 
2007 
Marini 
et al., 
2006 
Konturek 
et al., 2003 
FP: Forward Primer; RP: Reverse Primer; GR: Glucocorticoid Receptor; CRH: Corticotropin 
releasing hormone; POMC: Pro-opiomelanocortin. 
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3.1.5 Antibodies (Used in Western Blotting and Immuno-histochemistry) 
Tyrosine hydroxylase monoclonal primary antibody 
(raised in mouse) 
Glucocorticoid receptor polyclonal primary antibody 
(raised in rabbit) 
Corticotropin releasing hormone monoclonal primary 
antibody (raised in goat) 
Heat Shock protein-70 monoclonal primary antibody 
(raised in goat) 
P-Actin polyclonal primary antibody (raised in rabbit) 
Rabbit anti-goat HRP labeled secondary antibody 
Rabbit anti-mouse HRP labeled secondary antibody 
Goat anti- rabbit HRP labeled secondary antibody 
Sigma Aldrich 
Santa Cruz 
Sigma Aldrich 
Sigma Aldrich 
Santa Cruz 
Sigma Aldrich 
Santa Cruz 
Santa Cruz 
3.2 Plant material 
All the plants were collected by the Botany Division of the CDRI, and the voucher 
specimen numbers were assigned and preserved in the Herbarium of the Institute. All the 
extraction, fractionation, isolation, purification, and characterization procedures of plant 
extracts/fractions/pure compounds were performed by our chemistry counterparts. Medicinal 
Chemistry Division of CDRI. In the present study, total six plants were used to evaluate their 
anti-stress potential. These six plants are Ocimum sanctum (OS), Tinospora sinensis (TS), 
Pterosperpum acerifolium (PA), Commiphora wighittii (CW), Evolvulus alsinoides (EA) and 
Nardostachys Jatamanasi (NJ). 
3.2.1 Ocimum sanctum (OS) 
The plant material was collected from Azamgarh, Uttar Pradesh, India in November 
2002 and was confirmed as OS by the Botany Division of CDRI, where a voucher specimen 
(No. 38) preserved in the herbarium. The dried and powdered leaves of OS were extracted 
with ethanol and concentrated at 45 °C. The resulting dried ethanol extract was suspended in 
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water and sequentially partitioned with chloroform and «-butanol. The «-butanol-soluble 
fraction was separated by a combination of chromatographic procedures, which afforded 
three new compounds designated as Ocimumoside A, Ocimumoside B, and Ocimarin. The 
chemical details of OS compounds are as follows: 
Ocimumoside A 
(26)-1-0 -hexadecanoyl- 2-0-docosanoyl)-3-0-[6-deoxy-6-amino-R-D glucopyranoside] 
glycerol, 
Exact Mass: 813.67 
MoLWt.: 814.23 
m/e: 813.67 (100.0%), 814.67 (53.0%), 815.68 (14.3%), 816.68 (3.4%), 815.67 (2.0%), 814.68 (1.4%) 
C,69.33;H,11.26;N, 1.72; 0,17.68 
1' OH 
Ocimumoside B 
(25)-l-Ooctadecanoyl-2-0-tetradecanoyl)-3-0-[R-D-galactopyranosyl-(l"f6')-0-_-D-
galactopyranosyl] glycerol 
Exact Mass: 892.61 
Mol. Wt.: 893.19 
m/e: 892.61 (100.0%), 893.62 (54.2%), 894.62 (17.4%), 895.62 (3.9%) 
C, 63.20; H, 9.93; O, 26.87 
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Ocimarin 
7-hydroxy-3-(2-hydroxyethyl)-4-methyl-2//-1 -benzopyran-2-one 
E x a c t IVIass: 2 2 0 . 0 7 
Wlol. W t . : 2 2 0 . 2 2 
m/e: 220.07 (100.0%), 221.08 (13.7%), 222.08 (1.7%) 
C, 65.45; H, 5.49; O, 29.06 
CH3 
3.2.2 Tinospora sinensis (TS) 
TS (stem) were collected from Paschin Midnapur (W. B.) in the month of January, 
2006. Collection and authentication were made by Botany Division of CDRI. Specimen 
(4601) is preserved in the herbarium of CDRI. Powdered stem of TS (15.0 kg) were placed in 
a glass percolator with ethanol (25 L) and allowed to stand at room temperature overnight. 
The percolate was collected. This process of extraction was repeated four times. The 
combined extract was filtered, concentrated at 45 °C under vacuum, afforded ethanol extract 
720.0 g. 
3.2.3 Commiphora whighitii (Gugulipid) 
Commiphora whighitii (Family: Burseraceae) commonly called, as gum guggulu. 
Gugulipid, is an ethyl acetate extract of the resin of this plant. Gugulipid was prepared in 
CDRI, Lucknow, India. The Institute had obtained US patent no. 6896901 for the use of 
gugulipid as cognitive enhancer. 
3.2.4 Nardostachys jatamansi (NJ) 
The shade dried plant material, i.e., rhizomes of NJ was coarsely powdered and 
extracted with 70% ethanol at room temperature. The extract was then concentrated in 
reduced temperature and pressure on a rotary evaporator, then lyophilized and stored at 4°C 
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(yield 9%). The chemical constituents of the extract were identified by qualitative group 
analysis and confirmed by thin layer chromatography. 
3.2.5 Pterosperpum acerifolium (PA) 
PA (fruit) was collected and authenticated by the Botany Division of CDRI. 
Specimen number was preserved in the herbarium of CDRI. Powdered fruit of PA (13.0 kg) 
were placed in a glass percolator with ethanol (22 L) and allowed to stand at room 
temperature overnight. The percolate was collected. This process of extraction was repeated 
three times. The combined extract was filtered, concentrated at 45 °C under vacuum, afforded 
ethanol extract 580.0 g. 
3.2.6 Evolvulus alsinoides (EA) 
EA (whole plant) was collected and authenticated by the Botany Division of CDRI. 
Specimen (2659) was preserved in the herbarium of CDRI. Powdered whole plant (17kg) 
was placed in percolator with ethanol (30 L) and was allowed to stand at room temperature 
for about 36 hours. The percolate was collected. This process of extraction was repeated for 
five times. The combined extract was filtered and concentrated under vacuum using 
rotavapor at 40 °C, weight of extract obtained 1.19 Kg. Further successive partitioning of the 
dried extract in various fractions was done. Butanolic fraction was then subjected to sequence 
of normal and reverse-phase column chromatography, to yield various EA compounds (1-6). 
The chemical details of EA compounds are as follows: 
EA-1 
2,3,4-trihydroxy-3-methylbutyl 3-[3-hydroxy-4-(2,3,4-trihydroxy-2-methylbutoxy)-phenyl]-
2-propenoate 
E x a c t I V I a s s : 4 1 6 . 1 7 " 
M o l . W t . : 4 1 6 . 4 2 
m / e : 4 1 6 . 1 7 - ( 1 0 0 . 0 ° / & ) , 4 1 7 ^ . I T ( 2 2 . O S ^ ) , 4 1 8 . I T 
( 4 . 1 °A>) 
C 5 4 . S O ; H , 6 . T 8 ; O , 3 8 . 4 2 
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H O 
H Q H 
H O '- 5" 
O H 
H O H 
EA-2 
1,3-di-O-caffeoyl quinic acid methyl ester 
C 1 9 H 2 8 O 1 0 
E x a c t M a s s ; 4 1 6 . 1 7 
M o l . \A/t.: 4 1 6 . 4 2 
m / e : 4 1 6 . 1 7 ( 1 0 0 . 0 % ) , 4 1 7 . 1 7 ( 2 2 . 0 % ) , 4 1 8 . 1 7 
( 4 . 1 % ) 
C , 5 4 . 8 0 ; H , 6 . 7 8 ; O , 3 8 . 4 2 
O R 
O R 
R O O R 
EA-3 
Caffeic acid 
C9H-10O4 
Exac t M a s s : 182 .06 
Mo l . Wt . : 182.17 
m/e: 182 .06 ( 1 0 0 . 0 % ) , 183 .06 (10 .3%) , 184 .06 (1 .2%) 
C, 59 .34 ; H, 5 .53; O, 35 .13 
H O 
H O 
O H 
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EA-4 
6-methoxy-7-0-b -glucopyranoside coumarin 
E x a c t M a s s : 3 5 4 . 1 0 
M o l . W t . : 3 5 4 . 3 1 
m /e : 3 5 4 . 1 0 ( 1 0 0 . 0 % ) , 3 5 5 . 1 0 ( 1 8 . 4 % ) , 3 5 6 . 1 0 
( 3 . 4 % ) 
C, 5 4 . 2 4 ; H, 5 . 1 2 ; O , 4 0 . 6 4 
OH H3CO 
--^-^o^o 
EA-5 
2-C-methyl erythritol 
E x a c t I V I a s s : 1 5 0 . 0 9 
I V I o l . \ A / t . : I S O . I T ' 
m / e : 1 5 0 . 0 9 ( 1 0 0 . O S < , ) , 1 5 1 . 0 9 ( e . S ' J ^ ) 
C , 4 7 ^ . 9 9 ; H , 9 . 4 0 ; O , 4 2 . 6 2 
HO 
H Q H 
HO 
O H 
EA-6 
Quercetine-3-O-b -glucopyranoside 
C 2 1 H 2 0 O 1 2 
E x a c t M a s s : 4 6 4 . 1 0 
M o l . W t . : 4 6 4 . 3 8 
m /e : 4 6 4 . 1 0 ( 1 0 0 . 0 % ) , 4 6 5 . 1 0 ( 2 4 . 1 % ) , 4 6 6 . 1 0 ( 5 . 1 % ) 
C, 5 4 . 3 1 ; H, 4 . 3 4 ; O , 4 1 . 3 4 
O H 
O H 
O H 
O H 
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3.3 Synthetic novel Isoxazolines (IZL) 
Apart from plant sources, we also examined the anti-stress potential of some synthetic 
molecules, which were prepared in the Medicinal Chemistry Division of the Institute. A 
series of novel isoxazolines (IZL) were synthesized via 1, 3-dipolar cycloaddition of in situ 
generated nitrile oxide from 2, 4-dimethoxy benzaldoxime and naphthaldehyde oxime with 
4-alIyl-2-methoxyphenol derivatives (Scheme 1). Total 14 isoxazolines (IZL lA-lG, IZL 
5A-5G) were synthesized and screened. 
3.3.1 Chemical formulas of the synthesized Isoxazolines (IZL) are as follows: 
IZL-IA 
4-[3-(2,4-Dimethoxy-phenyl)-4,5-dihydro-isoxazol-5-ylmethyl]-2-methoxy-phenol 
Isoxazoline 
IZL-IB 
4-[3-(2,4-dimethoxy-phenyl)-4,5-dihydro-isoxazol-5-ylmethyl]-2-methoxy-phenyl acetate 
IZL-IC 
5-(3,4-Dimethoxy-benzyl)-3-(2,4-dimethoxy-phenyl)-4,5-dihydro-isoxazole 
IZL-ID 
3-(2,4-Dimethoxy-phenyl)-5-(4-ethoxy-3-methoxy-benzyl)-4,5-dihydro-isoxazole 
IZL-IE 
5-(4-Benzyloxy-3-methoxy-benzyl)-3-(2,4-dimethoxy-phenyl)-4,5-dihydro-isoxazole 
IZL-IF 
3-(2,4-Dimethoxy-phenyl)-5-[3-methoxy-4-(2-pyrroIidin-l-yl-ethoxy)-benzyl]-4,5-dihydro-
isoxazole 
IZL-IG 
l.(2-{4-[3-(2,4-Dimethoxy-phenyl)-4,5-dihydro-isoxazol-5-ylmethyl]-2-methoxy-phenoxy}-
ethyl)-piperidine 
IZL-5A 
2-Methoxy-4-(3-naphthalen-l-yl-4,5-dihydro-isoxazol-5-ylmethyl)-phenol 
IZL-5B 
2-Methoxy-4-(3-naphthalen-l-yl-4,5-dihydro-isoxazol-5-ylmethyl)-phenyl acetate 
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IZL-5C 
5-(3,4-Dimethoxy-benzyl)-3-(naphthalen-l-yl)-4,5-dihydroisoxazole 
IZL-5D 
5-(4-Ethoxy-3-methoxy-benzyl)-3-naphthalen-l-yl-4,5-dihydro-isoxazole 
IZL-5E 
5-(4-Benzyloxy-3-methoxy-benzyl)-3-naphthalen-l-yl-4,5-dihydro-isoxazole 
IZL-5F 
5-[3-Methoxy-4-(2-pyrrolidin-l-yl-ethoxy)-benzyl]-3-naphthalen-l-yl-4,5-dihydro-isoxazole 
IZL-5G 
1 - {2-[2-Methoxy-4-(3-naphthalen-1 -yl-4,5-dihydro-isoxazol-5-ylmethyl)-phenoxy]-ethyl} -
piperidine 
N-OH 
OCH3 
H3CO. .OCH 
OR 
chloramine T 
: ^ 
EtOH 
OCH 
EtOH 
a: R=H, b: R^COCHs, c: R=CH3, d: R^CHjCHs, e: R=CH2C6H5, 
f: R= H2CH2CN J\, g: R= H2CH2CN \ 
Scheme 1. Synthesis of Isoxazohne (IZL) compounds by ahering the substituent in 4-allyl-2-
methoxy-phenol. 
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3.4 Methodology 
3.4.1 Stress models 
3.4.1.1 Acute stress (AS) 
After 18 hr fasting (food deprivation) of rats, one stress session consisting of a 2.5 hr 
immobilization period inside the cylindrical steel tube (7cm diameter, 17.5cm long, with 
holes for ventilation) at room temperature was performed during the early phase of the light 
cycle. 
3.4.1.2 Chronic stress (CS) 
It is a homotypic chronic stress model in which rats were subjected to immobilization 
stress for 150 min. daily for a period of seven days. 
3.4.1.3 Chronic unpredictable stress (CUS) 
It is a heterotypic chronic stress model in which rats were subjected to different type 
of stressors mild and severe every day in an unpredictable manner, for a period of seven 
days. The CUS procedure is a modification of published procedures (Katz et al, 1981; 
Willner et al, 1987). Individual stressors and length of time applied each day are listed in 
Table 1. 
3.4.2 Different stressors used in the study are as foUows: 
(a) Immobilization (Restraint) stress: Immobilization stress was produced by restraining 
each animal for a period of 150 min. inside a cylindrical steel tube (7cm diameter, 17.5cm 
long) having holes for ventilation (shown in picture 1). 
Picture 1: Immobilization stressor 
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(b) Swim stressor; Animals were dropped individually into glass cylindrical tank (height 40 
cm, diameter 20 cm) containing fresh water (25±2 °C) up to a depth of 30 cm and forced to 
swim for 30 min. This depth of water prevented subjects from supporting themselves by 
touching the base of the swim tank with their hind paws and tail. After each swim session the 
tank was thoroughly rinsed in order to remove the presence of any potential alarm substances 
and the water changed. After testing, each animal was towel-dried and returned to their home 
cage (shown in picture 2). 
Picture 2: Swim stressor 
(c) Foot-shock: In foot shock stress, rats were subjected to one shock per 2s of 2 mA 
stimulus for a total duration of 20 min on a grid floor in agressometer (Techno Electronics, 
Lucknow, India), shown in picture 3. 
Picture 3: Foot-shock stress 
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(d) Wetted cage bedding: In cages, the bedding was wetted with water to produce overnight 
inconvenience (shown in picture 4). 
Picture 4: Wetted cage bedding stressor 
(e) Day and Night reversal: This stressor was employed to disturb the circadian rhythm. 
Day and night reversal was produced by keeping the animals in the dark during day (3 hr) 
and in high intensity light during the night (12 hr) (shown in picture 5). 
Picture 5: Day/Night reversal stressor 
(f) Tail pinching: Tail pinching was performed by pinching the tail end of the rats with 
specially designed steel clips for 5 min (shown in picture 6). 
Picture 6: Tail pinching stressor 
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(g) Cold Exposure: Cold exposure was performed by putting rats in programmable 
environment test chamber (Remi, Mumbai. India) for 3 h at 4°C (shown in picture 7). 
Picture 7: Cold exposure stressor 
(h) Cold Restraint: In cold restraint stress, restraint rats were kept in similar programmable 
environment test chamber for 2 h at 4°C (shown in picture 8). 
Picture 8: Cold restraint stressor 
(i) Isolation stress: For isolation stress, rats were kept alone in a cage for a period of 12 hrs 
(shown in picture 9). 
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Picture 9: Isolation stressor 
(j) Fasting: Rats were subjected to fasting (food deprivation) for 18 hrs, started from 2.0 p.m 
to 10.0 a.m of the next day and water was provided to them ad-libitium. 
(k) Water deprivation: During water deprivation, rats were deprived of water for 18 hrs, 
started from 2.0 p.m to 10.0 a.m of the next day. 
Table 1 
Schedule of stressors used during chronic unpredictable stress (CUS) for a period of 7 
days. 
Dav 
1 
2 
3 
4 
5 
6 
7 
Time 
10:00 a.m. 
10:00 a.m. 
9:00 a.m. 
12:30 p.m. 
10:00 a.m. 
10:00 a.m. 
9:00 a.m. 
Procedure 
Tail Pinching 
Restraint stress 
Isolation stress 
Cold restraint stress 
Foot shock 
Forced swimming 
Restraint stress 
Duration 
5 min 
150 min 
12 hr 
2hr 
20 min 
30 min 
150 min 
Time 
2:00 p.m. 
3:00 p.m. 
9:00 p.m. 
3:00 p.m. 
4:00 p.m. 
2:00 p.m. 
12:30 p.m. 
Procedure 
Fasting (food deprivation) 
Wetted cage bedding 
Day night reversal 
Water deprivation 
Cold exposure 
Fasting (food deprivation) 
Sacrificed by cervical 
dislocation 
Duratii 
18 hr 
18 hr 
15 hr 
18 hr 
3hr 
18 hr 
— 
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3.4.3 Experimental procedure 
The rats were randomly divided into various groups and acclimatized under 
laboratory conditions for a week prior to the commencement of experiments. Suspensions of 
plant extracts/fractions/ compounds/synthetic compounds, Panax quinquefolium (PQ; as anti-
stress standard drug) and Melatonin (MEL; as antioxidant standard drug) were prepared in 
1% sodium carboxy methyl cellulose or according to specific solubility of drug daily before 
administration. Plant extracts/fractions/ compounds/synthetic compounds and PQ were 
administered orally using a ball ended feeding needle and MEL was given intraperitoneally 
(i.p.). Two types of controls were run in the present study, one untreated non-stressed group 
and another vehicle-treated non-stressed. As there were no significant differences between 
the two groups in the basic stress parameters assayed, for further comparison purposes 
untreated non-stressed rats were used as controls. 
Groups 
(Control group) 
(Acute Stress 
group) 
(Chronic 
Homotypic Stress) 
(Chronic 
Heterotypic Stress) 
(Acute treatment 
groups) 
(Chronic treatment 
groups) 
(Standard groups) 
Procedure 
Rats were not subjected to stress and 
kept undisturbed in their home cages 
Rats were subjected to single 
immobilization stress (150 min) 
Rats were subjected to immobilization 
stress (150 min) daily for 7 days 
Rats were subjected to two different 
types of stressors daily for 7 days 
Rats were pretreated with 
extracts/fractions/compounds for 3 days, 
and then on the third day, 45 min after 
the administration of drug rats were 
subjected to AS 
Rats were pretreated with 
extracts/fractions/compounds 45 min 
prior to the exposure of stress regimen 
daily for 7 days 
Rats were pretreated with PQ (100 
mg/kg p.o.) or MEL (20 mg/kg i.p.) for 
3 and 7 days as acute and chronic 
treatment groups respectively prior to 
the exposure of stress regimen in each 
case. 
Name of groups 
Non-stress (NS) 
Acute Stress (AS) 
Chronic 
stress (CS) 
Chronic 
unpredictable 
stress (CUS) 
Extracts/fractions/ 
Compounds + AS 
Extracts/fractions/ 
Compounds + CUS 
PQ + AS/CUS 
MEL + AS/CUS 
Table 2: Tabular representation of the experimental protocol 
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3.4.4 Brain dissection and sample preparation 
Immediately after the last stressor all the rats were killed by conscious cervical 
dislocation followed by decapitation, the skull were immediately removed and the whole 
brain placed on ice-filled Petri-plate, where after the different brain regions (frontal cortex, 
striatum, hippocampus, hypothalamus and pituitary) were dissected out on an ice-cooled 
dissection slab (Glowinski and Iverson, 1966). The hypothalamus was pinched and scooped 
out with a forceps from the brain, ventral side up. For dissection of the frontal cortex and 
striatum, the brain was turned dorsal side up, the olfactory bulb was removed, the two 
hemispheres were split and the cortical tissue was dissected out behind the corpus callosum 
toward the anterior, leaving the sub-cortical tissues intact. The striatum was dissected with 
the external walls of the lateral ventricles as internal limits and the corpus callosum as 
external limits. The striatum is a well-defined structure resembling an orange wedge in 
texture and shape, and the characteristic striated appearance aids identification. With the 
brain still dorsal side up, the rest of the cortical tissue was removed and the hippocampus was 
removed. The Pituitary gland is a stalk like triangular structure. It was pinched and scooped 
out with a forceps from the floor of the skull region from where the brain was removed. The 
exact location of each brain structure was confirmed from ''The Rat Brain in Stereotaxic 
Coordinates" (Paxinos and Watson, 1998). All the dissected tissues were immediately stored 
at -70 °C until use. To avoid circadian rhythm induced variation all the samples were 
collected between 9-12 a.m. As the study involves estimation of neurotransmitters and 
corticosterone levels no anesthesia was used. 
3.4.4.1 Plasma separation 
Blood was collected by cardiac puncture in EDTA coated tubes and centrifiiged at 
lOOOg for 20 min at 4°C the plasma in the supernatant was obtained and used for the 
estimation of corticosterone levels. 
3.4.4.2 Neurotransmitter sample preparation 
For the estimation of neurotransmitter levels the dissected brain regions were 
weighed and an internal standard DHBA (2.5|il, with final concentration of 25 ng/ml) was 
added to each sample. Homogenization was performed in 0.17 M perchloric acid with an 
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Ultra-Turrax homogenizer (Model T25, IKA-Laborthechnik, Staufen, Gennany). The 
homogenates were then centrifuged at 35,000g (Model 3K30, Sigma Centrifuge, Osterode, 
Germany) at 4''C, supematants were passed through a 0.22 ^m membrane filter and were 
used for analysis. 
3.4.4.3 Sample preparation for other biochemical assays 
For the estimations of antioxidant parameters and lipid peroxidation, the dissected 
brain regions were homogenized in ice cold 50 mM phosphate buffer (pH 7.0) containing 0.1 
mM EDTA and centrifuged at 1 OOOg for 15 min at 4°C, the supematants thus obtained were 
used for the analysis. 
3.4.5 Adrenal gland weight 
The adrenals were dissected out and the adhering tissues were removed in saline. The 
tissues were weighed on the electronic balance, which was sensitive up to 0.0001 gms (Chyo, 
model-JSl 10). Adrenal hypertrophy was evaluated by measuring the change in adrenal gland 
weight/lOOgm body weight of rat. 
3.4.6 Mean ulcer score 
Stomach of control and stress rats were taken out by making an incision along the 
greater curvature to observe the change in gastric lesions with the help of Magnascope (5X 
magnification). The following arbitrary scoring system was used to grade the severity and the 
intensity of the lesions and the mean ulcer score was calculated (Srivastava et al, 1991). 
••• Shedding of epithelium = 10 
*t* Petechial and frank hemorrhages =20 
••• One or two ulcers =30 
••• More than two ulcers =40 
*V Perforated ulcers =50 
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3.4.7 Estimation of glucose and creatine kinase (CK) activity 
Plasma glucose level and CK activity was estimated by Auto-analyzer (Synchron Cx-
5, Beckman Coulter International, Nyon, Switzerland) using commercially available 
respective kits (Beckman Coulter International, Nyon, Switzerland). 
3.4.8 Corticosterone estimation by HPLC using UV detector 
An HPLC/UV system (Waters, USA) was used for quantification of plasma 
corticosterone by the method of (Woodward et al., 1987) with modifications. Dexamethasone 
was used as an internal standard. The mobile phase consisted of methanol: water (70:30) at a 
flow rate of 1.2 ml/ min and corticosterone was detected at 250nm using UV detector. The 
chromatogram was recorded and analyzed with Breeze soft ware (3.20 version). 
3.4.9 Neurotransmitters estimation by HPLC using Electrochemical Detector 
The HPLC estimation of neurotransmitters is based on the principle that the current of 
oxidation is proportional to the concentration of the amine concerned. The endogenous levels 
of noradrenaline (NA), dopamine (DA) and 5-hydroxy tryptamine (Serotonin; 5-HT), and 
their non-conjugated metabolites 3, 4-hydroxyphenylacetic acid (DOPAC), homovanilic acid 
(HVA) and 5-hydroxy indoleacetic acid (5-HIAA) were determined by reverse phase HPLC 
with electrochemical detection (Kim et al., 1987). The sample (20 |iiL) was injected via 
HPLC pump (Model 1525, Binary Gradient Pump, Waters, Milford, MA, U.S.A.) into a 
column (Spherisorb, RP C18, 5 ^m particle size, 4.6 mm i.d x 250 mm at 30''C) connected to 
an electrochemical detector (Model 2465, Waters, Milford, MA, U.S.A.). Oxidation potential 
was fixed at 0.80 V using a glass carbon working versus an Ag/AgCl reference electrode. 
Mobile phase consisted of 32 mM citric acid, 12.5 mM disodium hydrogen orthophosphate, 
1.4 mM sodium octyl sulfonate, 0.05 mM EDTA and 16% (v/v) methanol. pH of the mobile 
phase was adjusted to 4.05. Separation was carried out at a flow rate of 1.2 ml/min. The 
neurotransmitters were quantified using Breeze version 3.2 software purchased from Waters 
HPLC systems (Hietzinger 145, A1130 Wien, Austria). The levels were expressed in 
nanograms of neurotransmitter per gram of wet weight of brain tissue. Quantification was 
made by comparing peak heights of the samples to the corresponding standard curve. 
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Constant amount (25ng/ml) of DHBA was used for the tissue samples to calculate the 
recovery. 
3.4.10 Cu-Zn, superoxide dismutase (SOD, EC 1.15.1.1) activity 
SOD activity was measured based on its ability to inhibit the autoxidation of 
epinephrine to adrenochrome at alkaline pH (Misra and Fridovich, 1972). Brain samples 
(100^1) were added to 880 ^1 carbonate buffer (0.05 M NaiCOs, pH 10.2), 20 ^1 of 30 mM 
epinephrine in 0.05% acetic acid was added to the mixture and absorbance was followed for 
4 min at 480 nm in a spectrophotometer (Shimadzu, model 1201). Enzymatic activity was 
expressed as U/mg protein at 30°C. The amount of enzyme that caused in 50% inhibition of 
epinephrine autoxidation is defined as one unit (U). 
3.4.11 Catalase (CAT, EC 1.11.1.6) activity 
CAT activity was measured using H2O2 as substrate (Aebi, 1984). In 200 l^L of O.IM 
phosphate buffer (pH 7.0) and 50 )J,L of brain sample, 250 ^1 of 0.066 M H2O2 in phosphate 
buffer was added and decrease in absorbance was read at 240 nm for 30 s in a 
spectrophotometer. A molar absorptivity of 43.6 M/cm was used to determine CAT activity. 
Enzymatic activity was expressed as U/mg protein at 25°C, one unit (U) of which is equal to 
1 mole of H2O2 degraded/min/mg of protein. 
3.4.12 Selenium-dependent glutathione peroxidase (GSH-Px, EC 1.11.1.9) activity 
GSH-Px activity was measured using tert-butyl hydroperoxide as substrate (Flohe and 
Gunzler, 1984). The reaction mixture consisted of 500 ^L of 0.1 M phosphate buffer (pH 
7.0), 100 |iL of 0.01 M reduced glutathione, 100 ^L of 1.5 mM NADPH andlOO ^L of 
glutathione reductase (0.24U). Brain sample (100 ^L) was added to the reaction mixture and 
incubated at 37*'C for 10 min to this 50 |iL of 12 mM tert-butylhydroperoxide was added and 
absorbance measured at 340 nm for 180s in a spectrophotometer. A molar absorptivity of 
6.22x10'M/cm was used to determme enzyme activity, expressed as U/mg protein at 37 °C. 
One unit (U) of activity is equal to mM of NADPH oxidized/min/ mg protein. 
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3.4.13 Reduced glutathione (GSH) levels 
GSH was determined by its reaction with DTNB (EUman's reagent) to yield a yellow 
chromophore which was measured spectrophotometrically (Sedlak and Lindsey, 1968). To 
100 ^L of processed brain sample, 2 ml of O.IM phosphate buffer (pH 8.4), 500 ^L of 
DTNB and 400 ^L of double distilled water was added. The mixture was shaken vigorously 
on vortex and the absorbance read at 412 nm within 15 min. GSH levels were determined 
from a standard curve and expressed as \iM/mg protein. 
3.4.14 Lipid peroxidation, Malondialdehyde (MDA) assay: 
MDA levels (a thiobarbituric acid reactive species: TEARS) was measured using 
1,1,3,3 -tetraethoxypropane as the standard (Ohkawa et al., 1979). The reagents acetic acid 
1.5 ml (20%) pH 3.5, 1.5 ml thiobarbituric acid (0.8%) and 0.2 ml sodium dodecyl sulfate 
(8.1%) were added to 100 |j.L of processed sample. The mixture was then heated at 100°C for 
60 min. The mixture was cooled under tap water and 5 ml of n- butanol: pyridine (15:l%o 
v/v), 1 ml of distilled water was added. The mixture was shaken vigorously on vortex. After 
centrifugation at 4000 rpm for 10 min, the organic layer was withdrawn and absorbance was 
measured at 532 nm using spectrophotometer. MDA levels were determined from a standard 
curve and expressed as nM/mg protein. 
3.4.15 Protein assay: 
The Protein content of the samples was estimated by the method of Lowry et al. 
(1951) using Folin's Phenol reagent. Bovine Serum Albumin (1 mg/ml) was used as 
standard. 
3.4.16 Histological studies: 
Histological analyses of gastric tissues involve different sequential processing of the 
tissue. The steps are as follows: 
••• Fixation of the ulcerated tissue 
• Processing of the tissues: Dehydration, clearing and embedding 
<• Microtomy (sectioning of the blocks) 
••• Staining of the sections 
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• Mounting and analysis of the stained slides 
(a) Fixation: Gastric tissues were fixed in 10% neutral buffered formalin for at least 48 hrs. 
Fixation hardens the tissue and prevents it from cell death resulting in autolysis and 
putrification. 
(b) Processing of the tissues: After fixation the tissues were trimmed and dehydrated in 
increasing concentration (70-100%) of alcohol, for an hour, in each concentration. 
(c) Clearing: Finally the tissues were washed twice in benzene, for 30 mins each. Benzene is 
used as a clearing agent that removes the alcohol and makes the tissue transparent. 
(d) Impregnation: Paraffin wax was kept in embedding oven (45-60°C) and mehed. After 
clearing, the ulcerated tissue was kept in melted wax at 58-60°C for 3-4 hrs. This infiltration 
of the wax provides a support to the tissue making it firm for easier secfioning. 
(e) Embedding: The formalin fixed specimens were then embedded in paraffin and 
sectioned (3-5 |im) with automated microtome (Leica, Germany) and stained with 
hematoxylin and eosin dye. 
(f) Staining: Hematoxylin is a cationinc dye and is used to stain the anionic tissue 
compartment (nuclear portion) whereas, eosin stains the cytoplasmic counterparts. 
(g) Mounting and analysis of slides: The stained slides were mounted with DPX and 
visualized under bright field microscope with 40X magnification and photos were taken for 
respecfive slides. 
3.4.17 Gene expression studies 
(a) Isolation of total RNA from brain tissue: 
Total RNA was isolated from brain samples of various groups by TRIZOL Reagent 
(Invitrogen Life Technologies) using a single step RNA isolation method developed by 
Chomczynski and Sacchi, 1987. 
•> Briefly, brain tissues (lOOmg) were homogenised in 1.0 ml of TRIZOL reagent using 
a glass homogeniser. The homogenate was centrifuged at 12,000g for 5 mins at 4°C in 
order to remove the insoluble material from the homogenate. The supernatant was 
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kept at room temperature for 5 mins to permit complete dissociation of the 
nucleoprotein complexes. 
• Chloroform (0.2 ml) was then added and shaken vigorously for 15 seconds followed 
by an incubation of 3 mins at room temperature to precipitate the proteins. The 
samples were centrifuged at 12000g for 10 mins at 4°C (Sigma 3K30, Germany). 
Following centrifugation, the mixture separates into a lower phenol-chloroform 
phase, an interphase and an aqueous phase. The aqueous phase containing RNA was 
aspirated into a separate tube and re-extracted with chloroform (0.2ml) to remove any 
contaminants. The samples were again centrifuged at 12000g for 10 mins at 4*'C. 
*l* RNA present in the aqueous phase was aspirated into a separate tube and RNA was 
precipitated with 0.5 ml of isopropanol. The samples were incubated for 10 mins at 
room temperature and subsequently centrifuged at 12000g for 10 mins at 4°C (Sigma 
3K30, Germany). The supernatant was removed and the RNA pellet was washed with 
75% alcohol and centrifuged at 7500g for 5 mins at 4°C. 
••• The RNA pellet was dried and finally resuspended in 10 i^l DEPC water. RNA 
samples were stored at -80°C until analysis. 
(b) Quantification of RNA 
Following re-suspension, the quantity of RNA was estimated by measuring 
absorbance (OD) at 260 and 280 nm. The reading at 260 nm allows calculation of the 
concentration of nucleic acid in the sample. The ratio between the readings at 260 nm and 
280 nm (OD260: OD280) provides an estimate of the purity of the nucleic acid. Pure 
preparations of RNA have OD260: OD280 values of 1.8 - 2.0. Preparations within this range of 
value were considered for expression studies in our experiments. An OD of 1, corresponds 
to 40 fig/ml for single stranded RNA. 
The RNA precipitated was further electrophoresed to check its purity and extent of 
degradation in formamide gel. The solutions required are as follows: 
(c) Preparation of 5 x formaldehyde gel running buffer: 
MOPS 0.1M(pH7.0) 
Sodium acetate 40 mM 
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EDTA 5 mM (pH 8.0) 
20.6 gm of MOPS [3-N (morpholino) propane sulfonic acid] was dissolved in 800 ml of 50 
mM sodium acetate. pH was adjusted to 7.0 using 2N NaOH. 10 ml of 0.5 M EDTA (pH 8.0) 
was added and volume was adjusted up to 1 litre with DEPC water (0.1%). Solution was 
sterilized by filtration (Sambrook et al., 2001). 
(d) Gel preparation 
0.5 g Agarose was dissolved in 5 ml of lOx MOPS (pH 7.0) and 36.5 ml of water was added, 
solution was boiled and further kept for cooling at 55*'C . Then 8.5 ml of formalin was added 
to the gel mix. 
(e) RNA sample preparation 
RNA samples were prepared for electrophoresis as below: 
RNA 4.0 \i\ (2-3 ng) 
Formamide 10.0 fxl 
lOx MOPS buffer 2.0^1 
Formalin 4.0 |al 
The samples was denatured by heating at 65 C for 15 min and immediately chilled on ice. 
Then 6x gel loading dye with ethidium bromide were added to each sample. Samples were 
loaded and gel was run at 3 V/cm in Ix MOPS buffer, till the dye reaches 2/3 of the gel. Gel 
was visualized under UV and the image was captured using gel doc system (Alpha Image 
Analyzer,). The RNA thus extracted was then copied into its complementary DNA sequence 
(cDNA) in order to quantify the absolute and relative levels of mRNA targets by PCR. 
(f) cDNA synthesis 
Single-stranded cDNA was generated from 5 |xg of total cellular RNA using 
RETROscript kit (Ambion Inc., USA) following manufacturer's instructions. 
In brief the reaction mixture for cDNA was prepared as follows: 
Template RNA 5 pg 
Oligo dT primer 2 (il 
DEPC treated water up to 12 |al 
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The reagents were mixed gently and spun down for 3-5 seconds in a micro centrifuge. 
The mixture was incubated at 70° C for 5 mins in order to denature any secondary structure 
which could impede the reverse transcriptase from copying the RNA, chilled on ice and 
drops were collected by light centrifugation 
The following component were added in the indicated manner 
1 Ox RT buffer 2 \i\ 
dNTPmix(lOmM) 4^1 
RNAse inhibitor 1 |xl 
MMLV-RT l|il 
The reagents were mixed gently and drops were collected by light centrifugation. The 
mixture was incubated at 42° C for one hour. The reaction was stopped by heating at 92° C 
for 10 mins to inactivate the reverse transcriptase and then chilled on ice and stored at -20°C 
until use. The cDNA thus generated then serves as a template for the subsequent PCR-driven 
amplification step. Gene specific amplification was achieved by using sense and antisense 
primers targeted to sequences in the cDNA. 
(g) Primers 
In order to observe the changes in the expression levels of different genes during the 
course of stress, gene specific primers were used. The different primers used in the study 
have already been listed with their sequences (Page number 60). 
(h) Polymerase chain reaction (PCR) 
PCR reaction was set in 200 )al thin walled tubes. A typical reaction comprised of 
10% assay buffer, 200 ^M dNTPs, 0.3 )xmoles of each primer, 2.0 mM MgClj, 3^1 cDNA 
and 1 unit of Taq DNA polymerase. The final volume of 20 |il was made up with sterilized 
PCR grade water (Sambrook et al., 2001). cDNA samples were annealed at 94°C (5 min) and 
amplified for 30-35 cycles with the following cycling conditions: 94°C for 1 min; respecfive 
annealing temperature for specific genes for 1 min; 72°C for 1 min followed by a final 
extension at 72°C for 10 mins and was was carried out in a thennocycler (Bioer XP Cycler). 
PCR products were then resolved on 1.0 % agarose gel containing 0.5|ag/ml ethidium 
bromide using 100-bp ladder (Amersham Biosciences, UK). 
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(i) Agarose gel electrophoresis 
To analyze the alterations in expression PCR products were run on horizontal 
submarine gel electrophoresis apparatus (Genei, India). Briefly, dehydrated agarose powder 
was suspended in 1 x Tris Borate EDTA buffer (TBE) and melted by boiling. 
Composition of TBE buffer: 
45 mM Tris-borate 
ImM EDTA, pH 8.0 
Ethidium bromide was added to a concentration of 0.5^g/ml and left to cool till 45-
50 C. The cooled agarose was poured into a casting tray fitted with comb and allowed gel to 
solidify for 30-45 minutes. After solidification of the gel, comb was removed; the casting 
tray was then placed in an electrophoresis apparatus filled with Ix TBE buffer. 10^1 of PCR 
products were mixed with 2|xl of 6X tracking dye (final concentrafion IX) and loaded into 
the wells. Electrophoresis was carried out at a constant voltage of 5-10 V/cm (Sambrook et 
al., 2001). After proper resolving, the gel was visualized under UV transilluminator. The 
intensity of the PCR products was measured using Biovis gel documentation software. The 
signals for examined PCR products were standardized against that of the P-Actin gene 
expression from each sample and the results were expressed as investigated PCR-product/ P-
Actin mRNA ratio. 
3.4.18 Western blotting 
Glucocorticoid receptor and Heat Shock Protein-70 expression in different brain 
regions was studied by Western Blot analysis (Filipovic et al., 2005). Selected brain regions 
were homogenized in TEGMED buffer consisting of 50 mM Tris buffer (pH 7.2, 4°C), 6 mM 
MgCl, 1 mM EDTA, 10% (w/v) sucrose, 1 mM phenylmethylsulfonyl fluoride, 3 mM 
benzamidine, 5 mg/ml leupepfin, 1 mg/ml of pepstafin A, 1 mg/ml aprofinin. For whole-cell 
preparafions, brain tissue from individual rats were either homogenized with a motor driven 
pestle or sonicated. Tissue was homogenized in 1.0 ml buffer /lOO mg tissue. For fissue 
homogenizafion with motor driven pestle, TEGMED buffer was used with the addifion of 
0.5% sodium dodecyl sulfate (SDS). For sonicafion, western blot homogenization buffer 
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without SDS was used. In both cases the homogenate or sonicate was centrifuged (12000 g) 
for 15 min and the supernatant was used as whole-cell extract and stored at -70°C prior to 
carry out the analysis. 50^g protein from whole-cell fraction was size fractionated on 10 % 
SDS-PAGEatlOOmV. 
3.4.18.1 SDS polyacrylamide gel electrophoresis (SDS-PAGE): 
Proteins were separated on SDS polyacrylamide gel under conditions that ensure 
dissociation of proteins into their individual polypeptide subunits. The denatured 
polypeptides bind SDS and become negatively charged. Because the amount of SDS bound is 
almost always proportional to the molecular weight of the polypeptide, SDS-polypeptide 
complexes migrate through polyacrylamide gels in accordance with the size of the 
polypeptide. SDS-PAGE was run on Hoefer^ "^  mini vertical electrophoresis system 
(Amersham Biosciences, San Francisco, CA, USA) at a constant voltage of 80V. The 
resolving gel was run at lOOV for 2 hrs. 
(a) Solutions for SDS-PAGE: 
30% Acrylamide and bis-acrylamide solution: 29 g of acrylamide + 1 g of bis-
acrylamide in 100 ml of water 
Sodium dodecyl sulphate (10%) 
TEMED used as supplied 
Ammonium persulphate: 10%w/v 
(i) Resolving gel buffer composition (10%) for 10 ml: 
Components 
Distilled water 
30% acrylamide solution 
1.5MTris,pH8.8 
10% SDS 
10% Ammonium persulphate 
TEMED 
Volume 
4.0 ml 
3.3 ml 
2.5 ml 
0.1ml 
0.1 ml 
0.004 ml 
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(ii) Stacking gel buffer (5%) for 4 ml: 
Components 
Distilled water 
30% acrylamide solution 
1.5MTris,pH6.8 
10% SDS 
10% Ammonium persulphate 
TEMED 
Volume 
2.7 ml 
0.67 ml 
0.50 ml 
0.04 ml 
0.04 ml 
0.004 ml 
(iii) Electrophoresis buffer [Tris-glycine resolving buffer (pH 8.3)]: 
25mM Tris 
250mM glycine 
0.1%(w/v)SDS 
(iv) Gel loading buffer: 
50mM Tris-Cl (pH 6.8) 
100 mM dithiotreitol (added fresh before sample preparation) 
2% w/v SDS 
0.1%) bromophenol blue 
10% v/v glycerol 
Polypeptides separated by SDS-PAGE were simultaneously stained with Coomassie Brilliant 
Blue. This dye binds nonspecifically to the proteins but not to the gel. The gel was immersed 
for several hours in a concentrated methanol: acetic acid solution of the dye and excess dye 
was then allowed to diffuse from the gel during a prolonged period of destaining. 
(v) Coomassie blue staining solution: 
Coomasie blue (250 mg) were dissolved in 100ml of methanol: acetic acid solution. 
Solution filtered through whatmann no.l filter paper to remove any particulate matter. 
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(vi) De-staining solution: 
Methanol: acetic acid solution for 100 ml: 900 ml of methanol: water (500 ml of 
methanol and 400 ml of water) was combined with 100ml of glacial acetic acid. 
(b) Solutions for Western Blotting: 
(i) Transfer buffer: 
24mM Tris 192 mM glycine 20 % Methanol 
50mg % SDS 
(ii) Tris buffered saline- tween 20 (TEST) 
20 mM Tris 
0.9% NaCl 
0.1%Tween-20,pH7.6. 
(iii) Antibody Dilution buffer: 
1% BSA, 0.02% sodium azide in TBS-T. 
(iii) Composition of stripping buffer: 
25 mM Glycine pH 2.0 
2% SDS 
3.4.18.2 Immunoblotting 
After the protein samples were separated by gel electrophoresis the stacking gel was 
removed and the resolving gel was soaked in the protein transfer buffer (as mentioned below) 
for 10-20 mins. The membrane (Hybond ECL, Amersham Biosciences) was also equilibrated 
in the protein transfer buffer for at least 10 mins. The electroblotting cassette (Hoefer '^^  
TE70 Semi dry transfer unit, San Francisco, CA, USA) was assembled and was placed 
between the electrodes in the blotting unit, according to the manufacturer's instructions. 
Proteins were transferred for 3 hours at a constant current of 150 mA. Separation of proteins 
in gels and transfer to membranes was confirmed by staining with Ponceau S staining 
solution containing 0.2% Ponceau S in 1% glacial acetic acid. 
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3.4.18.3 Immunodetection 
• Following transfer the membrane was removed and used for immunodetection. Non-
specific blocking sites were blocked by immersing the membrane in 5% (w/v) 
blocking reagent (non-fat dry skimmed milk) in TBS-T for 2 hrs at 37°C. 
<• The membrane was then rinsed using 6 fresh changes of washing buffer (TBS-T) for 
10 mins each at room temperature. Heat Shock protein-70 monoclonal primary 
antibody (raised in goat) 
• The membrane was incubated for 4 hr at 4°C with goat anti-heat shock protein-70, 
rabbit anti-glucocorticoid receptor polyclonal primary antibodies (Santa Cruz 
Biotechnology, CA, USA) at a dilution of 1:2000, 1:4000 respectively diluted in 
diluting buffer. 
••• The membrane was again washed as previously mentioned and then incubated with 
secondary antibody for 1 hr at room temperature. 
*t* The membrane was again washed. If a biotinylated secondary antibody was used then 
it was incubated in Peroxidase-Streptavidin solution for 1 hr at room temperature. But 
if a peroxidase labeled secondary antibody was used the membrane was ready for 
development after washing. 
••• The ECL detection reagents supplied (Pierce, USA) was mixed in an equal volume of 
solution 1 to solution 2 to give sufficient liquid to cover the membranes. The excess 
wash buffer was drained from the washed blots and placed protein side up in the film 
cassette (Amersham Biosciences, UK). The prepared ECL detection reagent was 
added directly to the membrane and incubated for 1 min at room temperature. The 
excess detection reagent was drained off and the blot was placed on Saran wrap 
which was folded over the back of the blots to form an envelope. The Hyperfilm ECL 
(Amersham Biosciences, UK) was then placed on the blot in the developing cassette 
and exposed for 30 sees - Imin in a dark room. 
After detection with the desired antibodies against the proteins of interest the 
membrane was stripped with stripping buffer (composition as mentioned below). The 
membrane was agitated at room temp for 30 mins on a rocking platform and then washed 
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with distilled water until SDS was completely removed. The membrane was then blocked 
with 5% blocking reagent and the same steps were followed as previously mentioned for 
immunodetection. The membrane was reprobed with anti-P-Actin polyclonal primary 
antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at a dilution of 1:500. Further, 
membrane was probed with corresponding secondary antibody and chemiluminescence was 
detected using ECL-Plus detection system (Amersham Biosciences, UK). 
3.4.19 Immuno-histochemistry(IHC) 
Immunoreactivity (ir) of tyrosine hydoxylase (TH) enzyme and glucocorticoid 
receptor (GR) and Corticotrophin releasing hormone (CRH) was performed following the 
modification of the method of Chaturvedi et al., 2008. In brief, rats from each group were 
anaesthetized and transcardially perfused with 100 ml of 0.1 M phosphate buffered saline 
(PBS; pH 7.2) followed by 250 ml of chilled 4% paraformaldehyde in PBS for fixation of 
tissues. After perfusion the brains were excised out and post fixed in the same fixative 
overnight. Further, tissues were cryo-preserved by using 10%, 20%, and 30%) sucrose serially 
in PBS (w/v), by keeping the brains in each sucrose solution overnight. Blocks of specific 
brain region were prepared in OCT (a combination of \0% polj'vinyl alcohol and 4% 
polyethylene glycol in distilled water; w/v) and fixed on the frame inside the freezing 
microtome. Serial coronal sections of 20 \im thickness were cut on a freezing microtome, 
collected in PBS in a 24-well plate and stored at 4°C. Brain sections of each rat were 
processed for immunostaining using free-floating technique. 
In brief, the sections after three washes with PBS were incubated with 0.5%) H2O2 in 
methanol (w/v) for 10 minutes to quench endogenous peroxidase activity. After washing the 
sections three times with PBS, non-specific binding sites were blocked by incubating the 
sections with blocking buffer (consisting of 0.5% BSA, 1% NGS and 0.1% Triton X-100 in 
PBS) for 2 hours prior to incubation with monoclonal primary antibodies (diluted 1:500 in 
blocking buffer) with agitation, by keeping on a rocker-shaker for 28 hours. After removing 
the primary antibody, sections were washed three times with PBS and incubated in 
peroxidase linked secondary antibody (diluted 1: 100 in PBS) for 2 hours at room 
temperature followed by three washes with PBS. Color was developed for peroxidase-linked 
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antibody with DAB as chromogen. Sections were transferred onto gelatin-coated glass slides, 
air-dried and dehydrated in ascending series of graded ethanol (30%, 50%, 70%, 90% and 
100%)). Finally the sections were cleared in xylene, mounted in DPX mounting medium, 
cover slipped and then visualized under phase contrast microscope. 
3.4.19.1 Image analysis 
The density and number of TH/GR immunostained fibers and neurons in various 
brain structures was quantified using a computerized image analysis system (Leica Qwin 500 
image analysis software) as described by Shingo et al. (2002). The unbiased stereological 
method was applied, where a person unknown to the experimental design carried out the 
image analysis. Computerized analysis enabled the percent area of a selected field that was 
occupied by TH-IR fibers to be assessed. This area was expressed as f^ m^  per total field view 
(250 X250 [im, 75,000 ^im^. The density of TH/GR-IR fibers was measured in various brain 
structures of different groups and intact contralateral side at the level of bregma +1.2, +1.0, 
+0.2 (Paxinos and Watson, 1998). The total number of TH-IR neurons in the SN was counted 
on both sides at three levels: -5.3mm, -5.4mm and -5.5mm with respect to the bregma 
(Paxinos and Watson, 1998). Analyzed values obtained in the experimental side were 
expressed as a percentage of those present on the intact contralateral side. The data obtained 
was then averaged for statistical analysis. Similarly TH-IR neurons (cell bodies) in each 
group were counted on every third section on blind-coded slides. Particles less than 5 )am 
were excluded from counting. 
To avoid measuring the same neuron twice, the sections were separated by at least 
100 fim. A profile was counted as a cell body if both a nucleus and at least one neuritic 
process were present. TH-IR neurons were counted for per rat (i.e. per group) and averaged 
for 6 rats/group. Quantitative analysis of the TH-IR neurons in the control and treated culture 
was performed in ten microscopic fields using same software. The reactivity was expressed 
in tenns of the % area that showed staining with DAB in respective fields. The percentage 
change in expression was calculated over control. 
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3.4.20 Statistical analysis 
The statistical analysis of data was done using analysis of variance (ANOVA) with 
post-hoc analysis. The Tukey-Kramer tests were applied selectively in different observations 
to serve as significant among groups. The significance of results was ascertained at P<0.05. 
All the data are presented as means ± standard error (S.E.M). 
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4. Results 
4.1 Standard curves for Biochemical estimations 
4.1.1 Standard curve for protein estimation 
For the estimation of protein in the biological samples, a standard curve using 
bovine serum albumin (20-100|ig) was prepared. The absorbance of the samples 
increased linearly in relation with the amount of protein. The equation of linear regression 
is y= 0.004065 ± 0.0001115, with a correlation coefficient (r^ ) of 0.9977 (Tablel, Figure 
1). 
Table 1: Standard curve for protein estimation 
Amount of protein (fig) 
20 
40 
60 
80 
100 
Absorbance 
0.0990 
0.1780 
0.2580 
0.3310 
0.4290 
Figure 1: Standard curve for protein estimation 
r^  0.9977 
25 50 75 100 
Amount of protein (^g) 
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4.1.2 Standard curve for plasma corticosterone 
For the estimation of plasma corticosterone level using HPLC-UV detector 
(Woodward et al., 1987), a standard curve was constructed using corticosterone at a 
concentration range of 50-600 ng/ml with an internal standard dexamethasone (Dex) at a 
fixed concentration (500 ng/ml) (Table2). The ratio between areas of corticosterone and 
dexamethasone (response) was plotted against concentration to obtain the standard curve 
(Figure 2). 
Table 2: Concentration-dependant response ratio of corticosterone and 
dexamethasone 
SNo. 
1 
2 
3 
4 
5 
Sample name 
Cort-50ng/ml+Dex-500ng/ml 
Cort-100ng/ml+Dex-500ng/ml 
Cort-200ng/ml+Dex-500ng/ml 
Cort-400ng/ml+Dex-500ng/ml 
Cort-600ng/ml+Dex-500ng/ml 
Peak 
name 
Cort 
Cort 
Cort 
Cort 
Cort 
Amount 
50.0 
100.0 
200.0 
400.0 
600.0 
Response 
7.211e+001 
1.951e+002 
3.176e+002 
6.542e+002 
9.475e+002 
Calc. 
Amount 
43.990817 
119.01063 
193.77691 
399.11994 
578.03569 
Manual 
Point 
No 
No 
No 
No 
No 
Ignore 
Point 
No 
No 
No 
No 
No 
Table 2: The table was plotted and analyzed by the Waters software 'Breeze' version 3.2. 
Figure 2: Standard curve for the estimation of corticosterone 
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Figure 2: The figure was drawn by the Waters software 'Breeze' version 3.2. The amount 
of corticosterone was expressed in ng/ml. 
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4.1.3 Standard curve for the estimation of different neurotransmitters 
For the estimation of different neurotransmitters in different brain regions, we 
constructed standard curve for nor-adrenaline (NA) (Table 3, Figure 3), dopamine (DA) 
(Table 4, Figure 4), 3, 4-hydroxyphenylacetic acid (DOPAC) (Table 5, Figure 5) and 
homovanilic acid (HVA) (Table 6, Figure 6), serotonin (5-HT) (Table 7, Figure 7), 5-
hydroxy indole acetic acid (5-HIAA) (Table 8, Figure 8) with dihydroxylbenzylamine 
hydrobromide (DHBA) as an internal standard. The cocktails of the standards (20-
lOOng/ml) were prepared with DHBA at a fixed concentration of 25ng/ml. The area ratios 
of the standards increased linearly with correlation coefficient (r^) of 0.99. 
Table 3: Concentration-dependant response ratio of NA and DHBA 
SNo. 
1 
2 
3 
4 
5 
Sample name 
Cocktail 20ng/ml 
Cocktail 40ng/ml 
Cocktail 60ng/ml 
Cocktail 80ng/ml 
Cocktail lOOng/ml 
Peak 
name 
NA 
NA 
NA 
NA 
NA 
Amount 
20.0 
40.0 
60.0 
80.0 
100.0 
Response 
5.261 e+000 
9.713e+000 
1.606e+001 
1.912e+001 
2.528e+001 
Calc. 
Amount 
20.787565 
38.375031 
63.465940 
75.559783 
99.898301 
% 
Deviation 
3.938 
-4.062 
5.777 
-5.550 
-0.102 
Manual 
Point 
No 
No 
No 
No 
No 
Ignore 
Point 
No 
No 
No 
No 
No 
Table 3: The table was plotted and analyzed by the Waters software 'Breeze' version 3.2. 
Figure 3: Standard curve for the estimation of NA 
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Figure 3: The figure was drawn by the Waters software 'Breeze' version 3.2.The amount 
of NA was expressed in ng/ml. 
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Table 4: Concentration-dependant response ratio of DA and DHBA 
SNo. 
1 
2 
3 
4 
5 
Sample name 
Cocktail 20ng/ml 
Cocktail 40ng/ml 
Cocktail 60ng/ml 
Cocktail 80ng/ml 
Cocktail lOOng/ml 
Peak 
name 
DA 
DA 
DA 
DA 
DA 
Amount 
20.0 
40.0 
60.0 
80.0 
100.0 
Response 
4.353e+001 
6.743e+001 
9.343e+002 
1.225e+002 
1.445e+002 
Calc. 
Amount 
25.924722 
40.164034 
55.646321 
72.935253 
86.053369 
% 
Deviation 
29.624 
0.410 
-7.256 
-8.831 
-13.947 
Manual 
Point 
No 
No 
No 
No 
No 
Ignore 
Point 
No 
No 
No 
No 
No 
Table 4: The table was plotted and analyzed by the Waters software 'Breeze' version 3.2. 
Figure 4: Standard curve for the estimation of DA 
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Figure 4: The figure was drawn by the Waters software 'Breeze' version 3.2.The amount 
of DA was expressed in ng/ml. 
Table 5: Concentration-dependant response ratio of DOPAC and DHBA 
SNo 
1 
2 
3 
4 
Sample name 
Cocktail lOng/ml 
Cocktail 25ng/ml 
Cocktail 50ng/ml 
Cocktail lOOng/ml 
Peak 
name 
DOPAC 
DOPAC 
DOPAC 
DOPAC 
Amount 
10.0 
25.0 
50.0 
100.0 
Response 
6.525e+004 
2.375e+005 
3.479e+005 
1.912e+005 
Calc. 
Amount 
3.892277 
32.153359 
50.263863 
98.690501 
% 
Deviation 
-61.077 
28.613 
0.528 
-1.309 
Manual 
Point 
No 
No 
No 
No 
Ignore 
Point 
No 
No 
No 
No 
Table 5: The table was plotted and analyzed by the Waters software 'Breeze' version 3.2. 
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Figure 5: Standard curve for the estimation of DOPAC 
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Figure 5: The figure was drawn by the Waters software 'Breeze' version 3.2.The amount 
of DOPAC was expressed in ng/ml. 
Table 6: Concentration-dependant response ratio of HVA and DHBA 
SNo. 
1 
2 
3 
4 
5 
Sample name 
Cocktail 20ng/ml 
Cocktail 40ng/ml 
Cocktail 60ng/ml 
Cocktail 80ng/ml 
Cocktail lOOng/ml 
Peak 
name 
HVA 
HVA 
HVA 
HVA 
HVA 
Amount 
20.0 
40.0 
60.0 
80.0 
100.0 
Response 
4.135e+000 
8.605e+000 
1.426e+001 
1.775e+001 
2.099e+001 
Calc. 
Amount 
18.947578 
39.426277 
65.313851 
81.328847 
96.178941 
% 
Deviation 
-5.262 
-1.434 
8.856 
1.661 
-3.821 
Manual 
Point 
No 
No 
No 
No 
No 
Ignore 
Point 
No 
No 
No 
No 
No 
Table 6: The table was plotted and ana yzed by the Waters software 'Breeze' version 3.2. 
Figure 6: Standard curve for the estimation of HVA 
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Figure 6: The figure was drawn by the Waters software 'Breeze' version 3.2.The amount 
of HVA was expressed in ng/ml. 
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Table 7: Concentration dependant response ratio of 5-HT and DHBA 
SNo. 
1 
2 
3 
4 
5 
Sample name 
Cocktail 20ng/ml 
Cocktail 40ng/ml 
Cocktail 60ng/ml 
Cocktail 80ng/ml 
Cocktail lOOng/ml 
Peak 
name 
5-HT 
5-HT 
5-HT 
5-HT 
5-HT 
Amount 
20.0 
40.0 
60.0 
80.0 
100.0 
Response 
3.337e+001 
7.923 e+001 
1.221e+002 
1.589e+002 
2.001 e+002 
Calc. 
Amount 
17.2479 
40.9341 
63.2619 
82.0191 
103.4016 
% 
Deviation 
-13.79 
2.335 
5.437 
2.616 
3.402 
Manual 
Point 
No 
No 
No 
No 
No 
Ignore 
Point 
No 
No 
No 
No 
No 
Table 7: The table was plotted and analyzed by the Waters software 'Breeze' version 3.2 
Figure 7: Standard curve for the estimation of 5-HT 
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Figure 7: The figure was drawn by the Waters software 'Breeze' version 3.2.The amount 
of 5-HT was expressed in ng/ml. 
Table 8: Concentration-dependant response ratio of 5-HIAA and DHBA 
SNo. 
1 
2 
3 
4 
5 
Sample name 
Cocktail 20ng/ml 
Cocktail 40ng/ml 
Cocktail 60ng/ml 
Cocktail 80ng/nil 
Cocktail lOOng/ml 
Peak 
name 
5-HIAA 
5-HlAA 
5-HlAA 
5-HIAA 
5-HIAA 
Amount 
20.0 
40.0 
60.0 
80.0 
100.0 
Response 
2.980e+000 
4.899e+000 
6.665e+000 
1.023e+001 
1.556e+001 
Calc. 
Amount 
23.800340 
39.133224 
53.230936 
81.682557 
92.346291 
% 
Deviation 
19.002 
-2.168 
5.777 
-5.550 
-0.102 
Manual 
Point 
No 
No 
No 
No 
No 
Ignore 
Point 
No 
No 
No 
No 
No 
Table 8: The table was plotted and analyzed by the Waters software 'Breeze' version 3.2. 
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Figure 8: Standard curve for the estimation of 5-HIAA 
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Figure 8: The figure was drawn by the Waters software 'Breeze' version 3.2.The amount 
of 5-HIAA was expressed in ng/ml. 
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4.2 Standardization of stress models: 
4.2.1 Effect of stress [Acute Stress (AS), Chronic Stress (CS) and Chronic 
Unpredictable Stress (CUS)] on various stress biomarkers 
In order to delineate the physiological and biochemical responses to different 
stressful conditions, we exposed the rats to three different types of stress conditions, in 
which the stressors differ in intensity, duration, predictability and severity. In each 
condition (stress model), we examined various physiological changes to understand the 
stress response and related pathophysiology. First we identified the stress induced-
changes in the biochemical, hormonal, monoaminergic and oxidative systems, and then 
we evaluated various agents (plant or synthetic origin) for their preventive/normalizing 
effects under such stressfiil conditions. The various stress parameters tested in the present 
study were as follows: 
4.2.1.1 Adrenal gland weight (Adrenal Hypertrophy) 
Adrenal gland weight was significantly (P<0.05-0.001) increased in AS, CS and 
CUS groups when compared to the non stress (NS) control group. The results are 
represented in Table 9. 
4.2.1.2 Gastric Ulcers 
As shown in Table 9, all three stress groups (AS, CS and CUS) caused a 
significant (P<0.001) increase in ulcer severity compared to the control (NS) group, 
expressed in terms of mean ulcer score. 
4.2.1.3 Plasma Glucose level 
Plasma glucose level was significantly (P<0.01) increased in AS group only, 
while remained significantly (P>0.05) unaltered in CS and CUS groups in comparison to 
the NS control group (Table 9). 
4.2.1.4 Plasma Creatine Kinase (CK) activity 
Plasma CK activity was significantly (P<0.001) increased in AS and CUS groups 
in comparison to the NS control group, while no significant (P>0.05) change was 
observed in the CS group (Table 9). 
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4.2.1.5 Plasma Corticosterone level 
Table 9 illustrates the level of plasma corticosterone during stress. Exposure of 
AS and CUS caused a significant (P<0.001, P<0.05) increase in the plasma corticosterone 
level as compared to the NS control group, while no significant (P>0.05) change was 
observed in the CS group. 
Adrenal Gland 
Groups Wdght Glucose 
(mg/lOOgm body Mean Ulcer (mg/dLof 
w^ht) Score plasma) 
Creatine Kinase Corticosterone 
(lU/dLof (ng/mlof 
plasma) fJasma) 
NS 
AS 
CS 
CUS 
7.89+0.23 
9.56+0.54'' 
10.24+0.60^ 
12.46-+0.23'^  
o.o+o.o 81.6 ±4.4 452.64 ±82.67 
18.0^1.340® 136.63 ±6.5® 1031 ±23.79® 
23 Of 1 52® 83.0±4.03 467.90±26.79 
27.Ofl.51® 84.1±4.14 691.65±46.84® 
223.68+11.63 
426.4+27.22® 
242.34+1075 
303.2+11.93* 
Table 9: Each value is the mean + SEM with ten rats (n= 10) in every group. ''P<0.05, 
¥<0.01, ®P<0.001 vs. non-stress (NS) control group (One-way ANOVA followed by 
Tukey-Kramer multiple comparison test). 
A simplified schematic representation of the effects of different stress models on 
various peripheral stress biomarkers: 
•^  Glucose *-» 
CK h * ^ Plasma 
> Cort ^<-* 
r 
i 
1 
-^ > Glucose 
+ - • CK 
1 
-^ Cort 
r 
1 
Gastric 
Ulcer 
Adrenal 
Gland 
Gastric 
Ulcer 
Adrenal 
Gland 
11 
11 
Gastric 
Ulcer 
Adrenal 
lit 
The schematic diagram summarizing the results, clearly indicating that in CS model, no 
significant changes were observed in the biochemical parameters as the rats may get 
physiologically adapted due to the use of similar type and intensity of stressor. Thus, for 
further studies, we used only AS and CUS model. 
"t" Represents significant increase; ^ Represents significant decrease; « Represents no 
significant change. Higher the number of arrows means more significant is the effect. 
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4.3 Effect of stress (AS/CUS) on brain monoamlnergic system 
4.3.1 Alterations in the levels of dopamine (DA) and metabolites (DOPAC and 
HVA) in the selected brain regions 
During AS, DA level was significantly increased in the frontal cortex (P<0.01), 
while decreased in the striatum (P<0.001) and hippocampus (P<0.01) as compared to the 
NS control group. AS also significantly (P<0.001) increased the levels of DOPAC and 
HVA in the striatum and HVA (P<0.05) in the frontal cortex as compared to the NS 
control group (Table 10). 
On the other hand, CUS caused a significant (P<0.001) decrease of DA level in all 
the three selected brain regions. The DOPAC and HVA levels were significantly 
(P<0.001) increased in the frontal cortex and HVA (P<0.01) in the striatum, however, in 
the hippocampus, no significant changes in the DA metabolite levels were observed 
compared to the NS control group (Table 10). 
Brain regions 
Frontal cortex 
Striatum 
Hippocampus 
Groups 
NS 
AS 
CUS 
NS 
AS 
CUS 
NS 
AS 
CUS 
DA 
628.9+61.96 
894.4+53.69^ 
378.5+16.1* 
4464+139.6 
2929+89.82® 
2921+203.2® 
129.3 + 6.63 
75.38 + 5.503^ 
64.5 + 5.28® 
DOPAC 
21.25+2.37 
28.63+2.890 
101.8+12.2® 
173.6+17.93 
254.7+21.70'' 
226.4+17.11 
74.71 + 5.28 
61.25 + 6.829 
64.38+4.5 
HVA 
24.0+2.55 
54.13 + 2.438^' 
168.4±8.21® 
117.1 + 11.41 
289.5 + 28.20® 
169.1+9.01* 
89.29+5.78 
70.88+5.508 
78.13+4.37 
Table 10: Each value is the mean + SEM with ten rats (n= 10) in every group. *'P<0.05, 
¥<0.01, ®P<0.001 vs. non-stress (NS) control group (One-way ANOVA followed by 
Tukey-Kramer multiple comparison test). 
4.3.2 Alterations in the levels of nor-adrenaline (NA), serotonin (5-HT) and 5-
HIAA in the selected brain regions 
AS significantly decreased the NA levels in the frontal cortex (P<0.01) and 
hippocampus (P<0.001) regions only, whereas, the 5-HT and 5-HlAA levels were 
significantly (P<0.05-0.001) increased in all the three brain regions as compared to the 
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NS control group (Table 11). Contrastingly, CUS caused a significant (P<0.05-0.001) 
reduction in the NA, 5-HT and 5-HIAA levels in all the three selected brain regions as 
compared to the NS control group (Table 11). 
Brain regions 
Frontal cortex 
Striatum 
Hippocampus 
Groups 
NS 
AS 
CUS 
NS 
AS 
CUS 
NS 
AS 
CUS 
NA 
412.8+17.9 
285.1 + 16.29^ 
106.6+12.32® 
338.6+25.21 
351.1+40.33 
191.4+24.45® 
501.3+24.87 
258.6+18.59® 
110.3+12.35® 
5-HT 
228.8+17.9 
507.3+41.96® 
106.6+12.32® 
338.6+25.21 
426.6+26.41* 
191.4+24.45® 
201.3±24.87 
317.3+41.96'' 
110.3 + 12.35'' 
5-HIAA 
130.5+8.25 
189.8+12.39* 
85.06+10.01® 
236.5+20.24 
351.3+21.66** 
81.01 + 11.32® 
141 + 15.82 
189.8+12.39" 
133.8+9.84 
Table 11: Each value is the mean + SEM with ten rats (n= 10) in every group. *'P<0.05, 
*P<0.01, ®P<0.001 vs. non-stress (NS) control group (One-way ANOVA followed by 
Tukey-Kramer multiple comparison test). 
4.4 Effect of stress (AS/CUS) on in-vivo antioxidant status and lipid 
peroxidation 
AS significantly (P<0.05-0.01) enhanced the activities of SOD and GSH-Px in the 
frontal cortex and striatum, with no significant (P>0.05) changes in the hippocampus as 
compared to the NS control values. Conversely, CUS significantly (P<0.05-0.001) 
reduced the activities of SOD and CAT in all the three selected brain regions, with 
increased GSH-Px activity only in the frontal cortex and hippocampus regions when 
compared to the NS control group (Table 12). 
However, a significant (P<0.05-0.001) decrease in glutathione (GSH) level along 
with significant (P<0.05-0.001) increase in lipid per oxidation (MDA) were observed in 
both the AS and CUS groups in the frontal cortex, striatum and selectively in the 
hippocampus as compared to the NS control group (Table 12). 
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^:ain 
Regions 
Frontal 
cx)rtex 
Striatum 
Hippocampus 
Gh)ups 
>B 
AS 
CLE 
s^ 
AS 
OB 
^B 
AS 
CUS 
SOD 
(Uwg 
proton) 
5.5510.51 
8.0640.78* 
3.43i0.23^ 
7.853+1.07 
13.83+1.25* 
5.14-+0.44'' 
4.21i0.34 
5.59+0.79 
1.6640.27® 
CAT 
(U/mg 
protdn) 
0.23+0.02 
0.25+0.(M 
0.15+0.01® 
0.17+0.02 
0.21+0.03 
0.10+0.01* 
0.14+0.01 
0.22+0.03 
O.l+O.OM® 
GSItPx 
(U/mg 
Pl-otdn) 
0.03+0.003 
0.041+0.004* 
0.04+0.004* 
0.036+0.001 
0.062+0.004'' 
0.04-H).0O4 
0.034+0.001 
0.051±0.006 
0.(M5+0.002® 
GSH 
iliMivg 
protdn) 
88.67±7.11 
71.17±4.(M'' 
51.5+4.24* 
160.3+9.35 
102.5+5.0^ 
90.5+5.94® 
85.5±4.01 
70.67+4.3" 
40.67-+4.4® 
MDA 
(nMn^ 
protdn) 
6.71±0.45 
12.98±1.49* 
16.5±2.29* 
19.83+2.2 
42.33+3.53* 
49.17+5.82® 
12.34±1.69 
20.67+0.84* 
32.01+3.71® 
Table 12: Each value is the mean + SEM with ten rats (n= 6) in every group. P<0.05, 
*P<0.01, ®P<0.001 vs. non-stress (NS) control group (One-way ANOVA followed by 
Tukey-Kramer multiple comparison test). 
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4.5 Evaluation of anti-stress potential of various herbal plants 
Stepi 
( iMik- \ihmt vxtrdds HLTL- i-^aluateiJ at \ari(ius doses lor thtir dTtt-l on iliHeiviil 
s!av» narktrs (adrt-nai iiA |r<.'!tn)ph>, ivjan ularstDa- ,p!asnrj u>rtict)sttn)fiu. 
<»ii!i.i)M' and LTLntini' kinase knds) in acuti- stnss ( VS| ouuiition 
(1) Tbtospom 
sinensis 
(IS) 
_50mgA;g 
.100mg/kg 
-200mg/kg 
'j1--^f;T37Vf 
_400mg/kg/ 
(2)Odmum (3)Plemspennim (4)Conmphom (5)Evohiuh)us (^Nardostadtys 
sanctum acertfotium Jfh^hittU Alsnoides Jatanum 
(OS) (PA) (Gugguljpid) (E/^ (NJ) 
^50mgfl<;g 
_50mg/kg ^50tTig/kg 
_100nng/kgJ _100nng/kg 
•ineSfaive 
-200mg*g^ -2D0mg/kg 
-400mg/kg[ ^^ _400mg/kg/ 
^2Smgfl<g A 
^SOmgfl^ g 
-lOOmg/kg 
_20Chig/kg/ 
•IriirtEdiw? 
^SOng/kg-) 
^100rng/kd 
-200mgfl<g 
_400mg/kg 
•in^fecDve 
.1Q0mg/kg 
-200mgfl<g 
Hf.-ftBOi-r 
•HtecOva ^4(X>iTg/kg/ 
Step2 
( a;i[f iilant tAtracls aJ lowcNt eff«li\t' dost wttv fuftlJtr scrLttinl lor fheir anti-
stoNs |r.)tt*iitiai in ( i S nriJild usinji similar strtvs nsirkTs 
Odmum 
sanctum 20ang/kg \ BtecfivB 
(OS) 
Ewlvulous . 
Alsnoides 2oang/kg I 6:svaiv3 
(E4) J 
Steps 
Naricus fVaciicns rn!mt!M«ii\e plant L-vtracts W^TM (urthsr scrtenaJ at \aricu>.Ll:^*js 
inASrrrrJd uslr^isirr'lars-rtss rmrrttrs 
Odmim 
Butandlc 
Fraction 
5Chng/kg| irefefive 
lOarg/kg 
sanction 
(OS) 
- 200nigfl<g 
Bicdjva 
Aqucxjs 
iiaction 
- sang/kg 
-100mg*g 
- 2DChigfl<g 
. ir^ccnve 
Bvhtdous 
oMnades 
m 
BUtandic 
Fraction 
aiTg/kg| iPi^ racbve 
100nngfl<g 
2G0rTg^ 
Y Ksm^s 
Aquous 
Fraction 
r- SChp'kg 
r lOQingrtg 
- 200nigrt<g^ 
. naiacuvt 
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Step4 
• rations al low^ t^ L'fleclive dost vveiT furl her scat'ned for (lieir anti-str\.-\s 
j^)U'ntiaJ in C'L S mot el usin«j similar sla's.s ararki-rs 
Butanoiic Fraction of 
Odmim sanctum (OS) lOOrg/kg IfaigcSvs 
Butanoiic Fraction of 
Evolvulousai^ iioides (EA) 100mg/kg L Biecftw 
Steps 
1 'iia oirni:tmlnl^ inim efTivtiv«• t'raitiims \\fO." '^ crventii at ^umlus (J()M> ir \ s miniri 
uMh);, 'niJliirstri-Ns markers 
OditMim 
sanctum 
(OS) 
J^  J^  J 
OdmumosideA Q ^ ^ ^ ^ OdmumosideB 
Evolvulous 
alsinoides 
(EA) 
10mg/kg"| ^10mg/kg 
I'.aft&.iii.t-
20mg/kgj *"20mgfl<g 
40mg/kg]. Fflssctivv.' ~40rng/kg 
r^^.tt^-ove 
i—;—?—-^—;—J 
EA1 EA2 EA3 EA4 EA5 EA6 
^ 10mg/kg] 
I ^,#«.,ve 20mg/kgJ,^,^^,.^ 20mg/kg 
40mg/kg L btfccDve 
^nsttecfive at all 
_40mg/kg 
rfclfeCJiv 
Step 6 
!'un-nimpDunds yl ffTtx"ti\t ilost'wen- Further scnvnwi lur thi-ir jnt)-Mn.NN 
I^ iiti-nlial in ( I S r uidd usinsi similar stress markers 
OdmumosideA 40mg/kg i btfecnvvj OdmumosideB 4»Tig/kg I btraarvf 
Flowchart 1: Schematic representation of the sequential procedure to elucidate the anti-
stress potential of plant extracts/fractions/pure compounds. Step 1-6 summarized the 
sequential procedure for identifying the anti-stress potential in 6 different plants, starting 
from crude extracts, leading to the specific fractions and ultimately pure compounds. Out 
of these 6 plants only two (OS and EA) showed promising anti-stress potential, both in 
AS and CUS models. Panca quinquefolium (100 mg/kg p.o.) was used as an anti-stress 
standard drug to compare the anti-stress efficacy of plants extracts/fractions/pure 
compounds. We continued our study up to the level of active constituents (pure 
compounds) along with the examination of their possible mode of anti-stress action. For 
simplification, only the data of the two effective plants (OS and EA) is given. 
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4.6 Anti-stress effects of crude ethanolic extract from six medicinal plants 
We have evaluated the anti-stress potential of graded doses of crude ethanolic (Et-
OH) extracts of six medicinal plants [Tinospora sinensis (TS), Pterospermum acerifolium 
(PA), Ocimum sanctum (OS), Evolvulus alsinoides (EA), Commiphora whighitii 
(Guggulipid) and Nardostachys jatamansi (NJ)] in AS model. PQ (100 mg/kg p.o.) was 
used as an anti-stress standard drug to compare the anti-stress efficacy of these plants 
extracts/fractions/pure compounds. The crude Et-OH extracts of TS, PA, NJ and 
Guuggulipid showed no significant effect on AS-induced changes at any dose (data not 
given). However, OS and EA Et-OH extracts/fractions/pure compounds were found 
effective at various doses in preventing AS/CUS-induced changes. 
4.7 Effect of Ocimum sanctum (OS) extract/fractions on AS-induced changes 
OS was extracted with ethanol (EtOH) and further fractionated into their butanol 
and aqueous fractions. The graded doses of crude OS EtOH extract (100, 200, 400mg/kg) 
and fractions (50, 100, 100 mg/kg) were tested for their anti-stress activity in AS model. 
AS caused a significant (P<0.001) increase in the adrenal gland weight, mean 
ulcer score, plasma corticosterone, glucose levels and CK activity as compared to the NS 
control group. Administration of OS EtOH (200 and 400 mg/kg p.o.), butanolic fraction 
(100 and 200 mg/kg p.o.) and PQ (100 mg/kg p.o.) for a period of three days prior to the 
immobilization stress (150 min) significantly (P<0.05-0.001) prevented the AS-induced 
changes, while OS aqueous fraction produce no significant (P>0.05) changes. The results 
are graphically represented in Figure 9-13. 
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Figure 9: Adrenal gland weight 
JWJW. '• • • 
m 
<c{^ <^"^ <<>^ 
^ fS> f§> 
»c^  nP b? 
OS EtOH extract 
+ 
AS 
<^ "^  <^ "^  <^ '^  <>^ <>^ <>^ 
tS> fv<2> <^^ 
OS Butanolic fraction OS Aqeous fraction 
+ + 
AS AS 
Figure 9: Results are represented as mean ± S.E.M. with eight rats (n = 8) in each group. 
®P<0.001 vs. NS control group, 'P<0.05, ''P<0.01, 'P<0.001 vs. AS group (One-way 
ANOVA followed by Tukey-Kramer multiple comparison test). 
Figure 10: Mean Ulcer Score 
25n 
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Figure 10: Results are represented as mean ± S.E.M. with eight rats (n = 8) in each 
group. ®P<0.001 vs. NS control group, 'P<0.05, ''P<0.01,'P<0.001 vs. AS group (One-
way ANOVA followed by Tukey-Kramer multiple comparison test). 
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Figure 11: Plasma corticosterone level 
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Figure 11: Results are represented as mean ± S.E.M. with eight rats (n = 8) in each 
group. ¥<0.01 vs. NS control group, 'P<0.05, ''P<0.01/P<0.001 vs. AS group (One-way 
ANOVA followed by Tukey-Kramer multiple comparison test). 
Figure 12: Plasma glucose level 
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Figure 12: Results are represented as mean ± S.E.M. with eight rats (n = 8) in each 
group. '^P<0.001 vs. NS control group, ''P<0.05, T<0.01, T<0.001 vs. AS group (One-
way ANOVA followed by Tukey-Kramer multiple comparison test). 
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Figure 13: Plasma Creatine Kinase(CK) activity 
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Figure 13: Results are represented as mean ± S.E.M. with eight rats (n = 8) in each 
group. ®P<0.001 vs. NS control group, 'P<0.05, ''P<0.01,'P<0.001 vs. AS group (One-
way ANOVA followed by Tukey-Kramer multiple comparison test). 
A schematic diagram summarizing the effect of OS extracts/fractions at various 
doses on peripheral stress biomarkers 
Parameters 
Adrenal 
hypertrophy 
Mean ulcer 
score 
Cortcosterone 
level 
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level 
Creatine Kinase 
activity 
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ttt 
ttt 
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ttt 
ttt 
OS Et-OH extract 
100 
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— 
— 
100 
mg/kg 
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II 
II 
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— 
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— 
— 
— 
— 
— 
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mg/kg 
t Represents significant increase; • Represents significant decrease; » Represents no 
significant change. Higher the number of arrows means more significant is the effect. AS 
group was compared with NS control group, whereas, OS treatment group was compared 
with AS group. 
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4.8 Effect of OS Et-OH extract and Butanol fraction on CUS-induced 
changes 
As shown above (Figure 9-13), our preliminary studies indicated the anti-stress 
effect of OS Et-OH extract and its butanol fraction under AS condition. From these 
observations, the lowest effective doses of OS Et-OH extract (200 mg/kg p.o.) and 
butanol fraction (100 mg/kg p.o.) were identified and selected for studying their anti-
stress potential under more severe CUS condition (Table 13). 
Exposure of CUS significantly (P<0.001) increased the adrenal gland weight, 
mean ulcer score, plasma corticosterone level and CK activity as compared to the NS 
control group. Administration of OS Et-OH (200 mg/kg p.o.), butanolic fraction (100 
mg/kg p.o.) and PQ (100 mg/kg p.o.) for a period of seven days prior to the stress 
regimen significantly (P<0.05-0.001) normalized the CUS-induced changes (Table 13). 
Groups 
NS 
CUS 
Adrenal Gland 
Weight 
(mg/lOOgm 
body weight) 
7.77+0.21 
12.3740.27® 
Mean Ulcer 
Score 
0.0+0.0 
26.0+1.63® 
Corticosterone 
(ng/ml of 
I^asina) 
202.60+^.63 
285.2+11.93® 
Creatine Kinase 
(lU/dL of 
plasma) 
434.64 ±24.67 
685.65±48.77® 
CUS + OS EtOH 
extract (200mg/kg) 10.70+0.44" 
CUS + OS butanol 
fraction (lOOmg/kg) 10.75+0.38^ 
CUS+PQ (lOOmg) 9.68+0.35"= 
11.1+1.33'= 
12.0+1.79*= 
9.12+2.87"= 
236.1+13.73^ 505.9134.72" 
226.8+11.47" 514.5+33.06' 
217.5+6.81^ 488.1+28.83" 
Table 13: Each value is the mean + SEM with eight rats (n= 8) in every group. ®P<0.001 
vs. NS control group, 'P<0.05, ''P<0.01, '=P<0.001 vs. CUS group (One-way ANOVA 
followed by Tukey-Kramer multiple comparison test). 
4.9 Effect of OS pure compounds on AS-induced changes 
The anti-stress effect of OS Et-OH extract and its butanolic fracfion in both AS 
and CUS models further intrigued us to examine the anti-stress potential of OS derived 
pure compounds under AS/CUS conditions. Three OS pure compounds designated as 
Ocimumoside A, Ocimumoside B and Ocimarin were tested at graded doses (10, 20, 
40mg/kg) for their anti-stress acfivity in AS model. 
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AS caused a significant (P<0.05-0.001) increase in the adrenal gland weight 
(Figure 14), mean ulcer score (Figure 15), plasma corticosterone (Figure 16), glucose 
levels (Figure 17) and CK activity (Figure 18) as compared to the NS control group. 
Administration of Ocimumoside A, Ocimumoside B (40 mg/kg p.o.) and PQ (100 mg/kg 
p.o.) significantly (P<0.05-0.001) prevented these AS-induced changes, while Ocimarin 
produce no significant (P>0.05) changes. When rats were pretreated with Ocimumoside A 
and Ocimumoside B at a dose of 20 mg/kg only selective effect was observed in 
preventing the AS-induced changes. The results are graphically represented in Figure 14-
18. 
Figure 14: Adrenal gland weight 
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Figure 14: Results are represented as mean ± S.E.M. with eight rats (n = 8) in each group. 
*P<0.01 vs. NS control group, 'P<0.05, ''P<0.01, 'P<0.001 vs. AS group (One-way 
ANOVA followed by Tukey-Kramer multiple comparison test). 
Figure 15: Mean ulcer score 
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Figure 15: Results are represented as mean ± S.E.M. with eight rats (n 
group. ®P<0.001 vs. NS control group. ''P<0.01, 'P<0.001 vs 
AN OVA followed by Tukey-Kramer multiple comparison test). 
8) in each 
AS group (One-way 
Figure 16: Plasma Corticosterone level 
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Figure 16: Results are represented as mean ± S.E.M. with eight rats (n = 8) in each 
group, ¥<0.01 vs. NS control group. ''P<0.01,'P<0.001 vs. AS group (One-way ANOVA 
followed by Tukey-Kramer multiple comparison test). 
Figure 17: Plasma Glucose level 
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Figure 17: Results are represented as mean ± S.E.M. with eight rats (n - 8) in each 
group. ®P<0.001 vs. NS control group. "P<0.05, ''P<0.01/P<0.001 vs. AS group (One-
way ANOVA followed by Tukey-Kramer multiple comparison test). 
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Figure 18: Plasma CK activity 
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Figure 18: Results are represented as mean ± S.E.M. with eight rats (n = 8) in each 
group. ®P<0.001 vs. NS control group. ''P<0.01, 'P<0.001 vs. AS group (One-way 
ANOVA followed by Tukey-Kramer multiple comparison test). 
A schematic diagram summarizing the effect of OS pure compounds at various 
doses on peripheral stress biomarkers 
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4.10 Effect of OS pure compounds on CUS-induced changes 
From the above results, the lowest effective dose of OS pure compounds (40 
mg/kg) were selected and used for studying their anti-stress potential in a more severe 
CUS model. 
CUS significantly (P<0.001) increased the adrenal gland weight, mean ulcer 
score, plasma corticosterone level and CK activity as compared to the NS control group. 
Pretreatment with Ocimumoside A and B (40 mg/kg) and PQ significantly (P<0.01-
0.001) normalized the CUS-induced changes, while Ocimarin produce no significant 
(P>0.05) changes (Table 14). 
Groups 
NS 
CUS 
Ocimumoside 
A + CUS 
(40mg) 
Ocimumoside 
B + CUS 
(40mg) 
Ocimarin + 
CUS (40mg) 
CUS+PQ 
(lOOmg) 
Adrenal Gland 
Weight 
(mg/lOOgm body 
weight) 
7.89+0.23 
12.46+0.23® 
10.70+0.34" 
10.8510.38'' 
11.44-K).52 
9.68+0.35' 
Mean Ulcer 
Score 
0.0+0.0 
27.0+1.51® 
9.01+2.33' 
11.0±1.79' 
23.0+1.52 
9.12±2.87' 
Corticosterone 
(ng/ml of 
plasma) 
207.68+7.63 
284.2+9.93® 
230.1+8.73" 
226.8+16.47" 
260.8+7.01 
221.5+6.21' 
Creatine Kinase 
(lU/dL of 
plasma) 
452.64 + 21.67 
690.65+46.84® 
492.4+45.72" 
491.5+37.06" 
656.08+78.98 
488.1+28.83" 
Table 14: Each value is the mean + SEM with eight rats (n= 8) in every group. ®P<0.001 
vs. NS control group, ''P<0.01, 'P<0.001 vs. CUS group (One-way ANOVA followed by 
Tukey-Kramer multiple comparison test). 
4.11 Examination of histopathological changes in the gastric mucosal 
tissue in AS and OS treated rats 
To further ascertain the attenuating effects of Ocimumoside A and B to mucosal 
damage in AS-induced gastric ulcers, the microscopic evaluation of histopathological 
changes in gastric mucosal tissue were performed. The NS control group showed intact 
mucosal epithelium with well organized layers (mucosa, submucosa, muscularis mucosa 
and serosa layers) (Figure 19A). AS group was characterized by damaged mucosal 
epithelium, disorganization of glandular tissue and presence of inflammatory exudates 
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and cellular debris in the ulcerated wall of the stomach (Figure 19B). However, when rats 
were subjected to AS after the treatment of Ocimumoside A and B (40 mg/kg p.o.), 
glandular proliferation could be seen but differentiation and organization were not 
properly evident, suggesting only minor protective action of these two OS compounds 
following their acute treatment (Figure 19 C, D). 
Figure 19: Photomicrograph (representative) showing histopathological changes in 
sections of stomach obtained from the rats of NS control group (A) AS (B) Ocimumoside 
A + AS (C) and Ocimumoside B + AS (D), with four rats (n = 4) in each group. Arrows 
indicate ME: mucosal epithelium; M: mucosal layer; MM; muscularis mucosa; SM; 
submucosa. The H.E. stained slides were visualized under bright field microscope with 
lOOX magnification. 
4.12 Examination of histopathological changes in the gastric mucosal 
tissue in CUS and OS treated rats 
Evaluation of histopathological changes in the CUS group revealed the presence 
of disorganized glandular tissue, damaged mucosal epithelium, inflammatory exudates, 
proliferated fibroblasts, mixed leukocytic infiltrate and cellular debris. This is in contrast 
with NS control group, showing intact mucosal epithelium with properly-organized layers 
(mucosa, submucosa, muscularis mucosa and serosa layers) (Figure 20 A, B). 
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In Ocimumoside A + CUS and Ocimumoside B + CUS groups, reepithelization, 
reduced inflammatory exudates, mucosal regeneration and glandular organization could 
be seen (Figure 20 C, D). 
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Figure 20: Photomicrograph (representative) showing histopathological changes in 
sections of stomach obtained from the rats of NS control group (A) CUS (B) 
Ocimumoside A + CUS (C) and Ocimumoside B + CUS (D), with four rats (n = 4) in each 
group. Arrows indicate ME: mucosal epithelium; M: mucosal layer; MM; muscularis 
mucosa; SM; submucosa. The H.E. stained slides were visualized under bright field 
microscope with lOOX magnification. 
4.13 Effect of OS compounds on AS and CUS-induced monoaminergjc 
changes in selected brain regions 
4.13.1 Frontal cortex 
Figure 21 (A) and (B) depict the effect of OS compounds on AS-induced changes 
in the monoamine and metabolite levels. AS significantly (P<0.05-0.001) increased the 
levels of fi-ontal cortical DA, HVA, 5-HT and 5-HIAA, and decreased the NA levels as 
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compared to the NS control group. Pretreatment with Ocimumoside A, Ocimumoside B 
(40mg/kg p.o) and PQ (100 mg/kg p.o.) significantly (P<0.05-0.001) prevented these 
changes as compared to the respective AS group, however, no significant (P>0.05) effect 
of Ocimarin was observed. Further, OS compounds failed to prevent the AS-induced 
decrease in the NA levels. 
Figure 21 (C) and (D) depict the effect of OS compounds on CUS-induced 
alterations in the monoamine and metabolite levels. CUS significantly (P<0.05-0.001) 
decreased the levels of frontal cortical DA, NA, 5-HT and 5-HIAA, and increased the 
DO?AC and HVA levels as compared to the NS control group. Pretreatment with 
Ocimumoside A, Ocimumoside B and PQ significantly (P<0.05-0.001) restored these 
alterations as compared to the respective CUS group, however, no significant (P>0.05) 
effect of Ocimarin pretreatment was observed. 
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Figure 21: Histograms representing the acute stress (AS) induced changes in DA and its 
metabolite levels (A) and NA, 5-HT and 5-HlAA levels (B) and on chronic unpredictable 
stress (CUS) induced changes in DA and its metabolite levels (C) and NA, 5-HT and 5-
HIAA levels (D) in the frontal cortex in NS, AS/CUS and OS treated groups. Results are 
represented as mean ± S.E.M. with eight rats (n = 8) in each group. ''P<0.05, ¥<0.01, 
®P<0.001 vs. NS group, 'P<0.05, ¥<0.01, 'P<0.001 vs. AS/CUS group (One-way 
ANOVA followed by Tukey-Kramer multiple comparison test). 
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4.13.2 Striatum 
AS exposure significantly (P<0.05-0.001) increased the striatal DOPAC, HVA, 5-
HT and 5-HIAA levels, while significantly (P<0.05) decreased the DA levels in 
comparison to the NS control group. Pretreatment with Ocimumoside A, Ocimumoside B 
and PQ significantly (P<0.05-0.01) prevented these AS-induced changes, while, Ocimarin 
insignificantly (P>0.05) altered these changes [Figure 22(A) and (B)]. 
CUS exposure significantly (P<0.05-0.001) decreased the striatal DA, NA, 5-HT 
and 5-HIAA levels, while significantly (P<0.05) increased the HVA levels in comparison 
to the NS control group. However, pretreatment with Ocimumoside A, Ocimumoside B 
and PQ significantly (P<0.05-0.001) restated the altered levels of NA, DA and HVA as 
compared to the respective CUS group. The CUS-induced alterations in the levels of DA, 
HVA, NA, 5-HT and 5-HIAA were significantly (P<0.05-0.001) normalized following 
the treatment of PQ, while, Ocimarin insignificantiy (P>0.05) altered these changes 
[Figure 22(C) and (D)]. 
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Figure 22: Histograms representing AS induced changes in DA and its metabolite levels 
(A) and NA, 5-HT and 5-HIAA levels (B) and on CUS induced changes in DA and its 
metabolite levels (C) and NA, 5-HT and 5-HlAA levels (D) in the striatum in NS, 
AS/CUS and OS treated groups. Results are represented as mean ± S.E.M. with eight rats 
(n = 8) in each group. *P<0.05, ¥<0.01, ®P<0.001 vs. NS group, 'P<0.05, ''P<0.01, 
'P<0.001 vs. AS/CUS group (One-way ANOVA followed by Tukey-Kramer multiple 
comparison test). 
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4.13.3 Hippocampus 
The DA and NA levels were significantly (P<0.05, P<0.01 respectively) decreased 
by AS, while, the levels of 5-HT and 5-HIAA significantly (P<0.05, P<0.01 respectively) 
increased as compared to the NS control group [Figure 23(A) and (B)]. Pretreatment with 
Ocimumoside A, Ocimumoside B and PQ significantly (P<0.05-0.001) prevented the 
increased levels of 5-HT and 5-HIAA as compared to the respective AS group, while, 
Ocimarin insignificantly (P>0.05) altered these changes. 
CUS significantly (P<0.05, P<0.01) decreased the DA, NA and 5-HT levels as 
compared to the NS control group [Figure 23(C) and (D)]. Ocimumoside A and PQ 
significantly (P<0.05) reversed the decreased levels of NA and 5-HT as compared to the 
respective CUS group. The 5-HIAA levels were significantly (P<0.05) normalized by PQ 
only. However, DOPAC and HVA levels remained significantly (P>0.05) unaltered 
during CUS and following the treatment of OS compounds or PQ. Whereas, Ocimarin 
insignificantly (P>0.05) altered these changes. 
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Figure 23: Histograms representing the AS-induced changes in DA and its metabolite 
levels (A) and NA, 5-HT and 5-HIAA levels (B) and on CUS-induced changes in DA and 
its metabolite levels (C) and NA, 5-HT and 5-HlAA levels (D) in the hippocampus in NS, 
AS/CUS and OS treated groups. Results are represented as mean ± S.E.M. with eight rats 
(n = 8) in each group. ''P<0.05, ^P<0.01, @P<0.001 vs. NS group, 'P<0.05, ^P<0.01, 
'P<0.001 vs. AS/CUS group (One-way ANOVA followed by Tukey-Kramer multiple 
comparison test). 
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4.14 Effect of OS compounds on AS-induced changes in the brain 
antioxidant systems 
Table 15 details the effect of OS compounds on AS-induced changes in the 
activities of SOD, CAT and GSH-Px respectively in the selected brain regions. The 
activities of SOD and GSH-Px were significantly (P<0.01-0.001) increased in the frontal 
cortex and striatum by AS, while the CAT activity remained significantly (P>0.05) 
unaltered in all the three brain regions as compared to the NS control group. The AS-
induced changes in the antioxidant enzymes were significantly (P<0.05-0.001) restored to 
the control values by Ocimumoside A, Ocimumoside B and MEL pretreatment, while, 
Ocimarin showed no significant (P>0.05) changes. Moreover, in the hippocampus, the 
SOD, CAT and GSH-Px activities remained significantly (P>0.05) unaltered by AS and 
following the treatment of OS compounds. 
Brain 
Regions 
Frontal cortex 
Striatum 
Hippocanpus 
Groups 
NS 
AS 
Ocimumoside A+AS 
Ocimumoside B +AS 
Ocimarin +AS 
Melatonin 4AS 
NS 
AS 
Ocimumoside A+AS 
Ocimumoside B +AS 
Ocimarin +AS 
Melatonin+AS 
NS 
AS 
Ocimumoside A+AS 
Ocimumoside B +AS 
Ocimarin +AS 
Melatonin +AS 
SOD 
(U/mg protein) 
5.97±0.56 
9.42+0.91" 
7.84+0.71 
6.93-K).84 
7.54+0.69 
5.86+0.48' 
10.65±1.34 
21.7511.98*^  
13.71±1.7f 
15.08+2.41 
15.38+1.37 
12.79+1.96' 
5.28+0.75 
6.07+0.81 
5.87^.83 
8.01^.96 
7.62+0.77 
8.37+1.89 
CAT 
(U/mg protein) 
0.32+0.038 
0.44+0.061 
0.38+0.034 
0.39+0.041 
0.28+0.029 
0.26+0.03 f 
0.22+0.029 
0.43+0.095 
0.27+0.048 
0.32+0.076 
0.30+0.044 
0.16+0.032' 
0.23+0.041 
0.29+0.077 
0.28+0.046 
0.2140.047 
0.27+0.053 
0.27+0.052 
GSItPx 
(U/mg protein) 
0.027±0.003 
0.046+O.OM* 
0.031+0.002' 
0.033+0.003' 
0.052+0.002 
0.029+0.003" 
0.028+0.004 
0.062+0.006* 
0.039+0.004' 
0.041+0.005 
0.06^.006 
0.033+0.005'' 
0.033+0.003 
0.049+0.006 
0.033+0.005 
0.03640.005 
0.03^.008 
0.022+0.004' 
Table 15: Each value is the mean ± S.E.M. with eight rats (n = 8) in every group. 
''P<0.05, ¥<0.01, when compared with NS group, 'P<0.05, ''P<0.01 vs. AS group (One-
way ANOVA followed by Tukey-Kramer multiple comparison test). 
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4.15 Effect of OS compounds on AS-induced changes in the brain GSH and 
IVIDA levels 
The GSH content was significantly (P<0.05) reduced in all the three selected brain 
regions by AS when compared to the NS control group. Administration of Ocimumoside 
A, Ocimumoside B and MEL significantly (P<0.05-0.01) prevented the depletion of GSH 
levels in all the three brain regions as compared to the respective AS group, while, 
Ocimarin showed no significant (P>0.05) changes (Figure 24 A). 
Exposure to AS significantly (P<0.01-0.001) increased the MDA levels in the 
frontal cortex and striatum as compared to the NS control group. Further, pretreatment 
with Ocimumoside A, Ocimumoside B and MEL significantly (P<0.05) prevented the 
AS-induced increase of MDA levels, while, Ocimarin showed no significant (P>0.05) 
changes (Figure 24 B). 
(A) (B) 
Frontal cortex 
a Nsi 
Striatum Hippocimpns FrootjJ cortex Slriatum ICppocampus 
AS OdnuTOsideA-«S • OdrmrosideB+AS ^ Odnraln+AS E PC»AS 
Figure 24: Histograms representing the GSH (A) and MDA (B) levels in the frontal 
cortex, striatum and hippocampus in NS, AS and OS treated groups. Results are 
represented as mean ± S.E.M. with eight rats (n = 8) in each group. ''P<0.05, ^P<0.01, vs. 
NS group, 'P<0.05, ''P<0.01 vs. AS group (One-way ANOVA followed by Tukey-Kramer 
multiple comparison test). 
4.16 Effect of OS compounds on CUS-induced changes in the brain 
antioxidant enzymatic system 
Table 16 illustrates the effect of OS compounds on CUS-induced changes in 
enzymatic antioxidant system in all the three selected brain regions. CUS caused a 
significant (P<0.05-0.01) decrease in SOD and CAT activities, with increased GSH-Px 
activity as compared to the NS group in the frontal cortex, striatum and hippocampus. 
Pretreatment with Ocimumoside A, Ocimumoside B and MEL significantly (P<0.05-
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0.001) normalized these altered enzyme activities when compared to its respective CUS 
group, while, Ocimarin showed no significant (P>0.05) differences. 
Brain 
Regions 
Groups SOD 
(U/mg protein) 
CAT 
(U/mg protein) 
GSH-Px 
(U/mg protein) 
Frontal Cortex 
Striatum 
Hippocanpus 
NS 
CUS 
Ocimumoside A +CUS 
Ocimumoside B +CUS 
Ocimarin+CUS 
Melatonin+CUS 
NS 
CUS 
Ocimumoside A +CUS 
Ocimumoside B +CUS 
Ocimarin +CUS 
Melatonin+CUS 
NS 
CUS 
Ocimumoside A +CUS 
Ocimumoside B +CUS 
Ocimarin+CUS 
Melatonin+CUS 
5.97±0.56 
3.09+0.27* 
5.38±0.7f 
5.51+0.53' 
4.01+0.29 
5.61+0.47' 
10.4(H-2.31 
3.32310.52** 
11.25±1.65' 
12.75+2.11'' 
4.61±0.511 
11.88±1.65'' 
5.28+0.75 
2.28+0.3 f 
5.11±0.45' 
5.32+0.67' 
2.62+0.25 
6.2^1.05*' 
0.32±0.038 
0.16+0.019* 
0.30+0.027' 
0.2cm).022' 
0.23+0.029 
0.37±0.036' 
0.22+0.029 
0.07±0.011* 
0.19+0.031' 
0.18+O.017' 
0.12±0.013 
0.23±0.04l'' 
0.23+0.041 
0.06+0.009" 
0.24+0.035*' 
0.22+0.045' 
0.11+0.011 
0.25+0.032*' 
0.027±0.003 
0.049+0.003* 
0.029+0.002*' 
0.026+O.003'' 
0.041+0.002 
0.024+0.003' 
0.028+0.004 
0.083±0.02f 
0.031+0.01 f 
0.030+0.008' 
0.055+0.010 
0.030+0.005' 
0.033+0.003 
0.059+0.008* 
0.035+0.002' 
0.036iK).004' 
0.O44+0.005 
0.032-K).003'' 
Table 16: Each value is the mean ± S.E.M. with eight rats (n = 8) in every group. 
*'P<0.05, *P<0.01, vs. NS group, 'P<0.05, *'P<0.01,'P<0.001 vs. CUS group (One-way 
ANOVA followed by Tukey-Kramer multiple comparison test). 
4.17 Effect of OS compounds on CUS-induced changes in the GSH and 
MDA levels 
During CUS, the GSH content was significantly (P<0.01-0.001) depleted in all the 
three selected brain regions as compared to the NS control group, shown in figure 25 A. 
Pretreatment with Ocimumoside A and MEL significantly (P<0.05-0.01) replenished the 
depleted GSH levels when compared to its respective CUS group in all the three brain 
regions, while, administration of Ocimarin showed no significant (P>0.05) differences. 
However, pretreatment with Ocimumoside B significantly (P<0.05) normaHzed the GSH 
levels in the hippocampus only (Figure 25 A). 
CUS significantly (P<0.001) increased the MDA levels in all the three brain 
regions as compared to the NS control group, shown in figure 25 B. Pretreatment with 
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Ocimumoside A and MEL significantly (P<0.05-0.01) normalized the enhanced MDA 
levels when compared to its respective CUS group, with no significant (P>0.05) effect of 
Ocimarin pretreatment. Administration of Ocimumoside B significantly (P<0.05-0.01) 
restored the increased MDA levels both in the striatum and hippocampus (Figure 25 B). 
(B) 
Frontal cortei Striatum Hii^ocaiiipus Frontal cortex Striatum Hippocampus 
C3 NS CUS Ocimumoside A+CUS HUH Ocimumoside B+CUS ^ Ocimarin-tCUS Ca PQ-KXIS 
Figure 25: Histogram representing the GSH (A) and MDA (B) levels of the frontal 
cortex, striatum and hippocampus in NS, CUS and OS treated groups. Results are 
represented as mean ± S.E.M. with eight rats (n = 8) in each group. *P<0.01, ®P<0.001 vs. 
NS group, 'P<0.05, ''P<0.01, 'P<0.001 vs. CUS group (One-way ANOVA followed by 
Tukey-Kramer multiple comparison test). 
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A simplified schematic representation of the effects of OS compounds on 
different components of stress and their functional interrelations 
The schematic diagram summarizing the effects of OS compounds on the central 
monoaminergic and oxidative systems under AS and CDS conditions: 
Acute stress (AS, shown in white background) and Chronic unpredictable stress (CUS, shown in 
gray background). Solid line arrows signify the restoring effects of OS compounds on 
stress (AS/CUS)-induced alterations, while dashed lines indicate the inability to revert 
these changes. During stress the increased corticosterone (CORT) level modulates the 
monoaminergic and oxidative processes. Moreover, the central monoamine and 
antioxidant systems influence the functioning of each other during stressful conditions. 
Thus, the anti-stress activity of Ocimumoside A and B could be related to an overall 
restoration of HPA axis activation, and parallel alterations in the central monoamine and 
oxidative systems. 
"i" Represents significant increase; • Represents significant decrease; — Represents 
no significant change. 
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4.18 Effect of stress (AS/CUS) and OS compounds on Glucocorticoid 
Receptor (GR) mRNA expression in selected brain regions: 
4.18.1 Normal distribution of GR mRNA in selected brain regions: 
The Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) results showed 
that GR gene (GR mRNA) is distributed in the brain, with the highest density in the 
hippocampus followed by the frontal cortex, hypothalamus and pituitary (Figure 26). 
(607bp). 
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Figure 26: Image (upper panel) and quantitative analysis result (lower panel) of the 
expression levels of GR mRNA in the selected brain regions was analyzed by RT-PCR. 
Data expressed as mean ± S.E.M. of four independent experiments. The blots are 
representative and the results in the histogram are expressed as ratio of relative intensity 
of GR to P-Actin. Statistical analysis was done by One Way ANOVA followed by Tukey-
Kramer multiple comparison test. 
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4.18.2 Effect of Ocimumoside A and B on stress-induced changes in the 
expression of GR in the frontal cortex: 
CUS caused a significant (P<0.05) decrease in the expression of GR mRNA as 
compared to the NS control group. However, administration of Ocimumoside A and B at 
a dose of 40mg/kg p.o. significantly (P<0.05) increased the GR mRNA when compared 
with CUS group. On the other hand, neither AS nor the acute treatment of Ocimumoside 
A& B produce any significant (P>0.05) changes in the expression of GR mRNA (Figure 
26). 
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Figure 26: Image (upper panel) and quanfitadve analysis result (lower panel) of the 
expression levels of GR mRNA in the frontal cortex was analyzed by RT-PCR. Data 
expressed as mean ± S.E.M. of four independent experiments. The blots are 
representative and the results in the histogram are expressed as ratio of relative intensity 
of GR to P-Actin. ''P<0.05 vs. NS group, 'P<0.05 vs. AS/CUS group (One-way ANOVA 
followed by Tukey-Kramer multiple comparison test). 
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4.18.3 Effect of Ocimumoside A and B on stress-induced changes in tlie 
expression of GR in the hippocampus: 
Exposure of both AS and CUS caused a significant (P<0.05, P<0.01) decrease in 
the expression of GR mRNA as compared to the NS control group. Pretreatment with 
Ocimumoside A and B (40mg/kg p.o.) significantly (P<0.05) increased the GR mRNA 
expression both in AS and CUS condition as compared with their respective stress control 
groups (Figure 27). 
(607bp) 
(352bp) 
/ 
# # 
' d" d- C O O'' 
GR 
P-Actin 
a NS 
AS 
S Ocimumoside A + AS 
•ID Ocimumoside B + AS 
• CUS 
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Figure 27: Image (upper panel) and quantitative analysis result (lower panel) of 
expression levels of GR mRNA in the hippocampus was analyzed by RT-PCR. Data 
expressed as mean ± S.E.M. of four independent experiments. The blots are 
representative and the results in the histogram are expressed as ratio of relative intensity 
of GR to p-Actin. *P<0.05, ^ P<0.01 vs. NS group, 'P<0.05 vs. AS/CUS group (One-way 
ANOVA followed by Tukey-Kramer multiple comparison test). 
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4.18.4 Effect of Ocimumoside A and B on stress-induced changes in the 
expression of GR in the hypothalamus: 
Exposure of both AS and CUS caused a significant (P<0.05, P<0.001) decrease in 
the expression of GR mRNA as compared to the NS control group. However, in 
Ocimumoside A + AS, Ocimumoside A + CUS, Ocimumoside B + CUS groups there was 
a significant (P<0.05-0.01) increase in the expression of GR mRNA when compared with 
their respective stress (AS/CUS) control groups (Figure 28). 
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Figure 28: Image (upper panel) and quantitative analysis result (lower panel) of the 
expression levels of GR mRNA in the hypothalamus was analyzed by RT-PCR. Data 
expressed as mean ± S.E.M. of four independent experiments. The blots are 
representative and the results in the histogram are expressed as ratio of relative intensity 
of GR to p-Actin. ''P<0.05,@P<0.001 vs. NS group, 'P<0.05,''P<0.01 vs. AS/CUS group 
(One-way ANOVA followed by Tukey-Kramer multiple comparison test). 
130 
Chapter 4 Results 
4.18.5 Effect of Ocimumoside A and B on stress-induced changes in the 
expression of GR in the pituitary: 
AS and CUS significantly (P<0.05, P<0.01) decreased the GR mRNA expression 
when compared to the NS control group. No significant (P<0.05) change was observed in 
the expression of GR mRNA in AS + Ocimumoside A and AS + Ocimumoside A groups. 
However, in Ocimumoside A + CUS, Ocimumoside B + CUS groups there was a 
significant (P<0.05) increase in the expression of GR mRNA when compared to CUS 
group (Figure 29). 
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Figure 29: Image (upper panel) and quantitative analysis result (lower panel) of the 
expression levels of GR in the pituitary was analyzed by RT-PCR. Data expressed as 
mean ± S.E.M. of four independent experiments. The blots are representative and the 
results in the histogram are expressed as ratio of relative intensity of GR to P- Actin. 
''P<0.05, *P<0.01 vs. NS group, 'P<0.05 vs. AS/CUS group (One-way ANOVA followed 
by Tukey-Kramer multiple comparison test). 
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A schematic diagram summarizing the expression pattern of GR mRNA in selected 
brain regions following stress (AS/CUS) and OS compounds treatment 
Brain regions 
Frontal Cortex 
Hippocampus 
Hypothalamus 
Pituitary 
AS 
I 
I 
I 
Ocimumoside 
A + AS 
t 
ft 
— 
Ocimumoside 
B+AS 
t 
t 
— 
cus 
I 
u 
U4 
U 
Ocimumoside 
A + CUS 
t 
t 
t 
t 
Ocimumoside 
B + CUS 
t 
t 
t 
t 
't ' Represents significant increase; • Represents significant decrease; — Represents no 
significant change. Higher the number of arrows means more significant is the effect. GR 
mRNA expression in AS and CUS group was compared with NS control group, whereas 
the expression in OS treated groups was compared with their respective stress (AS/CUS) 
groups. 
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4.19 Effect of stress (AS/CUS) and OS compounds on the expression of 
Corticotrophin Releasing Factor (CRF) mRNA in selected brain regions: 
4.19.1 Normal distribution of CRF mRNA in selected brain regions: 
The RT-PCR results showed that CRF gene (CRF mRNA) is distributed in the 
brain, with the highest density in the hypothalamus, followed by the pituitary, frontal 
cortex and hippocampus (Figure 30). 
. sS^" 
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Figure 30: Image (upper panel) and quantitative analysis result (lower panel) of the 
expression levels of CRF mRNA in selected brain regions was analyzed by RT-PCR. 
Data expressed as mean ± S.E.M. of four independent experiments. The blots are 
representative and the results in the histogram are expressed as ratio of relative intensity 
of CRF to P-Actin. Statistical analysis was done by One Way ANOVA followed by 
Tukey-Kramer multiple comparison test. 
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4.19.2 Effect of Ocimumoside A and B on stress-induced changes in the 
expression of CRF in the frontal cortex: 
Exposure of AS and CUS significantly (P<0.01) increased the expression of CRF 
mRNA when compared to the NS control group. Administration of Ocimumoside A and 
B at a dose of 40mg/kg p.o. significantly (P<0.05-0.01) decreased the CRF mRNA 
expression compared to their respective stress (AS/CUS) control groups (Figure 31). 
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Figure 31: Image (upper panel) and quantitative analysis result (lower panel) of the 
expression levels of CRF mRNA in the frontal cortex was analyzed by RT-PCR. Data 
expressed as mean ± S.E.M. of four independent experiments. The blots are 
representative and the results in the histogram are expressed as ratio of relative intensity 
of CRF to P-Actin. ¥<0.01 vs. NS group, 'P<0.05,''P<0.01 vs. AS/CUS group (One-way 
ANOVA followed by Tukey-Kramer multiple comparison test). 
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4.19.3 Effect of Ocimumoside A and B on stress-induced changes in the 
expression of CRF in the hippocampus: 
CUS caused a significant (P<0.01) increase in the expression of CRF mRNA as 
compared to the NS control group. Pretreatment with Ocimumoside A and B (40mg/kg 
p.o.) significantly (P<0.05-0.01) decreased the CRF mRNA expression as compared to 
CUS group. Conversely, neither AS nor the acute treatment of Ocimumoside A and B 
produce any significant (P>0.05) changes in the expression of CRF mRNA (Figure 32). 
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Figure 32: Image (upper panel) and quanfitative analysis result (lower panel) of the 
expression levels of CRF mRNA in the hippocampus were analyzed by RT-PCR. Data 
expressed as mean ± S.E.M. of four independent experiments. The blots are 
representative and the results in the histogram are expressed as ratio of relative intensity 
of CRF to p-Acfin. ¥<0.01 vs. NS group, 'P<0.05,^P<0.01 vs. AS/CUS group (One-way 
ANOVA followed by Tukey-Kramer multiple comparison test). 
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4.19.4 Effect of Ocimumoside A and B on stress-induced changes in the 
expression of CRF in the hypothalamus: 
CUS caused a significant (P<0.05) increase in the expression of CRF mRNA as 
compared to the NS control group. Pretreatment with Ocimumoside A and B (40mg/kg 
p.o.) significantly (P<0.01) decreased the CRF mRNA expression as compared to CUS 
group. On the other hand, neither AS nor the acute treatment of Ocimumoside A & B 
produce any significant (P>0.05) changes in the expression of CRF mRNA (Figure 33). 
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Figure 33: Image (upper panel) and quantitative analysis result (lower panel) of the 
expression levels of CRF mRNA in the hypothalamus were analyzed by RT-PCR. Data 
expressed as mean ± S.E.M. of four independent experiments. The blots are 
representative and the results in the histogram are expressed as ratio of relative intensity 
of CRF to P-Actin. *P<0.05 vs. NS group, ''P<0.01 vs. AS/CUS group (One-way ANOVA 
followed by Tukey-Kramer multiple comparison test). 
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4.19.5 Effect of Ocimumoside A and B on stress-induced changes in the 
expression of CRF in the pituitary: 
Exposure of AS and CUS significantly (P<0.05, P<0.001) increased the 
expression of CRF mRNA when compared to the NS control group. Administration of 
Ocimumoside A and B at a dose of 40mg/kg p.o. significantly (P<0.05-0.001) decreased 
the CRF mRNA expression as compared to their respective stress (AS/CUS) control 
groups (Figure 34). 
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Figure 34: Image (upper panel) and quantitative analysis result (lower panel) of the 
expression levels of CRF mRNA in the pituitary were analyzed by RT-PCR. Data 
expressed as mean ± S.E.M. of four independent experiments. The blots are 
representative and the results in the histogram are expressed as ratio of relative intensity 
of CRF to P-Actin. *P<0.05, ®P<0.001 vs. NS group, "P<0.05, 'P<0.001 vs. AS/CUS 
group (One-way ANOVA followed by Tukey-Kramer multiple comparison test). 
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A schematic diagram summarizing the expression pattern of CRF mRNA in selected 
brain regions following stress (AS/CUS) and OS compounds treatment 
Brain regions 
Frontal Cortex 
Hippocampus 
Hypothalamus 
Pituitary 
AS 
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"t" Represents significant increase; • Represents significant decrease; -• Represents no 
significant change. Higher the number of arrows means more significant is the effect. 
CRF mRNA expression in AS and CUS group was compared with NS control group, 
whereas the expression in OS treated groups was compared with their respective stress 
(AS/CUS) groups. 
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4.20 Effect of stress (AS/CUS) and OS compounds on the expression of 
Pro-opiomelanocortin (POMC) mRNA in selected brain regions: 
4.20,1 Normal distribution of POMC mRNA in selected brain regions: 
The RT-PCR results showed that POMC gene (POMC mRNA) is distributed in 
the brain, with the highest density in the pituitary, followed by the hypothalamus, frontal 
cortex and hippocampus (Figure 35) 
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Figure 35: Image (upper panel) and quantitative analysis result (lower panel) of the 
expression levels of POMC mRNA in selected brain regions was analyzed by RT-PCR. 
Data expressed as mean ± S.E.M. of four independent experiments. The blots are 
representative and the results in the histogram are expressed as ratio of relative intensity 
of POMC to (3-Actin. Statistical analysis was done by One Way ANOVA followed by 
Tukey-Kramer multiple comparison test. 
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4.20.2 Effect of Ocimumoside A and B on stress-induced changes in the 
expression of POMC in the frontal cortex: 
CUS significantly (P<0.001) increased the expression of POMC mRNA when 
compared to the NS control group. Administration of Ocimumoside A and B at a dose of 
40mg/kg p.o. significantly (P<0.05-0.01) decreased the POMC mRNA expression 
compared to CUS group. Conversely, neither AS nor the acute treatment of Ocimumoside 
A and B produce any significant (P>0.05) changes in the expression of POMC mRNA 
(Figure 36) 
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Figure 36: Image (upper panel) and quantitative analysis result (lower panel) of the 
expression levels of POMC mRNA in the pituitary were analyzed by RT-PCR. Data 
expressed as mean ± S.E.M. of four independent experiments. The blots are 
representative and the results in the histogram are expressed as ratio of relative intensity 
of POMC to P-Actin.®P<0.001 vs. NS group, ''P<0.01,'P<0.001 vs. AS/CUS group (One-
way ANOVA followed by Tukey-Kramer multiple comparison test). 
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4.20.3 Effect of Ocimumoside A and B on stress-induced changes in the 
expression of POMC in the hippocampus: 
CUS caused a significant (P<0.01) increase in the expression of POMC mRNA 
when compared to the NS control group. Administration of Ocimumoside A and B 
(40mg/kg p.o.) significantly (P<0.05-0.01) decreased the POMC mRNA expression 
compared to CUS group. On the other hand, neither AS nor the acute treatment of 
Ocimumoside A & B produce any significant (P>0.05) changes in the expression of 
POMC mRNA (Figure 37). 
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Figure 37: Image (upper panel) and quantitative analysis result (lower panel) of the 
expression levels of POMC mRNA in the hippocampus were analyzed by RT-PCR. Data 
expressed as mean ± S.E.M. of four independent experiments. The blots are 
representative and the results in the histogram are expressed as ratio of relative intensity 
of POMC to (3-Actin. ¥<0.01 vs. NS group, 'P<0.05, ''P<0.01 vs. AS/CUS group (One-
way ANOVA followed by Tukey-Kramer multiple comparison test). 
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4.20.4 Effect of Ocimumoside A and B on stress-induced changes in the 
expression of POMC in the hypothalamus: 
AS caused a significant (P<0.01) increase in the expression of POMC mRNA, 
while CUS significantly (P<0.05) decreased the expression when compared to the NS 
control group. In Ocimumoside A + AS and Ocimumoside B + AS groups, a significant 
(P<0.01) decrease in POMC mRNA expression was observed as compared to AS group. 
However, In Ocimumoside A + CUS and Ocimumoside B + CUS groups, a significant 
(P<0.05) increase in POMC mRNA expression was observed as compared to CUS group 
(Figure 38) 
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Figure 38: Image (upper panel) and quantitative analysis result (lower panel) of the 
expression levels of POMC mRNA in the hypothalamus were analyzed by RT-PCR. Data 
expressed as mean ± S.E.M. of four independent experiments. The blots are 
representative and the results in the histogram are expressed as ratio of relative intensity 
of POMC to p-Actin.''P<0.05,*P<0.01 vs. NS group, 'P<0.05,''P<0.01 vs. AS/CUS group 
(One-way ANOVA followed by Tukey-Kramer multiple comparison test). 
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4.20.5 Effect of Ocimumoside A and B on stress-induced changes in the 
expression of POMC in the pituitary: 
Exposure of AS and CUS significantly (P<0.01, P<0.001) increased the 
expression of POMC mRNA when compared to the NS control group. Administration of 
Ocimumoside A and B at a dose of 40mg/kg p.o. significantly (P<0.05-0.001) decreased 
the POMC mRNA expression as compared to their respective stress (AS/CUS) control 
groups (Figure 39). 
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Figure 39: Image (upper panel) and quantitative analysis result (lower panel) of the 
expression levels of POMC mRNA in the pituitary were analyzed by RT-PCR. Data 
expressed as mean ± S.E.M. of four independent experiments. The blots are 
representative and the results in the histogram are expressed as ratio of relative intensity 
of POMC to (3-Actin. *P<0.01, ®P<0.001 vs. NS group, 'P<0.05, =P<0.001 vs. AS/CUS 
group (One-way ANOVA followed by Tukey-Kramer mulfiple comparison test). 
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A schematic diagram summarizing the expression pattern of POMC mRNA in 
selected brain regions following stress (AS/CUS) and OS compounds treatment 
Brain regions 
Frontal Cortex 
Hippocampus 
Hypothalamus 
Pituitary 
AS 
ft 
t 
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A + AS 
— 
— 
u 
4 
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B+AS 
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4r 
cus 
ttt ft 
* 
ttt 
Ocimumoside 
A + CUS 
*M 
* 
t 
Mi 
Ocimumoside 
B + CUS 
u 
u 
t 
*M 
t Represents significant increase; • Represents significant decrease; — Represents no 
significant change. Higher the number of arrows means more significant is the effect. 
POMC mRNA expression in AS and CUS group was compared with NS control group, 
whereas the expression in OS treated groups was compared with their respective stress 
(AS/CUS) groups. 
4.21 Effect of stress (AS/CUS) and OS compounds on the expression levels 
of GR in the frontal cortex and hippocampus: 
In order to dehneate the effect of different stress models (AS/CUS) on the HPA-
axis response, the expression profile of GR (whole cell fraction) was examined by 
western blotting in the GR-rich brain regions (frontal cortex and hippocampus). We also 
evaluated that whether OS compounds pretreatment can modulate the GR expression 
levels during such stressful conditions. 
Exposure of CUS significantly (P<0.05, P<0.001) down regulates (decrease) the 
GR expression levels both in the frontal cortex (Figure 40) and hippocampus (Figure 41) 
regions of the brain when compared to the NS control group. In Ocimumoside A + CUS, 
Ocimumoside B + CUS groups, a significant (P<0.05, P<0.01) increase in the expression 
level of GR was observed in both the brain regions when compared to the expression 
level in CUS group. However, no significant (P>0.05) changes were observed in the AS, 
Ocimumoside A + AS, Ocimumoside B + AS groups. 
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Figure 40: Image of blot (upper panel) and quantitative analysis result (lower panel) of 
the expression levels of GR protein in the frontal cortex were analyzed by western 
blotting. Data expressed as mean ± S.E.M. of three independent experiments. The blots 
are representative and the results in the histogram are expressed as ratio of relative 
intensity of GR to P-Actin. ''P<0.05 vs. NS group, 'P<0.05 vs. AS/CUS group (One-way 
ANOVA followed by Tukey-Kramer multiple comparison test). 
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Figure 41: Image of blot (upper panel) and quantitative analysis result (lower panel) of 
the expression levels of GR protein in the hippocampus were analyzed by western 
blotting. Data expressed as mean ± S.E.M. of three independent experiments. The blots 
are representative and the results in the histogram are expressed as ratio of relative 
intensity of GR to P-Actin. @P<0.001 vs. NS group, ''P<0.01 vs. AS/CUS group (One-way 
ANOVA followed by Tukey-Kramer multiple comparison test). 
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4.22 Effect of stress (AS/CUS) and OS compounds on the expression of 
Heat Shock Protein (HSP)-70 in the frontal cortex and hippocampus: 
In order to delineate the effect of different stress models (AS/CUS) on the 
activation of stress responsive proteins (HSPs), the expression profile of HSP-70 was 
examined by western blotting. We also study whether OS compounds can modulate the 
stress-induced activation of HSP-70 in terms of their effects on the expression level. 
Exposure of AS and CUS significantly (P<0.05, P<0.001) up regulates (increase) 
the HSP-70 expression levels both in the fi-ontal cortex (Figure 42) and hippocampus 
(Figure 43) regions of the brain when compared to the NS control group. However, 
administration of Ocimumoside A and Ocimumoside B significantly (P<0.05-0.01) 
decreased (down regulates) the stress (AS/CUS) induced up regulation in the expression 
of HSP-70 both in the fi-ontal cortex and hippocampus (Figure 42-43). 
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Figure 42: Image of blot (upper panel) and quantitative analysis result (lower panel) of 
the expression levels of HSP-70 protein in the frontal cortex were analyzed by western 
blotting. Data expressed as mean ± S.E.M. of three independent experiments. The blots 
are representative and the results in the histogram are expressed as ratio of relative 
intensity of HSP-70 to p-Actin. ®P<0.001 vs. NS group, 'P<0.05 vs. AS/CUS group 
(One-way ANOVA followed by Tukey-Kramer multiple comparison test). 
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Figure 43: Image of blot (upper panel) and quantitative analysis result (lower panel) of 
the expression levels of HSP-70 protein in the hippocampus were analyzed by western 
blotting. Data expressed as mean ± S.E.M. of three independent experiments. The blots 
are representative and the results in the histogram are expressed as ratio of relative 
intensity of HSP-70 to p-Actin. ®P<0.001 vs. NS group, 'P<0.05, ''P<0.01 vs. CUS group 
(One-way ANOVA followed by Tukey-Kramer multiple comparison test). 
4.23 Effect of stress (AS/CUS) on Glucocorticoid receptor (GR) expression 
in the striatum, frontal cortex and hippocampus: 
The effect of stress on the modulation of HPA axis was assessed in relation to the 
changes in the expression of GR, using monoclonal antibody against GR. In order to 
quantify total GR-ir neurons count in the striatum, cortex and hippocampus regions, 
image analysis (stereology) was performed in GR positive sections. The result was 
summarized in Figure 44 A-F and Table 17. A significant decrease in GR-
immunoreactive neurons was evident in CUS rats in the striatum (36.49%, P<0.01), 
cortex (41.8%, P<0.001) and hippocampus (39.8%, P<0.01) regions of the brain as 
compared to the NS control group. The decrease in GR-ir neurons was also observed in 
AS group in all the three brain regions, however, did not reach statistical significance. 
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Figure 44: Photomicrographs of GR-immunoreactive (GR-ir) neurons in the cortex, 
striatum (A-C) and hippocampus (D-F) in the NS, AS and CUS groups. Arrows indicate 
the GR-ir neurons in the cortex, striatum and hippocampus. Magnifications of figures are 
at 10 and 40X with scale bars 200^ lm and 50|xm respectively. 
Table 17: GR-immunoreactive (GR-ir) neurons count in selected brain regions 
in control (NS) and stressed (AS/CUS) groups. 
Groups 
% GR-ir neurons in the striatum 
% GR-ir neurons in the cortex 
% GR-ir neurons in the 
hippocampus 
NS 
100 
100 
100 
AS 
72.2±9.3 
73.1±11.1 
75.2±14.8 
CUS 
es.si'^is.s 
58.25®±2.8 
60.11 ^±2.3 
Table 17: The data represent mean ± S.E.M. with 4 rats (n = 4) in each group. P<0.01, 
®P<0.001 vs. NS control group (One-way ANOVA followed by Tukey-Kramer muhiple 
comparison test). 
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4.24 Effect of OS compounds on CUS-induced changes in the GR 
expression in selected brain regions 
CUS caused a significant (P<0.01-0.001) decrease in GR-immunoreactive neurons 
in the striatum, cortex and hippocampus as compared to the NS control group (Figure 45 
A-H and Table 18). A significant increase in GR-ir neurons was observed in rats 
receiving Ocimumoside A (Ocimumoside A + CUS) in the striatum (28.7%, P<0.05), 
cortex (29.9%, P<0.01) and hippocampus (33.2%, P<0.01) regions of brain as compared 
to CUS rats. Similarly administration of Ocimumoside B (Ocimumoside B + CUS) 
significantly increased the GR-ir neurons in the striatum (28.7%, P<0.05), cortex (33.9%, 
P<0.001) and hippocampus (29.4%, P<0.05) as compared to CUS group. 
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Figure 45: Photomicrographs of GR-immunoreactive (GR-ir) neurons in the cortex, 
striatum (A-D) and hippocampus (E-H) in the NS, CUS and OS treated groups. Arrows 
indicate the GR-ir neurons in these brain regions. Magnification of figure is at lOX with 
scale bar 200^m. 
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Table 18: GR-immunoreactive (GR-ir) neurons count in the selected brain regions 
in the control (NS), stressed (CUS) and OS treated groups. 
Groups 
% GR-ir neurons in the 
striatum 
% GR-ir neurons in the cortex 
% GR-ir neurons in the 
hippocampus 
NS 
100 
100 
100 
CUS 
63.51*±5.3 
58.25*±2.8 
60.11*±2.3 
Ocimumoside 
A + CUS 
89.2^±2.3 
83.2" ±3.1 
90.11 "±8.3 
Ocimumoside 
B + CUS 
93.5l"±5.3 
88.25'=±2.8 
85.2^ ±8.8 
Table 18: The data represent mean ± S.E.M. with 4 rats (n = 4) in each group. P<0.05, 
^P<0.01 vs. NS control group, ''P<0.05, ''P<0.01 vs. CUS group (One-way ANOVA 
followed by Tukey-Kramer multiple comparison test). 
4.25 Effect of stress (AS /CUS) on the expression of Corticotrophin 
Releasing Hormone (CRH) in the cortex and hippocampus 
Exposure of CUS led to a significant increase in CRH-ir neurons in the cortex 
(32.25%, P<0.01) and hippocampus (47.11%, P<0.001) as compared to the NS control 
group (Figure 46 A-F and Table 19). The decrease in GR-ir was also evident during AS 
condition in the cortex (13.1%, P>0.05) and hippocampus (19.1%, P>0.05), however, did 
not reach statistical significance (Figure 46 A, B, D, E and Table 20). 
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Figure 46: Photomicrographs of CRH-immunoreactive (CRH-ir) neurons in the cortex, 
striatum (A-C), hippocampus (D-F) of NS, AS and CUS groups. Arrows indicate the 
CRH-ir neurons in the cortex, striatum and hippocampus. Magnification of figure is at 
lOX with scale bar 200(im. 
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Table 19: CRH-immunoreactive (CRH-ir) neurons count in selected brain regions 
in control (NS) and stressed (AS/CUS) groups. 
Groups 
% CRH-ir neurons in the cortex 
% CRH-ir neurons in the hippocampus 
NS 
100 
100 
AS 
113.1±9.2 
119.2±11.3 
cus 
132.25*±7.2 
147.11%6.3 
Table 19: The data represent mean ± S.E.M. with 4 rats (n = 4) in each group. P<0.01, 
®P<0.001 vs. NS control group (One-way ANOVA followed by Tukey-Kramer multiple 
comparison test). 
4.26 Effect of OS compounds on CUS-induced changes in CRH expression 
in the cortex and hippocampus 
A significant (P<0.01-0.001) increase in CRH-ir neurons was observed in CUS 
rats in the striatum, cortex and hippocampus as compared to the NS control group 
(Figure 47 A-H and Table 20). A significant reduction in CRH-ir neurons was observed 
in Ocimumoside A + CUS group in the cortex (17.35%, P<0.05) and hippocampus 
(23.8%, P<0.01) regions as compared to CUS group. Similarly, pretreatment of 
Ocimumoside B significantly reduced the CRH-ir neurons in the cortex (18.1%, P<0.05) 
and hippocampus (23.13%, P<0.01) as compared to the values of CUS group. 
Ocimumoside A 
+ 
CUS 
Ocimumoside B 
+ 
CUS 
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Figure 47: Photomicrographs of CRH-immunoreactive (CRH-ir) neurons in the cortex 
(A-D), hippocampus (E-H) of NS, CUS and OS treated groups. Arrows indicate the CRH-
ir neurons. Magnification of figure is at lOX with scale bar 200^m. 
Table 20: GR-ir neurons count in selected brain regions in control (NS), stressed (CUS) 
and OS treated groups. 
Groups 
% CRH-ir neurons in the cortex 
% CRH-ir neurons in the 
hippocampus 
NS 
100 
100 
CUS 
132.25^±7.2 
147.11®±6.3 
Ocimumoside 
A + CUS 
109.3^ ±2.1 
112.5''±4.8 
Ocimumoside 
B + CUS 
108.1^±1.8 
113.l''±8.3 
Table 20: The data represent mean ± S.E.M. with 4 rats (n = 4) in each group. P<0.05, 
^P<0.01 vs. NS control group, 'P<0.05, ''P<0.01 vs. CUS group (One-way ANOVA 
followed by Tukey-Kramer multiple comparison test). 
4.27 Effect of stress (AS/CUS) on the expression of Tyrosine Hydroxylase 
(TH) enzyme in the striatum, medial forebrain bundle (MFB) and substantia 
nigra (SN) 
The effect of stress on the modulation and functionally of dopaminergic neurons 
was assessed in relation to the changes in fibre density and number of immunoreactive 
neurons of TH (rate-limiting enzyme of DA biosynthesis), using monoclonal antibody 
against TH. The result of TH-ir fibre density and TH-immunopositive neurons was 
summarized in Figure 48 A-L and Table 21. AS caused an insignificant (P>0.05) decrease 
in the TH-ir fibre density in the striatum (12.5%) and MFB (18.5%) and number of TH-ir 
neurons in the SN (7.8%), when compared with NS group. On the other hand, a 
significant (P<0.01) decrease in the expression of TH was observed in CUS group in the 
striatum (32.25%), MFB (36%) and SN (44.25%) as compared to NS control group. 
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Figure 48: Photomicrographs of TH-immunoreactive (TH-ir) fibres and neurons in the 
striatum (A-F), medial forebrain bundle (MFB) (A-F) and substantia nigra (SN) (G-L) in 
NS, AS and CUS groups. Arrows indicate the TH-ir fibres in the striatum and MFB and 
neurons in the SN. Magnification of figure A-C is IX with scale bar 1mm, Magnification 
of figure D-F is 4X with scale bar 500^m. Magnification of figure G-H is lOX with scale 
bar 200nm, Magnification of figure J-L is 40X with scale bar 50|im. 
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Table 21: TH-immunoreactive (TH-ir) fibre density and neurons count in selected brain 
regions in control (NS) and stressed (AS/CUS) groups. 
Groups 
% Striatal TH-ir fibre density 
% MFB TH-ir fibre density 
% TH-ir neurons in SN 
NS 
100 
100 
100 
AS 
87.5±14.2 
81.5±12.3 
92.2±16.2 
cus 
67.5^±6.2 
64.0^±3.1 
55.75®±4.2 
Table 21: The data represent mean ± S.E.M. with 4 rats (n = 4) in each group. P<0.01, 
®P<0.001 vs. NS control group (One-way AN OVA followed by Tukey-Kramer multiple 
comparison test). 
4.28 Effect of OS compounds on CUS-induced changes in TH expression in 
the striatum, MFB and SN 
The result of TH-ir fibre density and TH-immunoposifive neurons was summarized 
in Figure 49 A-D and Table 22. A significant (P<0.01-0.001) decrease in the TH-ir fibre 
density (striatum and MFB) and number of TH-ir neurons in the SN was observed in CUS 
group as compared to the NS control group. A significant enhancement in GR-ir fibre 
density was evident in rats receiving Ocimumoside A (Ocimumoside A + CUS) in the 
striatum (21.6%, P<0.05) and MFB (22.14%, P<0.05), along with enhanced TH-ir 
neurons in the SN (36.7%, P<0.01) as compared to CUS rats. Similarly administration of 
Ocimumoside B (Ocimumoside B + CUS) significantly enhanced the TH-ir fibre density 
in the striatum (22.5%, P<0.05) and MFB (25.75%, P<0.01), along with increased TH-ir 
neurons in the SN (35.55%, P<0.001) as compared to the values of CUS group. 
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Figure 49: Photomicrographs of TH-ir fibres and neurons in the striatum, MFB and SN 
(A-D) in NS, CUS and OS treated groups. Arrows indicate the TH-ir fibres in the striatum 
and MFB and neurons in the SN. Magnification of figures is 4X with scale bar SOO^ im. 
Table 22: TH-immunoreactive (TH-ir) fibres and neurons count in the striatum, MFB, 
and SN in the control (NS), stressed (CUS) and OS treated groups. 
Groups 
% TH-ir fibre density in the striatum 
% TH-ir fibre density in the MFB 
% TH-ir neurons in the SN 
NS 
100 
100 
100 
CUS 
67.5^±6.2 
64.0^±3.1 
55.75®±4.2 
Ocimumoside 
A+CUS 
86.1 ^ ±4.1 
82.2^ ±2.3 
88.l''±1.8 
Ocimumoside 
B + CUS 
87.1 ^ ±2.3 
86.2''±3.8 
91.3''±7.3 
Table 22: The data represent mean ± S.E.M. with 4 rats (n = 4) in each group. P<0.05, 
*P<0.01 vs. NS control group, ^P<0.05, ''P<0.01 v< 
followed by Tukey-Kramer muUiple comparison test). 
vs. CUS group (One-way ANOVA 
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4.29 Effect of Evolvulus alsinoides (EA) extract/fractions on AS-induced 
changes: 
EA was extracted with ethanol (EtOH) and further fractionated in their butanol 
and aqueous fractions. The graded doses of crude EA EtOH extract (100, 200, 400mg/kg 
p.o.) and fractions (50, 100, 100 mg/kg p.o.) were examined for their anti-stress potential 
in AS model . 
AS caused a significant (P<0.01-0.001) increase in the adrenal gland weight, 
mean ulcer score, plasma corticosterone, glucose levels and CK activity as compared to 
the NS control group. Administration of EA EtOH (200 and 400 mg/kg p.o.), butanolic 
fraction (100 and 200 mg/kg p.o.) and PQ (100 mg/kg p.o.) for a period of three days 
prior to the immobilization stress (150 min) significantly (P<0.05-0.001) prevented the 
AS-induced changes, while EA aqueous fraction produce no significant (P>0.05) 
changes. The results are shown in Table 23 and 24. 
Gtoips 
Adrenal Qand 
Wfeight Meanllcer 
(irg'lOOgm 
bodywa^t) Scare 
Glucose 
(mg'dd' 
I^ma) 
Cwticostaxxie 
(ng/niof 
plasma) 
Q^eatineNnase 
(HJ/dLof 
I^im) 
NS 
AS 
AS+MEtOH 
extract (lOOmg) 
AS+EAEtOH 
extract (200iTig) 
AS+EABOH 
extract (400iTig) 
7.39+0.21 0.0+0.0 85.9Ct7.13 227.90+10.63 ^•64±2467 
1023+0.27® 19.0+1.79® 125.2+1293® 331.2+25.93* 1057.65i44.7/® 
918+0.47 13.1+1.53 108.6+13.73 313.1+23.73 985.5+56.92^ 
8.01+O.31'' 8.0+279'' 100.1+4.47= 231.8+21.47^ 7393+45.75^ 
8.42+0.25^  10.1+1.47" m.l+5A\^ 2425+18.81^ 7591+^.83' 
AS+PQ(100n¥;) 7.41+0.24'= 7.21+1.51'= 86.5^3.81'= 2195+16.81'= 488.1+28.83'= 
Table 23: Each value is the mean + SEM with eight rats (n= 10) in every group. *P<0.01, 
'^"'P<0.001 vs. N S control group, 'P<0.05, ' 'P<0.01, 'P<0.001 vs. A S group (One-way 
A N O V A followed by Tukey-Kramer multiple comparison test). 
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&014)S 
NS 
AS 
AS + EAButanol 
fraction (50n^ 
AS + EAButanol 
fraction (lOOmg) 
AS + EAButanol 
fraction (200mg) 
AS + EA Aqueous 
fraction (SOmg) 
AS + EA Aqueous 
fraction (lOOmg) 
AS + EA Aqueous 
fraction (200nig) 
AS + PQ(100n«) 
Adrenal Gland 
Weight 
(mg/lOOgm 
body weight) 
7.3t^ f0.21 
10.23+0.27® 
9.71+0.41 
7.55+0.32'' 
8.03+0.34'' 
9.41+0.49 
9.21+0.48 
9.95+0.45 
7.41+0.24" 
MeanUcer 
Score 
0.0+0.0 
19.0+1.79® 
12.1+2.53 
7.1±2.19' 
7.21+2.71'= 
12.1+2.11 
14.0+3.79 
13.1+2.17 
7.21+1.5f 
Glucose 
(mg/dl of 
plasma) 
85.90+7.13 
125.2+12.93® 
1093+3.73 
104.4+3.97" 
103.1+2.81" 
109.9+13.73 
1113+4.82 
1153+7.22 
86.5+3.81" 
Corticosterone 
(ng/nil of 
plasma) 
227.90+10.63 
331.2+25.93* 
3233+13.73 
233.5+7.97" 
229.1+12.81" 
317.9+23.73 
288.3+15.82 
293.3+17.22 
219.5+16.81" 
Creatine Kinase 
aU/dLof 
plasma) 
409.64 + 24.67 
1057.65+44.77® 
817.5+57.82 
704.8+50.75" 
693.3+72.83" 
848.5+56.92 
860.2+77.75 
908.1+68.83 
583.2+18.93" 
Table 24: Each value is the mean + SEM with eight rats (n= 10) in every group. P<0.01, 
®P<0.001 vs. NS control group, 'P<0.05, ^P<0.01, 'P<0.001 vs. AS group (One-way 
ANOVA followed by Tukey-Kramer multiple comparison test). 
4.30 Effect of EA EtOH extract and butanol fraction on CUS-induced 
changes: 
As shown above (Table 23, 24), our preliminary studies indicated the anti-stress 
effect of EA EtOH extract and its butanol fraction under AS condition. From these 
observations, the lowest effective doses of EA EtOH extract (200 mg/kg p.o.) and butanol 
fraction (100 mg/kg p.o.) were identified and selected for studying their anti-stress 
potential under more severe CDS condition. 
Exposure of CUS significantly (P<0.001) increased the adrenal gland weight, 
mean ulcer score, plasma corticosterone level and CK activity as compared to the NS 
control group. Administration of EA EtOH (200 mg/kg p.o.), butanolic fraction (100 
mg/kg p.o.) and PQ (100 mg/kg p.o.) for a period of seven days prior to the stress 
regimen significantly (P<0.05-0.001) normalized the CUS-induced changes (Table 25). 
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Groups 
Adrenal Gland 
Weight 
(mg/lOOgm 
body weight) 
Mean Ulcer 
Score 
Corticosterone 
(ng/ml of 
plasma) 
Creatine Kinase 
(lU/dL of 
plasma) 
NS 
cus 
CUS + EA EtOH 
extract (200mg) 
CUS + EA 
Butanol Fraction 
(lOOmg) 
7.77+0.21 
12.37±0.27® 
10.5010.38" 
10.55+0.47" 
0.0+0.0 
26.0+1.63® 
10.0111.49'' 
11.0+1.79" 
202.60+6.63 
285.2+11.93® 
223.219.93" 
229.8+10.40" 
434.64 ± 24.67 
685.65+48.77® 
503.5124.42" 
536.0+35.56' 
CUS+PQ (lOOmg) 9.68+0.35' 8.12+2.87" 217.5+6.81" 488.1+28.83' 
Table 25: Each value is the mean + SEM with eight rats (n= 8) in every group. ®P<0.001 
vs. NS control group, 'P<0.01, ''P<0.01, 'P<0.001 vs. CUS group (One-way ANOVA 
followed by Tukey-Kramer multiple comparison test). 
4.31 Effect of EA pure compounds (EA 1-6) on AS-induced changes: 
The anti-stress effect of EA EtOH extract and its butanol fraction in both AS and 
CUS models further intrigued us to examine the anti-stress potential of EA derived pure 
compounds under AS conditions. Six EA pure compounds designated as EA-1, EA-2, 
EA-3, EA-4, EA-5 and EA-6 were tested at graded doses (20, 40mg/kg p.o.) for their anti-
stress activity in AS model. 
AS caused a significant (P<0.001) increase in the adrenal gland weight, mean 
ulcer score, plasma corticosterone, glucose levels and CK activity as compared to the NS 
control group. Administration of EA-1 at a dose of 40 mg/kg and PQ at 100 mg/kg p.o. 
significantly (P<0.05-0.001) prevented all these AS-induced changes, while other EA 
compounds (EA-2, EA-3, EA-4, EA-5 and EA-6 ) at a dose of 20 and 40 mg/kg remains 
significantly (P>0.05) ineffective in preventing one or the other AS-induced changes. 
Thus, it can be summarized that apart from EA-1, no other EA compound able to 
significantly alter the AS-induced changes. The results are represented in Table 26. 
158 
Chapter 4 Results 
Groups (dose 
mg/kg body 
weight p.o.) 
NS 
AS 
EA-1 
EA-2 
EA-3 
EA-4 
EA-5 
EA-6 
(20mg) 
(40mg) 
(20mg) 
(40mg) 
(20mg) 
(40mg) 
(20mg) 
(40mg) 
(20mg) 
(40mg) 
(20mg) 
(40mg) 
PQ(lOOmg) 
Adrenal 
Gland 
Weight 
(mg/lOOgm 
body 
weight) 
6.87±0.81 
9.93+0.84® 
9.87±0.31 
7.23+0.45" 
9.21±0.28 
8.57±0.35 
8.99±1.35 
9.60±0.41 
91.15 ±0.78 
8.33±0.35 
9.23±0.37 
11.4H0.48 
9.32±1.35 
11.51±0.47 
7.32±0.25' 
Mean Ulcer 
Score 
0.0±0.0 
21.67±3.07® 
15.23±5.66 
6.66+2.11' 
17.23±5.01 
16.66 ±3.07 
26.41 ±4.27 
18.33±1.667 
12.66±6.11 
16.33 ±3.07 
21.23 ±7.07 
18.33±3.07' 
14.99±1.17 
16.67±2.11 
11.00±2.23'' 
Glucose 
(mg/dl) 
81.50±3.374 
134.7±4.68® 
109.0±2.95' 
93.00+5.62' 
115±7.92 
80.12±6.63' 
141.50±15.6 
122.0±2.95 
115±3.95 
80.50±6.63' 
96.2^4.23" 
112±4.93 
98.1H2.62 
127.0±3.12 
86.33±4.19' 
Creatine Kinase 
(lU/dl) 
397.5±15.72 
915.0±29.43® 
732.62±31.33 
485.0+57.30' 
992.1 ±64.36 
612.7^47.73" 
850.2H58.21 
962.7R61.73 
1128.7±47.73 
600.7^47.73" 
789.61+17.83 
1092.0 ±64.26 
876.71±17.71 
1030.7±77.58 
649.3±101.3' 
Corticosterone 
(ng/ml) 
244.5±15.43 
397.7±15.77® 
311.1 +77.28 
213.2+18.70" 
376.2±27.78 
312.2±21.18" 
278.7±26.28'' 
301.0 +27.18" 
468.5±31.65 
320.2+20.18" 
410.2±10.28 
476.8+17.78 
435.2±10.18 
456.8±23.94 
238.3±15.27' 
Table 26: Each value is the mean ± SEM with eight rats (n= 8) in every group. ®P<0.001 
vs. NS control group, 'P<0.05, ''P<0.01, 'P<0.001 vs. AS group (One-way ANOVA 
followed by Tukey-Kramer multiple comparison test). 
4.32 Effect of Synthetic Compounds (Isoxazolines; IZL 1A-1G, 5A-5G) on 
AS-induced changes: 
Apart from plant sources, we also examined the anti-stress potential of some 
synthetic molecules, which were prepared in the medicinal chemistry division of the 
Institute. A series of novel isoxazolines (IZL) were synthesized via 1, 3-dipolar 
cycloaddition of in situ generated nitrile oxide from 2, 4-dimethoxy benzaldoxime and 
naphthaldehyde oxime with 4-allyl-2-methoxyphenol derivatives. 
All the 14 synthesized isoxazohnes (IZL lA-lG, IZL 5A-5G) were screened for 
their anti stress activity in AS model at a dose of 40 mg/kg p.o. body weight, as shown in 
Table 27. AS significantly (P<0.001) increase the adrenal gland weight when compared 
to the NS control group. Pretreatment with IZL-IB, IZL -ID, IZL-IE, IZL-IG, 1ZL-5B, 
IZL-5C, IZL-5D, IZL-5G and PQ significantly (P<0.05-0.001) prevented the increase in 
the adrenal gland weight in comparison to AS group. AS resulted in significant (P<0.001) 
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increase in mean ulcer score when compared to the NS control group. Pretreatment with 
IZL-IB, IZL-ID, IZL-IE, IZL-IG, IZL-5B, IZL-5C, IZL-5D, IZL-5G and PQ 
significantly (P<0.05-0.001) prevented this increase in mean ulcer score severity in 
comparison to AS group. Further, AS exposure resulted in a significant (P<0.001) 
increase in the plasma glucose level, C.K. activity and corticosterone level when 
compared to the NS control group. Pretreatment with IZL -IB, IZL-ID, IZL-IE, IZL-IG, 
IZL-5B, IZL-5C, IZL-5D, IZL-5G and PQ significantly (P<0.05-0.001) prevented the 
AS-induced increase in plasma corticosterone levels, whereas IZL-IA, IZL-IB, IZL-ID, 
IZL-IE, IZL-IG, IZL-5A, IZL-5B, IZL-5C, IZL 5D, IZL-5G and PQ were found 
significantly (P<0.05-0.001) effective in preventing AS-induced hyperglycemia. Further, 
pretreatment with IZL IB, IZL ID, IZL IE, IZL IG, IZL 5B, IZL 5C, IZL 5D, IZL 5G 
and PQ significantly (P<0.05-0.001) prevented the AS-induced increase in CK activity 
(Table 27). 
Thus, isoxazolines IZL ID, IG, 5B, 5C, 5D and 5G displayed most promising 
anti-stress effect by reverting all the AS-induced peripheral alterations at a dose of 40 
mg/kg p.o., whereas IZL lA, IC, IF, 5A, 5E and 5F were not significantly ineffective in 
these parameters (Table 27). 
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Groups 
(dose 
mg/kg 
body 
weight 
P.O.) 
NS 
AS 
IZL-IA 
(40mg) 
IZL-IB 
(40mg) 
IZL-IC 
(40mg) 
IZL-ID 
(40mg) 
IZL-IE 
(40mg) 
IZL-IF 
(40mg) 
IZL-IG 
(40mg) 
IZL-5A 
(40mg) 
IZL-5B 
(40mg) 
IZL-5C 
(40mg) 
IZL-5D 
(40mg) 
IZL-5E 
(40mg) 
IZL-5F 
(40mg) 
IZL-5G 
(40mg) 
PQ(IOO) 
Adrenal 
Gland 
Weight 
(mg/lOOgm 
body weight) 
6.87+0.81 
10.20+0.69® 
9.31+0.45 
7.0^0.54"= 
9.63+0.45 
7.82 ±0.47 " 
8.0110.42" 
9.82±0.42 
7.6010.28" 
9.86±0.35 
7.77+0.38" 
7.54+0.23" 
7.89+0.32" 
9.60±0.40 
10.58 ±0.58 
7.23+0.40' 
7.32±0.25' 
Mean Ulcer 
Score 
0.0+0.0 
21.67±3.07® 
13.33±2.11 
8.33 ±3.07" 
18.33±1.667 
6.66±2.1l" 
8.33±3.07" 
16.67±2.11 
10.00±2.58" 
11.67±3.07 
10.00±2.59" 
6.66±3.33" 
10.00±2.58" 
25.00 ±2.23 
16.67±2.10 
10.00±2.58" 
5.00±2.23" 
Glucose 
(mg/dl) 
81.50±3.374 
134.7±4.68® 
112.0±8.22" 
107.2±4.42" 
122.0±2.95 
93.00±5.62' 
80.50±6.63' 
127.0±3.12 
101.7±5.16' 
86.24±3.7r 
74.67±5.68' 
109.51±11.01" 
72.83±6.29' 
116.3±7.87 
125.0±4.83 
78.17±2.88' 
68.33±4.19' 
Creatine 
Kinase 
(lU/dl) 
323.5+15.72 
1115.0+29.43® 
1004.0±57.30 
766.71±47.73" 
1092.0 ±64.26 
729.7±77.58" 
664.3±77.36' 
934.7±75.78 
733.8±83.05" 
998.5±33.84 
673.0±60.36' 
590.0±82.55' 
625.7±79.46' 
994.5±50.50 
1074.0±73.93 
603.7±78.54' 
649.3±101.3' 
Corticosterone 
(ng/ml) 
244.5+15.43 
465.7+15.77® 
432.2±18.70 
364.2±20.18" 
446.0 ±27.18 
275.5±31.65' 
354.8±17.78" 
429.8±23.94 
320.0±15.49' 
417.2±21.09 
311.8±18.60' 
293.5±25.02' 
292.3±34.60' 
444.7±11.91 
421.0±20.96 
282.5±14.01' 
247.3±15.27' 
Table 27: Each value is the mean ± SEM with eight rats (n= 8) in every group. ®P<0.001 
vs. NS control group, 'P<0.05, "'P<0.01, 'P<0.001 vs. AS group (One-way ANOVA 
followed by Tukey-Kramer multiple comparison test). 
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Our study was designed to understand the insights of various stress components, 
identifying potential therapeutic targets and evaluating lead molecules (plant/synthetic 
origin) for their therapeutic efficacy. However, the insufficiency in understanding the 
etiology of stress-induced disorders and their simulation is the major obstacle in creating 
animal models of stress. The only approach, which has been used, is to try to reproduce 
one or more symptoms of that disorder in animals. Stress based animal models represents 
an indispensable preclinical approach to human pathology, since, the clinical data point 
towards the major role of stress experiences (life events) in the development of 
expression and exacerbation of various physiological and behavioural disturbances 
(Kalia, 2005; Habib et al., 2001). Thus, several models, in which primarily physical, 
psychological or a combination of both have been used to investigate stress (Pacak and 
Palkovits, 2001; Sahin and Gumuslu, 2004). On the basis of the available literature and 
considering the facts about different effects of stressors, we designed our study to include 
various stressors to explore the effect of stress on rats. In the present study, we employed 
three stress models (differ in intensity, duration and predictability of stressors) namely 
acute stress (AS), chronic stress (CS) and chronic unpredictable stress (CUS) to explore 
the stress-induced manifestations on biochemical, hormonal and molecular basis of stress-
induced pathologies. We selected acute immobilization (restraint) procedure to 
investigate the changes induced by a short acting severe stressor. AS procedure represents 
the reaction to an immediate threat, commonly known as the fight or flight response, 
whereas, the similar stressor lasting for several days or weeks fall with in the concept of 
CS. Among the various stress models, immobilization has been used extensively and 
accepted widely for studying stress-induced alterations as it produces both physical and 
inescapable psychological stress (Glavin and Hall, 1994; Marti et al., 1997). The 
distinction between acute and chronic stress rises from its intensity and duration. CUS 
was selected to reduce both, the anticipation of being exposed to stress as well as 
adaptation, which may occur due to repeated exposure to the same stressor. Though, the 
duration of the experiment employing CUS was quite short (7 days), but the number and 
intensity of stressors used were designed to compensate for this. CUS disrupts the 
adaptation response and leads to behavioural depression and other biochemical 
perturbations (Katz et al. 1981), thus it was considered to be a clinically relevant model 
for the humans. 
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5.1 Effect of different stress models (AS, CS and CUS) on various 
physiological and biochemical parameters: 
Stress research in the laboratory animals played an important role in understanding 
the biological and behavioural consequences of external and internal stressors. These 
stressors can perturb the homeostasis and thereby inducing a number of clinical diseases. 
A number of studies demonstrated that different types of stressors elicit specific responses 
(Sabban and Kvetnansky, 2001; Gilad and Gilad, 2002). The distinction between acute 
and chronic stress falls in its total difference in the behavioural and physiological 
consequences (Katz et al., 1981; Marti and Armario, 1998). When animals repeatedly 
subjected to the same stressor, as done in CS model, the decline of the initial response 
towards the same stressor might be a result from the contribution of different mechanisms 
of adaptation. These adaptations to homotypic stressor in CS model could be attributed to 
reduced emotional activation, peripheral and central biochemical habituation (Dronzak et 
al, 2004; Bobbert et al., 2005). Our results demonstrated that in CUS group, exposure of 
heterotypic stressors caused more intense biochemical disturbances, indicating its severity 
and damaging effects. Validity of the methods used in our experiments (stress models) is 
demonstrated by the biological effects induced by them i.e. gastric ulcerations, adrenal 
gland weight, plasma corticosterone, glucose levels and creatine kinase (CK) activity. All 
these parameters have been conclusively shown to be stress-dependent (Natelson et al., 
1981). 
In our study, stress-induced increase in the adrenal gland weight was observed as 
compared to the control rats, in all the three stress models, which could be attributed to 
the activation of the HPA-axis. It is one of the principal mechanism by which an 
organism mobilizes its defence against stress events (Makara and Haller, 2001; McEwen, 
2000). Exposure of different stressful condition in rats have generally indicated a 
transient activation of the pituitary adrenal system, as measured by increased adrenal size 
with subsequent increase of plasma corticosterone level and other correlates of adrenal 
activation (Vemikos et al., 1982). The prolonged activation of HPA-axis resulted in an 
increase in adrenal hypertrophy, the maximum being observed during CUS. In response 
to stress, the syinpathetic nervous system results in increased secretion of corticosterone 
from adrenal cortex and epinephrine from adrenal medulla (Selye, 1950; Walker et al, 
1986). These hormones are deemed to be essential in protecting/coping the body against 
stressful conditions. Thus, an increase in the adrenal gland (size) and the circulating 
corticosterone is a marker for the activation and involvement of the HPA-axis during 
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stress. In our study, the adrenal gland weight increased proportionally to the intensity of 
stress. However, the changes in circulating corticosterone level were inconsistent in the 
three stress models. In AS group, maximum rise in corticosterone level was observed, 
which may be related to novelty of the stressor that in turn triggers the activation of the 
HPA-axis (Selye, 1950; Walker et al., 1986). In CS group, the level of corticosterone was 
not significantly increased, which could be due to the adaptation against the repeated 
stress and depletion of reserve glucocorticoid stores in the adrenals. The enhanced 
secretion of the corticosterone in AS group could be due to the mobilization of 
glucocorticoid reserve stores in the adrenals. Interestingly, in another chronic model 
(CUS), the corticosterone level was significantly increased. The different corticosterone 
response among the two chronic models (CS and CUS), could be explained on the 
difference in the functionality state of HPA-axis feedback mechanism. It can be proposed 
that the unpredictability of stressors in CUS group may cause desensitization or 
deregulation of HPA-axis feedback mechanism; as a result of which persistent increased 
corticosterone level was observed. Desensitized feedback loop during intense stressfiil 
conditions has already been reported for various neuropsychiatric disordes like depression 
and anxiety (Arborelius et al., 1999; Pariante and Miller, 2001; Mizoguchi et al., 2001). 
Our findings concur with earlier reports, where, HPA-axis responded differently due to 
the differences in duration, intensity and predictability of stressors (Torres et al. 2002; 
Harvey et al. 2006; Vidal et al. 2007). Evidences also suggest that the medial basal 
hypothalamus is involved in the extra pituitary regulation of compensatory adrenal 
growth, triggered during stress, as reflected by an increase in the adrenal gland weight 
(Holzwath and Dallman, 1979). The stored glucocorticoids are released with the first 
stress signal, but with the increased demand during chronic stress, a hypertrophy take 
place in order to compensate the glucocorticoids demand and low corticosteroid levels are 
accompanied by a compensatory increase in ACTH secretion (Akana et al., 1983). 
Stressful events activate autonomic and endocrine responses which could be 
accountable for gastric ulceration (Henke, 1979; Zhang and Zheng, 1997). Stress-induced 
gastric ulcerafion in our stress models can be correlated primarily to the stimulation of 
paraventricular nucleus of hypothalamus, increased intestinal motility, acid secretion and 
group of other factors (Glavin and Hall, 1994; Mayer, 2000). It can be hypothesised that 
during stress the activated autonomic (NA) and endocrine system (corticosterone) can 
induce gastric ulcers by weakening the defensive factors and the hyperactivity of the 
aggressive factors in stomach. This includes increase of acid and pepsin (Hoogerwerf and 
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Pasricha, 2006), decrease in mucous secretion (Valle, 2008), alterations in adrenal 
steroids (Mayer, 2000), CRF (Bhatia and Tandon, 2005) and catecholamines (Saad et al, 
2001). Some of these events, if not all, appear to be controlled by the CNS in response to 
stress (Glavin et al., 1991; Mayer, 2000; Bousta et al., 2001). These factors 
synergistically cause ischemia and excessive oxidative damage which forms the basis for 
initial damage of gastric mucosa. In our investigations, the incidence of ulcer increased 
with the increase in the stress severity from AS to CUS. These findings are in conformity 
with the earher reports of Natelson et al. (1998). 
Stress conditions are known to increase the blood glucose level due to the release 
of corticosteroids (Mason, 1968). Increased activity of the HPA-axis leads to the 
activation of the pathways necessary to compensate the increased energy demand within 
the body, during crisis; the ultimate goal is to increase the circulating blood glucose 
(Brindley and Rolland, 1989). The blood glucose is the first available substrate, which is 
rapidly metabolized to produce energy in the form of ATP. In our study, AS induced 
hyperglycemia may occur for the availability of substrate and increased production of 
energy in order to escape the threat to life. These results are in support of a study, where, 
exogenous administrafion of corticosterone produced hyperglycemia (Wass et al., 1996). 
However, in CS and CUS groups, no significant increase in blood glucose levels was 
observed. This could be explained on the basis that in chronic stress groups, the 
immediate available carbohydrate source may get depleted, and the body is start ufilizing 
the secondary source of non-carbohydrate origin for glucose (lipids and proteins) which is 
slow and rate limifing, and the level of glucose is maintained at physiological quantities 
(Black and Garbutt, 2002; Rai et al., 2003b). 
Stress hormones not only stimulate and ensure supply of glucose, but they also 
increase CK activity, at a time, when there is an increased energy demand (Siripurapu et 
al., 2005). CK activity was increased both in AS and CUS groups. However, this increase 
was relatively less in CUS group as compared to AS group. On the other hand, in CS 
group no significant changes were observed. The increase of CK acfivity was crucial to 
meet the acute energy demand during AS to overcome the stress-induced challenges. 
Hyperactive CK, maintain the flow of ATP during stress (Davydov and Shvets, 2002). 
Intracellular phosphocreatine is an essenfial component of energy metabolism in muscles 
and brain, since it acts as a store of high-energy phosphate which can be converted into 
ATP by CK (Zorzano et al., 2000), thus maintaining the CK reaction in a state of 
equilibrium, keeping ADP and ATP almost constant is crucial for the proper functioning 
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of a variety of cellular ATPases (Wyss and Kaddurah-Daouk, 2000). The CK system may 
be important in stabilizing the ATP level and energy metabolism in myocardium and 
other skeletal muscles of rats during stress, and disturbances of CK activity during stress 
may results in ischemia due to non-availability of ATP (Davydov and Shvets, 2002). 
Following CUS exposure a reduced CK activity compared to AS group shows partial 
resistance and the other energy compensatory mechanisms playing role as described 
earlier. Whereas, no change observed in CK activity following CS exposure shows 
complete adaptation against stress in rats. From these results of peripheral stress 
biomarkers, it was evident that in CS model the rats may get adapted due to the use of 
similar type and intensity of stressor. Thus, in further studies we used only AS and CUS 
model. 
5.2 Effect of stress (AS/CUS) on monoaminergic system 
Our results showed that AS decreased the NA levels in the frontal cortex and 
hippocampus, while in CUS group, this decrease was observed in all the three brain 
regions (frontal cortex, striatum and hippocampus). It is showed that the brain 
noradrenergic system is robustly activated by a diverse array of stressful stimuli (Cecchi 
et al., 2002; Pacak and Palkovits, 2001). However, the increased levels of NA are short 
lived and are generally terminated after an initial rise (Hellreigel and D'Mello, 1997). 
Also, increased corticosterone levels can reduce the efficacy of NA to enhance firing 
frequency with a delay of 1-2 h, through a glucocorticoid-dependent mechanism (Joels et 
al., 2007). 
In the present study, dopaminergic response during AS condition is variable. AS 
significantly increased DA level in the frontal cortex, and decreased in the striatum and 
hippocampus. In contrast, CUS led to a decrease of DA levels in all the three brain 
regions. These results were accompanied with selective increase of DOPAC and HVA 
levels both in AS and CUS condition in the frontal cortex and striatum. These 
observations can be explained on the basis that the brain monoamine levels and 
metabolism changes differently after acute and chronic exposure to stress (Maura et al., 
1978; Bhutani et al., 2009). For example, in the frontal cortex, increased DA levels were 
observed after AS supposedly due to the of activation monoaminergic system (Deutch et 
al., 1990; Sorg and Kalivas, 1993). On the other hand, chronic stress over several days 
reduced DA levels (Imperato et al, 1992; Mangiavacchi et al, 2001). Further, the 
variable response of DA in the frontal cortex and striatum by AS can be explained on the 
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basis that the terminals of DA neurons on the frontal cortex may differ from those in the 
striatum (Bannon et al., 1981). In the striatum and frontal cortex, decreased DA levels 
were accompanied by subsequent increased DOPAC and HVA levels indicating the 
increased conversion of DA to its metabolites in response to CUS. The increased DA 
turnover ratio in these regions may reflect either the increase in catabolism of DA by 
intraneuronal monoamine oxidase to DOPAC and/or by catechol-0-methyl transferase to 
HVA (Maura et al. 1978; Bhutani et al. 2009). The paradoxical decrease in monoamine 
levels in CUS group can partly be explained on the basis of increased stress sensitization 
and their preferential and higher utilization (Gamaro et al., 2003; Bekris et al., 2005). 
However, in the hippocampus, DA levels were decreased with no significant changes in 
DOPAC and HVA both in AS and CUS condition. Hippocampus is rich in cholinergic 
innervations and reciprocal relation exists between acetylcholine and DA responses in 
brain (Vakalopoulos et al., 2006). The decrease of DA in the hippocampus in our study 
might be due to decreased cholinesterase activity and excess acetylcholine turnover, 
which explains for increased memory and attention during stressful conditions (Das et al., 
2005). 
Results demonstrated that 5-HT system responded differentially following the 
exposure of AS and CUS. AS led to an increase of 5-HT and 5-HIAA levels, while CUS 
caused depletion of the same in all the selected brain regions. Others workers also 
reported increased serotonergic transmission during acute exposure of various physical 
and psychological stressors (Inoue et al., 1994; Miura et al., 2002). A report suggested 
that an acute exposure to stress activates tryptophan hydroxylase in the cortex and 
midbrain which could result in an increase level of 5-HT (Singh et al., 1990). In contrary, 
5-HT reduction during CUS is in accordance to reports in which male rats when exposed 
to chronic social stress, responded in similar fashion (Berton et al., 1998; Chung et al., 
1999). Hippocampus has the highest number of corticosteroid receptors as well as 5-HT 
innervations, and expresses a variety of 5-HT receptors (Chalmers et al., 1993; Fontella et 
al., 2005). Thus, the reduction of 5-HT levels in CUS group with simultaneous 
enhancement of corticosterone might have relevance to the glucocorticoid feedback 
mechanism of HPA-axis. The results obtained in the current study may be related to the 
different effects observed in these animals when compared to the other stress models 
(Torres et al. 2002; Harvey et al., 2006; Vidal et al, 2007), as there could be differences 
in duration, intensity and predictability of stressors, which are important determinants of 
stress induced brain responses. The differential monoaminergic responses might also be 
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attributed to the regional variations in their levels of distribution, synthesis and 
degradation. 
5.3 Effect of stress (AS/CUS) on in-vivo anti-oxidative status and lipid 
peroxidation 
Our results demonstrated that the antioxidant system alters diversely in response 
to AS and CUS in a brain region specific manner. These results support the view that 
cellular antioxidant system may respond differently depending upon the duration, 
intensity, novelty etc of the stressors used (Sahin and Gumuslu, 2004; Zafir and Banu, 
2007). AS enhanced the activities of SOD and GSH-Px in the fi-ontal cortex and striatum, 
while no significant alterations was observed in the hippocampus. On the other hand, 
CUS reduced the acfivifies of SOD and CAT in all the three selected brain regions. 
Furthermore, an increase in the activity of GSH-Px, with reduced GSH content and 
increased lipid peroxidation was observed in both the stress models in all the three brain 
regions. These differential alterations in antioxidant system in selected brain regions may 
arise from the differences in antioxidant buffering capacities or differential 
susceptibilities to oxidative stress. The increased activity of SOD during AS is an 
indicator of a relative increase in the superoxide radical production and suggesting that 
the brain antioxidant machinery is initially activated in response to excessive generation 
of free radicals. Enhanced SOD activity could stimulate the second line of defence which 
includes GSH-Px and CAT (Fridovich, 1994), rationalizing the cause for the elevation of 
these two during AS. However, a lesser change in the CAT activity in AS group, as 
compared to GSH-Px, depicting that in the brain, CAT activity has been found to be low 
and confined to peroxisomes (Gaunt and de Duve, 1976). GSH-Px, therefore, appears to 
be primarily responsible for destruction of excess H2O2 formed in nervous tissues 
(Halliwell and Gutteridge, 2007). 
In contrast to AS, CUS displayed a different redox state as evidenced in terms of 
deceased activities of SOD and CAT. Similar decline in the activities of SOD and CAT 
by chronic stress has been reported in eariier studies (Zafir and Banu, 2007). This could 
be explained on the basis that chronic stress is shown to increase the vulnerability of 
different brain regions, by altering the neuronal defence capacity against oxidative 
damage (Mcintosh et al., 1998). Other studies also reported decline in the activities of 
SOD and CAT in the brain during chronic exposure of stress (Zafir and Banu, 2007). We 
found an increase in the activity of GSH-Px in the frontal cortex and hippocampus, with 
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reduced GSH content in all the three brain regions in CUS group. In the hippocampus, 
increased GSH-Px activity and decreased GSH content was reported after excitotoxic 
injury (Gilberti and Trombetta, 2000). The increase in GSH-Px activity found both in AS 
and CUS groups, indicates the increase in cellular peroxide levels. GSH plays an 
important role in the detoxification of ROS in the brain. The decreased GSH content 
could be explained on the basis that loss of GSH may occur during an oxidative stress 
event due to its increased rate of utilization (Sahin and Gumuslu, 2007; Zafir and Banu, 
2007). The significant elevation of lipid peroxidation marker (MDA) is in agreement with 
previous reports, which showed stress induced lipid peroxidation in brain (Liu et al., 
1996; Zaidi et al., 2004), and in different tissues of animals (Sahin and Gumuslu, 2007). 
5.4 Possible interaction between the central monoaminergic and oxidative 
systems 
We found simultaneous alterations in both monoamines and oxidative processes, 
poinfing towards the possibility of interconnection between the two systems, especially 
during CUS. This hypothesis is strengthened by other reports too, showing some direct 
and indirect involvement of the production of free radicals in brain with catecholamine 
metabolism (Venarucci et al., 1999; Perez-Nievas et al., 2007). Elevated catecholamine 
levels may undergo auto-oxidation, in which electrons are generated that in turn can 
produce ROS (Carpagnano et al., 2003). DA forms ROS through its metabolism by MAO 
and by auto-oxidation. Molecular oxygen can react with DA forming quinones and 
semiquinones, which can fiirther deplete GSH with simultaneous generation of ROS 
(Miyazaki and Asanuma, 2008). Another study showed a decrease in CAT activity in the 
frontal cortex and striatum after cocaine administration, suggesting the mediation of 
distinct monoamine systems (Macedo et al., 2005). Thus, increased monoamine 
metabolite concentrations and turnover could be one of the contributing factors for 
increased oxidative load and altered antioxidant enzyme activities during CUS. These 
results support the hypothesis of Siraki and O'Brien (2002) that biogenic amines form 
pro-oxidant radicals. The increase in DA turnover and metabolism might produce H2O2 
through MAO activity (Miyazaki and Asanuma, 2008), which could be responsible for 
neuronal membrane lipid peroxidation observed in our study. 
The present study demonstrates increased oxidative load during CUS in all the 
selected brain regions. Considering that the striatum and frontal cortex have a high DA 
content its oxidation could contribute to a greater oxidative burden in these regions. 
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However, the results indicate that the oxidative load during CUS was generally similar in 
all three brain regions. Also, there were no significant changes in the levels of 
monoamine metabolites in the hippocampus. Thus, it could be predicted that increased 
oxidative load during stress may not always be reflective of the pro-oxidant effect of 
metabolites and/or altered neurotransmitter metabolism. Interestingly, some workers have 
suggested that the hippocampus is susceptible to oxidative damage because of its high 
sensitivity towards increased corticosterone levels (Mcintosh et al., 1998; Jankord and 
Herman, 2008). Thus, during CUS the alterations in the antioxidant status in the 
hippocampus might be related to the increased corticosterone levels. 
Altered 5-HT transmission might also contribute to oxidative load during CUS in 
different brain regions as other reports (Wrona and Dryhurst, 1998; Siraki and O'Brien, 
2002; Kanarik et al., 2008) also highlighted the potential neurotoxic role for 5-HT 
metabolites arising from superoxide mediated oxidation. Thus, the perturbed central 
monoamine response and metabolism could amplify the oxidative load during CUS, in a 
region specific manner. Furthermore, ROS influences brain functions by altering signal 
transduction across membranes and changing the properties of several receptors (Haile et 
al., 1992; Tang and Aizenman, 1993). Thus, the different levels of free radicals in various 
brain regions during chronic stress exposure may determine modulation of 
neurotransmitters either through the changes in neurotransmitter levels and/or by effects 
on receptor functioning. Thus, both the monoaminergic and oxidative systems may 
influence each other's functioning. 
5.5 Anti-stress effects of crude extract, fractions and pure compounds of 
Ocimum sanctum (OS) 
OS is one of the most widely used medicinal herb in indigenous system of 
medicine, it belongs to the family Lamiaceae and is commonly known as sacred basil or 
"Tulsi". Various aspects of the stress alleviating and immuno-modulatory potential of 
OS have been established (Nigam et al., 2006; Shetty et al., 2008). 
We start our study by evaluating the anti-stress potential of graded doses of OS 
crude ethanolic (Et-OH) extract (100, 200, 400mg/kg) and fractions (50, 100, 200mg/kg) 
in acute stress (AS) model. OS Et-OH at a dose of 200 and 400mg/kg p.o. and its 
butanolic fraction at a dose of 100 and 200mg/kg p.o. was found effective in preventing 
AS-induced adrenal hypertrophy, ulcer severity, increased plasma corticosterone, glucose 
level and CK activity when compared to the control group. Similar extract and fraction 
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were tested for anti-stress efficacy in CUS group, OS Et-OH at a dose of 200mg/kg p.o. 
and its butanolic fraction at a dose of 1 OOmg/kg p.o. showed restoring effects on CUS-
induced adrenal hypertrophy, ulcer severity, increased plasma corticosterone level and 
CK activity. 
Keeping in view of tremendous pharmacological activities of OS and significant 
anti-stress potential at the extracts and fraction level, it was considered important to 
explore its phyto-chemical constituents responsible for anti-stress and anti-oxidant 
activities. Thus, we continued our study by examining the anti-stress activity of three 
newly isolated OS derived pure compounds namely Ocimarin, Ocimumoside A and 
Ocimumoside B at graded doses (10, 20, 40 mg/kg p.o.) in AS model. Administration of 
Ocimumoside A, Ocimumoside B at dose of 40 mg/kg p.o. prevented all AS-induced 
changes, while Ocimarin produce no significant changes. Ocimumoside A & B at a dose 
40 mg/kg p.o. also able to restore the CUS-induced adrenal hypertrophy, ulcer severity, 
increased plasma corticosterone level and CK activity. 
Stress-induced ulcers are mainly due to the initial acid secretion and further 
aggravated due to the activation of inflammatory mediators and oxidative stress (Mayer, 
2000). OS is well known for its effect against stress-induced ulceration. In our study, OS 
Et-OH extract, butanolic fraction and OS pure compounds (Ocimumoside A and B) were 
effective in decreasing the mean ulcer score which could be related to the reduction in the 
stress-induced intestinal haemorrhages. Various studies demonstrated the anti-ulcer effect 
of various extracts of OS in more intense and specific ulcer models (Singh and 
Majumdar, 1999, Dharmani et al, 2005). These studies attributed the anti-ulcer activity of 
OS due to its anti-secretary, cytoprotective and anti-oxidant properties which may directly 
or indirectly affecting the ulcer causative factors. 
The hypoglycemic effect of OS is well demonstrated by various authors in more 
specific models in which oral administration of ethanolic leaf extract potentiates the 
action of exogenous insulin in normal rats (Chattopadhyay, 1993). The activity of the 
extract was 91.55 and 70.43% of that of tolbutamide in normal and streptozotocin 
induced diabetic rats respectively (Chattopadhyay, 1993). To explore further evidence, 
effect of treatment with holy basil leaves on fasting and post-prandial blood glucose and 
serum cholesterol levels in humans were assessed through a randomized placebo 
controlled crossover single blind trial in patients of non insulin dependent diabetes 
mellitus (NIDDM) (Agarwal et al, 1996). The results of the trial indicated a significant 
decrease m fasting and post-pandial blood glucose levels during treatment as compared to 
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placebo and the findings suggested that basil leaves might be prescribed as an adjunct to 
dietary therapy and as a drug treatment in mild to moderate NIDDM. Tulsi leaf powder 
supplementation at 1% dose level showed significant hypoglycemic and hypolipidemic 
effects in diabetic rats and suggested that it could be associated with the essential oil, 
eugenol present in OS leaf powder (Rai et al., 1997). 
Our results also showed that AS and CUS caused adrenal hypertrophy, increased 
plasma corticosterone levels and CK activity which may be considered as an index of 
HPA-axis activation as explained earlier. This is in confirmation to other studies 
(Siripurapu et al., 2005; Jankord and Herman, 2008), indicating the effectiveness of the 
stress models. The nonnalization of these stress-induced parameters following the 
treatment of OS extract/fi-action and pure compounds, pointing towards their anti-
stress/adaptogenic properties, in terms of normalizing stress-induced activation of HPA-
axis. OS leaves contain 0.7% volatile oil comprising about 71% eugenol and 20%) methyl 
eugenol along with carvacrol, sesquiterpine hydrocarbon caryophyllene, apigenin, 
luteolin, apigenin-7-(9-glucuronide, orientin, oUudistin and ursolic acid (Gupta et al, 
2002; Gupta et al., 2007). Thus, the anti-stress activity of OS could be attributed to these 
biologically diverse active constituents. Interestingly, a number of reports indicated the 
anti-stress potential of various extracts and fractions of OS (Bhargava and Singh, 1981; 
Sen et al., 1992; Sembulingam et al., 1999; Samson et al., 2006), we for the first time 
reported the anti-stress efficacy of OS derived pure compounds; Ocimumoside A and 
Ocimumoside B in both acute and chronic models of stress. 
5.6 Effect of OS compounds on gastric histopathological changes in AS 
and CUS groups 
To fiirther ascertain the attenuating effects of OS compounds in relation to 
mucosal damage in gastric ulcers, microscopic evaluation of histopathological changes in 
gastric mucosal tissue in AS and CUS group was performed. Control group showed intact 
mucosal epithelium with well organized layers (mucosa, submucosa, muscularis mucosa 
and serosa layers). AS group is characterized by damaged mucosal epithelium, 
disorganization of glandular tissue and presence of inflammatory exudates and cellular 
debris were found in the ulcerated wall of the stomach. Interestingly, when rats were 
subjected to AS after the treatment of Ocimumoside A and B at a dose of 40 mg/kg p.o., 
glandular proliferation could be seen but differentiation and organization was not property 
evident, suggesting only minor protective activity. 
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Evaluation of histopathological changes in CUS group revealed the presence of 
disorganized glandular tissue, damaged mucosal epithelium, inflammatory exudates, 
proliferated fibroblasts, mixed leukocytic infiltrate and cellular debris. Ocimumoside A 
and B pretreatment caused re-epithelization, reduced inflammatory exudates, mucosal 
regeneration and glandular organization could be seen. However, pretreatment of Ocimrin 
failed to revert stress-induced gastric mucosal damage. The histopathological changes in 
the gastric mucosa, supported the observations regarding the gastro-protective and ulcer-
healing effects of Ocimumoside A and B, both in AS and CUS condition. Ulcer-healing is 
a complex process that involves combination of wound retraction and re-epitheliazation 
and depends on regeneration of mucosal glandular structure and migration of epithelial 
cells to cover ulcerated region (Helander 1983; Helpap et al. 1981; Szabo and Hollander, 
1989). In this regard, re-epithelization, reduction in inflammatory exudates, and 
regeneration of mucosal and glandular organization by Ocimumoside A and B, signifies 
their role in ulcer protecfion. 
5.7 Effect of OS compounds on central monoamine and oxidative system 
in AS and CUS groups 
The brain monoamine and antioxidant systems interact closely with the HPA-axis 
and are implicated in the acquisition and maintenance of psychological and physical 
stress (Jankord and Herman, 2008; Zafir and Banu, 2009). Thus, it is very essential to 
assess the anti-stress activity of any medicinal plant or its constituents in relation to the 
changes in central monoamines and cellular redox state. In the present study, the 
modulatory role of OS pure compounds (Ocimarin, Ocimumoside A and B) was 
investigated for the first time on the rat brain monoamines and oxidative processes in AS 
and CUS condition. 
Results demonstrated that AS exposure significantly increased the 5-HT and its 
metabolite level and decreased the NA levels in the frontal cortex, striatum and 
hippocampus, while DA level was significantly increased in the frontal cortex and 
decreased in the striatum and hippocampus. In CUS group, the levels of NA, DA and 5-
HT were significantly depleted in all the three brain regions. The possible explanations of 
these stress-induced monoaminergic changes have already been discussed in above 
portion. Administration of Ocimumoside A and B at a dose of 40mg/kg p.o. restated the 
CUS-induced decrease of NA levels, although remains ineffective in AS condition. 
Pretreatment with Ocimumoside A and B also restored altered DA levels in the frontal 
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cortex and striatum, while Ocimarin failed to restore any of these changes towards normal 
values. Impaired monoamine function is one of the major contributors to stress-mediated 
disorders like anxiety and depression (Kalia, 2005). Various classes of anti-depressants 
and anxiolytics exert their therapeutic effects by improving any of the monoamine 
processing mechanisms like synthesis, release and synaptic availability (Kalia, 2005). 
Thus, our findings regarding the restoration of stress-altered monoamine levels by 
Ocimumoside A and B appeared to be in accordance with these observations. Similar 
effects of OS ethanolic extract regarding the normalization of stress-induced 
monoaminergic alterations has been reported (Ravindran et al., 2005; Samson et al., 
2006).The exact mode of acfion of these two compounds cannot be explained, however, a 
corticosterone like effect can be hypothesized as such effects are inhibited either by 
alpha-helical CRF, a CRF antagonist or adrenalectomy, suggesting the possible mediafion 
through corticosterone (Singh et al., 1990; Flugge 1995). However, the present data is 
unable to explain the incapability of OS compounds to revert the AS-induced decrease of 
DA levels in the hippocampus, depicting the probable involvement of some other 
complex DA regulating pathways. 
We also found that 5-HT system responded differentially following the exposure 
of acute and chronic stress. AS led to an increase of 5-HT and 5-HIAA levels, while CUS 
caused deplefion of the same in all the selected brain regions. Ocimumoside A and B 
prevented the AS-induced increase of 5-HT and 5-HIAA levels in all the three brain 
regions. Hence it can be assumed that OS compounds may acts by influencing either the 
activity of TH or the reuptake of 5-HT (Singh et al., 1990; Fujino et al, 2002). During 
CUS, Pretreatment of Ocimumoside A and B normalized the depleted levels of 5-HT and 
5-HlAA in the frontal cortex. Decreased 5-HT level in the hippocampus was reversed by 
Ocimumoside A, while remain unchanged following the treatment of Ocimumoside and 
Ocimarin. Furthermore, all these OS compounds remained ineffecfive in restoring the 
decreased levels of 5-HT and 5-HIAA in the striatum. Thus, OS compounds showed 
differential regional effects in terms of the restorafion of altered serotonergic system in 
CUS condition. These differential monoaminergic changes observed might be attributed 
to the regional variations in their levels of distribufion, synthesis and degradation. 
It was observed that AS significantly enhanced the acdvities of SOD and GSH-Px 
in the frontal cortex and striatum, while, CAT activity was increased but did not reach 
statistical significance. Interestingly, in the hippocampus there was no significant change 
in the activity of these enzymes in AS group. On the other hand, CUS reduced the 
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activities of SOD and CAT in all the three brain regions. An increase in the activity of 
GSH-Px, with reduced glutathione content and increased lipid peroxidation was observed 
in both AS and CUS condition. During AS, the increased GSH-Px activity in the frontal 
cortex and striatum was normalized by Ocimumoside A, whereas in the frontal cortex 
only Ocimumoside B was effective. Ocimumoside A and B also replenished the 
decreased GSH content and normalized the increased MDA levels in a region selective 
manner. However, OS compounds remained ineffective in reverting AS-induced change 
in SOD activity in the frontal cortex. Also, in the hippocampus there was no significant 
change in the activity of these enzymes in stressed or OS treated groups. Thus, acute 
treatment of OS compounds showed restricted antioxidant potential, and this 
normalization effect remained confined in the frontal cortex and striatum regions only. 
Chronic treatment with Ocimumoside A and B for a period of 7 days normalized 
the CUS-induced perturbations in the antioxidant enzyme activities, GSH content and the 
extent of lipid peroxidation. However, Ocimarin failed to alter such oxidative processes. 
These differential alterations in the antioxidant systems and variable effect of OS 
compounds in selected brain regions may arise from the differences in antioxidant 
buffering capacities or differential susceptibilities to oxidative stress. Moreover, the 
antioxidant potential of OS has been confirmed by other workers also (Devi and 
Ganasoundari, 2000; Samson et al., 2007). 
Many reports demonstrated that the damage to oxidative defense system is 
directly or indirectly exacerbated by stress-induced glucocorticoids (Patel et al., 2002; 
Zafir and Banu, 2009). Increased production of free radicals in brain by catecholamine 
metabolism is also proposed (Venarucci et al., 1999; Carpagnano et al., 2003). Thus, the 
perturbed central monoamine response and metabolism might have amplified the 
oxidafive load during chronic stress. Hence, improvement of altered redox state in various 
brain regions by Ocimumoside A and B could be ascribed to their potential in altering the 
plasma corticosterone and brain monoamine levels during such stressftil conditions. 
The data revealed herein may gather importance in respect to several facts. Firstly, 
the results provide insight into the stress-induced differential brain regional responses in 
central stress pathways. Studies aimed at establishing the reasons for this brain regional 
changes warrant further exploration, which may help in understanding the mechanisms 
involved in the simultaneous alterations of the neurochemical and oxidative systems 
under stressful conditions Secondly, Ocimumoside A and B reinstated the alterations in 
the brain regions only where they were affected by stress. The decreased activafion of 
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HPA-axis (reduction of corticosterone levels), along with the restoration of altered 
monoamine levels and redox state following the treatment of Ocimumoside A and B 
suggested that these compounds might work by an overall normalization of stress-induced 
changes. Owing to these central affects of OS compounds it can be postulated that 
Ocimumoside A and B might have crossed the blood brain barrier and induced their 
beneficial effects. 
5.8 Standard anti-stress (Panax quinquefolium) and antioxidant 
(IVIelatonin) drugs: 
In our study, for comparative analysis, Panax quinquefolium (PQ; 100 mg/kg p.o.) 
and melatonin (MEL; 20 mg/kg i.p.) were used as the standard anti-stress and antioxidant 
drugs respectively. The respective doses of PQ and MEL were selected on the basis of our 
pilot investigation and available literature (Sripurapu et al, 2005; Rasheed et al., 2008; 
Lahiri et al., 2009). The commercially available standardized root powder of PQ contain 
total of 7.01% ginsenosides (Rg: 0.13%, Re: 1.32%, Rb, <0.10%, Re : 1.49, Rbj: 0.14%, 
Rd :0.54%, others: 1.17%). PQ was selected due to its widely accepted position as an 
"adaptogen" and scientifically proven herb for offering non-specific resistance during 
stressful conditions. Steroids possess numerous physiological activities, partly due to the 
nature of the steroid skeleton. Ginsenosides are amphiphilic in nature, and have the ability 
to intercalate into the plasma membrane. This leads to changes in membrane fluidity, and 
thus affects membrane function, eliciting a cellular response. There is evidence to suggest 
that ginsenosides interact directly with specific membrane proteins (Banthrope, 1994). 
Moreover, like steroid hormones, they are lipid-soluble signalling molecules, which can 
traverse the plasma membrane and initiate genomic effects. In our study oral 
administration of PQ powder at a dose of lOOmg/kg was effective in normalizing AS and 
CUS-induced changes in mean ulcer score, adrenal gland weight plasma corticosterone, 
glucose levels and CK activity. These results are in accordance to the reported activities 
of ginseng during alarm phase reaction of stress response (Rai et al., 2003c). Crude 
extracts and fractions of the plants considered in our study were compared for their 
potency. PQ was also effective at a dose of 1 OOmg/kg in nomializing most of the stress-
induced monoaminergic changes during both AS and CUS condition. These effects of PQ 
may be related to the major constituents of PQ ginsenosides Rbl, which are found to 
enhance cholinergic action and alter DA response in the cortex and hippocampus regions 
(Singh et al., 1990; Benishin, 1992). Ginsenosides also known to possess corticosteroid 
— _ — f _ _ j . , ^-^ .-
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like actions (Lee et al, 1997). Another study demonstrated that PQ restored the chronic 
stress-induced 5-HT changes in the brain (Zhao and McDaniel, 1998). The ginsenosides 
of PQ may also modulate the nerve transmissions by altering the availability of 
neurotransmitters (Tsang et al., 1985). 
MEL is a major secretory product of the pineal gland. MEL and its metabolites are 
established potent endogenous free radical scavengers (Rodriguez et al., 2004). In our 
study, MEL restored the altered redox state in both AS and CUS conditions. This is in 
agreement with several reports that MEL plays important role in modulating antioxidant 
enzyme activities, extent of lipid peroxidation and GSH content (Rodriguez et al, 2004; 
Lahiri et al., 2009). 
5.9 Effect of stress (AS/CUS) and OS compounds on the expression of 
various stress responsive genes in selected brain regions: 
In order to delineate the molecular basis of stress response under different stressful 
condition (AS and CUS), we examined the alterations in the expression of various stress 
responsive genes such as corticotrophin releasing hormone (CRH), pro-opiomelanocortin 
(POMC) and glucocorticoid receptor (GR) in the extra-hypothalamic centers (frontal 
cortex, hippocampus) and the hypothalamus and the pituitary gland. Our results 
demonstrated that CUS caused a significant increase in the expression of CRH mRNA in 
the frontal cortex, hippocampus, hypothalamus and pituitary. However, in AS group, it 
was increased only in the frontal cortex and pituitary. CRH, a 41 amino acid peptide, is 
the principal hypothalamic stimulus to the pituitary-adrenal axis (Engler et al., 1999). 
The increase in the expression of CRH mRNA suggested an induction of stress response 
and thereby activation of HPA-axis. However, its region selective and stressor specific 
changes can be explained on the basis that different brain regions have variable 
abundance of CRH (Pacack and Palkovits, 2001), which might also reflect at the gene 
expression level in response to AS and CUS. The CRH system is widespread throughout 
the brain but is best characterized in the PVN of the hypothalamus and one of the 
principal components of general adaptation syndrome (Van Pett et al., 2000). CRH 
mRNA express in the cerebral cortex, amygdala and hippocampus (Bittencourt and 
Sawchenko, 2000) as well as in periphery like adrenal gland, testis, spleen and thymus 
(Dautzenberg and Hauger, 2002). Furthemiore, increase in CRH mRNA observed 
consistently only after 4-5 hours exposure to stressors (Suda et al, 1992; Harbuz et al, 
1993) and this increase is not usually observed after exposure to mild stressors, because 
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of the already high resting levels of CRH mRNA levels (Armario et al., 2006; Makino et 
al , 1995). Another report suggested no change in CRH mRNA levels in the 
hypothalamus, under acute foot shock model (Aoki et al., 1997. They explained that CRH 
may cause modulation with melanocortin signaling in some parts of the hypothalamus, as 
there are several lines of evidences, showing interactions between melanocortinergic 
system and CRH in the hypothalamus (Aoki et al., 1997). During CUS, the increased 
expression of CRH mRNA in all the brain regions studied, suggested a more sensitized 
condition. In most of the depressed subjects an increase in CRH or CRH mRNA levels in 
hypothalamic nuclei was found (Gaykema and Dijkstra, 1995), which mostly explained 
on the basis of impaired glucocorticoid negative feedback. 
The hypothalamic factors (CRH and/or AVP) act on the corticotrope cells of the 
anterior pituitary to control the synthesis and release of the ACTH, which is formed from 
a larger precursor protein called POMC. The putative hypothalamic factors controlling 
the synthesis and release of ACTH and other POMC-derived peptides from the anterior 
pituitary have been intensively studied, although its complexity makes it difficult to reach 
firm conclusions in most cases. In our study, we observed an increase in the levels of 
POMC mRNA in the hypothalamus and pituitary of AS rats. Similarly, CUS rats also 
showed an increased POMC mRNA levels in the frontal cortex, hippocampus and 
pituitary. However, in the hypothalamus, POMC mRNA levels were decreased. Some of 
these results concur with earlier findings (Keller-Wood and Dallman, 1984; Aoki et al., 
1997; Hughes et al., 2003). Interestingly, a decrease in POMC mRNA in the 
hypothalamus in chronic stress model was also reported (Chen et al., 2008). Repeated or 
prolonged sfimulation of CRH can cause reduced ACTH responsiveness or 
desensitization (Mason et al., 2002). Melanocortin 4 Receptor (MC4R) is co-localized 
with PVN CRF secretory neurons in the hypothalamus which may be regulated via the 
negative feedback mechanism of increased corticosterone and/or CRF (Imaki et al, 
2001). Although MC4R present through out the brain, including limbic system (Kishi et 
al., 2003), the regulafion of expression of MC4R and its endogenous ligand is poorly 
understood. A study suggested that the increase in POMC mRNA in limbic structures 
may cause anxiety and stress-related behavior (Jegou et al., 2006). Thus, the interrelation 
of stress-related behavior with increased POMC mRNA expression in limbic regions 
cannot be ruled out. 
Glucocorticoids are the final effectors of the HPA-axis and participate in the 
control of whole body homeostasis and the organism's response to stress. They play a key 
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regulatory role on the basal activity of the HPA-axis and on the termination of the stress 
response by acting at extra-hypothalamic centers (cortex and hippocampus), the 
hypothalamus and the pituitary gland through GR and MR (Pariante and Miller, 2001). A 
number of reports suggested that persistent increase in the corticosterone level may cause 
desensitization or down regulation of GR (Gustafsson et al., 1987; Pacack and Palkovits, 
2001). Thus, the decreased expression of GR mRNA levels, observed in our study, can be 
considered as a secondary effect of increased corticosterone levels during AS and CUS 
condition. 
The changes induced by AS and CUS, in the expression of CRH, POMC and GR 
mRNA levels, in these brain regions, is indicative of impaired HPA-regulation (Habib et 
al, 2001; Armario, 2006). It was evident that most of these changes were prevented or 
normalized by the pretreatment of Ocimumoside A and B at a dose of 40mg/kg in the 
both the stress models. A number of possibilities can be hypothesised in relation to these 
molecular effects of OS compounds. Firstly, OS treatment may attenuate the 
adrenocortical secretory response to stress as evidenced by the normalization of CRH 
mRNA levels. Secondly, OS compounds may differentially influences the hypothalamic 
ACTH secretagogues, depending on the duration of the stressful challenge as evidenced 
by the variable response on POMC mRNA expression following stress (AS or CUS) and 
OS compounds administration. Thirdly, OS treatment may increases the sensitivity of the 
HPA-axis to glucocorticoid suppression as evidenced by their normalizing effects on 
stress-induced decrease of GR mRNA levels, especially during CUS. Fourthly, OS 
treatment may attenuate the inadequate responsiveness of hypothalamo-pituitary 
components to stress. Since persistently increased adrenocortical secretion, blunted the 
responsiveness of pituitary corticotrophs to neuropeptide secretagogues, and decreased 
the sensitivity of the HPA-axis to glucocorticoid feedback. These are considered as 
hallmarks of disturbed neuroendocrine regulation in stress-related disorders; our data 
suggested that OS treatment may normalize several of these mechanisms. 
5.10 Effect of stress (AS/CUS) and OS compounds on the expression of GR 
and HSP-70 in the frontal cortex and hippocampus: 
In order to delineate the response of HPA-axis and cellular machinery to AS and 
CUS condition, the expression profile of GR and HSP-70 protein was evaluated 
respectively in the frontal cortex and hippocampus regions of the brain by western 
blotting. It is well reported that during stress, GRs in the brain are sensitive to elevated 
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glucocorticoid levels (Reul and de Kloet, 1985), and the GR proteins or their mRNA are 
down-regulated by chronic stress (Sapolsky et al, 1986; Herman et al., 1995). Thus, in 
our study, the down regulation of whole cell extract of GR, both in the frontal cortex and 
hippocampus in CUS group, might be related to the increased circulating corticosterone 
levels, which may cause disruption in the HPA-axis feedback mechanism (Mizoguchi et 
al., 2003; Jankord and Herman, 2008). The restoration of decreased GR expression in 
CUS group, following the administration of Ocimumoside A and B, could be related to 
their attenuating effect on stress-induced increase in the corticosterone level. Thus, the 
possible anti-stress mechanism can be speculated in terms of their pharmacological 
effects on the secretory activity of HPA-axis. In other words, the disruption of the HPA-
axis feedback mechanism during CUS might be resolved by restoring the GR expression 
level, following the administration of Ocimumoside A and B. 
Stress responses in brain cells by denaturation of proteins, changes of protein 
synthesis, and changes of protein glycosylation, which leads to the induction of HSPs. 
HSP-70 is highly inducible during stress and can be considered as a marker of 
insult/stress (Rajdev and Sharp, 2000). In our study, we observed an increased expression 
of HSP-70 protein in the frontal cortex and hippocampus regions of the brain during both 
AS and CUS conditions, confirming the induction of HSP-70 in both these stress models. 
The expression of HSP has been seen in endothelial cells in the neurons, and glia cells in 
the brain. Since normal brain cells have little detectable HSP protein and are induced in 
response to stress, their increased expression serves as a marker of cellular injury. HSP-70 
is up-regulated in response to different stress conditions in the brain, such as hypoxia, 
ischemia, hyperthermia and exposure to toxic compounds (Nowak et al., 1990; Nowak, 
1991; Tu et al., 2004). The sustained expression of HSP-70 in vulnerable regions of the 
brain appears to be a constitutive marker for the cellular pathophysiology. The expression 
level of HSP-70 was decreased by the pretreatment of Ocimumoside A and B in the 
frontal cortex and hippocampus in both AS and CUS conditions, which could be 
attributed to their potential in reducing the stress-induced oxidative load. As a number of 
studies indicated that the expression of HSP-70 in the brain can be attributed to oxidative 
stress (Kukreja et al., 1994; Ambrosio et al., 1995). This may also reflect a condition, 
where oxidative load inducing factors (corticosterone, monomaine metabolism) were 
normalized by these OS compounds, and hence lesser induction of HSP-70 was observed. 
In other words, Ocimumoside A and B administration prevented the induction of HSP-70 
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expression in the brain, indicating that the brain tissue was able to cope better with stress 
in presence of these compounds. 
5.11 Effect of stress (AS/CUS) and OS compounds pretreatment on the 
expression level of CRF, GR and Tyrosine hydroxylase (TH): 
In order to further confirm the alterations in the HPA-axis and monoamine 
biosynthesis following the exposure of different stressful conditions and OS compounds 
administration, the expression profile of CRF, GR and TH was examined in various brain 
regions by immunohistochemistry. Alterations in monoamine biosynthesis, as a response 
to repeated or chronic stress are associated with changes in the expression of TH which is 
proposed to be controlled by both DA and GC hormone receptors (Van Craenenbroeck et 
al., 2005). There are some evidences that at the level of neurotransmission, stress and thus 
corticosterone may increase the release of DA and influence the activity of TH, while 
relatively little is known about impact of stress exposure on the dopaminergic 
transmission and its state of synthesis. Thus, we thought that it would be of importance to 
find the impact of stress and modulatory role of OS compounds on the monoaminergic 
neurotransmission, by studying the expression of biosynthetic enzyme TH, along with 
HPA-axis regulating factors (CRF and GR) under similar conditions. The effect of 
exposure of AS and CUS on the modulation and functionally of dopaminergic neurons 
was assessed in relation to the changes in fibre density and number of immunoreactive 
neurons of TH the rate-limifing enzyme of DA biosynthesis. Exposure of CUS caused a 
significant decrease in the expression of TH in the striatum, MFB and SN as compared 
with NS control group. This decrease of TH-ir in these brain structures was also evident 
during AS condition, however, did not reach statistical significance. The decreased 
expression of TH in the striatum and MFB fibres and a decrease in number of TH 
immunopositive neurons in SN, suggested that CUS might cause a down regulafion in 
expression of the TH enzyme (Checkley, 1996). This down regulation may have several 
biological implicafions under stressful condition. For instance it can explain the 
simultaneous dopaminergic changes at the level of DA levels and its receptor 
stimulation/'function. We observed that AS significantly increased the DA levels in the 
frontal cortex, while in striatum and hippocampus it was significantly decreased. In 
contrast to AS, CUS led to a decrease of DA level in the frontal cortex, striatum and 
hippocampus. Therefore, the decreased levels of DA during stress may be secondary to 
either its increased metabolism or decreased synthesis. The possible cause for decreased 
181 
Chapter 5 Discussion 
DA biosynthesis could be related to the alterations in TH expression and /or activity. 
Thus, the decreased expression of TH further supports the observed decreased DA levels 
in CUS condition. Chronic treatment of Ocimumoside A and B at dose of 40mg/kg p.o. 
significantly normalized the CUS-induced decreased expression of TH as compared to 
CUS group. 
Similarly, the effect of stress on the modulation of HPA-axis was assessed in 
relation to the changes in immunoreactivity (ir) of CRF and GR. Exposure to CUS 
caused a significant increase in the expression of CRF with decrease in GR in the cortex 
and hippocampus as compared to control group. These observations are in agreement 
with our results of RT-PCR and western blot analysis regarding the increased expression 
of CRF and decreased levels of GR. As explained earlier, these changes might be related 
to the increased circulating corticosterone levels, and the disruption of glucocorticoid 
negative feedback mechanism (Armario, 2006; Mizoguchi et al, 2003). These changes 
observed only in CUS group, suggesting that CUS led to a more pronounce and long 
lasting neuroendocrine effects. Chronic treatment of Ocimumoside A and B at dose of 
40mg/kg p.o. significantly normalized the CUS-induced altered expression of CRH and 
GR as compared to CUS group. 
A number of studies proposed an intricate relationship between TH, GR, CRF and 
monoamine levels, and suggested their regulatory role and complex crosstalk under 
different physiological adverse conditions (Czyrak et al., 2003; Kalia, 2005; Mizoguchi et 
al, 2004). Glucocorticoid hormones are released as a result of HPA-axis activation in 
response to various stressful conditions (Carrasco and Van de Kar, 2003). There are also 
data showing that TH mRNA transcription (at least in adrenal glands) is under 
glucocorticoid control (De Kloet et al., 1990; Rastogi and Singhal, 1978). Few studies 
found that chronic corticosterone administration decreased the amount of TH protein in 
the VTA while no changes were observed in substantia nigra (Czyrak et al., 2003). A 
number of studies suggested that corticosterone may enhance the transport of TH to the 
terminal region by, for example, increasing the amount of the neurofilaments or their 
phosphorylation (Beitner-Johnson, 1992). Thus, the net effect will be the increase in the 
amount of TH in the nucleus accumbens with the subsequent decrease in the VTA. Such a 
lowering of the level of TH, the rate limiting enzyme in DA synthesis will immediately 
decrease synthesis of DA in the VTA and, consequently, will induce further decrease in 
the presynaptic inhibition (Beitner-Johnson, 1992; Nestler, 1992; Czyrak et al., 2003). On 
the other hand, the increased amount of TH in the terminal regions may increase the 
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synthesis of DA and its "releasability" in response to the environmental stimulation. 
Nevertheless, this hypothesis may, at least partly, explain how dopaminergic system is 
adapted to the prolonged corticosterone exposure and offers some mechanisms underlying 
increases in dopaminergic tone due to long-term exposure to glucocorticoids. Thus, 
further elucidation of the effects of glucocorticoids on dopaminergic transmission and its 
synthesizing enzyme (TH), will help in understanding the biological basis of stress 
induced behavioural and psychiatric conditions. However, the exact mechanism regarding 
the interaction of TH, CRT and GR with monoamine system to modulate stress response 
warrants further studies. Many other studies also indicated that during stress dopamine 
receptors are critically involved in modulating activity or synthesis of TH (Czyark et al., 
2003). Co-localization of Di receptors and TH with GRs has been demonstrated in 
various brain regions (Czyark et al., 2003), further confirmed the involvement of 
monoamine receptors in such crosstalk and could be accounted for observed effects of OS 
compounds. 
5.12 Anti-stress effects of crude extract, fractions and pure compounds of 
Evolvulus alsinoides (EA): 
The anti-stress potential of graded doses of EA crude ethanolic (Et-OH) extract 
(100, 200, 400mg/kg) and fractions (50, 100, 200mg/kg) in AS model was evaluated. EA 
Et-OH at an oral dose of 200 and 400mg/kg p.o. and its butanolic fraction at 100 and 
200mg/kg was found effective in preventing AS-induced adrenal hypertrophy, mean ulcer 
score, increased plasma corticosterone, glucose level and CK activity when compared to 
the control group. Similar extract and fraction were tested for anti-stress activity in CUS 
group, EA Et-OH at 200mg/kg p.o. and its butanolic fraction at lOOmg/kg p.o. showed 
restoring effects on CUS-induced adrenal hypertrophy, ulcer severity, increased plasma 
corticosterone level and CK activity. 
The significant anti-stress potential of EA extract and its butanol fraction intrigued 
us to fiirther explore its phytochemical constituents responsible for anti-stress activity. 
The anti-stress activity of six newly isolated EA derived pure compounds (EA-1, EA-2, 
EA-3, EA-4, EA-5 and EA-6) was examined in AS model. Administration of EA-1 at a 
dose of 40 mg/kg p.o. prevented the AS-induced changes, while all other EA compounds 
produce no significant changes. EA is an important plant that has been well documented 
in Ayurveda for its therapeutic values. It is well known for its therapeutic effect on brain 
disorders like insanity, epilepsy, memory enhancement and nervous debility in Indian 
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Ayurvedic system of medicine (Chatterjee, 1990). Recent pharmacological studies on 
leaves and whole plant of EA have indicated its antiulcer (Asolkar et al., 1992) and 
immunomodulatory properties (Lilly et al., 2003). Some in vitro experiments have 
revealed the anti-oxidant properties of EA (Auddy et al., 2003). In Africa, EA is used to 
treat low spirits and depression (Bussman et al, 2006). EA is also reported to anti-
amnesic effects (Siripurapu et al, 2005). Thus, our study, for the first time provide a lead 
molecule from EA (EA-1), having anti-stress potential under acute stressful condition. 
Further studies are required to probe the anti-stress efficacy of EA derived pure 
compounds in a more severe and chronic stress model. 
5.13 Anti-stress activity of Synthetic Isoxazolines (IZL) Moieties: 
Previous studies showed several isoxazoline moieties, possessing a wide spectrum 
of acfivities like protein tyrosine phosphatases IB inhibitory activity (Ahmad et al., 2006; 
Maurya et al., 2008), antimicrobial (Gaonkar et al, 2007), anti-influenza virus (Kai et al., 
2001), antifungal (Basappa et al, 2003), glycoprotein Ilb/IIIa receptor antagonists 
(Sielecki et al., 2001), anti-HIV (Ichiba et al., 1993), analgesic and anti-inflammatory, 
(Habeeb et al., 2001) and a-adrenergic receptor antagonist properties (Conti et al., 1998). 
However, their role during stressful condition is not known. In the present study, we have 
synthesized a series of novel isoxazolines via 1, 3-dipolar cycloaddition of in situ 
generated nitrile oxide from 2, 4-dimethoxy benzaldoxime and naphthaldehyde oxime 
with 4-allyl-2-methoxyphenol derivafives. All the 14 synthesized isoxazolines (IZL lA-
IG, IZL 5A-5G) were screened for their anfi-stress activity in AS model. Isoxazolines 
IZL ID, IG, 5B, 5C, 5D and 5G at a dose of 40 mg/kg p.o. displayed most promising 
anti-stress effect by restoring the AS-induced adrenal hypertrophy, mean ulcer score, 
increased plasma corticosterone, glucose level and CK acfivity when compared to the 
control group. 
The anti-stress effect of synthetic Isoxazolines, could be attributed to the fact that 
these were prepared by altering the substituent group in eugenol (4-allyl-2-methoxy-
phenol). Eugenol is a known active constituent of many herbal plants (Norr and Wagner, 
1992). It has been used for epilepsy and forgetfulness and demonstrated to decrease Api-
40-induced cytotoxicity on PC-12 cells in-vitro suggesting its central effects (Irie et al., 
2004). Eugenol and its glycosides are widely known for their anti-oxidant, dental 
analgesic, anti-inflammatory and anti-microbial properties (Tominaga et al., 2005; Chami 
et al, 2005; Kong et al., 2001). Numerous studies also suggested antidepressant-like 
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activity of eugenol and its direct involvement on NMDA receptor (Wie et al., 1997) and 
MAO-A activity (Tao et al., 2005). Since, most of the above effects of eugenol are related 
to stress-induced HPA axis. Thus, the anti-stress activity of these isoxazoline moieties can 
be linked to their constituent source molecule eugenol. 
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Physiological and psychological responses to stress are mediated by the 
Hypo thai amic-Pituitary-Adrenal (HPA), symphatoadrenergic and brain monoaminergic 
systems. The duration and nature of an applied stressor are important determinants whether 
adaptation to the stress response acts as being protective or damaging. However, stress-
related diseases require scientific assessment and medical evaluation. Thus, we focused our 
study to understand the stress-induced peripheral and central alterations, and its prevention 
by various anti-stress agents of plant or synthetic origin. We have developed three stress 
models [Acute stress (AS), chronic stress (CS) and chronic unpredictable stress (CUS)], 
which primarily differ in intensity, duration and predictability of stressors. 
Peripheral effects of stressors in rats subjected to AS and CUS were similar in which 
there was a significant increase in the mean ulcer score, adrenal hypertrophy, increased 
plasma creatine kinase (CK) and corticosterone levels, which could be attributed to the 
activation of the HPA-axis. However, hyperglycemia was observed only in AS group. In CS 
group, no significant changes in the plasma CK activity and corticosterone levels were 
observed, which could be due to the physiological adaptation and depletion of reserve 
glucocorticoid stores in the adrenals. However, increased mean ulcer score and adrenal 
hypertrophy was observed in CS group, which may reflect failure in the recovery of the 
initially stress-induced changes in these parameters. Interestingly, in CUS group, the plasma 
corticosterone levels were significantly increased. The different corticosterone response 
among the two chronic models (CS and CUS), could be explained on the differences in the 
functional state of HPA-axis feedback mechanism. Furthermore, in CS and CUS groups, 
there was no hyperglycemia observed, which could be explained on the basis that in chronic 
stress groups, the immediate available carbohydrate source may get depleted, and the body is 
start utilizing the secondary source of non-carbohydrate origin for glucose (lipids and 
proteins) which are slow and rate limiting. From these results, it was evident that in CS 
model the rats may get adapted due to the use of similar type and intensity of stressor. Thus, 
in further studies we used only AS and CUS model. 
With this data, we further studied the neurochemcial changes in the brain regions of 
rats subjected to AS and CUS. AS decreased the NA levels in the frontal cortex and 
hippocampus, while in CUS group, this decrease was observed in the frontal cortex, striatum 
and hippocampus. Dopaminergic response during AS condition is variable. AS significantly 
increased DA level in the frontal cortex, and decreased in the striatum and hippocampus. In 
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contrast, CUS led to a decrease of DA levels in all the three brain regions. These results were 
accompanied with selective increase of DOPAC and HVA levels both in AS and CUS 
condition in the frontal cortex and striatum. The variable response of DA in the frontal cortex 
and striatum by AS can be explained on the basis that the terminals of DA neurons on the 
frontal cortex may differ from those in the striatum. In the striatum and frontal cortex, 
decreased DA levels were accompanied by subsequent increased DOPAC and HVA levels 
indicating the increased conversion of DA to its metabolites in response to CUS. The 
increased DA turnover ratio in these regions may reflect either the increase in catabolism of 
DA by intraneuronal monoamine oxidase to DOPAC and/or by catechol-0-methyl 
transferase to HVA. The paradoxical decrease in monoamine levels in CUS group can partly 
be explained on the basis of increased stress sensitization and their preferential and higher 
utilization. Results also demonstrated that 5-HT system responded differentially following 
the exposure of AS and CUS condition. AS led to an increase of 5-HT and 5-HIAA levels, 
while CUS caused depletion of the same in all the three selected brain regions. Hippocampus 
has the highest number of corticosteroid receptors as well as 5-HT innervations, and 
expresses a variety of 5-HT receptors. Thus, the reduction of 5-HT levels in CUS group with 
simultaneous enhancement of corticosterone might have relevance to the glucocorticoid 
feedback mechanism of HPA-axis. The results obtained in the current study may also be 
related to the different effects induced by individual stress models, as the differences in 
duration, intensity and predictability of stressors are important determinants of stress induced 
brain responses. The differential monoaminergic responses might also be attributed to the 
regional variations in their levels of distribution, synthesis and degradation. 
Our results showed that the antioxidant system alters diversely in response to AS and 
CUS in a brain region specific manner. AS enhanced the activities of SOD and GSH-Px in 
the frontal cortex and striatum, while no significant alterations was observed in the 
hippocampus. On the other hand, CUS reduced the activities of SOD and CAT in all the three 
selected brain regions. Furthermore, an increase in the activity of GSH-Px, with reduced 
GSH content and increased lipid peroxidation was observed in both the stress models in all 
the three brain regions. These differential alterations in antioxidant system in selected brain 
regions may arise from the differences in antioxidant buffering capacities or differential 
susceptibilities to oxidative stress. The increased activity of SOD during AS is an indicator of 
a relative increase in the superoxide radical production and suggesting that the brain 
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antioxidant machinery is initially activated in response to excessive generation of free 
radicals. Enhanced SOD activity could stimulate the second line of defense which includes 
GSH-Px and CAT. In contrast to AS, CUS displayed a different redox state as evidenced in 
terms of deceased activities of SOD and CAT. This could be explained on the basis that 
chronic stress is shown to increase the vulnerability of different brain regions, by altering the 
neuronal defense capacity against oxidative damage. The increase in GSH-Px activity found 
both in AS and CUS groups, may indicates the increase in cellular peroxide levels. The 
decreased GSH content could be explained on the basis that loss of GSH may occur during 
an oxidative stress event due to its increased rate of utilization. We found simuUaneous 
alterations in both monoamines and oxidative processes, pointing towards the possibility of 
interconnection between the two systems, especially during CUS. We hypothesized that the 
elevated catecholamine levels during stress may undergo auto-oxidation, in which electrons 
are generated, that in turn can produce ROS. 
Medicinal plants and plant-derived products play an essential holistic role in the 
primary health care. Scientific approaches are directed towards the isolation, purification and 
characterization of various constituents of traditionally used herbal medicines. We have 
evaluated the anti-stress potential of crude ethanolic (Et-OH) extracts of six medicinal plants 
[Tinospora sinensis (TS), Pterospermum acerifolium (PA), Ocimum sanctum (OS), Evolvulus 
alsinoides (EA), Commiphora whighitii (Guggulipid) and Nardostachys jatamansi (NJ)] at 
various doses in AS model. OS and EA Et-OH extracts at oral doses of 200 and 400mg/kg 
and their butanolic fractions at 100 and 200mg/kg were found effective in preventing AS-
induced adrenal hypertrophy, ulcer severity, increased plasma corticosterone, glucose level 
and CK activity in comparison to NS control group. Similar extracts and fractions were 
tested for their anti-stress efficacy in CUS group, OS and EA Et-OH extracts (200mg/kg p.o.) 
and butanolic fractions (lOOmg/kg p.o.) showed restoring effects on CUS-induced adrenal 
hypertrophy, ulcer severity, increased plasma corticosterone level and CK activity. However, 
crude Et-OH extracts of TS, PA, NJ and Guuggulipid showed no significant effect at any 
dose in AS model. 
The significant anti-stress potential of OS and EA extracts/fractions intrigued us to 
further explore their phytochemical constituents responsible for anti-stress activities. Thus, 
we examined the anti-stress activity of three newly isolated OS derived pure compounds 
(Ocimarin, Ocimumoside A and Ocimumoside B) and six newly isolated EA derived pure 
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compounds (EA-1, EA-2, EA-3, EA-4, EA-5 and EA-6) at various doses (10, 20, 40 mg/kg 
p.o.) in AS model. Administration of Ocimumoside A, Ocimumoside B at a dose of 40 
mg/kg p.o. prevented the AS-induced changes in the adrenal gland weight, mean ulcer score, 
plasma corticosterone, glucose levels and CK activity, while Ocimarin produce no significant 
changes. Ocimumoside A and B at a dose 40 mg/kg p.o. also restored the CUS-induced 
adrenal hypertrophy, ulcer severity, increased plasma corticosterone level and CK activity. In 
case of EA derived pure compounds, administration of EA-1 at a dose of 40 mg/kg p.o 
significantly prevented the AS-induced changes, while other EA compounds (EA-2, EA-3, 
EA-4, EA-5 and EA-6) remains significantly ineffective in preventing one or the other AS-
induced changes. 
Apart from the plant sources, we also examined the anti-stress potential of 14 
synthetic Isoxazolines (IZL lA-lG, IZL 5A-5G) at a dose of 40 mg/kg p.o. body weight in 
AS model. Isoxazolines (IZL ID, IG, 5B, 5C, 5D and 5G) displayed most promising anti-
stress effect by reverting the AS-induced changes at a dose of 40 mg/kg p.o., whereas IZL 
lA, IC, IF, 5A, 5E and 5F were found ineffective. The anti-stress effect of synthetic 
Isoxazolines, could be attributed to the fact that they were prepared by altering the 
substituent group of Eugenol, which is a known modulator of HPA-axis. 
For comparative analysis, Panax quinquefolium (PQ; 100 mg/kg p.o.) and melatonin 
(MEL; 20 mg/kg i.p.) were used as the standard anti-stress and anti-oxidant drugs 
respectively. The respective doses of PQ and MEL were selected on the basis of our pilot 
investigation and available literature. PQ was selected due to its widely accepted position as 
an "adaptogen" and scientifically proven herb for offering non-specific resistance during 
stress. Administration of PQ powder at a dose of lOOmg/kg p.o. was effective in normalizing 
stress-induced changes in mean ulcer score, adrenal gland weight plasma corticosterone, 
glucose levels and CK activity. PQ was also effective in normalizing most of the stress-
induced monoaminergic changes. These effects of PQ may be related to its major 
constituent's ginsenosides- known to possess corticosteroid like actions. The ginsenosides 
may also modulate the nerve transmissions by altering the availability of neurotransmitters. 
In our study, MEL restored the altered redox state in both AS and CUS conditions. This is in 
agreement with several reports that MEL plays important role in modulating antioxidant 
enzyme activities, extent of lipid peroxidation and GSH content. 
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To further ascertain the attenuating effects of OS compounds (Ocimumoside A and 
Ocimumoside B) in relation to mucosal damage in stress-induced gastric ulcers, microscopic 
evaluation of histopathological changes in gastric mucosal tissue in AS and CUS group was 
performed. When rats were subjected to AS after the treatment of Ocimumoside A and B at a 
dose of 40 mg/kg p.o., glandular proliferation could be seen but differentiation and 
organization was not properly evident, suggesting only minor protective activity. On the other 
hand, in CUS group, chronic pretreatment of Ocimumoside A and B (40 mg/kg) caused re-
epithelization, reduced inflammatory exudates, mucosal regeneration and glandular 
organization signifying their role in ulcer protection. 
We also examined the alterations in the expression of various stress responsive genes 
such as corticotrophin releasing hormone (CRH), pro-opiomelanocortin (POMC) and 
glucocorticoid receptor (GR) in the extra-hypothalamic centers (frontal cortex, hippocampus) 
and the hypothalamus and the pituitary gland to delineate the molecular basis of stress 
response under AS and CUS condition. CUS caused a significant increase in the expression 
of CRH mRNA in the frontal cortex, hippocampus, hypothalamus and pituitary. However, in 
AS group, it was increased only in the frontal cortex and pituitary. The increase in the 
expression of CRH mRNA suggested an induction of stress response and thereby activation 
of HPA-axis. The levels of POMC mRNA in the hypothalamus and pituitary were increased 
by AS. Similarly, CUS rats also showed an increased POMC mRNA levels in the frontal 
cortex, hippocampus and pituitary. However, in the hypothalamus, POMC mRNA levels 
were decreased. In contrast, the decreased expression of GR mRNA levels can be considered 
as a secondary effect of increased corticosterone levels during AS and CUS condition. The 
changes induced by AS and CUS, in the expression of CRH, POMC and GR mRNA levels, 
in these brain regions, may indicate a state of impaired/deregulated HPA-feedback 
mechanism. It was evident that most of these changes were prevented or normalized by the 
pretreatment of Ocimumoside A and B at a dose of 40mg/kg in both the stress models, 
suggesting their molecular mechanism through which they modulates the stress response. 
Further, at the protein expression level, the observed down regulation of whole cell 
fraction of GR, both in the frontal cortex and hippocampus in CUS group, could be due to the 
increased circulating corticosterone levels, which may lead to the disruption of HPA-axis 
feedback mechanism. The restoration of decreased GR expression in CUS group, following 
the administration of Ocimumoside A and B (40mg/kg), could be related to their attenuating 
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effect on stress-induced increase in the corticosterone level. Thus, the possible anti-stress 
mechanism can be speculated in terms of their pharmacological effects on the secretory 
activity of HPA-axis. In other words, the disruption of the HPA-axis feedback mechanism 
during CUS might be resolved by restoring the GR expression level, following the 
administration of Ocimuraoside A and B. Increased expression of HSP-70 protein, in the 
frontal cortex and hippocampus regions of the brain during both AS and CUS conditions 
confirming the induction of stress. The expression level of HSP-70 was decreased by the 
pretreatment of Ocimumoside A and B in the frontal cortex and hippocampus in both AS and 
CUS conditions, which could be attributed to their potential in reducing the stress-induced 
oxidative load. As a number of studies indicated that the expression of HSP-70 in the brain 
can be attributed to oxidative stress. This may also reflect a condition, where oxidative load 
inducing factors (corticosterone, monoamine metabolism) were normalized by these OS 
compounds, and hence lesser induction of HSP-70 was observed. In other words, 
Ocimumoside A and B administration prevented the induction of HSP-70 expression in the 
brain, indicating that the brain tissue was able to cope better with stress in presence of these 
compounds. 
In order to fiirther confirm the alterations in the HPA-axis and monoamine 
biosynthesis following the exposure of different stressful conditions and OS compounds 
administration, the expression profile of CRF, GR and TH was examined in various brain 
regions by immunohistochemistry. The decreased expression of TH in the striatum and the 
medial fore bundle (MFB) fibers and a decrease in number of TH immunopositive neurons in 
the substantia nigra (SN) in CUS group, suggesting a down regulation of TH enzyme. This 
may have several biological implications under stressful condition. For instance it can 
explain the simultaneous dopaminergic changes at the level of DA levels and its receptor 
stimulation/function. We observed that AS significantly increased the DA levels in the 
frontal cortex, while in striatum and hippocampus it was significantly decreased. In contrast 
to AS, CUS led to a decrease of DA level in the frontal cortex, striatum and hippocampus. 
Therefore, the decreased levels of DA during stress may be secondary to either its increased 
metabolism or decreased synthesis. The possible cause for decreased DA biosynthesis could 
be related to the alterations in TH expression and /or activity. Thus, the decreased expression 
of TH explains the decrease in DA levels during CUS condition. Chronic treatment of 
Ocimumoside A and B at dose of 40mg/kg p.o. significantly normalized the CUS-induced 
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decreased expression of TH as compared to CUS group. Similarly, the effect of stress on the 
modulation of HPA-axis was further assessed in relation to the changes in immunoreactivity 
of CRF and GR. Exposure of CUS caused a significant increase in the expression of CRF 
with decrease in GR in the cortex and hippocampus as compared to control group. These 
observations were in agreement with the results of RT-PCR and western blot analysis 
regarding the increased expression of CRF and decreased levels of GR. As explained earlier, 
these changes might be related to the increased circulating corticosterone levels, and the 
disruption of glucocorticoid negative feedback mechanism. These changes observed only in 
CUS group, suggesting that CUS led to a more pronounce and long lasting neuroendocrine 
effects. Chronic treatment of Ocimumoside A and B at dose of 40mg/kg p.o. significantly 
normalized the CUS-induced altered expression of CRH and GR as compared to CUS group. 
Thus, the possible anti-stress mechanism of OS compounds could be related to their 
restorative action of the disrupted HPA-axis through the modulation of CRF, POMC, GR and 
TH expression. 
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In the present study, the three stress models used (AS, CS and CUS) showed 
heterogeneous stress response both at central (brain monoamine and antioxidant system) and 
peripheral (plasma corticosterone, glucose) level. Ulcer index severity and adrenal 
hypertrophy reflected the intensity and severity of the experimental stress as it increased 
from AS to CUS. The alterations in the levels of circulating corticosterone and glucose may 
be the outcome of the psychological factor of the immobilization stress; thus, habituation 
(reduced emotional activation) was found in response to CS. The rise in plasma glucose and 
corticosterone levels, and CK activity during AS were due to the novelty of stressor, 
triggering a cascade leading to the ultimate response. In CUS group, persistent increase of 
circulating corticosterone level could be secondary to the failure of glucocorticoid negative 
feedback mechanism. Of the three different models of stress, the CUS model in rats appears 
to be clinically relevant to humans. Biochemical markers like plasma corticosterone, glucose 
and CK activity can be used as more effective markers for clinical conditions. 
During the evaluation of the anti-stress potential of crude ethanolic (Et-OH) extracts 
of six medicinal plants [Tinospora sinensis (TS), Pterospermum acerifolium (PA), Ocimum 
sanctum (OS), Evolvulus alsinoides (EA), Commiphora whighitii (Guggulipid) and 
Nardostachys jatamansi (NJ)] at various doses in AS model, only OS and EA Et-OH 
extracts/fractions/pure compounds were found effective at various doses in preventing AS-
induced changes. The anti-stress activity of OS and EA extracts/fractions could be attributed 
to a number of important active constituents. Our study suggested that EA extracts/fractions 
have anti-stress potential. However, out of six EA derived pure compounds, only EA-1 
(40mg/kg p.o.) showed promising anti-stress activity in AS model. Further, synthetically 
derived Isoxazolines IZL ID, IG, 5B, 5C, 5D and 5G also showed anti-stress effect by 
preventing the AS-induced changes. The biological activity of Isoxazolines could be 
attributed to the fact that they were prepared from eugenol (4-allyl-2-methoxy-phenol), 
which is a known active constituent of many herbal plants, and a modulator of HPA-axis. 
Although, we did not evaluated the anti-stress potency of EA and synthetic Isoxazolines 
compounds in a more severe CUS model, these preliminary studies provides evidence that 
EA and Isoxazolines could be the potential candidate molecules for further exploring their 
anti-stress related effects. 
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The main focus of our study was on three OS derived novel compounds 
(Ocimumoside A, Ocimumoside B and Ocimarin). This investigation revealed 
preventive/restorative actions of Ocimumoside A and Ocimumoside B at an oral dose of 40 
mg/kg body weight, as evidenced by the normalization of stress-induced peripheral (plasma 
corticosterone, glucose, CK, adrenal hypertrophy, ulcer severity) and central (brain 
monoamine and antioxidant system) alterations, and was found associated with normalizing 
effects on HPA-axis and monoamine metabolism regulating factors such as CRF, POMC, 
GR, HSP-70 and TH enzyme both at the mRNA and protein levels. On the contrary, no 
significant recovery was observed in any of the stress-induced perturbations by Ocimarin 
pretreatment. Further, the responses in different brain regions do not follow a specific 
pattern, also acute and chronic stress exposure produced differential effects in these 
parameters. 
We found simultaneous alterations in both monoamines and oxidative processes, 
pointing towards the possibility of interconnection between the two systems, especially 
during CUS. The perturbed central monoamine response and metabolism might have 
amplified the oxidative load during CUS. Hence, improvement of altered redox state in 
various brain regions by Ocimumoside A and B could be ascribed to their potential in 
altering the plasma corticosterone and brain monoamine levels during such stressful 
conditions. 
The data revealed herein may gather importance in respect to several facts. Firstly, 
the results provide insight into the stress-induced differential brain regional responses in 
central stress pathways. Studies aimed at establishing the reasons for this brain regional and 
stressor specific changes warrant further exploration, which may help in understanding the 
mechanisms involved in the simultaneous alterations of the neurochemical and oxidative 
systems under stressful conditions. Secondly, Ocimumoside A and B reinstated the 
alterations in the brain regions only where they were affected by stress. Interestingly, when 
OS compounds were administered alone, they were unable to cause any alterations in the 
baseline values of these parameters. Thus, the decreased activation of HPA axis (reduction in 
corticosterone levels), along with the restoration of altered monoamine levels and redox state 
following the treatment of Ocimumoside A and B suggested that these compounds might 
work by an overall normalization of stress-induced responses. Owing to these central affects 
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of OS compounds it can be postulated that Ocimumoside A and B might have crossed the 
blood brain barrier and induced their beneficial effects. This is the first report which 
identified the anti-stress potential of Ocimumoside A and B in relation to their simultaneous 
modulatory effects on the central monoaminergic, antioxidant systems and circulating 
corticosterone levels during acute and chronic stressful condition. 
Further, the normalization of stress-induced changes in the expression of CRF, 
POMC, GR and TH by Ocimumoside A and B, might explain their restorative actions on 
various stress-induced parameters. A number of possibilities can be hypothesized in relation 
to these molecular effects of OS compounds. Firstly, OS treatment may attenuate the 
adrenocortical secretory response to stress as evidenced by the normalization of CRH mRNA 
levels. Secondly, OS compounds may differentially influences the hypothalamic ACTH 
secretagogues, depending on the duration of the stressful challenge as evidenced by the 
variable response on POMC mRNA expression following stress (AS or CUS) and OS 
compounds administration. Thirdly, OS treatment may increases the sensitivity of the HPA-
axis to glucocorticoid suppression as evidenced by their normalizing effects on stress-
induced decrease of GR mRNA levels, especially during CUS. Fourthly, OS treatment may 
attenuate the inadequate responsiveness of hypothalamo-pituitary components to stress. Since 
persistently increased adrenocortical secretion, blunted the responsiveness of pituitary 
corticotrophs to neuropeptide secretagogues, and decreased the sensitivity of the HPA-axis to 
glucocorticoid feedback. These are considered as hallmarks of disturbed neuroendocrine 
regulation in stress-related disorders; our data suggested that OS treatment may normalize 
several of these mechanisms. 
Thus, the possible anti-stress mechanism of OS compounds could be related to their 
restorative action of the disrupted HPA-axis through the modulation of CRF, POMC, GR and 
TH expression. Ocimumoside A and B administration also prevented the induction of HSP-
70 expression in the brain, indicating that the brain tissue was able to cope better with stress 
in presence of these compounds. Thus, the present study highlights the importance of 
pharmacological interventions of OS constituents in the prevention of stress-induced 
neurological and related disorders. 
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Alterations in monoamine levels and oxidative systems in frontal 
cortex, striatum, and hippocampus of the rat brain during chronic 
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Abstract 
Stress plays a key role in the induction of various clinical disorders by altering monoaminergic response and antioxidant 
defenses. In the present study, alterations in the concentrations of dopamine (DA), serotonin (5-HT) and their metabolites, 
and simultaneous changes in the antioxidant defense system and lipid peroxidation in different brain regions (frontal cortex, 
striatum, and hippocampus) were investigated immediately and 24 h after exposure to chronic unpredictable stress (CUS). 
CUS involved subjecting Sprague-Dawley rats to two different types of stressors varying from mild to severe intensity every 
day in an unpredictable manner, over a period of 7 days. CUS significantly decreased DA and 5-HT concentrations, with 
increased DA turnover ratios in the selected brain regions. In tlie frontal cortex and striatum, DA metabolite concentrations 
were increased; however, in the hippocampus they remained unaltered. Further, a decrease of 5-hydroxyindoleacetic acid 
content was observed in the frontal cortex and striatum, with no significant alteration in the hippocampus. CUS also reduced 
the activities of superoxide dismutase and catalase, with increased lipid peroxidation and decreased giutatliione levels in the 
selected brain regions. Glutathione peroxidase activity was increased in the frontal cortex and hippocampus only. The pattern 
of CUS-induced monoamine and oxidative changes immediately after the last stressor and 24 h later were similar when 
compared widi the control group, indicating that tlie observed changes were due to the chronic exposure to the various 
stressors and were not merely acute effects of the last stressor. The altered redox state in the striatum and frontal cortex might 
be related to the perturbed DA and/or 5HT levels, while the hippocampus seems to be less influenced by CUS in terms of 
monoamine metabolite changes. These results suggest that the perturbed monoamine levels could interact with the oxidative 
load during CUS. Hence, the current study has implications for pharmacological interventions targeting both central 
monoamines and cellular antioxidants as a potential stress management strategy for protecting against central stress-induced 
disorders. 
Keywords: Chronic unpredictable stress, dopamine, frontal cortex, lipid peroxidation, oxidative stress, serotonin 
Introduction neurodegenerative and psychiatric disorders, while 
~, , , 1 • • -^  J 1 /TJ^ >A^  • J these conditions are also known to have altered 
The hypothalamic-pituitary-adrenal (HPA) axis and 
the monoaminergic-sympathetic nervous system play ntonoaminergic regulation (Gamaro et al. 2003; 
an important role in stress responses (Armario 2006) ^^"^"k et al. 2008; Lucca et al. 2009). Moreover, 
by inducing various physiological and behavioral s^ ^^ '"^ ' studies in rodents have shown that different 
changes Qankord and Herman 2008). However, the stress paradigms produce changes in monoamine 
duration and nature of an applied stressor are levels in various brain regions (Harvey et al. 2006; 
important determinants ofwhether adaptation to the Hirooka 2008). The brain is more vulnerable to 
stress response acts as being protective or damaging. oxidative damage compared to other organs for several 
Chronic stress exerts detrimental effects on several cell reasons (Metodiewa and Koska 2000). The brain has 
functions, through impairment of antioxidant a higher rate of oxygen consumption per unit mass of 
defenses, which are proposed to lead to numerous tissue, contains high levels of peroxidizable lipids, 
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excitotoxic amino acids, and low levels of antioxidants 
(Metodiewa and Koska 2000; Andersen 2004). 
Furthermore, stress leads to increased serum gluco-
corticoid (GC) concentrations which may alter 
antioxidant enzyme activities in brain (Mcintosh 
ct al. 1998; Zafir and Banu 2009). Importantly, 
some studies indicate a link between the alterations in 
centra] monoaminergic systems and increased oxi-
dative load during physiologically adverse conditions 
(Wrona and Dryhurst 1998; Siraki and O'Brien 
2002). However, the extent to which oxidation 
products contribute to the perturbed redox state 
during chronic stressful condition in the brain regions 
with monoaminergic innervation is still unclear. 
Dopamine (DA) and serotonin (5-HT) oxidation 
products are postulated to contribute to neurodegen-
erative disease process (Andersen 2004). However, 
except for a few in vitro studies indicating the pro-
oxidant effect of phenol-containing neurotransmitters, 
animal studies that address the simultaneous changes 
in monoamine levels and antioxidant defense 
systems in the brain regions are lacking (Siraki and 
O'Brien 2002). 
The frontal cortex and striatum have a high DA 
content (Miyazaki and Asanuma 2008), while the 
hippocampus has a high concentration of GC 
receptors (Jankord and Herman 2008). These brain 
regions are connected with each other through 
different neurotransmitter systems and have been 
proposed to play an important modulatory role in 
stress responses (Bekris et al. 2005; Herman et al. 
2005). In the present study, we hypothesized that 
these brain regions could be particularly vulnerable to 
chronic stress exposure, and that changes in central 
monoamine and antioxidant systems could be 
interrelated. It was also hypothesized that the source 
of oxidative damage during stress may vary in a region-
specific manner depending on the microenvironment 
of the brain region. Therefore, the aim of the present 
investigation was to evaluate the response of DA and 
5-HT concentrations with simultaneous changes in 
enzymatic and non-enzymatic antioxidant defense 
systems and lipid peroxidation in selected brain 
regions in a chronic unpredictable stress (CUS) 
model in rats. Furthermore, we evaluated monoamine 
metabolite concentrations and turnover ratios to 
provide information about the monoamine metab-
olism resulting from CUS. In order to evaluate 
oxidative alterations during CUS, we measured the 
activity of Cu-Zn superoxide dismutase (SOD), 
cataiase (CAT), selenium-dependent glutathione 
peroxidase (GSH-Px), extent of lipid peroxidation 
[malondialdehyde (MDA) concentrations] and 
reduced glutathione (GSH) concentrations in the 
selected brain regions. 
Materials and methods 
Animals 
Experimental protocols were approved by the Insu-
tuuonal Ethical and Usage Committee of Central 
Drug Research Institute (CDRI), Lucknow, following 
the guidelines of the Committee for the Purpose of 
Control and Supervision of Experiments on Animals 
(CPCSEA). Adult male Sprague-Dawley rats, weigh-
ing 180-220 g procured from the National Labora-
tory Animal Centre, CDRI, were used in the study. 
For bodi control and stressed groups, three rats were 
housed per cage, in a room with temperature regulated 
at 22 ± 2°C, with a 12h:12h light/dark cycle (lights 
on 07:00h, lights off 19:00h). Standard chow pellets 
and water were given ad libitum, except during the 
period when food or water deprivation was applied. 
Chemicals 
DA, dihydroxyphenylacetic acid (DOPAC), homo-
vanillic acid (HVA), serotonin (5-HT), 5-hydroxyin-
dole acetic acid (5-HIAA), dihydroxybenzylamine 
(DHBA), epinephrine, t-butyl hydroperoxide, 
reduced GSH, GSH reductase, thiobarbituric acid 
(TBA), 1,3,3-tetraethoxypropane, and 5,5'-dithio-
bis(2-nitrobenzoic acid) (DTNB) were purchased 
from Sigma Aldrich (St Louis, MO, USA). All other 
chemicals used in the study were of analytical or 
HPLC grade and were purchased locally. 
Experimental procedure 
All the rats were acclimatized to laboratory conditions 
and handled daily for a week prior to the experiment. 
The rats were randomly divided into two groups, i.e. a 
control non-stress (NS) and stressed (CUS) group. 
NS group: Rats were kept undisturbed in their 
home cages for 7 days. 
CUS group: Rats were subjected to two different 
types of stressor of variable intensity daily in an 
unpredictable manner for 7 days. The schedules of 
stressors were designed to make minimal repetition of 
stressors in order to avoid habituation. The CUS 
group was further divided into two groups, based 
upon the time of killing the rats after the last stress 
regimen. In one group, rats were killed immediately 
after the last stressor (0 h CUS group), but in the other 
group, rats were killed 24 h after the last stressor (24 h 
CUS group). A total of 48 rats were used in the 
experiment, with 16 rats per group. Six rats from each 
group were used for the biochemical estimations of the 
antioxidant system and lipid peroxidation, and 10 rats 
from each group were used for the estimation of 
monoamine concentrations. 
The CUS procedure was a modification • of 
previously published procedures (Katz et al. 1981; 
Willner et al. 1987). We chose the seventh day of CUS 
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for analysis because in our previous reports, we have 
successfully used stressors for the same duration and 
observed stress-induced alterations both at peripheral 
and central levels (Siripurapu et a), 2005; Sheikh et ai. 
2007; Rasheed et al. 2009). Individual stressors and 
duration of exposure each day are listed in Table I. 
The stressors comprised fasting, tail pinching, 
restraint, overnight wet cage bedding, isolation, forced 
swimming, day-night reversal, cold-restraint, water 
deprivation, foot-shock, and cold exposure. Briefly, 
rats were subjected to fasting (food deprivadon) for 
18h, between 14:00 and 10:00h the next day. Tail 
pinching comprised pinching the tail tip with specially 
designed steel clips for 5min. Restraint stress 
comprised confinement for 150min, inside a cylind-
rical steel tube (7 cm diameter, 17.5 cm long, with 
holes for ventilation). The bedding material was 
soaked with water overnight as a further stressor. For 
isolation stress, rats were kept alone in a cage for 12 h. 
For swimming stress, rats were placed in a glass jar 
(35.5 cm high, 20 cm diameter) containing water 
(depth: 25 cm) at 25''C for 30min. Day and night 
reversal involved keeping the rats in the dark during 
the usual day (3 h) and in high intensity light during 
the night (12 h). During water deprivation, water was 
removed for 18h, between 14:00 and 10:00 h the next 
day. In foot-shock stress, rats were subjected for 
20 min to one shock per 2 s of 2 mA via a grid floor in 
an agressometer (Techno electronics, Lucknow, 
India). Cold exposure involved placing rats in a 
programmable environment test chamber (Remi, 
Mumbai, India) for 3h at 4°C. In cold-restraint 
stress, rats were restrained as above and kept in the 
cold chamber for 2h at 4°C. The last stressor 
employed on the seventh day was restraint stress. 
Sample preparation 
Immediately after the last stressor, all the rats from NS 
and CUS groups were killed by conscious cervical 
dislocation followed by decapitation, and the brains 
were immediately removed. The discrete regions 
(frontal cortex, striatum, and hippocampus) were 
dissected on an ice-cold glass plate (Glowinski and 
Iversen 1966). For the estimation of neurotransmitter 
concentrations, the dissected brain regions were first 
weighed and 25ng/ml of internal standard DHBA 
was added to each sample. Homogenization was 
performed in 0.17 M perchloric acid with an Ultra-
Turrax homogenizer (Model T25, IKA-Laborthechnik, 
Staufen, Germany). Homogenates were then centri-
fuged at 35,000^ (Sigma centrifuge, model 3K30, 
Osterode, Germany) at 4°C, the supernatant was 
passed through a 0.22 fim membrane filter and used for 
the analysis. For the estimations of antioxidant 
parameters and lipid peroxidation, the dissected brain 
regions were homogenized in an ice cold 50 mM 
phosphate buffer (pH 7.0) containing 0.1 mM EDTA 
and centrifuged at 1000^ for 15 min at 4°C, and die 
supernatant was used for analysis. 
Estimation of monoamines and their metabolites 
The endogenous concentrations of DA, 5-HT, and 
their non-conjugated metabolites DOPAC, HVA, and 
5-HIAA were determined by reverse-phase HPLC 
with electrochemical detection (Kim et al. 1987). 
The sample (20fxl) was injected via an HPLC 
pump (Model 1525, Binary Gradient Pump, Waters, 
Milford, MA, USA) into a column (Spherisorb, RP 
CI8, 5)jim particle size, 4.6mm i .dx250mm at 
30°C) connected to an electrochemical detector 
(Model 2465). Oxidation potential was fixed at 
0.80 V using a glass carbon working electrode vs. an 
Ag/AgCl reference electrode. The mobile phase 
consisted of 32 mM citric acid, 12.5 mM disodium 
hydrogen orthophosphate, 1.4mM sodium octyl 
sulfonate, 0.05 mM EDTA, and 16% (v/v) metiianol. 
pH of the mobile phase was adjusted to 4.05. 
Separation was carried out at a flow rate of 
1.2ml/min. The neurotransmitters were quantified 
using the Breeze version 3.2 software purchased from 
Waters HPLC systems (Hietzinger Hampststrasse 
145, Al 130 Wien, Austria). The concentrations were 
expressed in nanograms of neurotransmitter per gram 
of wet weight of brain tissue. Quantification was made 
by comparing peak heights of the samples to the 
corresponding standard curve. Two ranges of standard 
curves, i.e. 10-100 and 100-1000 ng/ml were used 
depending upon the abundance of monoamines in 
respective brain regions. The constant amount 
(25 ng/ml) of DHBA added to the tissue samples 
Table I. Schedule of stressors used during CUS for a period of 7 days. 
Day Time Procedure Duration Time Procedure Duration (h) 
10:00h 
10:00h 
9:00h 
12:30h 
lO.OOh 
10:00h 
9:00 h 
Tail pinching 
Restraint 
Isolation 
Cold-restraint 
Foot-shock 
Forced swimming 
Restraint 
5 min 
150 min 
12h 
2h 
20 min 
30 min 
150 min 
14:00 h 
15:00h 
21:00h 
15:00h 
16:00h 
14:00 h 
12:30h 
Fasting (food deprivation) 
Wet cage bedding 
Day-night reversal 
Water deprivation 
Cold exposure 
Fasting (food deprivation) 
Killed by cervical dislocation 
18 
18 
15 
18 
3 
18 
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was used to calculate recovery. The turnover of the 
dopaminergic and serotonergic systems were 
expressed as DOPAC/DA, HVA/DA, and 5-HIAA/ 
5-HT ratios. 
were added. The mixture was shaken vigorously on a 
vortexer and the absorbance read at 412nm within 
15 min. GSH concentrations were determined from a 
standard curve and expressed as |xM/mg protein. 
Cu-Zn, SOD (EC 1.15.1.1) activity 
SOD activity was measured based on its ability to 
inhibit the auto-oxidation of epinephrine to adreno-
chrome at an alkaline pH- (Misra and Fridovich 
1972). Brain samples (100 pil) were added to 880 jil 
carbonate buffer (0.05 M NazCOa, pH 10.2), 20 |xl of 
30 mM epinephrine in 0.05% acetic acid was added 
and the absorbance was followed for 4 min at 480 nm 
in a spectrophotometer (Shimadzu, model 1201, 
Kyoto, Japan). Enzymatic activity was expressed as 
U/mg protein at 30°C. The amount of enzyme that 
caused 50% inhibition of epinephrine auto-oxidation 
is defined as one imit (U). 
CAT (EC 1.11.1.6) activity 
CAT activity was measured using H2O2 as substrate 
(Aebi 1984). Brain samples (SOp-O were added to 
200 |il of O.IM phosphate buffer (pH 7.0) and 250(1,1 
of 0.066 M H2O2 (prepared in phosphate buffer) was 
added and decrease in the absorbance was read at 
240 nm for 30 s in a spectrophotometer. A molar 
absorption of 43.6 M/cm was used to determine CAT 
activity. Enzymatic activity was expressed as U/mg 
protein at 25°C, one unit (U) of which is equal to 1 
mole of H2O2 degraded/min/mg of protein. 
Selenium-dependent GSH-Px, (EC 1.11.1.9) activity 
GSH-Px activity was measured using t-butyl hydro-
peroxide as a substrate (Flohe and Gunzler 1984). 
The reaction mixture consisted of 500)xl of O.IM 
phosphate buffer (pH 7.0), 100 jxl of 0.01 M reduced 
GSH, 100 fxl of 1.5 mM NADPH, and 100 (JLI of GSH 
reductase (0.24 U). Brain sample (100 \i]) was added 
to the reaction mixture and incubated at 37°C for 
10 min, then 50|xl of 12mM t-butyl hydroperoxide 
was added and absorbance measured at 340 nm for 
180 s in a spectrophotometer. A molar absorptivity of 
6.22x10^ M/cm was used to determine enzyme 
activity, expressed as U/mg protein at 37°C. One 
unit (U) of activity is equal to mM of NADPH 
oxidized/min/mg protein. 
Reduced GSH concentrations 
GSH was determined by its reaction with DTNB 
(Ellman's reagent) to yield a yellow chromophore, 
which was measured spectrophotometrically (Sedlak 
and Lindsay 1968). To 100|JL1 of processed brain 
sample, 2ml of O.IM phosphate buffer (pH 8.4), 
500 |JL1 of DTNB, and 400 |JL1 of double distilled water 
MDA assay 
MDA concentrations (a TBA reactive species: an 
indicator of lipid peroxidation) were measured using 
1,1,3,3-tetraethoxypropane as the standard (Ohkawa 
et al. 1979). The reagents 20% acetic acid 1.5 ml (pH 
3.5), 1.5 ml (0.8%) TBA, and 0.2 ml (8.1%) sodium 
dodecyl sulfate were added to 100|xl of processed 
sample. The mixture was heated at 100°C for 60 min, 
after cooling under tap water, 5 ml of n-butanol: 
pyridine (15:1% v/v) and 1 ml of distilled water were 
added and the mixture vortexed. After centrifugation at 
1400^ for 10 min, the organic layer was withdrawn and 
absorbance was measured at 532nm using a spectro-
photometer. MDA concentrations were determined 
from a standard curve and expressed as nM/mg protein. 
Protein assay 
The protein content of the samples was determined by 
the method of Lowry et ai. (1951) using Folin's 
Phenol reagent. Bovine serum albumin (1 mg/ml) was 
used as a standard. 
Statistical analysis 
Data were evaluated by one-way analysis of variance 
(ANOVA), with post hoc analysis by Newman-Keuls 
multiple comparison test. Significance was set at 
P < 0.05. All data are presented as means ± SE of the 
means. 
Results 
Effect ofCUS on the concentrations of monoamines, their 
metabolites, and turnover in selected brain regions 
Frontal cortex. As shown in Figure 1 (A), there was a 
significant decrease in the cortical DA (F2,27 = 19.70, 
P < 0.001), 5-HT (F2,27 = 8.85, P < 0 . 0 1 ) , and 
5-HIAA (F2,27 = 7.10, P<0.01, P < 0 . 0 5 ) 
concentrations, with significantly increased DOPAC 
(F2,27 = 24.04, P< 0,001) and HVA (F2,27 = 21.66, 
P < 0.001) concentrations in both the 0 and 24h 
CUS groups as compared to the NS control group. Post 
hoc tests (Newman-Keuls) revealed no significant 
differences (P > 0.05) in the concentrations of DA, 
5HT, and their metabolites between 0 and 24 h CUS 
groups (Figure 1(A)). 
The effect of CUS on DA and 5-HT turnover in the 
frontal cortex is depicted in Figure 1(B). There was a 
significant increase in DOPAC/DA (F2,27 = 15.03, 
P < 0.001) and HVA/DA (F2,27 = 25.57, P < 0,001) 
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Figure 1. Histogram representing the concentrations of DA, 
DOPAC, HVA, 5-HT, and 5-HIAA (A) and turnover ratios; 
DOPAODA, HVA/DA, and 5-HIAA,'5-HT (B) in the frontal cortex 
of the control group (non-stress, NS) and groups exposed to chronic 
unpredictable stress (CUS; 0 and 24h after last stressor). Values are 
group mean ± SEM; ti = 10 rats per group. *P < 0.05, **P < 0.01, 
***P < 0.001 vs. NS control group (ANOVA, Newman-Kculs;>oji 
hoc test). 
• NS 
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Figure 2. Histogram representing the concentrations of DA, 
DOPAC, HVA, 5-HT, and 5-HIAA (A) and turnover ratios; 
DOPAC/DA, HVA/DA, and 5-HIAA/5-HT (B) in the striatum of 
the control group (non-stress, NS) and groups exposed to chronic 
unpredictable stress (CUS; 0 and 24 h after last stressor). Values 
are group mean ± SEM; n=lO rats per group. **P<0.01, 
*«*P< 0.001 vs. NS control group (ANOVA, Newman-Keuls 
piKt hoc test). 
ratios in both the 0 and 24 h CUS groups as compared 
to the NS control group, whereas the 5-HIAA/5-HT 
ratio (F2,27 = 0.815, P > 0.05) remained unaltered in 
all the groups. Furthermore, there were no significant 
differences (P > 0.05) in the DA and 5-HT turnover 
ratios between 0 and 24 h CUS groups. 
Striatum. There was a significant decrease in the 
striatal DA (F2,27 = 14.19, P < 0.001, P<0 .01) , 
5-HT (F2,27 = 10.70, P < 0.001, P < 0 . 0 1 ) , and 
5-HIAA (F2,27 = 9.55, P < 0.001, P < 0 . 0 1 ) 
concentrations, with significantly increased HVA 
(F2,27 = 7.52, P < 0.01, P < 0.05) concentrations in 
both the 0 and 24 h CUS groups when compared with 
the NS control group (Figure 2(A)). However, 
DOPAC (F2,27 = 1.54, P > 0 . 0 5 ) concentrations 
were not significantly changed in either group. Post 
hoc tests (Newman-Keuls) revealed no significant 
differences (P>0 .05) in DA, 5-HT, and their 
metabolite concentrations between 0 and 24 h CUS 
groups (Figure 2(A)). 
Furthermore, there was a significant increase in the 
DOPAC/DA (F2,27 = 8.53, P < 0.01) and HVAyDA 
(F2,27 = 15.90, P < 0.001) ratios in both the 0 and 
24 h CUS groups compared with the NS control 
group (Figure 2(B)). The 5-HIAA/5-HT 
(F2,27 = 0.019, P > 0.05) ratio was not significantly 
changed in either group. Furthermore, there were no 
significant differences (P > 0.05) in DA and 5-HT 
turnover ratios between 0 and 24 h CUS groups 
(Figure 2(B)). 
Hippocampus. There was a significant decrease in DA 
(F2,27= 12.25, P < 0.001, P < 0 . 0 1 ) and 5-HT 
(F2,27 = 7.52, P < 0 . 0 1 ) concentrations, with no 
significant changes in DOPAC (F2,27 = 0.82, 
P>0 .05 ) , HVA (F2,27 = 3.09, P > 0 . 0 5 ) , or 5-
HIAA (F2,27 = 0.46, P > 0 . 0 5 ) concentrations in 
both the 0 and 24 h CUS groups compared with the 
NS control group (Figure 3(A)). Post hoc tests 
(Newman-Keuls) revealed no significant changes 
(P > 0.05) in DA, 5-HT, and their metabolite 
concentrations when compared between 0 and 24 h 
CUS groups. 
There was a significant increase in HVA/DA 
(F2,27 = 6.09, P < 0 . 0 1 , P<0 .05 ) ratio, with no 
changes in the DOPAC/DA (F2,27 = 3.11, P > 0.05) 
and 5-HIAA/5-HT (F2,27 = 2.41, P > 0.05) ratios in 
either the 0 or 24 h CUS groups compared with the 
NS control group (Figure 3(B)). Furthermore, no 
significant differences (P > 0.05) were observed in 
DA and 5-HT turnover ratios between 0 and 24 h 
CUS groups. 
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Figure 3. Histogram representing the concentrations of DA, 
DOPAC, HVA, 5-HT, and 5-HIAA (A) and turnover ratios; 
DOPAC/DA, HVA . A, and 5-HIAA/5-HT (B) in the hippocampus 
of control (NS) *;• .t (non-stress, NS) and groups exposed to 
chronic unpredict:. . ^ircss (CUS; 0 and 24 h after last stressor). 
Values are group r . . r. SEM; n = 10 rats per group. *P < 0.05, 
***P < 0.001 (AKi ' > .\) vs. NS control group (ANOVA, Newman-
Keuls/)o«/loc test,!. 
Effect of CUS on antioxidant enzyme activities in selected 
brain regions 
Alterations in the activities of SOD, CAT, and GSH-
Px are depicted in Table II. 
SOD: SOD activit}' was significantly decreased in 
both the 0 and 24 h CUS groups in the frontal cortex 
(F2,i5 = 4.72, P < 0.05), striatum (F2,i5 = 4.62, 
P < 0 . 0 5 ) , and hippocampus (Fj,15 = 21.53, 
P < 0.001) compared to the NS control 
group. Furthermore, post hoc tests (Newman-Keuls) 
revealed no significant differences {P > 0.05) in SOD 
activities between 0 and 24 h CUS groups in any of the 
three brain regions. 
CAT: There was a significant decrease in 
CAT activity in the frontal cortex (F2,i5 = 11.31, 
P < 0.001, P < 0 . 0 1 ) , striatum (F2,i5 = 6.66, 
P < 0 . 0 5 , P < 0 . 0 1 ) , and hippocampus 
(F2,i5= 10.06, P < 0 . 0 1 , P<0 .05 ) in both die 0 
and 24 h CUS groups as compared to the NS 
control group. Furthermore, there were no 
significant differences (P > 0.05) in CAT activities 
between 0 and 24 h CUS groups in any of the three 
brain regions. 
GSH-Px: There was a significant increase in GSH-
Px activity in the frontal cortex (F2,i5 = 4.38, 
P < 0 . 0 5 ) and hippocampus (F2,i5 = 9.10, 
P < 0 . 0 1 , P<0 .05) in both the 0 and 24 h CUS 
groups, with no significant differences in the striatum 
(F2,i5 = 0.22, P > 0.05) compared to die NS control 
group. Furthermore, post hoc tests (Newman-Keuls) 
revealed no significant differences (P > 0.05) in GSH-
Px activity between 0 and 24 h CUS groups in any of 
the three brain regions. 
Effect of CUS on non-enzymatic antioxidant 
concentrations in selected brain regions 
As shown in Table II, the non-enzymatic antiox-
idant defense marker GSH was significantly 
depleted in the 0 and 24 h CUS groups in the 
frontal cortex (Fj , , , = 13.46, P < 0.01, P < 0.05), 
striatum (F2,i5 = 11.34, P < 0 . 0 1 ) , and hippo-
campus (F2,i5 = 26.84, P < 0.001) compared to 
the NS control group. Furthermore, post hoc 
tests (Newman-Keuls) revealed no significant 
differences (P>0 .05 ) in GSH concentrations 
between 0 and 24 h CUS groups in any of the 
three brain regions. 
Table II. CUS induced changes in antioxidant defense system and lipid peroxidation in the frontal cortex, striatum, and hippocampus. 
Brain regions 
Frontal cortex 
Striatum 
Hippocampus 
Groups 
NS 
CUS (Oh) 
CUS (24 h) 
NS 
CUS (Oh) 
CUS (24 h) 
NS 
CUS (Oh) 
CUS (24 h) 
SOD 
(U/mg protein) 
5.55 ± 0.51 
3.43 ± 0.23* 
3.83 ± 0.69* 
7.853 ± 1.07 
5.14 + 0.44* 
5.41 ±0.34* 
4.21 ±0.34 
1.66 ±0.27*** 
2.24 ± 0.24*** 
CAT 
(U/mg protein) 
0.23 ± 0.02 
0.15 ± 0.01*** 
0.18 ± 0.01** 
0.17 ±0.017 
0.10 ±0.005* 
0.11 ± 0.017** 
0.14 ±0.010 
0.09 ± 0.004** 
0.11 ± 0,007* 
GSH-Px 
(U/mg protein) 
0.025 ± 0.003 
0.041 ± 0.004* 
0.039 ± 0.005* 
0.036 ± O.OOI 
0.041 ± 0.004 
0.039 ± 0.005 
0.034 ± 0.001 
0.045 ± 0.002** 
0.039 ± 0.002* 
GSH 
((iM/mg protein) 
88.67 ±7.11 
51.5 ±4.24*** 
65.5 ± 3.17** 
160.3 ±9.35 
90.5 ± 5.94** 
101.2 ± 15.1** 
85.5 ±4.01 
40.67+4.4*** 
53.01 ±4.95*** 
MDA 
(nM/mg protein) 
6.71 ±0.45 
16.5 ± 2.29** 
12.9 ± 1.24* 
19.83 ±2.2 
49.17 ± 5.82** 
46.67 ± 5.75** 
12.34 ± 1.69 
32.01 ± 3.71*** 
29.33 ± 3.08*** 
Data arc expressed as mean ± SEM; n = 6 rats per group, representing the changes in the antioxidant defense system and lipid peroxidation in 
the frontal cortex, striatum, and hippocampus of control (non-stress, NS) and stressed (0 and 24 h after CUS) groups. *P < 0.05, **P < 0.01, 
***/'< 0.001 vs. NS control group (ANOVA, Newman-Keuls/>a« hoc test). 
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Effect ofCUS on lipid peroxidation in selected brain regions 
Table II shows that there was a significant increase in 
lipid peroxidation, expressed as increased MDA 
concentrations, in both the 0 and 24 h CUS groups 
in the frontal cortex (Fj,!? = 10.51, P < 0 . 0 1 , 
P<0 .05) , striatum (F2,i5 = 11.05, P<0 .01) , and 
hippocampus (F2,i5 - 13.08, P < 0.001) compared 
to the NS control group. Furthermore, there were no 
significant differences (P > 0.05) in MDA concen-
trations between 0 and 24 h CUS groups in any of the 
three brain regions. 
Discussion 
The brain monoamine and antioxidant defense 
systems interact closely with the HPA-axis and are 
implicated in the acquisition and maintenance of 
psychological and physical stress responses Gankord 
and Herman 2008; Zafir and Banu 2009). In the 
present study, we selected CUS to reduce both the 
anticipation of being exposed to stress as well as 
adaptation, which may occur due to repeated 
exposure to the same stressor. Although the duration 
of the experiment employing CUS was quite short 
(7 days), the number and intensity of stressors used 
were designed to compensate for this. CUS disrupts 
the adaptation response and leads to behavioral 
depression (Katz et al. 1981), and other biochemical 
perturbations (Rai et al. 2003); thus, it is considered 
to be a clinically relevant model for humans. 
This study demonstrated that CUS led to a decrease 
in DA and 5-HT concentrations in the frontal cortex, 
striatum, and hippocampus. IVloreover, the alterations 
in monoamine metabolite concentrations and con-
sequent turnover ratios did not follow a specific 
pattern indicating a region-specific effect of CUS. 
Interestingly, the pattern of CUS-induced changes 
from the control state immediately after the last 
stressor and 24 h later were similar, indicating that 
these changes are due to the chronic exposure to 
various stressors and are not merely acute effects of the 
last stressor. In the striatum and frontal cortex, 
decreased DA concentrations were accompanied by 
increased DOPAC and HVA concentrations, indicat-
ing increased conversion of DA to its metabolites in 
response to CUS. The increased DA turnover ratio 
in these regions may reflect either the increase in 
catabolism of DA by intraneuronal monoamine 
oxidase (MAO) to DOPAC and/or by catechol-0-
methyl transferase to HVA (Maura et al. 1978; 
Bhutani et al. 2009). CUS increased DA metabolism 
in the frontal cortex and striatum which was evident 
both immediately and 24 h after the last stress 
exposure, indicating the prolonged effect of CUS. It 
is also proposed that decreased monoamine concen-
trations are related to increased stress sensitization 
and their preferential and higher utilization (Gamaro 
et al. 2003; Bekris et al. 2005). However, die 
hippocampus has a rich cholinergic innervation and 
a reciprocal relation exists between acetylcholine and 
DA responses in brain (Vakalopoulos 2006). Hence, 
the decreased DA levels in the hippocampus could be 
linked with a possible decrease in cholinesterase 
activity (Das et al. 2005). The decrease in levels of 
5-HT and its metabolite during CUS is in agreement 
with a study in which reduction of 5-HT in brain alters 
responses to chronic social stress in rats, suggesting a 
role for 5-HT in such a process (Berton et al. 1998; 
Chung et al. 1999). The hippocampus has the highest 
number of corticosteroid receptors as well as 5-HT 
innervation, and expresses a variety of 5-HT receptors 
(Chalmers et al. 1993; Jankord and Herman 2008). 
The increased plasma corticosterone levels during 
CUS (Sheikh et al. 2007) and the altered serotonergic 
transmission might have relevance to the GC feedback 
mechanism regulating the HPA-axis. The results 
obtained in the present study may differ from earlier 
observations (Torres et al. 2002; Harvey et al. 2006; 
Vidal et al. 2007), due to differences in duration, 
intensity, and predictability of stressors, which are 
important determinants of stress-induced brain 
responses. The differential monoaminergic responses 
might also be attributed to regional variations in their 
levels of distribution, synthesis, and degradation. 
CUS also significantly reduced the activities of SOD 
and CAT in all three selected brain regions, and these 
changes persisted for at least 24 h after the exposure to 
the last stressor. Similar decline in the activities of 
SOD and CAT by chronic stress has been reported in 
earlier studies (Zafir and Banu 2007). Chronic stress 
has been shown to increase the vulnerability of 
different brain regions, particularly the hippocampus, 
by altering the antioxidant defense capacity through 
the mediation of GCs (Mcintosh et al. 1998; Patel 
et al. 2002). We found an increase in the activity of 
GSH-Px in the frontal cortex and hippocampus, with 
reduced GSH content in all three brain regions in the 
CUS groups. Increased GSH-Px activity observed in 
our study also indicates the increase in cellular 
peroxide levels. However, in the striatum, GSH-Px 
activity remained unaltered. This differential effect 
may arise from the differences in regional antioxidant 
buffering capacities or differential susceptibilities to 
oxidative stress. Decreased GSH levels could be 
explained on the basis that loss of GSH may occur 
during an oxidative stress event due to its increased 
rate of utilization (Sahin and Gumuslu 2007; Zafir 
and Banu 2007). The significant elevation of the lipid 
peroxidation marker (MDA) level in the CUS group in 
all three brain regions is in agreement with 
previous reports (Fontella et al. 2005; Sahin and 
Gumuslu 2007). 
We found simultaneous alterations in both mono-
amine and oxidative processes, pointing toward the 
possibility of interconnection between the two systems 
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during CUS. This hypothesis is strengthened by other 
reports showing some direct and indirect involvement 
of the production of free radicals in the brain with 
catecholamine metabolism (Venarucci et al. 1999). 
Elevated catecholamine levels may undergo auto-
oxidation, in which electrons are generated that in 
turn can produce reactive oxygen species (ROS) 
(Carpagnano et al. 2003). DA forms ROS through its 
metabolism by MAO and by auto-oxidation. Molecu-
lar oxygen can react with DA forming quinones and 
semiquinones, which can further deplete GSH with 
simultaneous generation of ROS (Miyazaki and 
Asanuma 2008). Another study showed a decrease 
in CAT activity in the frontal cortex and striatum after 
cocaine administration, suggesting the mediation of 
distinct monoamine systems (Macedo et al. 2005). 
These results support the hypothesis of Siraki and 
O'Brien (2002) that biogenic amines form pro-
oxidant radicals. The increase in DA turnover and 
metabolism might produce H2O2 through MAO 
activity (Miyazaki and Asanuma 2008), which could 
be responsible for neuronal membrane lipid peroxi-
dation observed in our study. 
The present study demonstrates increased oxidative 
load during CUS in all the selected brain regions. 
Considering that the striatum and frontal cortex have 
a high DA content, its oxidation could contribute to a 
greater oxidative burden in these regions. However, 
the results indicate that the oxidative load during CUS 
was generally similar in all three brain regions. Also, 
there were no significant changes in the levels of 
monoamine metabolites in the hippocampus. Thus, it 
could be predicted that increased oxidative load 
during stress may not always be reflective of the pro-
oxidant effect of metabolites and/or altered neuro-
transmitter metabolism. Interestingly, some workers 
(Mcintosh et al. 1998; Jankord and Herman 2008) 
have suggested that the hippocampus is susceptible to 
oxidative damage because of its high sensitivity toward 
increased corticosterone levels (Mcintosh et al. 1998; 
Jankord and Herman 2008). Thus, during CUS, the 
alterations in the antioxidant status in the hippo-
campus might be related to the increased corticoster-
one levels. 
Altered 5-HT transmission might also contribute to 
oxidative load during CUS in different brain regions 
as other reports (Wrona and Dryhurst 1998; Siraki 
and O'Brien 2002; Kanarik et al. 2008) also 
highlighted the potential neurotoxic role for a 
group of 5-HT metabolites arising from superoxide-
mediated oxidation. Thus, the perturbed central 
monoamine response and metabolism could amplify 
the oxidative load during CUS, in a region-specific 
manner. Furthermore, ROS influence brain functions 
by altering signal transduction across membranes and 
changing the properties of several receptors (Haile 
et al. 1992; Tang and Aizenman 1993). Thus, the 
different levels of free radicals in various brain regions 
generated after exposure to chronic stress may 
determine modulation of neurotransmitters either 
through the changes in neurotransmitter levels and/or 
by effects on receptor functioning. Thus, both the 
monoamine and oxidative system may influence each 
other's functioning. 
The present findings support the hypothesis that 
neurotransmitter intervention in oxidative damage 
should be considered seriously; however, understand-
ing its precise mechanisms warrants further studies. 
Our study contributes to the understanding of the 
neurochemical and antioxidant defense system inter-
actions that are possibly involved in the biological 
basis of central stress-induced disorders such as 
depression and other neurodegenerative conditions. 
Future studies are required to explore these integrated 
dual mechanisms operating during stressful con-
ditions, following treatment with specific monoamine 
agonists and/or antagonists. Therefore, current 
studies suggest implications for pharmacological 
interventions targeting both central monoamines and 
cellular antioxidants as a potential stress management 
strategy for protecting against stress-induced brain 
disorders. 
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Anti-Stress Constituents of Evolvulus alsinoides: An Ayurvedic Crude 
Drug 
Prasoon GUPTA," AKANKSHA," Kiran Babu SIRIPURAPU,* Ausaf AHMAD,* Gautam PALIT,* 
Ashish ARORA,'' and Rakesh MAURYA*-" 
"Division of Medicinal and Process Chemistry. Central Drug Research Institute; ''Division of Pharmacology, Central 
Drug Research Institute; and 'Division of Molecular and Structural Biology, Central Drug Research Institute; Lucknow-
226 001, India. Received January 15, 2007; accepted February 10, 2007 
Bioactivity-guided purification of n-BuOH soluble fraction from the ethanol extract of Evolvulus alsinoides 
resulted in the isolation of two new compounds, 2,3,4-trihydroxy-3-methylbutyl 3-[3-hydroxy-4-(2,3,4-trihydroxy-
2-methylbutoxy)-phenylI-2-propenoate (1) and 1,3-di-O-cafreoyl quinic acid methyl ester (2) along with six 
known compounds, caffeic acid (3), 6-methoxy-7-0-^glucopyranoside coumarin (4), 2-C-methyl erythritoi (5), 
kaempferol-7-O-^glucopyranoside (6), kaempferol-3-O-^glucopyranoside (7) and quecetine-3-0-)?-glucopyra-
noside (8). The structure of new compounds 1 and 2 were elucidated by spectroscopic analysis, while known com-
pounds were confirmed by direct comparison of their NMR data with those reported in literature. This is the 
first report of the presence of phenolic constituents in Evolvulus alsinoides. The isolated compounds 1—5 and 8 
were screened for anti-stress activity in acute stress induced biochemical changes in adult male Sprague-Dawley 
rats. Stress exposure has resulted in significant increase of plasma glucose, adrenal gland weight, plasma creatine 
kinase (CK), and corticosterone levels. Compound 1 displayed most promising antistress effect by normalizing 
hyperglycemia, plasma corticosterone, CK and adrenal hypertrophy, while compounds 2 and 3 were also effec-
tive in normalizing most of these stress parameters, however compounds 4, 5 and 8 were ineffective in normaliz-
ing these parameters. 
Key words Evolvulus alsinoides; Shankhpuspi; Convolvulaceae; phenyl propanoid; flavonol glycoside; quinic acid; erythritoi 
Physiological adaptation during stressful conditions is de-
fined as a biochemical change in an organism that results 
from exposure to certain environmental conditions or stres-
sors and generates a more effective response to their survival. 
Long-term stress can induce a range of disorders like hyper-
tension, coronary heart disease,'* gastric ulcers,^ * immuno-
suppression, '^ metabolic disorders like diabetes,''' reproduc-
tive dysfunction,^ ' mental depression, memory loss and host 
of other diseases. '^ Due to the nonspecific nature of the stress 
pathogenesis, a drug having central and peripheral activity is 
needed to combat stressfijl conditions. Since ancient times 
therapeutic approach to combat stress has involved utiliza-
tion of substances from natural origin. Pharmacological in-
vestigations have shown that the basic effect of Panax gin-
seng, Elutherococciis senticosus and Rhodiola rosea, is their 
ability to increase non-specific resistance of the organism to 
various untoward influences." Initial studies on plants origi-
nating from folk medicine along with an exponential increase 
in knowledge regarding the interactions among components 
of the stress system have encouraged various investigators to 
evaluate the potential of plant derived anti-stress agents for 
usage in modem day medicine. Further enrichment of the 
study on plant derived adaptogens was enabled by the sub-
stantial work carried out on plants such as Ocimum sanc-
tum,^^ Emblica officinalis^^ Bacopa monniera,^^^ Ginkgo 
biloba^^^ and Withania somnifera}^^ In our continuing efforts 
to identify biologically active secondary metabolites, we 
have initiated our study on Evolvulus alsinoides to identify 
anti-stress agents. 
Evolvulus alsinoides hxm. (Family: Convolvulaceae) com-
monly known as Shankhpuspi in India. It is an important me-
dicinal plant that grows in the open and grassy places almost 
throughout the India and subtropical countries of the 
worid.'^''*' Plant extracts have been used in traditional medi-
cine for treatment of bronchitis, asthma'''''^' and brain disor-
ders like insanity, epilepsy, nervous disability, and scrof-
ula.'''~'" Evolvulus alsinoides is well known for its memory 
enhancing property in traditional Indian system of medicine 
and extensively commercialized as nervin tonic in Asian 
countries. Evolvulus alsinoides extracts have exhibited an-
tioxidant,'*' anti-ulcer,'" and immunomodulatory activi-
ties.^ "' Eariy phytochemical studies of this species resulted in 
the isolation and identification of chemical constituents such 
as triacontane, pentatriacontane, ;8-sitosterol and two alka-
loids betaine and shankpushpin.^'"""' Four unidentified alka-
loids A, B, C and evolvine have also been described in litera-
jm-g 2],24) IJJ jjjg yjg^ Q^  jjg importance in traditional medici-
nal system, no substantial phytochemical and pharmacologi-
cal works have been reported. In addition, recently we have 
disclosed adaptogenic and anti-amnesic properties of ethano-
lic extract of Evolvulus alsinoides.^^^ Further phytochemical 
investigation led to the isolation of two new compounds 
evolvoids A (1) and B (2) along with six known compounds 
(3—8). The structures of isolated compounds were eluci-
dated on the basis of extensive spectroscopic analysis. The 
anti-stress activity of compounds 1—5 and 8 were evaluated 
in acute stress induced biochemical changes in adult male 
Sprague-Dawley rats. In the present study, we have described 
isolation, structure elucidation and anti-stress activity of 
these compounds. 
Results and Discussion 
Following the extraction of whole plant of Evolvulus alsi-
noides with ethanol and successive partitioning of the dried 
extract in HjO/CHClj, HjO/w-BuOH, significant anti-stress 
activity of the n-BuOH fraction was observed. However, 
CHCI3 soluble fraction showed insignificant anti-stress activ-
ity while aqueous fraction was found to be inactive. The ac-
' To whom correspondence should be addressed, e-mail: mauryarakesh(§rediffmail.com ) 2007 Pharmaceutical Society of Japan 
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OH H 3 C 0 ^ ^ 
H O - OH 
6. R| = R3 = R^  = H, R2 = p-glucopyranose 
7. Ri = P-glucopyranose, R^ = R3 = R4 = H 
8. R, = p-glucopyranose. Rj = R< = H, R3 = OH 
Fig. 1. Structural Formula of Isolated Compounds (1—8) 
tive fraction was then subjected to sequence of normal- and 
reverse-phase column chromatography, to yield two new 
compounds 1 and 2 along with six known compounds. The 
structure of new compounds were established using chemical 
and spectroscopic (FAB-MS, 'H-NMR, '^ C-NMR, COSY, 
HSQC, HMBC) studies. 
Compound 1 was obtained as yellow solid, possessing ele-
mental composition CI9H280[Q as concluded from ESI-MS 
pos. spectrum (m/z at 417 [M+H]') and HR-ESI-MS 
416.1709 (Calcd 416.1683). The IR spectrum of 1, displayed 
absorption bands for a-p unsaturated C=0 (1670cm"'), 
aromatic ring (1483, 1341 cm~') and polyhydroxyl group at 
(3340 cm"'). The UV absorption bands at (324,239, 213 nm) 
were characteristic of caffeoyl unit.^'' The 'H- and '^ C-NMR 
spectra (Table 1) displayed chemical shift pattern of caffeoyl 
moiety, showed olefinic protons at 6„ 7.61 (d, J= 15.8 Hz, H-
3; 5c 147.0) and 6.31 (d, y=15.8Hz, H-2; 5c 115.1). The 
presence of three proton signals at 5^ 7.06 (brs, H-5), 6.97 
(d, J=8.2Hz, H-9) and 6.79 (d, J=8.2Hz, H-8) in the 'H-
NMR spectrum, and resonance of typical carbons at 5c 127.1 
(C-4), 115.1 (C-5), 149.6 (C-6), 147.1 (C-7), 116.4 (C-8) and 
122.9 (C-9) including a-/3 unsaturated carbonyl carbon at 
169.5 (C-1) indicated presence of 6,7-disubtituted caffeoyl 
moiety in the molecule. In addition, the existence of two tet-
rose sugars (erythritol) were inferred from the 'H- and '^C-
NMR spectrum,^'' which showed presence of four oxy-
genated methylenes, two methines, two methyls and two oxy-
genated quaternary carbons. Acid/base hydrolysis of 1 af-
forded erythritol sequentially, which was confirmed by co-
TLC with authentic sample 5 isolated from same plant. The 
'H- and '^ C-NMR signals of both erythritol units were as-
signed using 'H, '^ C, HSQC, HMBC and ' H - ' H COSY 
NMR spectral data. The first erythritol unit was resonated as 
ABX and AB system at 5„ 4.53 (dd, J= 11.2, 6.0Hz, H-l'a), 
4.20 (dd, y= 11.2,2.4 Hz, H-1 'b), 3.87 (dd, 7=6.0,2.4 Hz, H-
2') and 5^ 3.49 (d, J= 11.0Hz, H-4'a), 3.63 (d, 7= 11.0 Hz, 
H-4'b) and corresponding carbon signals were appeared at 
5c 67.0 (C-r), 73.6 (C-2'), 68.4 (C-4') including quaternary 
carbon at 5c 77.9 (C-3'). The methyl signal was assigned at 
5H 1.20 (s, H-5'; 5c 19.2). 'H- and ''C-NMR spectrum ex-
hibited second erythritol unit at S^^ 4.25 (d, J= l 1.4 Hz, H-
l"a), 4.14 (d, 7=11.4 Hz, H-l"b); 5c 70.0 (C-1") as AB spin 
system and 5,, 3.65 (brd, J=6.8Hz, H-3"); 5c 75.6 (C-3"), 
Table 1. NMR Spectroscopic Data for Compound 1 
1 (CDjOD)"' 
5H(mu!t.,yinHz) S^ COSY HMBC 
1 
2 
3 
4 
5 
6 
7 
8 
9 
I'a 
I'b 
2' 
3' 
4'a 
4'b 
5' 
l"a 
l"b 
2" 
3" 
4"a 
4"b 
5" 
6.31 
7.61 
(d, 15.8) 
(d, 15.8) 
7.06 (brs) 
6.79 
6.97 
4.53 
4.20 
3.87 
3.49 
3.63 
1.20 
4.25 
4.14 
3.65 
3.91 
3.61 
1.17 
(d, 8.2) 
(d, 8.2) 
(dd, 11.2,6.0) 
(dd, 11.2,2.4) 
(dd, 6.0, 2.4) 
(d,11.0) 
(d,n.O) 
(s) 
(d,11.4) 
(d,n.4) 
(brd, 6.8) 
(dd, 11.2,6.8) 
(brd, 11.2) 
(s) 
169.5 
115.1 
147.0 
127.1 
115.1 
149.6 
147.1 
116.4 
122.9 
67.0 
73.6 
77.9 
68.4 
19.2 
70.0 
74.6 
75.6 
63.6 
19.3 
I'b, 2' 
I'a, 2' 
I'a, I'b 
4'b 
4'a 
I'T) 
l"a 
4"a 
3", 4"b 
4"a 
C-1, 4 
C-1,5,9 
C-3, 7,9 
C-4, 6, 9 
C-3, 5,7, 8 
C-1, 3' 
C-1,3' 
C-4', 5' 
C-2', 3', 5' 
C-2', 5' 
C-2', 4' 
C-7, 3", 5" 
C-7, 3", 5" 
C-1", 4", 5" 
C-2'', 3" 
C-2" 
C-2", 4" 
a) 'H-NMR: 200 MHz, "C-NMR: 300 MHz, 2D NMR: 600 MHz (TMS a,s internal 
standard), chemical shifts, multiplicity and coupling constants (7, Hz) were assigned by 
means of 'H, "C and 2D NMR data. 
3.91 (dd,y=11.2, 6.8 Hz, H-4"a), 3.61 (brd, 7=11.2 Hz, H-
4"b); 5c 63.6 as ABX spin system, whereas methyl signal 
was assigned at 5H 1.17 (s, H-5"); 5c 19.3 (C-5"). The qua-
ternary carbon resonated at 5c 74.6 (C-2"). HMBC spectrum 
was utilized to identify the position of attachment (Fig. 2); it 
gave useful correlation between Hab-l'/C-l, 2', 3'; H-2'/C-
1', 4', 5'; H,b-4'/C-5', 2' and H^.-V'/C-l, 2", 3", 5"; H,,-
4"/C-3", 2"; H-5"/C-l", 2", 3" indicated that first eythritol unit 
was attached to acid carbonyl (C-1) with ester linkage and 
second unit was attached to aromatic hydroxyl group (C-7) 
with ether linkage. The D-configuration of erythritol was de-
termined by optical rotation [a]^' +24.5° (c=0.02, H p ) and 
supported with the data available in literature.^'' Thus, com-
pound 1 was characterized as a 2,3,4-trihydroxy-3-methyl-
butyl 3-[3-hydroxy-4-(2,3,4-trihydroxy-2-methyl-butoxy)-
phenyl]-2-propenoate, a new compound named evolvoid A. 
Compound 2 was obtained as amorphous powder with few 
complex impurities. Our repeated effort to obtain pure com-
pound by column chromatography was unsuccessful. IR 
spectrum exhibited absorption bands for aromatic ring (1604, 
1514cm""'), a-/3 unsaturated carbonyl (1672cm"') and ester 
(1737 cm"'') function in the molecule. The 'H-NMR of 2 
(impure sample) showed presence of caffeoyl unit, ester 
methyl and few aliphatic signal although acetyl signal were 
absent in the spectrum. Acetylation followed by chromatog-
raphy led to isolation of pure compound 2a as polyacetate. 
However in nature this exists as non-acetylated compound. 
Compound 2a exhibited molecular ion peak m/z at 783 
[M+H]"*^  in ESl-MS spectrum, corresponding to molecu-
lar formula CjjHjgOig suggested by HR-ESI-MS 782.2073 
(Calcd 782.2058). 
Analysis of 'H- and "C-NMR data guided by COSY spec-
trum (Table 2) displayed presence of two overiapped caffeoyl 
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units and an oxygenated cyclohexyl ring. On the basis of 
HMBC, HSQC and COSY spectral data each signals of cy-
clohexyl ring were assigned, three mutual coupled acetylated 
methine signals at 6^ 5.28 (ddd, J=3.3, 7.1, 9.2 Hz, H-3; ^e 
68.4), 5.67 (dd, y=7.2, 9.2 Hz, H-4; 5c 70.0), 5.60 (ddd, 
J=4.5, 5.4, 7.2 Hz, H-5; 5c 71.2), two methylenes at 5H 2.26, 
2.63 (m, H-2a,b; 5c 37.7) and 5„ 2.67, 2.78 (m, H-6a,b; 5c 
37.5), separately coupling with H-3 and H-5 protons. An 
oxygenated quaternary carbon resonated at 5Q 80.4 (C-1). 
Additional signal in NMR spectrum at 5^ 172.3 (C=0), 
gave HMBC correlations with H-2, 6 and methyl group at 5^ 
3.73 (s, Sc 53.4). Other important HMBC correlations, H-
2/C-3, 4, 6; H-3/C-1, 5; H-4/C-2, 6 and H-5/C-1, 3, 4 con-
Table 2, NMR Spectroscopic Data for Compound 2a 
Position 
1 
2a 
2b 
3 
4 
5 
6a 
6b 
7 
COjCHj 
r 
2' 
3' 
4' 
5' 
6' 
r 
8' 
9' 
1" 
2" 
3" 
4" 
5" 
6" 
7" 
8" 
9" 
Ar-OCOCHj 
Al-OCOCHj 
(5H (mult., y in Hz) 
2.63 (m) 
2.26 (m) 
5.28 (ddd, 3.3, 7.1,9.2) 
5.67 (dd, 7,2,9.2) 
5.60 (ddd, 4.5,5.4, 7.2) 
2.67 (m) 
2.78 (m) 
— 
3.73 (s) 
— 
6.51 (d, 15.9) 
7.69 (d, 15.9) 
— 
7.58 (brs)" 
— 
— 
7.27 (d, 8.7)'' 
7.58 (d, 8.7)*' 
— 
6.57 (d, 15.9) 
7.74 (d, 15.9) 
— 
7.58 (brs)"' 
— 
— 
7.29 (d, 8.7)''' 
7.58 (d, 8.7)*' 
2.30 (s), 2.3 l(s) 
2.00 (s), 2.07 (s) 
2a (CDjOD)"' 
Sc 
80.4 
37.7 
— 
68.4 
70.0 
71.2 
37.5 
— 
172.3 
53.4 
167.1'" 
119.5" 
144.2 
134.4 
124.4 
147.3 
147.7 
125.3 
127.8 
167.2'" 
119.6" 
145.5 
134.4 
124.4 
147.3 
147.7 
125.3 
127,8 
171.6, 
172.3 
169.7, 
169.9 
COSY 
2b, 3 
2a, 3 
2a, 2b, 4 
3,5 
4,6a, 6b 
5,6b 
5,6a 
— 
— 
3' 
2' 
— 
— 
— 
— 
9' 
8' 
— 
3" 
2' 
— 
— 
— 
— 
9" 
8" 
— 
HMBC 
C-3,4,6,7 
— 
C-1, 5,1" 
C-2,6 
C-1,3,4 
C-1,2,4, 7 
— 
— 
C-7 
— 
r , 4 ' 
r , 5 ' , 9 ' 
— 
3', 7',9' 
— 
— 
4', 6' 
3 ' ,5 ' ,7 ' 
1",4" 
1",5",9" 
— 
3", 7", 9" 
— 
— 
4", 6", r 
3", 5", 7" 
a) 'H-, "C- and 2D NMR: 300 MHz, chemical shifts, multiplicity and coupling con-
stants (J, Hz) were assigned by means of 'H-, "C- and 2D NMR data, b) Overlapped 
signals, c—e) interchangeable within the row. 
firmed cyclohexyl ring as quinic acid methyl ester (Fig. 2). 
The large coupling values of H-3, 4, 5 protons clearly indi-
cated their axial orientation in the ring. The J values of sub-
stituted cyclohexane has shown to be in the range of ca. 
10 Hz for axial-axial, ca. 5 Hz for axial-equatorial and ca. 
2—3 Hz for equatorial-equatorial.^^* The J values were 
slightly lower than would be expected for a perfect chair con-
formation, therefore, quinic acid moiety of 2a may exist in a 
skewed/boat form. The stereochemistry at C-1 could not be 
decided by the above method, therefore, relative stereochem-
istry deduced by the NOESY experiments (Fig. 2). Since 
axial proton H-3 and H-5 gave diagnostic NOE cross peaks 
with CO2CH3, indicated their axial orientation in the ring. 
Such correlation is possible only if the orientation of C-1 OH 
group is equatorial. Other diagnostic cross peaks (Fig. 2) 
confirmed the relative stereochemistry of cyclohexyl ring in 
2a. Presence of two caffeoyl units confirmed by two set of 
olefinic protons at 5^^ 7.69 (d, 7= 15.9Hz, H-3'); 6.51 (d, 
y= 15.9 Hz, H-2') and 5^ 7.74 (d, 7= 15.9 Hz, H-3"); 6.57 (d, 
J= 15.9 Hz, H-2"). The J values 15.9 Hz confirmed both are 
the trans isomers. Other ABX aromatic protons of caffeoyl 
units were overiapped and assigned respectively (Table 2). 
One caffeoyl unit must be present at C-3 with ester linkage, 
as evident from HMBC cross peak between H-3/C-r' (167.2) 
but no cross peak observed for second caffeoyl unit indicated 
that it must be attached to C-1 (OH). This was also supported 
by HMBC correlation of H-4 and H-5 with acetyl carbonyl 
5c 172.3 and 171.3 (due to acetylation, Fig. 2). Thus, above 
data confirmed the structure of evolvoid B hexaacetate repre-
sented by structure 2 a and the corresponding parent structure 
by 2, which has not been previously reported. 
The known compounds 3—8 were characterized as 3-(3,4-
dihydroxyphenyl)-2-propenoic acid (caffeic acid, 3),^" 6-
methoxy-7-(9-j3-glucopyranoside coumarin (4),^°' 2-C-methyl 
erythrifo! (5),"* kaempferoI-7-0-)3-gIucopyranoside (6),^" 
kaempferol-3-C>-j3-gIucopyranoside (7),^ '^ and quecetine-3-
0-j3-glucopyranoside (8),^ '^ by direct comparison of NMR 
data with those reported in literature. All the compounds 
were isolated first time from this plant. 
Isolated compounds 1—5 and 8 were screened for anti-
stress activity in acute stress (AS) model at the dose of 
40 mg/kg body weight, as shown in Table 3. A significant in-
crease (/7<0.001) in the adrenal gland weight after AS was 
observed when compared to non-stressed (NS) group. Com-
pound 1 and standard drug powder of the roots of Panax 
quinquifolium (PQ) were significantly (p<0.01) effective in 
reducing the stress induced adrenal hypertrophy. The plasma 
creatine kinase (CK) and glucose levels were also increased 
by AS significantly (p<0.00\) when compared to NS con-
Fig. 2. Key HMBC (->) and NOESY (--) Correlation of Compounds 1 and 2a 
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Table 3. Effect of Pure Compounds I—5, 8 and PQ on Acute Stress In-
duced Changes in Adrenal Gland Weight, Glucose, Creatine Kinase and 
Corticosterone Levels 
Groups Adrenal gland Glucose CK Corticosterone 
(dosemg/lcg/7.0.) (mg/kgwt) (mg/dl) (mg/dl) (ng/ml) 
NS 
AS-l-Vehicle 
COMP-1 (40) 
COMP-2 (40) 
COMP-3 (40) 
COMP-4 (40) 
COMP-5 (40) 
COMP-8(40) 
PQ(IOO) 
6.17 ±0.32 
9.93±0.84** 
7.23±0.41« 
8.33+0.35 
9.60±0.4I 
II.15±0.78 
11.41 ±0.48 
11,51 ±0.48 
7.33+0.44' 
81.5±3.37 
134.7±4.68*« 
78.I7±2.88* 
96.33±5.74» 
97.33±7.14* 
I23.7±6.83 
108.7+6.82 
I21.2±10.21 
86.5±3.51» 
297.5 ±17.55 
1115+29.43" 
485.3±85.I2* 
600+51.81* 
962.7±61.23 
1128+50.38 
1090±62.13 
1036±88.86 
493.3+49.96' 
244.5 ±15.43 
477.2+22.2" 
213.3±21.16' 
320±24.21' 
301±22.5I* 
468±30.69 
476.2+31.69 
456.5 ±20.98 
238.5± 13.59' 
Mmean±S.E.M of changes in adrenal gland weight, plasma glucose, creatine kinase 
and corticosterone. The stress group was compared with non-stress control group and 
the drug treated groups were compared with acute stress group. "p<0.001 when com-
pared to NS control and •p<0.01 when compared with acute stress control group. 
trol. Pretreatment with compounds 1, 2 (/7<0.01) and PQ 
(p<0.01) were effective in reducing the AS-induced increase 
in CK levels and compounds 1, 2 and 3 in reducing increased 
glucose levels. Similarly AS {p<0.00l) exposure resulted in 
increased plasma corticosterone when compared to NS con-
trol. Pretreatment with compounds 1, 2 and 3 {p<O.Ol) and 
PQ (/)<0.01) significantly reduced the increase in corticos-
terone levels. 
In conclusion, compound 1 has shown significant 
{p<0.0\) anti-stress activity by normalizing hyperglycemia, 
corticosterone level, creatine kinase and adrenal hypertrophy. 
Compound 2 also shown anti-stress activity but having no ef-
fect on adrenal hypertrophy similar is the case with com-
pound 3, which was found to be effective in some of the 
stress parameters but showing no effect on adrenal hypertro-
phy and increased CK levels. The compounds 4, 5 and 8 
were found to be ineffective in normalizing these parameters 
(Table 3). The biological activity profiles of compounds 1, 2 
and 3 are worthy for further investigation to develop anti-
stress drug. 
Experimental 
General Procedures Melting points (uncorr.) were recorded on a Com-
plab melting point apparatus. IR spectra were recorded on a Perkin-Elmer 
RX-1 spectrophototneter using either KBr pallets or in neat. UV spectra 
were obtained on a Perkin Elmer A-15 UV spectrophotometer, optical rota-
tions were measured on a Perkin-Elmer Model 241 digital polarimeter. 'H-
and '^ C-NMR spectra were recorded on an Avance DPX-200 and Bruker 
DRX 300 MHz spectrometer and chemical shift are expressed as 5 (ppm) 
values. The abbreviations of 'H-NMR signals pattern are as follows: s, sin-
glet; d, doublet; dd, double doublet; ddd, doublet of doublet of doublet; t, 
triplet; m, multiplate. Proton detected heteronuclear correlations were meas-
ured using HSQC and HMBC. 2D spectnuns were recorded on Varian 
Inova-600MHz NMR and Bruker DRX 300 MHz spectrometer FAB-MS 
were carried out on Jeol SX 102/DA-6000 mass spectrometer using m-nitro 
benzyl alcohol as matrix. ESI-MS spectra were obtained on LCQ Advantage 
Max Thermo Finnigan. Elemental analyses were obtained in a Carlo-Erba-
1106 CHN elemental analyzer. HR-ESI-MS analysis was carried out on 
Jeol-MS 600H instrument. Preparative HPLC were performed on Shimadzu 
CLC-Octa decyl silane RP-18 (ODS) column with (20 mm 10X25 cm 
length); 8ml/min flow rate, PDA UV A 254 and 220 nm as detector Column 
chromatography was performed using silica gel (60—120 and 230—400 
mesh); TLC: pre-coated silica gel plates 60 Fj54 or RP-18 F^ j^  plates with 
0.5 or 1 mm film thickness (Merck). Spots were visualized by UV light or by 
spraying with HjSOj-MeOH, anisaldehyde-H^SOj reagents. 
Plant Materials The plant material was collected from district 24-Par-
ganas, West Bengal (state of India) in the month of September 2002 and 
identified as Evolvulus alsinoides (LINN.) by Botany Division of CDRI and 
preserved with voucher specimen number 2659 in the herbarium. 
Extraction and Isolation Powdered Evolvulus alsinoides whole plant 
(17 kg) was extracted with ethanol (each 301 for 24hX5) at room tempera-
ture. The resulting extracts were combined and concentrated under reduced 
pressure using rotavapor at 40 "C, to give a dark green extract (1.19 kg), 
which was suspended in distilled water (800ml) and partitioned with CHCI3 
(1000mix7). The CHCI3 soluble extract was concentrated under vacuum 
using rotavapor at 40 °C, yielded 380.3 g residue. Water soluble fraction vras 
further extracted with n-BuOH saturated with water (1000mix5). The n-
BuOH and water soluble fractions were concentrated under reduced pressure 
using rotavapor at 50 °C, yielded 260.0 g and 530.2 g of crude residue re-
spectively. All the extracts were stored in refrigerator till further purification. 
A portion of n-BuOH soluble fraction (200 g) was subjected to column 
chromatography (CC) over silica gel (230—400 mesh, 1.8 kg) and eluted 
with a gradient of chloroform: methanol (95:05) to methanol: water 
(95:05) sequentially Seventy three fractions (800 ml each) were sampled 
and their composition monitored by TLC, with those showing similar TLC 
profiles grouped into nine fractions (F-1 to F-9). Further purification of 
F-l (5.2 g) over silica gel (60—120 mesh, 130g), using gradient of 
EtOAc/MeOH (100 to 80%) afforded 3 (800 mg). Column chromatography 
of F-3 (20.0g) over silica gel (60—120 mesh, 450g) with gradient of 
CHClj/MeOH (95:5) to (85: 15), afforded thirteen pooled fractions (F-IO to 
F-22) on the basis of TLC profiles from total sixty two fractions of 500 ml 
each. Compound 4 (55 mg) was obtained as amorphous powdered from F-18 
at room temperature. Successive purification of mother of F-l8 (800mg) 
over silica gel (230^100 mesh, 25 g), eluted with isocratic CHCIj/MeOH 
(90: 10) resulted in the isolation of compound 5 (463 mg). Rechromatogra-
phy of F-19 (3.0g) over silica gel (60—120 mesh, 85 g) using ethyl acetate 
saturated with water (isocratic) as mobile phase, afforded F-23 to F-29. 
Fraction F-23 (122mg) containing 2 with few complex impurities were 
acetylated using (pyridine/ACjO) followed by CC over silica gel (60—120 
mesh, 11 g) eluted with isocratic hexane: EtOAc (85:15) afforded 2 in their 
acetate form 2a (75 mg). Fraction F-26 containing compound 1 (75 mg) in 
minor quantity was purified by preparative HPLC (RP-18), eluted with gra-
dient of Hp/MeOH (80—50%). Preparative HPLC (RP-18) of F-27 
(120 mg) using gradient HjO/MeOH (75—40%) yielded 6 (27 mg). Fraction 
F-20 (4.0 g) was rechromatographed over silica gel (60—120 mesh, 70 g), 
eluted with EtOAc/Acetone (80—70%) yielded F-30 to F-33 respectively 
Further purification of F-31 (200 mg) by preparative HPLC (RP-18) with 
gradient HjO/MeOH resulted in purification of compound 7 (30 mg). Com-
pound 8 (70 mg) was eluted from F-21 (285 mg) using same condition as for 
F-31. 
Acid Hydrolysis of 1 The compound 1 (25 mg, 0.06 mmol) was treated 
with 2N HCl (5 ml) and refluxed for 30min. The reaction mixture was 
worked up in the usual manner. The sugar fraction of compound 1 over CC 
on an activated silica column yielded 2-C-methyl-D-erythritol identified by 
co-TLC with authentic sample and optical rotation [ a ] " +24.5° (c=0.02, 
HP). 
Basic Hydrolysis 1 The compound 1 (2 mg, 0,004 mmol) was dissolved 
in methanol (3 ml) and NaOMe (5mg, 0.092 mmol) was added, reaction 
mixtore was stirred at rt. for 3h. The reaction was quenched with acidic 
resin amberlite IRC-50 (Rohm and Hass, H* form), the resin was removed 
by simple filtration and filtrate was dried under reduced pressure. The sugar 
erythritol were identified by co-TLC with authentic sample. 
Acetylation of Compound 2 Crude fraction containing 2 (122 mg) was 
dissolved in dry pyridine (5 ml) and acetic anhydride (5 ml) was added. Re-
action mixture was left overnight at room temperature. The reaction mixture 
was dried under reduced pressure. The crude residue on column chromatog-
raphy over silica gel (60—120 mesh, l lg) eluted with isocratic hexane: 
EtOAc (85; 15), yielded amorphous powder of 2a (75 mg). 
2,3,4-Trihydroxy-3-methylbutyl 3-[3-Hydroxy-4-(2,3,4-trihydroxy-2-
methylbutoxy)phenyl]-2-propenoate (1): Yellow solid. 'H-NMR (CD3OD, 
200 MHz) and "C-NMR (CD3OD, 75 MHz) see Table 1. IR (KBr) cm ': 
3340, 2888, 1670, 1483, 1341, 1293. UV A„„ (MeOH) nm; 324, 239, 213. 
ESI-MS (pos.): m/z417 [M + H]^ [a]^' -t-lS.O" (c=0,04, MeOH), Positive 
HR-ESI-MS: m/z[M]* 416,1709 (Calcd4l6.1683 forC|,Hj80,„), 
1,3-Di-O-cafTeoyl Quinic Acid Methyl Ester (2a): Amorphous powder, 
'H-NMR (CD3OD, 300 MHz) and "C-NMR (CD3OD, 75 MHz) see Table 2, 
IR (CDCI3) cm"': 3351, 2871, 1737, 1672, 1604, 1514. UV A„„, (MeOH) 
nm: 327, 273, 211. ESI-MS (pos.): miz 783 [M+H]*. [a]^ -50.8° (c= 
0.04, CDCI3). Positive HR-ESI-MS: mIz [M]' 782.2073 (Calcd 782.2058 for 
Anti-stress Activity. Animals Adult male Sprague-Dawley rats 
(180—200 g) were obtained ft-om National Animal Laboratory Centre, 
May 2007 775 
CDRl, Lucknow. Animals were kept in raised mesh bottom cages to prevent 
coprophagy in environmentally controlled rooms (25±2°C, 12 h light and 
dark cycle), animals had free access to standard pellet chow and drinking 
water except during experiments. Experiments were conducted between 
09:00 and 14:00h. Experimental protocols were approved by our institu-
tional ethical committee following the guidelines of CPCSEA (Committee 
for the Purpose of Control and Supervision of Experiments on Animals), 
which complies with international norms of INSA (rndian National Science 
Academy). 
Administration of Drug Suspension of pure compounds in 0.1% 
sodium carboxy methyl cellulose were prepared and administered by oral 
gavage using a ball ended feeding needle at a dose of 40mg/kg, once daily 
for 3 d in case of AS. Drug was prepared fresh daily before administration. 
A freshly prepared aqueous suspension of crude powder of ginseng root 
Panax quinquifolium was used as a standard at a dose of lOOmg/kg body 
weight and purchased from Sigma, U.S.A. (Cat. No. G7253). 
Stress Protocol The rats were divided into control non-stress group, AS 
group, and drug-treated groups. Each group consists of 6 rats. A parallel 
group of rats were fed with vehicle for the same number of treatment days 
but were not immobilized and they were used as non-stress control group to 
obtain baseline data for various parameters. On the second day after feeding 
drug or vehicle, animals were fasted overnight with free access to water. On 
the third day, 45 min after feeding the drug or vehicle, rats were stressed ex-
cept the non stress group. AS was produced by immobilizing animals for 
ISOmin once only and sacrificed immediately by cervical dislocation. 
Briefly, immobilization stress was produced by restraining each naive animal 
inside an acrylic hemi cylindrical plastic tube (4.5 cm diameter, 12 cm long) 
for 150 min."' 
Biochemical Estimations The blood was collected in EDTA coated 
tubes, through cardiac puncture after the stress regime and ccntrifiaged at 
2000rpmX20min at 4°C and plasma was separated. The plasma was used 
to estimate corticosterone, glucose, creatine kinase (CK). 
Estimation of Glucose and CK Auto analyzer (Synchron Cx-5, Beck-
man) was used to estimate glucose and CK with their respective kits (Beck-
man Coulter International, Nyon, Switzeriand). 
Estimation of Corticosterone An HPLCAJV system (Waters, U.S.A.) 
was used for quantification of plasma corticosterone by the method of 
Woodword and Emery with modifications.'^ ' Dexamelhasone was used an 
internal standard. The mobile phase consisted of methanol: water (70:30) at 
a flow rate of 1.2ml/min and corticosterone was detected at 250 nm using 
UV detector. The chromatogram was recorded and analyzed with Breeze 
software (3.20 version). 
Statistical Analysis Mean and S.E.M. were calculated. The data was 
analyzed using one-way analysis of variance (ANOVA) followed by Sm-
dent-Newman-Keul's multiple comparison test. Data of ulcer was analyzed 
by non-parametric ANOVA followed by Dunn's multiple comparison tests. 
p<0.05 was considered to be statistically significant. 
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A B S T R A C T 
Oxidative damage is an established outcome of chiotiic stress. Thus, the present study was 
designed to investigate the modulatory role of ethanolic extract o( Evolvulus alsinoides (EA) 
in terms of oxidative alterations at peripheral and central level in rats subjected to chronic 
unpredictable stress (CUS). CUS exposure for 7 days reduced Cu, Zn superoxide dismutase and 
catalase activity with increase in glutathione peroxidase activity and lipid peroxidation, while 
decrease in reduced glutathione level in blood plasma, frontal cortex and hippocampus regions 
of brain. Oral administration of EA extract at 200 nig/kg p.o. normalized these stress induced 
oxidative alterations with an efficacy similar to that of melatonin. Further, EA extract was taken 
up for detailed chemical investigation. Two new flavonoM'-glycoside, kaempferol 4'-0-(VD-
glucopyranosyl-( 1 -»2)-fVD-glucopyranoside (3) and kaempferol 4'-0-a-L-rhamnopyranosyl-
(1 -»6)-lVD-glucopyranoside (5) were isolated, along with eight known compounds (1, 2, 4 
and 6-10). The structures of new compounds were established by detailed spectroscopic 
studies, while known compounds were characterized by direct comparison of their reported 
NMR data. All these compounds were evaluated for their in vitro antioxidant activity. Compounds 
3,5,9 and 10 at 100 and 200 ^ig/ml showed significant in vitro antioxidant activity. Therefore, EA 
may hold great potential in preventing clinical deterioration in stress induced oxidative load and 
related disorders. 
© 2009 Elsevier B.V. All rights reserved. 
1. Introduction 
Chronic stress adversely affects different brain regions and 
alters the normal homeostasis of antioxidant defence system, 
causing oxidative damage which plays a critical role in the 
pathophysiology of numerous neurodegenerative and psy-
chiatric disorders [1,2). Brain is more vulnerable to oxidative 
stress as it is rich in oxidizable substrates, has high oxygen 
tension and low antioxidant capacity [3]. Thus, the evaluation 
of antioxidant potential of centrally acting drugs is becoming 
more relevant and essential. 
* CDRI communication No, 7404. 
• Corresponding author. Tel.: +91 522 2612411 18x4235; fax; +91 522 
2623405/2623938,/2629504. 
E-mail address; mauryarake.sh@rediftmail.com (R. Maurya). 
As the damaging role of oxidative stress being clear, several 
medicinal plants like Curcuma longa, Emblica officinalis, Mangi-
fera indica, Santalum album and Withania somnifera, are reported 
with potent antioxidant activity [4j. Evolvulus alsinoides (EA) is 
an important plant that has been well documented in Ayurveda 
for its therapeutic values. EA (Linn) (Family: Convolvulaceae) 
commonly known as Shankhpuspi is found tliroughout India 
ascending to 6000 ft in the Himalayas. It is well known for 
its therapeutic effect on brain disorders like insanity, epilepsy, 
memory enhancement and nervous debility in Indian Ayurvedic 
system of medicine [5]. Recent pharmacological studies on 
leaves and whole plant of EA have indicated its antiulcer [6] and 
immunomodulatory properties [7). Some in vitro experiments 
have revealed the antioxidant properties of EA [8]. In Africa EA is 
used to treat low spirits and depression [9]. Studies in our lab 
have reported the anti-stress and anti-amnesic effects of EA 
[lOj. However, the underlying mechanisms of its therapeutic 
0367-326X/$ - see front matter 0 2009 Elsevier B.V. All rights reserved. 
doi:10.1016/j.ritote.2009.09.003 
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efficacy remain unclear, particularly with reference to prevent-
ing oxidative routes of damage in stressfi.il conditions. The 
present study has been focused to evaluate the in vivo 
antioxidant potential of ethanolic extrart of EA and its com-
parison with melatonin (MEL) in rats exposed to chronic un-
predictable stress (CUS). We selected CUS model to reduce the 
anticipation of being exposed to stress by the animal, thus it 
appears to be a more clinically relevant model to humans [11]. 
MEL has been selected as a standard drug, as it effectively 
possesses antioxidant properties (12). 
Further, phytochemical investigation of EA extract was done 
to isolate and evaluate the possible components of EA extract 
responsible for its biological activities. Two new compounds 
flavonol-4'-glycoside (3) and (5) along with eight known 
compounds (1,2,4 and 6-10) were isolated. Tlie structures of 
the isolated compounds were elucidated on the basis of 
extensive spectroscopic analysis. Thus, in the present study we 
also described isolation, strurture elucidation of EA compounds 
and evaluation of their in vitro antioxidant activity. 
2. Materials and methods 
2./. Plant material 
Whole plant material of £i'o/vu/us alsinoides (Linn.) was 
collected from 24-paraganas, West Bengal, India in Septem-
ber 2002. The collection and identification was done by 
Division of Botany. Central Drug Research Institute, Lucknow, 
India, a voucher specimen is preserved in the herbarium of 
the institute. 
2.2. General procedure 
Melting points (uncorr.) were recorded on a Complab 
melting point apparatus. IR spectra were recorded on a Perkin-
Elmer RX-1 spectrophotometer using either KBr pallets or in 
neat UV spectra were obtained on a Perkin-Elmer A-15 UV 
spectrophotometer, optical rotations were measured on a 
Perkin-Elmer Model 241 digital pclarimeter. 'H and '^ C NMR 
spectra were recorded on an Avance DPX-200 and Bruker DRX 
300 MHz spectrometer and chemical shift are expressed as fi 
(ppm) values. The abbreviations of H^ NMR signals pattern are 
as follows: s, singlet; d, doublet; dd, double doublet; ddd, 
doublet of doublet of doublet; t, triplet; m, multiplates. Proton 
detected heteronudear correlations were measured using 
HSQC and HMBC. 2D spectrums were recorded on Varian 
Inova- 600 MHz NMR and Bruker DRX 300 MHz spectrometer. 
FAB-MS were carried out on Jeol SX 102/DA-6000 mass 
spectrometer using m-Nitro benzyl alcohol as matrbc. ESl-MS 
spectra were obtained on LCQ Advantage Max Thermo 
Finnigan. Elemental analyses were obtained in a Carlo-Erba-
1106 CHN elemental analyzer. HRESIMS analysis was carried 
out on Jeol-MS 600H instrument Preparative HPLC were 
performed on Shimadzu CLC-Octa decyl silane RP-18 (ODS) 
column with (20 mm IDx25 cm length); 8 ml/min. flow rate, 
PDA UV a 254 and 220 nm as detector. Column chromatogra-
phy was performed using silica gel (60-120 and 230-400 
mesh); TIC: pre-coated silica gel plates 60 F254 or RP-18 F254 
plates with 0.5 or 1 mm film thickness (Merck). Spots were 
visualized by UV light or by spraying with H2S04-MeOH, 
anisaldehyde-H2S04 reagents. 
2.3. Bioassay-guided extraction, fractionation and isolation of 
EA compounds 
The dried powdered of Evolvulus alsinoides (7 kg) was 
extracted with ethanolic, yielded extract 1.19 kg (yield 17%). 
The ethanolic extract was dissolved in water and fraction-
ated successively with CHCI3 and n-BuOH resulted in CHCI3 
(380.3 g), n-BuOH (260.0 g) and aqueous (530.2 g) crude 
residue respectively. A portion of n-BuOH soluble fraction 
(200 g) was subjected to column chromatography (CC) over 
silica gel (230-400 mesh, 1.8 kg) and eluted with a gradient 
of chloroform: methanol (95:05) to methanol: water (95:05) 
sequentially. Seventy-three fractions (800 ml each) were 
sampled and their composition monitored by TLC, with those 
showing similar TLC profiles grouped into nine fractions (r-1 
to F-9). Further column chromatography of f-3 (20.0 g) over 
silica gel (60-120 mesh, 450 g) with gradient of CHCl3:MeOH 
(95:5) to (85:15), afforded thirteen pooled fractions (F-10 to 
F-22) on the basis of TLC profiles from a total of sixty two 
fractions of 500 ml each. Purification of f-21 (285 mg) by 
preparative HPLC (RP-18) with gradient H20:MeOH (7:3) 
resulted in purification of compound 1 (70 mg, yield 
0.0058%). Fraction 11 was further purified on silica gel 
(230-400 mesh) with MeOH:CHCl3 (94:06) elute, yielded 
com.pound 2 (50 mg, yield 0.042%) as amorphous powder. 
Further purification using the same condition as for F-3 
yielded ten fractions f-23 to f-33. HPLC purification of F-33 
(230 mg) on RP-18 silica gel, eluted with H20:MeOH (6:4), 
afforded sub-fraction 1-65, 10 ml in volume yielded 3 
(59 mg, yield 0.0049%), Fr. 14-19; 4 (54 mg, yield 0.0045%), 
Fr. 23-34 respectively. Fraction F-31 (4.2 g) was rechromato-
graphed over silica gel (60-120 mesh, 90 g), eluted with a 
gradient of ethyl acetate: 5% Aq. acetone (100-50%) afforded 
sub-fractions 1 to 8. Sub-fraction 5 (210 mg) containing two 
compounds 5 and 6 with other impurities, was purified by 
preparative HPLC (RP-18), eluted with MeOH:H20 gradient 
(30:70-50:50) gave sub-fraction 1-52, 15 ml in volume 
afforded 5 (67 mg, yield 0.0056%), Fr. 23-29 (MeOH: 
H2O::40:60) and 6 (68 mg, yield 0.0057%), Fr. 31-40 
(MeOH:H20:: 45:55). Chloroform fraction was subjected to 
repeated CC using silica gel (230-400 mesh), eluted with 
Hexane: EtOAc (5-15%) afforded eight fractions F-34 to F-41. 
Successive purification of F-37 over silica gel (60-120 mesh), 
eluted with EtOAc:Hexane (05:95-15:85) yielded 7 (70 mg, 
yield 0.0059%) and 8 (141 mg, yield 0.012%) respectively. 
Whereas sub-fraction F-34 delivered compounds 9 (20 mg, 
yield 0.0016%) and 10 (35 mg, yield 0.0029%) on silica gel 
column chromatography employing ethyl acetate:hexane 
(1:1) as eluents. The structures of these compounds were 
established using chemical and spectroscopic (FAB-MS, ' H 
NMR. '^ C NMR, COSY, HSQC. HMBC, NOESY) studies. 
2.4. Acid hydrolysis of compounds 3 and 5 
An ethanol solution (3 ml) of each sample (5 mg) was 
refluxed with 2 M HCI (3 ml) for 4 h. After neutralization with 
NaHC03 solution, the reaction mixture was extracted with 
CHCI3 (3x6 mL). CHCI3 part was evaporated and subjected to 
silica gel CC using CHCI3/CH3OH (19:1) as eluents to yield an 
aglycone. The water layer was concentrated and submitted to 
silica gel CC (EtOAc/CH30H/H20 = 7:3:0.4) yielded sugars 
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which were identified by TLC (EtOAc/CH30H/H20 = 7:3:0.4) 
with authentic samples and optical rotations [13] as follows: 
D-glucose [a]^'' + 9.6° (c0.12, H2O), L-rliamnose [al^^ + G.Z" 
(c 0.10, H2O), spots were detected by spraying with EtOH-
H2SO4 (9:1) followed by heating. D-glucose, i-rhamnose were 
identified. 
2.5. Animah 
Experimental protocols were approved by our Institutional 
Ethical Committee following the guidelines of CPCSEA (Com-
mittee for the Purpose of Control and Supervision of Experi-
ments on Animals) which complies with International norms of 
INSA (Indian National Science Academy). Adult male Sprague-
Dawley rats, weighing 150-180 g were employed in the study. 
Rats were housed three to four per cage at constant 
temperature (22±2 T) and 12/12-h light/dark cycle (8:00 a. 
m. to 8:00 p.m.). Rats were fed with standard chow pellet and 
water was given ad Wbhum. 
2.6. Stress protocol 
CUS regimen involved subjecting animals to two different 
types of stressors varying from mild to severe intensity every 
day in an unpredictable manner to avoid habituation, over a 
period of seven days [11]. Stressors included immobilization, 
forced swimming, overnight soiled cage bedding, foot shock, 
cold exposure, day-night reversal and fasting (12 h). The im-
mobilization stress was produced by restraining each ani-
mal inside an acrylic hemi-cylindrical wire mesh tube (7 cm 
diameter and 17.5 cm long) for 150 min. In swimming stress, 
animals were allowed to swim in a glass jar (35.5 cm long and 
20.2 cm diameter) containing water at 25 °C for 20 min. In 
soiled cages, the bedding was wetted with water to produce 
overnight inconvenience. In foot shock stress, animals were 
subjected to foot shock (2 mA) in agressometer (Techno Elec-
tronics, Lucknow, India) for 20 min on a grid floor with a shock 
interval of 2 s. Cold exposure was administered by placing rats 
in programmable environment test chamber (Remi, Mumbai, 
India) for 2 h at 4 °C. Day and night reversal was produced by 
keeping the animals in the dark during the day and in high 
intensity light during the night. 
2.7. Treatment schedule 
A suspension of ethanolic extract of EA and of MEL (SRL-
1348140) was prepared in 1% sodium carboxy methyl 
cellulose (CMC) daily before administration. EA was admin-
istered orally by oral gavage using a ball ended feeding needle 
and MEL was given intraperitoneally (i.p.). Pilot studies 
revealed that 20 mg/kg of MEL was effective in restoring 
antioxidant status and normalizing other markers of oxida-
tive stress, and this dose was selected for the present 
investigation (data not given). After 1 week of acclimatiza-
tion, animals were randomized into six groups of six animals 
each. 
Croup I In this group animals were not subjected to stress 
and served as non-stressed controls (NS). 
Group II Animals were exposed to two different stressors for 
7 days as explained earlier (CUS). In NS and CUS 
groups, animals were pre-treated with vehicle (con-
sisting of 1% CMC) and were used to obtain baseline 
data for various parameters. 
Groups III, IV and V These groups of animals were pre-
treated with ethanolic extract of EA at 50, 100 and 
200 mg/kg body weight p.o. daily 45 min prior to 
exposure to stress regimen for 7 consecutive days 
(EA50, EA100andEA200). 
Group VI Animals were pre-treated with MEL at 20 mg/kg 
body weight i.p. daily 45 min prior to exposure to 
stress regimen for 7 consecutive days (MEL 20). 
In CUS vehicle and drug treated groups rats were fasted 
over night on the sixth day and sacrificed on the seventh day. 
2.8. Plasma separation and brain liomogenate preparation 
Immediately after the last stress regimen on 7th day 
animals were sacrificed by rapid decapitation and blood was 
collected in EDTA coated tubes kept in ice and centrifuged at 
lOOOg for 20 min at 4 °C. Plasma was separated, aliquoted 
and stored at -70°C for various biochemical estimations. 
Brains were collected on ice; hippocampus and frontal cortex 
were isolated [14) and weighed. The brain regions were 
homogenized in ice-cold 50 mM phosphate buffer (pH 7.0) 
containing 0.1 mM EDTA. The resulting homogenates were 
centrifuged at lOOOg for 15 min at 4 °C. The supernatant was 
used for biochemical estimations. 
2.9. Superoxide dismutase (SOD) activity 
Cu, Zn-SOD activity was measured, based on its ability to 
inhibit the auto-oxidation of epinephrine to adrenochrome at 
alkaline pH [15]. Absorbance was followed for 4 min at 
480 nm in a spectrophotometer (Shimadzu, model 1201). 
Enzymatic activity was expressed as U/mg protein at 30 °C. 
The amount of enzyme that results in 50% inhibition of 
epinephrine auto-oxidation is defined as one unit (U). 
3. Catalase (CAT) activity 
CAT activity was measured using hydrogen peroxide as 
substrate [16]. The disappearance of H2O2 was followed 
spectrophotometrically at 240 nm. A molar absorptivity of 
43.6 M/cm was used to determine CAT activity. Enzymatic 
activity was expressed as U/mg protein at 25 °C, one unit (U) 
of which is equal to 1 mol of H2O2 degraded per min per mg of 
protein. 
3.1. Glutathione peroxidase (GSH-Px) activity 
GSH-Px activity was measured using f-butyl hydroperox-
ide as substrate [ 17]. Absorbance was followed for 180 s at 
340 nm in a spectrophotometer (Shimadzu, model 1201). A 
molar absorptivity of 6.22 x 10^  M/cm was used to determine 
enzyme activity. Enzymatic activity was expressed as U/mg 
protein at 37 °C. One unit (U) of activity is equal to mM of 
NADPH oxidized per minute per mg protein. 
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3.2. Lipid peroxidation (LPO) assay 
Malondialdehyde (MDA) a product of LPO was measured 
spectrophotometrically at 532 nm (ISJ. MDA level was 
determined from a standard curve and expressed as nM/mg 
protein. 
3.3. Reduced glutathione (CSH) levels 
GSH was determined by its reaction with 5,5'-ditliiobis 
(2-Nitrobenzoic acid) (Ellman's reagent) to yield a yellow 
chromophore which was measured spectrophotometrically 
at 412 nm [19]. GSH level was determined from a standard 
curve and expressed as pM/mg protein. 
3.4. Protein assay 
The protein content of the sample was determined using 
Folin Phenol reagent [20]. 
3.5. In vitro antioxidant activity (generation of free radicals) 
Superoxide anions were generated enzymatically [21] by 
xanthine (150 mM), xanthine oxidase (0.04U) and nitroblue 
tetrazolium (320 mM) in the absence or presence of EA 
derived compounds (100 and 200ng/ml) in 100 mM phos-
phate buffer (pH 8.2). Compounds were sonicated well in 
phosphate buffer before use. The reaction mixtures were 
incubated at 37 °C and after 30 min the reaction was stopped 
by adding 0.5 ml glacial acetic acid. The amount of formazone 
formed was measured at 560 nm on a spectrophotometer. 
Percentage inhibition was calculated taking absorption 
coefficient of formazone as 7.2 x 103 M/cm. In another set of 
experiment, an effect of EA derived compounds on generation 
of hydroxyl radicals (OH) was also studied by non-enzymic 
reactants [22]. Briefly OH were generated in a non-enzymic 
system comprised of deoxyribose (2.8 mM) FeS04-7H20 
(2 mM), Sodium ascorbate (2.0 mM) and H2O2 (2.8 mM) in 
50 mM KH2PO4 buffer, pH-7.4 to a final volume of 2.5 ml the 
above reaction mixture in the absence or presence of EA 
derived compounds (100 and 200|.ig/ml) were incubated at 
37 °C for 90 min. Reference samples and reagent blanks were 
also run simultaneously. Malondialdehyde (MDA) content in 
both experimental and reference samples were estimated 
spectrophotometrically by thiobarbituric acid method as 
mentioned above [22,23]. 
3.6. Statistical analysis 
The results of in vivo antioxidant analysis of EA extract 
were expressed as mean ± S.E.M. The statistical significance 
was determined by One-Way Analysis of Variance (ANOVA) 
followed by Tukey's multiple comparisons test. Whereas, the 
generations of free radicals with different EA compounds by 
in vitro analysis were compared with that of their formation 
without compounds using Student's f-test. P<0.05 was 
considered to be statistically significant. 
OH 0 
1. Ri = R4 = H. R3 = OH. R2 = p-D-glucopyranosyl 
3 Ri = R2 =R3 =H,R4 = p-D-glucopyranosyl (1-2)-p-glucopyranoside 
4. Ri = R2 = p-D-glucopyranosyl. R3 = R4 = H 
5, Ri = R2 = R3 = H,R4=a-L-rhamnopyranosyl (1-6)-p-D-glucopyranoside 
6 Ri = a-L-rhamnopyranosyl (1-6)-p-D-glucopyranoside. R2 = R3 = R4 = H 
9. Ri = p-D-glucopyranosyl, R2 = R3 = R4 = H 
10.Ri = p-D-glucopyranosyl. R2 = R4 = H, R3 = OH 
HO 
0 H \ OH 
H3CO 
HO' 
"V*^ ^ 
.^ 0 " ^ 0 
Fig. 1. Structural formula of isolated compounds (1-10) of £vo/vii/us alsinoides. 
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4. Results 
4. J. Characterization ofEvolvulus alsinoides constituents 
The compound 3 (Fig. 1) was obtained as a hygroscopic 
yellow amorphous solid, possessing elemental composition 
C27H3oO,6 as concluded from HR-El-MS pes. spectrum {m/z at 
610.1555 [M]+). The IR spectrum of 3, displayed absorption 
bands for a,p-unsaturated carbonyl at (1663 cm" ' ) , aromat-
ic rings (1595, 1464, and 1392 cm" ' ) and hydroxyl groups 
(3453 cm" ' ) . The UV spectrum showed absorption bands at 
Amax 362 and 263 nm, typical of flavonol nucleus. Bath-
ochromic shift of 12 nm in band Jl with sodium acetate (C-7 
OH), 55 nm bathochromic shift of band I in presence of AICI3 
(C-5 OH) and 27 nm bathochromic shift in band 1 with de-
creased intensity upon addition of NaOMe (C-3 OH) revealed 
the presence of free hydroxyl groups at C-3,5 and 7 positions 
with substituted 4'-hydroxy group (no retention of peak 
intensity with NaOMe). The ESl-MS spectrum exhibited |IVI -t-
H]^ ion peaks at m/z 611 with two important fragment due 
to loss of two monosaccharide units sequentially at m/z 449 
[M-^H-C6H,o05]+ and 287 [M + H-2xC6Hio05]+. The 
monosaccharide units were identified as o-glucose fay acid 
hydrolysis of 3, followed by co-TLC with authentic sample and 
optical rotation. On acetylation (pyridine/Ac20) it formed 
decaacetate derivative 3a. The formation was confirmed by 
FAB-MS: m/z 1031 [M-l-H]+. indicated presence of ten 
acylable hydroxyl groups in compound 3. 
These preliminary obseivations were confirmed by exten-
sive analysis of both one and two dimensional 'H and '^ C NMR 
spectra. The aromatic region of the 'H NMR (Table 1) spectrum 
of 3 contained a characteristic resonance at CSH 6.19 (IH, s, H-6; 
(K 99.4 by HSQC) and 6H 6.44 (IH. s, H-8; 6c 94.5 by HSQC) 
respectively, an assignment confirmed by long-range connec-
tivity of H-6/C-7, 8, 10; H-8/C-9, 10 in the HMBC spectrum 
(Fig. 2). Two doublets at AH 8.04 (2H, d,; = 8.4 Hz, H-2', 6'); fie 
131.0 and 7.19 (2H, d,J = 8.4 Hz, H-3', 5'); ^c 115.2 comprised 
the A2B2 aromatic resonances, a downfield shift of H-3'/5' at ^H 
7.19 was characteristic of 4'-0 substituted B-ring of a flavonoid. 
The remaining signals in the 'H NMR spectrum were those of 
two glucose units, which showed anomeric proton signals at <\, 
5.20 (IH, d, i=7.6Hz) and 4.93 (IH, d,;:=6.4Hz). The 'H 
resonances of other sugar protons were assigned using ' H - ' H 
COSY spectrum as multiplates in the range of 6H 3.90-3.12 (m), 
as in this case the signals of the sugar protons were overlapped 
by moisture signal of the solvent. The corresponding '^ C 
resonances (Table 1) were obtained from the HSQC spectaim 
utilizing ' H - ' H COSY spectrum. These chemical shifts and 
coupling constant data (Table 1) indicated that both glucose 
units represented by the anomeric protons at 3n 5.20 and 4.93 
were p-glucopyranoside. The HMBC spectrum was utilized to 
confirm the position of sugar residues. A long-range connectiv-
ity between H-17C-4' and H-l"VC-2" in the HMBC spec-
trum (Fig. 2) indicated that glucose residues were interlinked 
[V"/2") and attached to C-4' position of the flavonol. Thus 
compound 3 was determined to be kaempferol 4'-0-p-D-
Table 1 
NMR spectral dau of compounds 3 and 5. 
Pes. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
TO 
1' 
2' 
3' 
4' 
5' 
6' 
r 
2" 
3" 
4" 
5" 
6"a 
6"b 
1'" 
2" 
3 " 
4 " 
5'" 
6'"a 
6"b 
BCDMSOde)" 
I5H fmul ty in Hz) 
-
-
-
-
6.19 (s) 
-
6.44 (s) 
-
-
-
8.04 (d, 8.4) 
7.19 (d, 8.4) 
-
7.19 (d, 8.4) 
8.04 (d, 8.4) 
5.20 (d, 7.6) 
3.57 (ill) 
3.49 (m) 
3.41 (m) 
3.26 (m) 
3.90 (m) 
3.72 (m) 
4,93 (d. 6.4) 
3.54 (m) 
3.41 (m) 
328 (m) 
3.12 (m) 
3.75 (m) 
3,53 (m) 
«c 
146.9 
136.7 
176.1 
160.2 
99.4 
163.9 
94.5 
156,1 
105.7 
124.8 
131.0 
115.2 
160.9 
115,2 
131.0 
99.8 
81.9 
76,8 
69.6 
76.5 
60.9 
-
101,7 
73.1 
76.5 
70.0 
76.7 
60.7 
-
HMBC 
-
-
-
-
C-7,8,10 
-
C-6, 9, 10 
-
-
-
C-2, l ' . 4 ' , 6 ' 
C-r,4',5' 
-
C-l'.3',4' 
C-2, 1', 2', 4' 
C-4', 3", 5" 
C-4", 1" 
C-1', 5" 
C-2", 5", 6"a 
C-l',3",6"a 
C-4', 5" 
C-4", 5" 
C-2''. 3" 
C-3'", 4'" 
C-1".5'" 
C-2'", 6"'a 
C-1'", 3" 
C-4" 
-
5(CD30D)" 
(5H(mult.,7inHz) 
-
-
-
6,23 (d, 1.8) 
-
6.42 (d, 1.8) 
-
-
-
8.13 (d, 8.8) 
7,23 (d, 8.8) 
-
7,23 (d, 8.8) 
8.13 (d, 8.8) 
5.16 (d, 7.2) 
3.72 (m) 
3.54 (m) 
3.39 (m) 
3.23 (m) 
3,79 (m) 
3.64 (m) 
4.55 (5) 
3.82 (m) 
3.76 (m) 
3.53 (m) 
3.65 (m) 
1.22 (d, 6.2) 
-
«c 
147.8 
135.9 
176.7 
163.0 
99.9 
166.3 
95.0 
156.6 
104.6 
124.3 
131.4 
116.1 
161.5 
116.1 
131.4 
100.1 
75.8 
77,2 
71,4 
78.2 
68,6 
-
102.4 
72,1 
72.3 
73.9 
69.7 
17.9 
-
HMBC 
-
-
-
-
C-7, S. 10 
-
C-6, 9, 10 
-
-
-
C-2, l ' , 4 ' 
C-l ' ,5 ' 
-
C-1', 3 ' 
C-2,1',4' 
C-4', 3", 5 ' 
c-r,4" 
C-l",5" 
c-2", 6"a 
C-r.3", 6''a 
C-4», 5M'" 
C-5", 1" 
C-6"a.b,3" 
C-1 " , 4 " 
C-1", 5'" 
C-2'", 5", 6" 
C-3", 6'" 
C^", 5'" 
-
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Fig. 2. Key HMBC (-•) correlation of compounds 3 and 5, 
glucopyranosyl-(1-»2)-p-D-glucopyranoside, a new flavonol 
glycoside named evolvoside h. 
The compound 5 (Fig. 1) was obtained AS a hygroscopic 
yellow solid. The IR absorption bands at 3436, 1671, 1607, 
1509 cm"' and UV absorption bands at 
^mi\ 368 and 261 nm 
were typical of flavonol nucleus. Bathochromic shift of 13 nm in 
band 11 with sodium acetate (C-7 OH), 52 nm bathochromic shift 
of band 1 in presence of AICI3 (C-5 OH) and 30 nm bathochromic 
shift in band I with decreased intensity upon addition of NaOMe 
(C-3 OH) revealed the presence of free hydroxy! groups at C-3,5 
and 7 positions, with substituted 4'-hydroxy group. The HR-EI-
MS of compound 5 gave mass ion [M)"^  at mjz 594.1611 
corresponding to molecular formula C27H30O15 (cal. 594.1585). 
The ESl-MS spectrum exhibited [M + Hj+ ion peaks at miz 595 
and sodiated ion peak [M + Na]' at mjz 617 with two important 
fragments due to loss of rhamnose 449 [M + H-Rha (C6Hio04)]'^  
and glucose at 287 [M + H-Rha-Glc (CBHIOOS)]^, suggested 
presence of terminal rhamnose sugar in the molecule. On 
acetylation (pyridine/Ac20), it formed a nonaacetate derivative 
5a, which was further confirmed by FAB-MS: mIz 973 [M + H] * 
thereby indicating the presence of nine acylable hydroxyl groups 
in compound 5. 
The 'H and '^ C NMR spectrum (Table 1) of 5 was identical 
to 3 except for signal attributed to rhamnose methyl at 6'H 
1.22 (d,7=6.2 Hz; 6cl7.9). All spin systems attributed to 
two sugar units; aromatic A2B2 and aromatic AX system 
were assigned respectively (Table 1). On acid hydrolysis 
compound 5 afforded two sugars, identified as o-glucose and 
L-rhamnose by co-TLC with authentic samples optical rota-
tion. The anomeric proton 6H 5-16 (d, J=7 .2 Hz) indicated 
that glucosyl moiety was involved in the fi-glycosidation 
with flavonol nucleus. Further downfield shift of glucose 
methylene carbon (C-6") at ("ic 68.6, indicated (glycosidation 
effect) i.e. anomeric proton of rhamnose 6H 4.55 (s) was 
attached at C-6" hydroxy! group of glucosyl moiety with a-
linkage. The position of the glucose at C-4' was confirmed 
with analysis of the UV spectrum utilizing NaOlVle shift 
reagents. All these observations were confirmed by HIVIBC 
spectrum (Fig. 2). On the basis of foregoing spectral and 
chemical data, compound 5 was identified as kaempferol 4'-
0-a-L-rhamnopyranosyl-(l — 6)-ti-D-glucopyranoside, a 
new flavonol glycoside named evolvoside B. 
The known compounds were characterized as querce-
tine-7-0-(VD-glucopyranoside (1) [24), vitexin (2) [25], 
kaempferol-3,7-di-0-(VD-glucopyranoside (4) (26), kaemp-
ferol -3-0-p-L-rhamnopyranoside (1-•6)-(^-0-glucopyra-
noside (6) [26], lupeol (7) [27], 7-hydroxy-6-methoxy 
coumarin (8) [28], kaempferol-3-0-|i-glucopyranoside (9) 
[29] and quercetin-3-0-(-^-g'ucoside (10) [30] by direct 
comparison of NMR data with those reported in literature. 
All the known compounds were isolated for the first time 
from this plant (Fig. 1). 
4.2. Effect ofEA extract and MEL on the alteration of superoxide 
dismutase (SOD) and Catalase (CAT) activity in plasma, frontal 
cortex and hippocampus during CUS 
CUS induced significant decrease in the activity of SOD in 
plasma (P<0.001), frontal cortex (P<0.05) and hippocampus 
(P<0.001) as compared to NS control group. Oral administra-
tion of EA at 200mg/kg p.o. and MEL at 20mg/kg i.p 
significantly enhanced SOD activity in plasma (P<0.05), 
(P<0.01), frontal cortex (P<0.05), (P<0.001) and hippocampus 
(P<0.01), (P<0.01), respectively when compared to CUS group. 
Although, in hippocampus EA at lOOmg/kg p.o. also signifi-
cantly ((P<0.05) normalized CUS induced decrease in SOD 
activity (Fig. 3A). 
Similarly, CUS significantly decreased the activity of CAT in 
plasma (P<0.01), frontal cortex (P<0.05) and hippocampus 
(P<0.01) as compared to NS control group. Oral administra-
tion of EA at 200mg/kg p.o. and MEL at 20mg/kg i.p 
significantly enhanced CAT activity in plasma (P<0.05), 
(P<0.01), frontal cortex (P<0.05), (P<0.01) and hippocam-
pus (P<0.05), (P<0.05) respectively when compared to CUS 
group. Although, in frontal cortex EA at 100 mg/kg p.o. also 
significantly (P<0.05) normalized CUS induced decrease in 
CATactivity(Fig. 3B). 
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4.3. Effect of EA extract and MEL on glutathione peroxidase 
(CSH-Px) activity in plasma, frontal cortex and hippocampus 
during CUS 
CDS induced significant (P<0.01) increase in the activity 
of CSH-Px in plasma, frontal cortex and hippocampus as 
compared to NS control group. Oral administration of EA at 
200mg/kg P.O. and MEL at 20 mg/kg i.p significantly 
normalized the activity of GSH-Px in plasma (P<0.01), 
(P<0.0]), frontal cortex (P<0.05), (P<^0.01) and hippocam-
pus (P<0.01), (P<0.001) respectively when compared to CUS 
group (Fig. 3C). 
4.4. EA extract and MEL replenished GSH content and 
nonnalized CUS induced lipid peroxidation in plasma, frontal 
cortex and hippocampus 
During CUS, GSH was significantly reduced in plasma 
(P<0.001), frontal cortex (P<0.05) and hippocampus (P< 
0.001) as compared to NS control group. Oral administration 
of EA at 200 mg/kg p.o. and MEL at 20 mg/kg i.p significantly 
restored the depleted GSH levels in plasma (P<0.01), 
(P<0.01), frontal cortex (P<0.05), (P<0.001) and hippocam-
pus (P<0.01), (P<0.001), respectively when compared to CUS 
group (Fig, 3D). 
Exposure to CUS significantly increased the MDA levels in 
plasma (P<0.01), frontal cortex (P<0.001) and hippocampus 
(P<0.001) as compared to NS control group. Further, pre-
treatment with EA at 200 mg/kg p.o. and MEL at 20 mg/kg i.p 
significantly normalized the MDA levels in plasma (P<0.001), 
{P<0.001), frontal cortex (P<0.05), (P<0.01) and hippocam-
pus (P<0.05), (P<0.05), respectively when compared to CUS 
group (Fig. 3E). 
4.5. EA compounds showed signj^cant in vitro antioxidant 
capacity 
The scavenging potential of EA compounds at a dose of 
100 and 200ng/ml against formation of 0'^" and OH in non-
enzymic system was studied. The results of compounds 
which showed antioxidant activity was presented in Table 1. 
Compounds 3, 5, 9 and 10 showed significant decrease in 
super oxide anions inhibition by 10, 21, 22 and 20 % and 
hydroxyl radicals inhibition by 19, 18, 34, and 28%, respec-
tively. The standard drugs Alloperinol at 20 pg/ml showed 
70% inhibition of superoxide anions and Manitol at a dose of 
100 ng/ml showed 50 % inhibition of hydroxyl ions (Table 2). 
5. Discussion 
The present investigation demonstrated that chronic 
administration of ethanolic extract of EA for 7 days at a 
dose of 200 mg/kg normalized the CUS induced oxidative 
changes in blood plasma, frontal cortex and hippocampus 
regions of brain, with an efficacy similar to that of MEL. 
Further, Two new flavonol-4'-glycoside, kaempferol 4'-0-p-
D-glucopyranosyl-(l-»2)-p-D-glucopyranoside (3) and 
kaempferol 4'-0-H-L-rhamnopyranosyl-(l -•6)-fVD-gluco-
pyranoside (5) were isolated, along with eight known 
compounds, quercetine-7-O-p-D-glucopyranoside (1), 
vitexin (2), kaempferol-3,7-di-0-(i-D-g!ucopyranoside (4), 
kaempferol -3-0-a-L-rhamnopyranoside (1-+6)-|i-D-gluco-
pyranoside (6), lupeol (7), 7-hydroxy-6-methoxy coumarin 
(8), kaempferol-3-O-p-glucopyranoside (9) and quercetin-3-
0-(i-glucoside (10). All the known compounds Vv^ ere isolated 
for the first time from this plant. The finding of potent 
antioxidative activity of EA extract was further strengthened 
from the fact that the compounds 3, 5 (new) and 9, 10 
(known) also exhibited in vitro antioxidant activity. 
In our study, CUS significantly reduced the activity of SOD 
and CAT in both the brain regions and blood plasma. Our results 
are in accordance to a study [31 ] showing that chronic stress 
resulted in the generation of ROS, with a concomitant decline in 
the activities of SOD, CAT and GST in plasma and other tissues. 
Chronic stress also proposed to increase the vulnerability of 
different brain regions, particularly hippocampus, upon meta-
bolic insults by altering the neuronal defence capacity against 
oxidative damage [32]. This can be regarded as a possible 
component of glucocorticoid (GC) mediated neuroendanger-
ment [33]. An increase in GSH-Px activity in our study might 
Table 2 
Effect of EA compounds on super oxide anions and hydroxyl radical generation (in vitro antioxidant activity). 
Compounds Concentration (Mg/ml) Formation of super oxide anions Formation of hydroxyl radicals 
3 
5 
9 
10 
Standard drug 
100 
200 
: 100 
200 
100 
200 
100 
200 
Control 77.94 ±6,27 
73,02±5.12*'(-15) 
60,34 ±4.23** (-22) 
Control 78.40 ±5.93 
74.30±5.77**(-]6) 
62.61 ±4.33" (-20) 
Control 77.22 ±6.10 
70.10±5.79*(-13) 
67.40 ±4.88* (-10) 
Control 78.94 ±6.33 
73,20±5.44*(-13) 
61.62±6.10**(-21) 
Control 25.44 ±2.00 
Exp 7.61 ±0,76 (-70) 
[Alloperinol 20 fig/mlj 
Control 65.67 ±3.82 
50.11 ±2.87** (-23) 
43.37±3.14***(-34) 
Control 69.81 ±6.00 
55.53±3.79**(-20) 
50.11 ±4.12*** (-28) 
Control 72.41 ±6.00 
64.67±4.39*(-lI) 
58.53±3.87** (-19) 
Control 70.88 ±5.92 
61.88±4.73*(-13} 
57.77±5.01**(-]8) 
Control 34.88 ±2.73 
Expl7.10±1.10(-50) 
[Manitol 100 fig/ml] 
Table 2 showing the effect of EA derived compounds (100 and 200ng./ml) on superoxide ion (n mole formazone formed/min) and hydroxyl ion (n mole MDA 
formed/h). Standard drug for superoxide anions-Alloperinol (20 fig/ml) and hydroxyl ions-Manitol (100 ng/ml) were used. Each value is the mean ± SD of four 
separate observations, *P<0.05; "P<0.01; '"P'.O.OOl when compared to the system without EA compounds pre-treatment. 
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indicate an increase in cellular peroxides. CSH plays an im-
portant role in the detoxification of ROS in brain. Our results are 
in agreement with many studies which support the theory that 
a loss of CSH may occur due to an oxidative event and this could 
be one of the important mechanisms of utilization [31,34). 
Reduction in GSH levels after corticosterone treatment has also 
been reported (33). The significant elevation of lipid peroxida-
tion marker (MDA) in CUS group in the brain and plasma is in 
agreement with previous reports, which are related to stress 
induced lipid peroxidation in erythrocytes [35) and in different 
tissues [34] of animals. 
With the detrimental role of free radicals in stressful 
conditions being clear the antioxidant therapy should therefore 
include either free radical scavenging enzymes or agents, which 
are capable of augmenting the activity of major antioxidant 
enzymes [12,31]. Our results showed that EA at a dose of 
200 mg/kg p.o. normalized all the stress induced alterations in 
the activity of antioxidant defence enzymes (SOD, CAT and 
GSH-Px) both in plasma and brain, indicating the reduction in 
free radical load as marked by reduced lipid peroxidation and 
improved GSH levels. The observed normalization of severely 
compromised in vivo antioxidant status by EA treatment may 
thus largely contribute to the increased resistance of stressed 
rats, in comparison to parallel CUS group receiving no treat-
ment. This modulation of antioxidant parameters to basal levels 
by EA was strikingly at par with the powerful antioxidant 
efficacy of MEL It is well reported that MEL plays an important 
role in modulating antioxidant enzyme activities, extentof lipid 
peroxidation and GSH content [12,36]. 
The potent antioxidant activity of EA during CUS as 
observed in the present investigation could be explained on 
several lines. Firstly, the EA compounds 3, 5, 9 and 10 at a 
dose of 100 and 200ng/ml showed significant antioxidant 
and scavenger of oxygen free radicals in our study which 
could possibly through metal ion chelation and xanthine 
oxidase inhibition in an in vitro model of non-enzymatic and 
enzymatic lipid peroxidation as described by other workers 
as well [2].39|. They belong to the class of flavonoids and 
terpenoids. Their multiple biological effects including anti-
oxidant activity is well known [37]. The antioxidant proper-
ties of phenolic acids and flavonoids are due to their redox 
properties, ability to chelate metals and quenching of singlet 
oxygen [38]. Secondly, it could be attributed to the anti-stress 
capacity of EA extract and its constituents as explained in our 
previous two independent studies, where EA extract [10] and 
its derived compounds [40] normalized the stress induced 
increase in GC levels. It becomes more relevant as numerous 
other reports suggesting that the damage to oxidative de-
fence system is directiy or indirectly regulated and/or exacer-
bated by stress induced GCs [32,41,42]. 
In conclusion, our study demonstrated the antioxidant 
potential of ethanolic extract of EA and providing the sti^ctural 
details of its constituents. The in vitro antioxidant activity of 
some of the EA constituents stirengthened the finding of potent 
in vivo antioxidant activity exhibited by EA extract. Tliis study 
provide insights into the central and peripheral oxidative alter-
ations during chronic stressful condition and extends previous 
findings, implicating the importance of antioxidant therapy in 
stress disorders and the consequent need to evaluate anti-
sti-ess agents in terms of their antioxidant/proxidant ability. 
Therefore, EA may hold great potential in preventing further 
clinical deterioration in stress related disorders. 
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Abstract We have synthesized a series of novel isoxazolines via 1,3-dipolar 
cycloaddition of in situ generated nitrile oxide from 2,4-dimethoxy benzaldoxime 
and naphthaldehyde oxime with 4-allyl-2-methoxyphenol derivatives. The synthe-
sized compounds were evaluated for anti-stress activity in acute stress (AS) induced 
peripheral changes. Adult male Sprague-Dawley rats, subjected to AS, cause a 
significant increase in gastric ulceration, adrenal gland weight, plasma glucose, 
corticosterone levels, and creatine kinase activity. Compounds 3d, 3g, 5b, 5c, 5d, 
and 5g displayed most promising anti-stress effect by reverting these peripheral 
stress parameters at a dose of 40 mg/kg p.o. 
Keywords Isoxazoline • 1,3-Dipolar cycloaddition • Acute stress • 
Corticosterone • Ulcer 
Introduction 
Hyperactivity of hypothalamic-pituitary-adrenal axis (HPA) during stressful 
conditions has been implicated in etiopathogenesis of various disorders of central 
and peripheral systems like hypertension, coronary heart disease (Roy et al, 2001), 
gastric ulcers (Yadin and Thomas, 1996), immunosuppression (Purett, 2001), 
metabolic disorders like diabetes (Fitzpatrick et al, 1992), reproductive dysfunction 
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(Dabson and Smith, 2000), mental depression and memory loss (Gareri etal, 2000). 
Thus, the treatment of stress pathologies is of great concern because of their 
increasing incidence (McEwen and Wingfield, 2003). Due to the limitations of 
tolerance, sedation and physical dependence on prolonged use of modern anti-stress 
drugs; the identification of new effective and safe anti-stress agents is desperately 
needed. 
Previous studies showed that several isoxazoline moieties possessed a wide 
spectrum of activities like PTPIB inhibitory activity (Ahmad et al, 2006), 
antimicrobial (Gaonkar e/a/., 2007), anti-influenza virus (Kai etal, 2001), antifungal 
(Basappa et al, 2003), glycoprotein Ilb/IIIa receptor antagonists (Sielecki et al, 
2001), anti-HIV (Ichiba et al, 1993), spermicidal and anti-HIV (Srivastava et al, 
1999), analgesic and anti-inflammatory (Habeeb et al, 2001), and )8-adrenergic 
receptor antagonist properties (Conti et al, 1998). However, their role during stressful 
condition is unknown. We report herein the synthesis of series of new 3,5-disubstituted 
isoxazolines and their evaluation for anti-stress activity under acute stress (AS) 
condition in relation to the peripheral (ulcer severity and adrenal hypertrophy) and 
biochemical changes [glucose, creatine kinase (CK), and corticosterone]. 
Results and discussion 
Chemistry 
The starting materials, aldoximes 1 (Maurya et al, 2008) and 4 (Yamada et al, 
2006), were prepared from the 2,4-dimethoxy benzaldehyde and 1-naphthaldehyde. 
The olefin 2b was prepared by acetylating 2 with acetic anhydride and pyridine. The 
olefins 2c-g were prepared in almost quantitative yield by treatment of 2 with methyl 
iodide, ethyl iodide, benzyl bromide, yV-(2-chloroethyl) pyrrolidine hydrochloride. 
H,CO. .OCH, 
a; R=H, b: R-COCH3, c: R^CHg, d: R=CH2CH3, e; R=CH2C6H5, 
o f: R= H2CH2CN J , g: R= H2CH2CN o 
Scheme 1 Synthesis of isoxazoline compounds by altering the substituent in 4-allyl-2-methoxy-phenol 
onaaiomin 
Med Chem Res 
and A -^(2-chloroethyl) piperidine hydrochloride in presence of K2CO3 in dry acetone, 
respectively. The cycloaddition reaction of oximes 1, 4 with olefins 2 in presence of 
chloramines-T (Hassner and Rai, 1989) afforded new isoxazolines 3a-d, 5a-d in 77-
88% yields (Scheme 1). The structure of cycloadducts was determined by elemental 
analysis and their spectral data. 
Biological activity 
We select immobilization stressor in our AS model because of the fact that it 
produces both physical as well as inescapable psychological stress (Marty et ai, 
1997). All the synthesized isoxazolines (3a-g, 5a-g) were screened for anti-stress 
activity in AS model at a dose of 40 mg/kg p.o. body weight (Table 1) (Gupta et ai, 
2007). We used PQ at a dose of 100 mg/kg p.o. body weight as a standard drug (Rai 
et ai, 2003). AS (F(16, 85) = 6.397, P < 0.001) resulted in significant increase in 
the scores of ulcer index when compared to non-stress control (NS) group. So the 
stimulation of Para ventricular nucleus of hypothalamus increased intestinal 
motility, acid secretion, and group of other factors during stressful conditions 
(Glavin et ai, 1991; Mayer, 2000). Pretreatment of 3b (P < 0.05), 3d (P < 0.01), 
3e (P < 0.05), 3g (P < 0.05), 5b (P < 0.05), 5c (P < 0.01), 5d (P < 0.05), 5g 
(P < 0.05), and PQ (P<0.01) significantly decreased mean ulcer score when 
compared to AS group, whereas administration of 3a, 3c, 3f, 5a, 5e, 5f produced no 
significant changes in ulcer index as compared to AS group. Also exposure to AS 
(F(16, 85) = 9.38, P < 0.001) significantly increased the adrenal gland weight 
when compared to NS group. These results are in accordance to a number of studies, 
suggesting that stress caused an increased adrenocorticoid secretion, plasma 
corticosterone levels, and enlarged pituitary and adrenal size (Dhabhar et ai, 1997). 
Pretreatment of 3b (P < 0.001), 3d (P < 0.01), 3e (P < 0.05), 3g (P < 0.01), 5b 
(P < 0.01), 5c (P < 0.01), 5d (P < 0.05), 5g (P < 0.001), and PQ (P < 0.001) 
significantly normalized the increased adrenal gland weight, whereas administration 
of 3a, 3c, 3f, 5a, 5e, and 5f produced no significant changes as compared to AS 
group (Table 1). 
AS exposure resulted in a significant increase in the plasma glucose level (F(16, 
85) = 14.09, P < 0.001), CK activity (F(16, 85) = 10.98, P < 0.001), and 
corticosterone levels (P(16, 85) = 12.95, P < 0.001) when compared to NS group. 
This could be attributed to the release of glucocorticoids as a result of HPA axis 
stimulation, to compensate the initial demand of energy (Mason, 1968). Stress 
hormones not only stimulate and insure supply of glucose, but also increase CK 
activity during stress (Adelbert, 2000). Pretreatment of 3b (P < 0.05), 3d 
(P < 0.001), 3e (P < 0.05), 3g (P < 0.001), 5b (P < 0.001), 5c (P < 0.001), 5d 
(P< 0.001), 5g ( P < 0.001), and PQ (P< 0.001) significantly normalized the 
increased plasma corticosterone levels when compared to AS group, whereas 3a 
(P < 0.05), 3b (P < 0.001), 3d (P < 0.001), 3e (P < 0.001), 3g (P < 0.001), 5a 
(P < 0.001), 5b (P < 0.001), 5c (P < 0.05), 5d (P < 0.001), 5g (P < 0.001), and 
PQ (P < 0.001) were found effective in normalizing AS-induced hyperglycemia 
(Table 1). Also, pretreatment of 3b (P < 0.01), 3d (P < 0.01), 3e (P < 0.001), 3g 
(P < 0.01), 5b (P < 0.001), 5c (P < 0.001), 5d (P < 0.001), 5g (P < 0.001), and 
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PQ (P < 0.001) significantly normalized the decreased CK activity when compared 
to AS group. 
Conclusion 
In summary, we have synthesized a series of novel isoxazolines and evaluate their 
anti-stress potential in AS model. AS resulted in significant elevation in gastric 
ulceration adrenal hypertrophy, hyperglycemia, plasma CK activity, and cortico-
sterone levels, which was significantly countered by pretreatment of isoxazolines 
3d, 3g, 5b, 5c, 5d, and 5g. Thus, the protective effects of these compounds during 
AS condition might be due to the normalization of increased HPA axis response 
during an immediate threat condition such as acute immobilization stress. Hence, 
these compounds might have important therapeutic implications in stress-induced 
neuropathological conditions, and biological activity profiles of these compounds 
are worthy for further investigation to develop anti-stress drugs. 
Experimental 
General 
Mps are uncorrected and were determined on Complab apparatus. IR spectra were 
recorded on Perkin-Elmer RX-1 spectrometer using either KBr pallets or neat. The 
FAB MS results were recorded using a beam of argon (208 eV) on a Jeol SX 102/ 
DA-6000 mass spectrometer. H^ NMR spectra were recorded at AVANCE DPX 
200 spectrometer and ''^ C NMR spectra at 50 MHz on the same spectrometer, and 
are quoted relative to C4H]2Si as internal reference. Elemental analyses were 
obtained in a Carlo-Erba-1108 CHN elemental analyzer. Thin-layer chromatogra-
phy was run on precoated 60F254 (Merck, Darmstadt, Germany) plated. Detection 
of spots was done either by Ij vapor and spraying with 1 % eerie sulfate in 1 M 
H2SO4 or spraying with 10% methanolic sulfuric acid followed by heating at 110°C. 
Synthesis of olefins 2c-g 
General procedure 
The mixture of 2 (1 equiv) with methyl iodide, ethyl iodide, benzyl bromide, N-(2' 
chloroethyl) pyrrolidine hydrochloride, and //-(2-chloroethyl) piperidine hydro-
chloride (1.2 equiv) and K2CO3 (1.2 equiv) in dry acetone was refluxed with stirring 
for 3 h, respectively. After that acetone was evaporated, water was added and the 
mixture was extracted with ethyl acetate, washed with water and brine, and dried 
over anhydrous sodium sulfate. The products were purified by column chromatog-
raphy over silica gel. 
(ooaiQiss 
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4-Allyl-1,2-dimethoxy-benzene f2cj 
Yield 95.0, viscous oil, 'H NMR (CDCI3,200 MHz) d 6.80 (IH, dd, 7 = 8.6,1.6 Hz, 
H-5), 6.72 (IH, d,7 = 8.6 Hz, H-6), 6.70 (IH, d, 7 = 1.6 Hz, H-3), 5.94 (IH, m, H-
8), 5.10 (IH, d, 7 = 18.2, 7.6 Hz, H-9a), 5.07 (IH, dd, 7 = 18.2 Hz, H-9b), 3.85 
(6H, s, 2x OCH3), 3.32 (2H, d, 7 = 6.8 Hz, H-7); FAB MS m/z 179 [M+l]+. 
4-Allyl-l-ethoxy-2-methoxy-benzene (2dj 
Yield 89%, viscous oil, 'H NMR (CDCI3, 200 MHz) d 6.82 (IH, dd, 7 = 8.6 Hz, H-
6), 6.69 (2H, d, 7 = 8.6 Hz, H-3,5), 5.94 (IH, m, H-8), 5.11-5.02 (2H, m, H-9a,9b), 
4.86 (2H, q, 7 = 7.0 Hz, OCH2CH3), 3.84 (3H, s, OCH3), 3.32 (2H, d, 7 = 6.6 Hz, 
H-7), 1.44 (3H, t, 7 = 7.0 Hz, OCH2CH3); FAB MS miz 193 [M+l]+. 
4-Allyl-l-benzyloxy-2-methoxy-benzene (2ej 
Yield 84.0%, viscous oil, 'H NMR (CDCI3, 200 MHz) d 1M-122> (5H, m, Ar), 6.81 
(IH, d, 7 = 8.0 Hz, H-6), 6.72 (IH, d, 7 - 1.8 Hz, H-3), 6.65 (IH, dd, 7 = 8.0, 
1.8 Hz, H-5), 5.96 (IH, m, H-8), 5.11 (2H, s, -CHj-Ar), 5.10^.99 (2H, m, H-9a,9b), 
3.86 (3H, s, OCH3), 3.31 (2H, d, 7 = 6.6 Hz, H-7); FAB MS mIz 255 [M+l]+. 
]-[2-(4-Allyl-2-methoxy-phenoxy)-ethyl]-pyrrolidine (Zfj 
Yield 88.5%, brown viscous oil, 'H NMR (CDCI3, 200 MHz) 5 6.83 (IH, d, 
7 = 8.6 Hz, H-6), 6.69 (2H, brd, 7 = 8.6 Hz, H-3,5), 5.93 (IH, m, H-8), 5.11 (2H, 
m, H-9a,9b), 4.12 (2H, t, 7 = 6.2 Hz, OCH2), 3.84 (3H, s, OCH3), 3.32 (2H, d, 
7 = 6.6 Hz, H-7), 2.93 (2H, t, 7 = 6.2 Hz, OCH2CH2N), 2.60 (4H, m, N(CH2)2-), 
1.78 (4H, m, 2x CH2); FAB MS mIz (+ve) 262 [M-|-l]+. Elemental anal. calc. for 
C16H23NO2: C, 73.53; H, 8.87; N, 5.36%; found C, 73.59; H, 8.39; N, 5.43. 
/-[2-(4-Allyl-2-methoxy-phenoxy)-ethyl]-piperidine (Zgj 
Yield 90.7%, brown viscous oil, ' H NMR (CDCI3, 200 MHz) S 6.82 (IH, d, 
7 = 8.6 Hz, H-6), 6.70 (2H, brd, 7 = 8.5 Hz, H-3,5), 5.96 (IH, m, H-8), 5.10 (2H, 
m, H-9a,9b), 4.11 (2H, t, 7 = 6.4 Hz, OCH2), 3.82 (3H, s, OCH3), 3.32 (2H, d, 
7 = 6.8 Hz, H-7), 2.79 (2H, t, 7 = 6.4 Hz, OCH2CH2N), 2.52 (4H, m, N(CH2)2-), 
1.62 (6H, m, 3x CH2); FAB MS m/z 276 [M-1-1J+. Elemental anal. calc. for 
C17H25NO2: C, 74.14; H, 9.15; N, 5.09%; found C, 74.17; H, 9.19; N, 5.14%. 
Synthesis of isoxazolines 3a-g and 5a-g 
General procedure 
A mixture of oxime (1.1 equiv), chloramines-T-3H20 (1.1 equiv) and olefin (1.0 
equiv) in ethanol (50 ml) were refluxed for 3 h. The progress of reaction was 
monitored by TLC. After completion of the reaction, the solvent was removed using 
msasmm 
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rotavapor. The residue was dissolved in ether, washed with 1 N NaOH solution (3 x 
15 ml), water (25 ml), and saturated solution of NaCl, dried over anhydrous sodium 
sulfate. The solvent was evaporated and the cycloadduct was purified by column 
chromatography over silica gel. 
4-[3-(2,4-Dimethoxy-phenyl)-4,5-dihydro-isoxazol-5-ylmethyl]-2-methoxy-phenol (3a) 
Yield 78.9%, brown sticky solid; IR (CHCI3) v^^ x: 3285, 2947, 1607, 1528, 1353, 
1159 cm-^ 'H N M R (CDCI3, 200 MHz) d 7.58 (IH, d, 7 = 8.4 Hz, H-6'), 6.85 
(IH, d, y = 8.0 Hz, H-6), 6.81 (IH, d, 7 = 1.8 Hz, H-3), 6.72 (IH, dd, J = 8.0, 
1.8 Hz, H-5), 6.57 (IH, d, / = 2.4 Hz, H-3'), 6.50 (IH, dd, J = 8.6, 2.2 Hz, H-5'), 
5.60 (IH, brs, OH), 4.86 (IH, m, H-8), 3.84 (9H, brs, 3x OCH3), 3.41 (IH, dd, 
J= 18.1, 10.2 Hz, H-9a), 3.13 (IH, dd, / - 18.1, 7.6 Hz, H-9b), 3.01 (IH, dd, 
J = 13.8, 9.7 Hz, H-7a), 2.94 (IH, dd, J = 13.8, 6.6 Hz, H-7b); FABMS (+ve): m/ 
z 344 [M+l]+. Elemental anal. calc. for C,9H2iN05: C, 66.46; H, 6.16; N, 4.08; 
found C, 66.50; H, 6.12; N, 4.13%. 
4-[3-(2,4-dimethoxy-phenyl)-4,5-dihydro-isoxazol-5-ylmethyl]-2-methoxy-phenyl 
acetate (3bj 
Yield 81.9%, white solid, mp 117-118T. IR (KBr) v^a :^ 2930, 1762, 1683, 1511, 
1101 cm-^; 'H NMR (CDCI3, 200 MHz) <5 7.61 (IH, d, 7 = 8.4 Hz, H-6'), 6.96 
(IH, d, 7 = 8.0 Hz, H-6), 6.91 (IH, d, 7 = 1.4 Hz, H-3), 6.81 (IH, dd, 7 = 8.0, 
1.8 Hz, H-5), 6.52 (IH, d, 7 = 2.2 Hz, H-3'), 6.47 (IH, dd, 7 = 8.2, 1.8 Hz, H-5'), 
4.87 (IH, m, H-8), 3.83 (9H, brs, 3x OCH3), 3.49 (IH, dd, 7 = 17.2, II.O Hz, H-
9a), 3.15 (IH, dd, 7 = 17.2, 7.6 Hz, H-9b), 3.08 (IH, dd, 7 = 13.8, 9.2 Hz, H-7a), 
2.83 (IH, dd, 7 = 14.2, 6.6 Hz, H-7b), 2.29 (3H, s, OCOCH3); FAB MS (-f ve): miz 
385 [M-|-l]+. Elemental anal. calc. for C21H23NO6: C, 65.44; H, 6.02; N, 3.63; 
found C, 65.48; H, 6.07; N, 3.58%. 
5-(3,4-Dimethoxy-benzyl)-3-(2,4-dimethoxy-phenyl)-4,5-dihydro-isoxazole (3c) 
Yield 82.0%, white needle-shaped crystals, mp 98-99°C. IR (KBr) v^ax: 2938,1597, 
1515,1351,1157 cm-^ ' H NMR (CDCI3,200 MHz) S 7.80 (IH, d, 7 = 8.2 Hz, H-
6'), 7.59 (IH, d, 7 = 8.4 Hz, H-6), 7.29 (2H, d, 7 = 8.8 Hz, H-3,5), 6.80 (IH, d, 
7 = 2.2 Hz,H-3'),6.49(lH,dd,7= 8.4,2.4Hz,H-5'),4.87(IH,m,H-8),3.87(12H, 
brs, 4x OCH3), 3.41 (IH, dd, 7 = 17.2, lO.O Hz, H-9a), 3.12 (IH, dd, 7 = 17.2, 
7.6 Hz,H-9b),3.04(IH,dd,7= 13.4,6.2 Hz,H-7a),2.80(IH,dd,7= 13.8,6.6 Hz, 
H-7b); FAB MS (+ve): m/z 357 [M+], 358 [M+l]+. Elemental anal: calc. for 
C20H23NO5: C, 67.21; H, 6.49; N, 3.92; found C, 67.25; H, 6.54; N, 3.98%. 
3-(2,4-Dimethoxy-phenyl)-5-(4-ethoxy-3-methoxy-benzyl)-4,5-dihydro-isoxazole 
(3d) 
Yield 75.6%, white solid, mp 92-93°C. IR (KBr) v„,,: 3021, 2361, 1769, 1628 
1216 cm '; ' H NMR (CDCI3, 200 MHz) d 7.76 (IH, d, 7 = 8.2 Hz, H-6'), 7.58 
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(IH, d, / = 8.4 Hz, H-6), 7.34 (IH, s, H-3), 6.79 (2H, dd, / = 8.2, 1.5 Hz, H-3',5), 
6.47 (IH, dd, J = 8.4, 2.4 Hz, H-5'), 4.86 (IH, m, H-8), 4.06 (2H, q, J = 7.0 Hz, 
OCH2CH3), 3.82 (9H, brs, 3x OCH3), 3.33 (IH, dd, 7 = 18.1, 10.0 Hz, H-9a), 3.12 
(IH, dd, J = 18.1, 7.4 Hz, H-9b), 3.01 (IH, dd, J = 13.1, 6.6 Hz, H-7a), 2.98 (IH, 
dd, 7 = 13.1, 6.6 Hz, H-7b), 1.43 (3H, t, 7 = 7.0 Hz, OCH2CH3); FAB MS (+ve): 
m/z 372 [M+]. Elemental anal: calc. for C21H25NO5: C, 67.91; H, 6.78; N, 3.77; 
found C, 67.84; H, 6.71; N, 3.72%. 
5-(4-Benzyloxy-3-methoxy-benzyl)-3-(2,4-dimethoxy-phenyl)-4,5-
dihydro-isoxazole (3ej 
Yield 81.0%, white crystals, mp 83-84°C. IR (KBr) v^.^^\ 3021, 1616, 1216 cm"'; 
'H NMR (CDCIB, 200 MHz) b 7.60(1H, d, 7 = 8.4 Hz, H-6'), 7.45-7.23 (5H, m, H-
2" to 6"), 6.84 (IH, d, 7 = 1.8 Hz, H-3), 6.81 (IH, d, 7 = 8.2 Hz, H-6), 6.70 (IH, d, 
7 = 8.2, 1.8 Hz, H-5), 6.51 (IH, d, 7 = 2.4 Hz, H-3'), 6.46 (IH, dd, 7 = 7.0, 
2.4 Hz, H-5'), 5.13 (2H, s, CH2Ar), 4.87 (IH, m, H-8), 3.88 (9H, brs, 3x OCH3), 
3.40 (IH, dd, 7 = 17.2,10.0 Hz, H-9a), 3.13 (IH, dd, 7 = 17.2, 7.6 Hz, H-9b), 3.03 
(IH, dd, 7 = 13.8, 6.8 Hz, H-7a), 2.81 IH, dd, 7 = 13.8, 6.6 Hz, H-7b); FAB MS 
(+ve): miz 434 [M+1]^. Elemental anal. calc. for C26H27NO5: C, 72.04; H, 6.28; N, 
3.23; found C, 72.12; H, 6.31; N, 3.16%. 
3-(2,4-Dimethoxy-phenyl)-5-[3-methoxy-4-(2-pyrrolidin-l-yl-ethoxy)'benzyl]-4,5-
dihydro-isoxazole (3fj 
Yield 73.9%, brown viscous oil. IR (neat) v^.^^: 3020, 1613, 1513, 1216 cm"'; 'H 
NMR (CDCI3, 200 MHz) d 7.39(1H, d, 7 = 8.4 Hz, H-6'), 6.62 (IH, d, 7 = 7.4 Hz, 
H-6), 6.56 (2H, m, H-3,5), 6.30 (IH, d, 7 = 2.2 Hz, H-3'), 6.27 (IH, dd, 7 = 8.3, 
1.7 Hz, H-5'), 4.72 (IH, m, H-8), 3.95 (2H, t, 7 = 6.2 Hz, OCH2), 3.85 (3H, brs, 
OCH3), 3.84 (3H, brs, OCH3), 3.82 (3H, brs, OCH3), 3.39 (IH, dd, 7 = 17.1, 
10.4 Hz, H-9a), 3.14 (IH, dd, 7 = 17.1, 10.0 Hz, H-9b), 3.09 (IH, dd, 7 = 14.1, 
6.8 Hz, H-7a), 2.87 (IH, dd, 7 = 14.1, 6.2 Hz, H-7b), 2.85 (2H, t, 7 = 6.2 Hz, 
-CH2-N), 2.60 (4H, m, -N(CH2)2-), 1.79 (4H, m, -CH2CH2-); FAB MS (-f-ve): mIz 
441 [M-t-l]"^. Elemental anal. calc. for C25H32N2O5: C, 68.16; H, 7.32; N, 6.36; 
found C, 68.07; H, 7.40; N, 6.40%. 
l-(2-(4-[3-(2,4-Dimethoxy-phenyl)-4,5-dihydro-isoxazol-5-ylmethyl]-2-methoxy-
phenoxy}-ethyl)-piperidine (Sgj 
Yield 80.9%, brown viscous oil. IR (neat) v a^x: 3019, 1609, 1350, 1216 cm"'; 'H 
NMR (CDCb, 200 MHz) 5 7.60(1H, d, 7 = 8.4 Hz, H-6'), 6.83 (IH, d, 7 = 7.6 Hz, 
H-6), 6.81 (2H, m, H-3,5), 6.49 (IH, dd, 7 = 8.0, 1.8 Hz, H-5'), 4.86 (IH, m, H-8), 
6.52 (IH, d, 7 = 1.8 Hz, H-3'), 4.13 (2H, t, 7 = 6.2 Hz, OCH2), 3.85 (3H, brs, 
OCH3), 3.84 (3H, brs, OCH3), 3.82 (3H, brs, OCH3), 3.39 (IH, dd, 7 = 17.2, 
10.0 Hz, H-9a), 3.14 (IH, dd, 7 = 17.2, 10.0 Hz, H-9b), 3.09 (IH, dd, 7 = 14.2, 
6.2 Hz, H-7a), 2.87 (IH, dd, 7 = 14.2, 6.8 Hz, H-7b), 2.84 (2H, t, 7 = 6.0 Hz, 
-CH2-N), 2.58 (4H, m, -N(CH2)2-), 1.66 (6H, m, -CH2CH2CH2-); FAB MS 
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(+ve): m/z 455 [M+1]^. Elemental anal. calc. for C26H34N2O5: C, 68.70; H, 7.54; 
N, 6.16; found C, 68.73; H, 7.48; N, 6.10%. 
2-Methoxy-4-(3-naphthalen-l-yl-4,5-dihydro-isoxazol-5-ylmethyl)-phenol fSaj 
Yield 88.0%, sticky solid. 'H NMR (CDCI3, 200 MHz) d 8.80 (IH, d, 7 = 7.3 Hz, 
H-8'), 7.80 (2H, m, H-2',4'), 7.58 (4H, m, H-3',5',6',r), 6.80 (3H, m, H-3,5,6), 5.00 
(IH, m, H-8), 3.89 (3H, brs, OCH3), 3.56 (IH, dd, J = 16.1, 10.3 Hz, H-9a), 3.27 
(IH, dd, J = 16.1, 7.7 Hz, H-9b), 3.08 (IH, dd, J = 14.5, 7.8 Hz, H-7a), 2.97 (IH, 
dd, J = 14.5, 6.4 Hz, H-7b); FAB MS (+ve): m/z 333 [M]+, 334 [M+l]+. 
Elemental anal. calc. for CsiHigNOs: C, 75.66; H, 5.74; N, 4.20; found C, 75.58; H, 
5.70; N, 4.13%. 
2-Methoxy-4-{3-naphthalen-l-yl-4,5-dihydro-isoxazol-5-ylmethyl)-phenyl 
acetate (5bj 
Yield 85.0%, brown sticky solid. IR(KBr)Vn,ax:3021,2361,1601,1514,1216 cm"'; 
'H NMR (CDCI3,200 MHz) <5 8.88 (IH, d, 7 = 7.6 Hz, H-8'), 7.78 (2H, m, H-2',4'), 
7.58(4H,m,H-3',5',6',7'),6.98(lH,d,y = 8.1 Hz,H-6),6.95(lH,d,y = 1.2 Hz,H-
3), 6.81 (IH, dd, / = 8.1,1.2 Hz, H-5), 5.02 (IH, m, H-8), 3.87 (3K, brs, OCH3), 3.54 
(IH, dd, J = 16.6,10.2 Hz, H-9a), 3.26 (IH, dd, J = 16.6,7.8 Hz, H-9b), 3.17 (IH, 
dd, J = 13.2, 6.2 Hz, H-7a), 2.95 (IH, dd, J = 13.2, 5.2 Hz, H-7b), 2.45 (3H, s, 
COCH3); FAB MS (-l-ve): miz 376 [M+l]+. Elemental anal. calc. for C23H21NO4: C, 
73.58; H, 5.64; N, 3.73; found C, 73.66; H, 6.01; N, 3.65%. 
5-(3,4-Dimethoxy-benzyl)-3-(naphthalen-l-yl)-4,5-dihydroisoxazole (Sc) 
Yield 87.1%, white needle-shaped crystals, mp 103-104°C. IR (KBr) v^ ^^ :^ 2938, 
1592, 1235, 1030 cm"'; 'H NMR (CDCI3, 200 MHz) d 8.84 (IH, dd, J = 7.4, 
2.0 Hz, H-8'), 7.88 (2H, m, H-2',4'), 7.56 (4H, m, H-3',5',6',7'), 6.84 (3H, m, H-
3,5,6), 5.01 (IH, m, H-8), 3.88 (3H, brs, OCH3), 3.85 (3H, brs, OCH3), 3.53 (IH, dd, 
J= 16.6, 10.2 Hz, H-9a), 3.24 (IH, dd, J= 16.6, 7.6 Hz, H-9b), 3.12 (IH, dd, 
J = 14.2, 8.0 Hz, H-7a), 2.94 (IH, dd, J = 14.2,6.4 Hz, H-7b); FAB MS (+ve): m/ 
z 348 [M+l]+. Elemental anal. calc. for C22H21NO3: C, 76.06; H, 6.09; N, 4.03; 
found C, 76.00; H, 6.01; N, 4.11%. 
5-(4-Ethoxy-3-methoxy-benzyl)-3-naphthalen-l-yl-4,5-dihydro-isoxazole f5d) 
Yield 77.4%, brown sticky solid. IR (KBr) v„,ax: 3377, 1596, 1514, 1261 cm"'; 'H 
NMR (CDCI3, 200 MHz) S 8.86 (IH, dd, J = 7.6, 1.8 Hz, H-8'), 7.87 (2H, m, H-
2',4'), 7.61 (4H, m, H-3',5',6',7'), 6.85 (3H, m, H-3,5,6), 4.99 (IH, m, H-8), 4.06 
(2H, q, y = 7.0 Hz, OCH2CH3)), 3.87 (3H, brs, OCH3), 3.52 (IH, dd, J = 16.6, 
10.2 Hz, H-9a), 3.23 (IH, dd, J= 16.6, 7.8 Hz, H-9b), 3.14 (IH, dd, J= 15.8, 
7.8 Hz, H-7a), 2.93 (IH, dd, J = 15.8, 6.6 Hz, H-7b); ESI MS m/z 361 [M+l]+. 
Elemental anal. calc. for C23H23NO3: C, 76.43; H, 6.41; N, 3.88; found C, 76.35; H, 
6.49; N, 3.79%. 
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5-(4-Benzyloxy-3-methoxy-benzyl)-3-naphthalen-1 -yl-4,5-dihydro-isoxazole fSeJ 
Yield 72.8%, white crystals, mp 104-105°C. IR (KBr) v^ ^^ x: 2930, 1593, 1236, 
1147 cm-^ 'H N M R (CDCI3, 200 MHz) d 8.86 (IH, dd, / = 7.6, 1.8 Hz, H-8'), 
7.88 (2H, m, H-2',4'), 7.58-7.30 (9H, m, H-3',5',6',r, 2"-6"), 6.88 (IH, d, 
J = 1.8 Hz, H-3), 6.82 (IH, dj = 8.0 Hz, H-6), 6.74 (IH, dd, / = 8.0, 1.8 Hz, H-
5), 5.11 (2H, s, -CHsAr), 5.01 (IH, m, H-8), 3.89 (3H, brs, OCH3), 3.55 (IH, dd, 
J = 14.8, 10.2 Hz, H-9a), 3.22 (IH, dd, J = 14.8, 7.6 Hz, H-9b), 3.12 (IH, dd, 
J = 14.0, 5.8 Hz, H-7a), 2.92 (IH, dd, J = 14.0, 6.2 Hz, H-7b); ESI MS m/z 423 
[M]+, 424 [M+l]+. Elemental anal. calc. for C28H25NO3: C, 79.41; H, 5.95; N, 
3.31; found C, 79.51; H, 6.00; N, 6.30%. 
5-[3-Methoxy-4-(2-pyrrolidin-l-yl-ethoxy)-benzyl]-3-naphthalen-l-yl-4,5-dihydro-
isoxazole (5fj 
Yield 78.6%, brown solid. 'H NMR (CDCI3, 200 MHz) b 8.87 (IH, dd, 7 = 9.1, 
1.7 Hz, H-8'), 7.91 (2H, m, H-2',4'), 7.59-7.40 (4H, m, H-3',5',6',7'), 6.98 (IH, d, 
y = 1.8 Hz, H-3), 6.80 (IH, dd, J = 8.0, 1.8 Hz, H-5), 6.70 (IH, d, 7 = 8.0 Hz, H-
6), 5.04 (IH, m, H-8), 4.16 (2H, t, 7 = 5.8 Hz, -OCH2), 3.88 (3H, brs, OCH3), 3.65 
(IH, dd, 7 = 15.1, 9.5 Hz, H-9a), 3.32 (IH, dd, 7 = 15.1, 6.5 Hz, H-9b), 3.02 (IH, 
dd, 7 = 14.0, 6.5 Hz, H-7a), 2.81 (IH, dd, 7 = 14.0, 6.2 Hz, H-7b), 2.82 (2H,t, 
7 = 6.0 Hz -NCH2), 2.64 (4H, m, H-N(CH2)2-), 1.72 (4H, m, -CH2CH2-); 
FABMS m/z 431 [M-M]+. Elemental anal. calc. for C27H30N2O3: C, 75.32; H, 7.02; 
N, 6.51; found C, 75.41; H, 7.11; N, 6.42%. 
l-{2-[2-Methoxy'4-{3-naphthalen-l-yl-4,5-dihydro-isoxazol-5-ylmethyl)-phenoxy]-
ethylj-piperidine (Sgj 
Yield 88.6%, brown sticky solid. 'HNMR(CDCl3,200 MHz)^8.85(lH,dd,7 = 9.2, 
1.8 Hz, H-8'), 7.94 (2H, m, H-2',4'), 7.60-7.43 (4H, m, H-3',5',6',7'), 6.96 (IH, d, 
7 = 2.1 Hz, H-3), 6.82 (IH, dd,7 = 8.2,2.1 Hz, H-5), 6.69 (IH, d, 7 = 8.2 Hz, H-6), 
5.03 (IH, m,H-8),4.18 (2H, t,7 = 5.8 Hz,-OCH2),3.85 (3H,brs,OCH3), 3.61 (IH, 
dd,7= 15.6,9.8 Hz,H-9a),3.30(lH,dd,7 = 15.6,6.8 Hz,H-9b),3.25-3.06(2H,m, 
H-7ab), 3.00 (2H,brs, -NCH2), 2.70 (4H, m, H-N(CH2)2-), 1.71-1.65 (6H, m, H-
CH2CH2CH2-); FAB MS miz 444 [M]+, 445 [M-M]- .^ Elemental anal. calc. for 
C28H32N2O3: C, 75.65; H, 7.26; N, 6.30; found C, 75.57; H, 7.1; N, 6.37%. 
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Abstract We aimed to evaluate the response of dopa-
minergic system in acute stress (AS) and chronic unpre-
dictable stress (CUS) by measuring dopamine (DA) levels, 
its receptor densities in the frontal cortex, striatum, hip-
pocampus, amygdala and orbito-frontal cortex regions of 
rat brain, and investigated the corresponding behavioral 
locomotor changes. Involvement of D] receptor was also 
examined during AS and CUS using A 68930, a Dj 
selective agonist. Rats were exposed to AS (single immo-
bilization for 150 min) and CUS (two different stressors for 
7 days). AS significantly decreased the DA levels in the 
striatum and hippocampus, and A 68930 pretreatment 
significantly reverted these changes. However, in the 
frontal cortex significantly increased DA levels were 
remain unchanged following A 68930. CUS led to a 
decrease of DA levels in the frontal cortex, striatum and 
hippocampus, which were normalized by A 68930. Satu-
ration radioligand binding assays revealed a significant 
decrease in the number of Dj-like receptors in the frontal 
cortex during CUS, which were further decreased by A 
68930 pretreatment. However, in the striatum and 
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hippocampus, A 68930 pretreatment reduced the CUS 
induced increase in the number of Dplike receptors. No 
significant changes were observed in the amygdala and 
orbito-frontal cortex during AS and CUS, while D2-like 
receptors were unchanged in all the brain regions studied. 
Locomotor activity was significantly decreased in both the 
stress models, A 68930 pretreatment significantly increased 
stereotypic counts and horizontal activity. Thus, present 
investigation provide insights into the differential regional 
response of dopaminergic system during AS and CUS. 
Further, neurochemical and behavioral effects of D) ago-
nist pretreatment suggest specific modulatory role of Di 
receptor under such stressful episodes. 
Keywords Acute stress • Chronic unpredictable stress • 
Dopamine • Dopamine receptors • Locomotor activity 
Introduction 
The dopaminergic system is involved in many behavioral 
and biological functions of the central nervous system 
(CNS) including locomotor activity, emotional responses 
and neuroendocrine secretion [1], and has been the focus of 
research for many years. DA neurotransmission are directly 
or indirectly involved in several brain dysfunctions [2], The 
pathophysiology of various neurodegenerative and behav-
ioral disorders are also attributed to DA neurotransmission 
[3]. Stress has been shown to alter normal dopaminergic 
neurotransmission [4] and exposure to stress profoundly 
increases the dopaminergic activity [5], and induces rele-
vant adaptive responses of DA receptors in various brain 
regions [6]. Several studies suggested alterations in brain 
DA functioning during chronic or repeated stressful con-
ditions [7, 8]. 
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Abstract 
Bacopa monniera (BM) is vv-ell known for its neuropharmacological effects. Our previous studies indicated the adaptogenic effect of standardized 
extract of BM in various stress models. In the present study, effect of BM was evaluated on acute stress (AS) and chronic unpredictable stress (CUS) 
induced changes in plasma corticosterone and monoamines-noradrenaline (NA), dopamine (DA) and serotonin (5-HT) in cortex and hippocampus 
regions of brain in rats. Panax root powder [Panax quinquefolium) was taken as standard. Subjecting animals to AS (immobilization for 150 min once 
only) and CUS (different stressors for 7 days) resulted in significant elevation in plasma corticosterone levels, which was significantly countered by 
treatment with BM at a dose of 40 and 80 mg/kg p.o. similar to the effects oi Panax quinquefolium (PQ) at 100 mg/kg p.o. AS exposure significantly 
increased the levels of 5-HT and decreased NA content in both the brain regions while DA content was significantly increased in cortex and 
decreased in hippocampus regions. In CUS regimen, levels of NA, DA and 5-HT were significantly depleted in cortex and hippocampus regions of 
brain. Treatment with BM (40 and 80 mg/kg) attenuated the stress induced changes in levels of 5-HT and DA in cortex and hippocampus regions 
but was ineffective in normalizing the NA levels in AS model, whereas PQ treatment significantly reverted back the effects of stress. In CUS model, 
pretreatment with BM and PQ significantly elevated the levels of NA, DA and 5-HT levels in cortex and levels of NA and 5-HT in hippocampus 
regions. Hence, our study indicates that the adaptogenic activity of BM might be due to the normalization of stress induced alteration in plasma 
corticosterone and levels of monoamines like NA, 5-HT and DA in cortex and hippocampus regions of the brain, which are more vulnerable to 
stressful conditions analogous to the effects of PQ. 
© 2007 Elsevier Ireland Ltd. All rights reserved. 
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1. Introduction is well established during stressful conditions (Tsigos and 
Chrousos, 2002; Gonzalo et ai., 2003). Changes in monoamin-
Severe stressful conditions are responsible for the etiopatho- ergic activity results in behavioral changes as well as a cascade 
genesis of various psychosomatic disorders. Homeostasis is of hormonal release from the hypothalamus-pituitary-adrenal 
controlled by various physiological mediators working in (HPA) axis. Dysfunction ofthese monoamines due to prolonged 
concert by interacting with receptors placed at various physi- stressful conditions has been associated with a wide range of 
ological levels and the functional identity of neurotransmitters central and peripheral disorders like depression, anxiety, drug 
is challenged during stressful conditions. Out of various abuse, obsessive compulsive disorder, eating and sleeping dis-
neurotransmitters noradrenaline (NA), dopamine (DA) and 5- orders, hyperglycemia, and decreased immune response (Neveu 
hydroxy tryptamine (5-HT) are the important monoamines et al., 1994; Pijl and Edo, 2002; Kalia, 2005; Jayanthi and 
which are widely distributed in brain and their functional role Ramamoorthy, 2005; Filip et al., 2005). Due to increased phys-
ical and psychological demands in the present day life style and 
advent of various stress related disorders, there is an urgent need 
, to develop agents to overcome these abnormalities. 
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Abstract 
Panca quinquefolium (PQ) is well acclaimed in literature for its effects on central and peripheral nervous system. The present study explores the 
effects of PQ on stress induced changes of corticosterone level in plasma, monoamines (NA, DA and 5-HT) and interleukin (IL-2 and IL-6) levels 
in cortex and hippocampus regions of brain and also indicate their possible roles in modulating stress. Mice subjected to chronic unpredictable 
stress (CUS, for 7 days) showed significant increase in plasma corticosterone level and depletion of noradrenaline (NA), dopamine (DA) ami 
5-hydroxytryptamine (5-HT) levels in cortex and hippocampal regions along with an increased level of IL-2 and IL-6 in the same areas. A.queous 
suspension of PQ was administered daily at a dose of 100 and 200 mg/kg p.o. prior to the stress regimen and its effects on selected stress markers 
in plasma and brain was evaluated. PQ at a dose of 200 mg/kg p.o. was found to be effective in normalizing the CUS induced elevation of plasma 
corticosterone and IL-2, IL-6 levels in brain. Moreover, it was signiHcantly effective in reinstating the CUS induced depletion of NA, DA and S-HT 
in hippocampus, while NA and 5-HT in cortex of brain. However, PQ at a dose of 100 mg/kg p.o. was found ineffective in regulating any of these 
CUS induced changes. Present study provides an insight into the possible role of PQ on hyperactive HPA axis in the regulation of immediate stress 
effectors like corticosterone, cytokines and brain monoamines. In this study, PQ has emerged as a potential therapeutic in the cure of stiess related 
disorders and needs to be evaluated in clinical studies to ascertain its efficacy. 
© 2008 Elsevier Ireland Ltd. All rights reserved. 
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1. Introduction 
It has been proposed that nearly two thirds of the clinical ail-
ments that come to physicians for medication are either induced, 
or exacerbated b>' stress (Sabban and Kvetnansky, 2001). The 
hypothalamic-pituitary-adrenal (HPA) axis is activated to pre-
pare the body for "adaptation" during stressful conditions. 
Chronic stressful conditions lead to consistent hyperactivity 
of HPA axis and are known to influence several physiologi-
cal responses that adversely affect the normal psychosomatic 
homeostasis (Chiousos, 1998). HPA axis activation releases glu-
cocorticoids (corticosterone in rodents and Cortisol in humans) 
whose actions are mediated through glucocorticoid receptors 
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that are abundantly expressed in brain regions involved in the 
stress response such as the cortex, hypothalamus, hippocampus, 
amygdala, various brain stem nuclei and pituitary (Morimoto 
et al., 1996). Central neurotransmitters are important mediators 
implicated in physiological and behavioral responses to stress 
(Pacak et al., 1995). Among these central neurotransmitters, 
noradrenaline (NA), dopamine (DA) and 5-hydroxytryptamine 
(5-HT) are studied extensively and their role is well estab-
lished in various stress-mediated disorders (Nowakowska et 
al., 2001). Cytokines are produced in several brain regions 
and cell types, e.g. glia, neurons, and macrophages, which 
also show preponderance of cytokine receptors (Kennedy et 
al., 2001a,b; Szelenyi, 2001). Besides their well characterized 
role in mediating the central components of the host innate 
immune response, various findings point to a direct or indi-
rect role for cytokines in stress-related disorders, including 
depression (Dantzer et al., 1999). The interactions between neu-
rotransmitters and immune cells have been reported (Vizi, 1998). 
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1. Introduction 
Japanese encephalitis (JE) is associated with a variety of movement disorders including 
transient form of pakinsonian features, dystonia and miscellaneous movement disorders. The 
neurotransmitters have important role in movement disorders. However their role in different 
brain regions in relation to behavioral activities in animal model of JE is not understood. The 
presentstudy was aimed to investigate the behavioral parameters, the levels of catecholamine 
in brain regions—thalamus, midbrain, corpus striatum and frontal cortex on 0,10 and 20 days 
post inoculation (dpi) with histopathological observations. Twelve day old Wistar stiain rats 
were inoculated intracerebrally with a dose of 3 x 10* pfu of JE virus. Spontaneous locomotor 
activity (SLA) and grip strength were monitored. The levels of catecholamine were estimated 
using HPLC-ECD and histopathological changes were observed using haematoxylin and eosine 
staining. A significant decrease in SLA and grip strength was observed in JEV infected rats as 
compared to controls on 10 and 20 dpi. The levels of norepinephrine, dopamine, 3,4-
dihydroxyphenylacetic acid, homovanillic acid, and serotonin were significanfly decreased in 
all the brain regions studied with respect to contiols. We did not find significant recovery in 
catecholamine levels and locomotor activities up to 20 dpi and any significant correlation 
between behavioral changes and neurotransmitter levels. However histopathological studies 
revealed mild reduction in degree of damage on 20 dpi. The present study demonstrates the 
involvement of different brain regions in altered locomotor activity which may be associated 
with reduction in catecholamine levels in rat model of JE. 
© 2009 Elsevier B.V. All rights reserved. 
Extrapyramidal syndromes are recognized as a sequelae of a 
number of acute \riral encephalitides including western equine 
encephalitis, central European tick-born encephalitis, polio 
virus, Coxsackie B virus, measles, vericella zoster, encephalitis 
lethargic and Japanese encephalitis (JE) (Duvoisin and Yahr, 
1965; Howard and Lees, 1987). JE is one of the most important 
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